10-K

0000934549-16-000100.txt : 20160315 0000934549-16-000100.hdr.sgml : 20160315 20160315154845 ACCESSION NUMBER: 0000934549-16-000100 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 82 CONFORMED PERIOD OF REPORT: 20151231 FILED AS OF DATE: 20160315 DATE AS OF CHANGE: 20160315 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACACIA RESEARCH CORP CENTRAL INDEX KEY: 0000934549 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 954405754 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-26068 FILM NUMBER: 161506814 BUSINESS ADDRESS: STREET 1: 520 NEWPORT CENTER DRIVE STREET 2: 12TH FLOOR CITY: NEWPORT BEACH STATE: CA ZIP: 92660 BUSINESS PHONE: 9494808300 MAIL ADDRESS: STREET 1: 520 NEWPORT CENTER DRIVE STREET 2: 12TH FLOOR CITY: NEWPORT BEACH STATE: CA ZIP: 92660 10-K 1 actg2015123110-k.htm 10-K 10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

____________________

FORM 10-K

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE FISCAL YEAR ENDED DECEMBER 31, 2015

o TRANSACTION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM TO .

Commission File Number 0-26068

____________________

(Exact name of registrant as specified in its charter)



DELAWARE	95-4405754
(State or other jurisdiction of	(I.R.S. Employer
incorporation organization)	Identification No.)

520 NEWPORT CENTER DRIVE,
NEWPORT BEACH, CA	92660
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (949) 480-8300

Securities registered pursuant to Section 12(b) of the Act:



Title of Each Class	Name of Each Exchange on Which Registered
Common Stock, $0.001 par value	The NASDAQ Stock Market, LLC

Securities registered pursuant to Section 12(g) of the Act: None

____________________

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities

Act. Yes £ No R

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes £ No R

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to filing requirements for the past 90 days. Yes R No £

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes R No £

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. R

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.



Large accelerated filer £		Accelerated filer R
Non-accelerated filer £ (Do not check if a smaller reporting company)		Smaller reporting company £

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes £ No R

The aggregate market value of the registrant’s voting and non-voting common stock held by non-affiliates of the registrant on June 30, 2015, the last business day of the registrant’s most recently completed second fiscal quarter, computed by reference to the last sale price of the registrant’s common stock as reported by The Nasdaq Global Select Market on such date, was approximately $437,867,000. This computation assumes that all executive officers and directors are affiliates of the registrant. Such assumption should not be deemed conclusive for any other purpose.

As of March 11, 2016, 50,458,905 shares of common stock were issued and outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

In accordance with General Instruction G(3) to Form 10-K, portions of the registrant’s Definitive Proxy Statement on Schedule 14A for its Annual Meeting of Stockholders to be filed with the Commission within 120 days after the close of the fiscal year covered by this Annual Report on Form 10-K are incorporated by reference into Part III of this Annual Report on Form 10-K. Only those portions of the proxy statement that are specifically incorporated by reference herein shall constitute a part of this Annual Report on Form 10-K.

ACACIA RESEARCH CORPORATION

ANNUAL REPORT ON FORM 10-K

FISCAL YEAR ENDED DECEMBER 31, 2015

TABLE OF CONTENTS



		Page
PART I

Item 1.	Business	3
Item 1A.	Risk Factors	10
Item 1B.	Unresolved Staff Comments	19
Item 2.	Properties	19
Item 3.	Legal Proceedings	19
Item 4.	Mine Safety Disclosures	20


PART II

Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	21
Item 6.	Selected Financial Data	23
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	25
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	43
Item 8.	Financial Statements and Supplementary Data	44
Item 9.	Changes in and Disagreements With Accountants on Accounting and Financial Disclosure	44
Item 9A.	Controls and Procedures	44
Item 9B.	Other Information	44


PART III

Item 10.	Directors, Executive Officers and Corporate Governance	45
Item 11.	Executive Compensation	45
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	45
Item 13.	Certain Relationships and Related Transactions, and Director Independence	46
Item 14.	Principal Accounting Fees and Services	46


PART IV

Item 15.	Exhibits, Financial Statement Schedules	47

PART I

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

As used in this Annual Report on Form 10-K, “we,” “us” and “our” refer to Acacia Research Corporation and/or its wholly and majority-owned operating subsidiaries. All patent portfolio investments, development, licensing and enforcement activities are conducted solely by certain of our wholly owned operating subsidiaries.

This Annual Report on Form 10-K, or the annual report, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, which include, without limitation, statements about our future business operations and results, our strategies and competition, and other forward-looking statements included in this annual report. Such statements may be identified by the use of forward-looking terminology such as “may,” “will,” “expect,” “believe,” “estimate,” “anticipate,” “intend,” “continue,” or similar terms, variations of such terms or the negative of such terms. Such statements are based on management’s current expectations and are subject to a number of risks and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. Such statements address future events and conditions concerning earnings, capital expenditures, litigation, competition, regulatory matters, stock price volatility, liquidity and capital resources and accounting matters. Actual results in each case could differ materially from those anticipated in such statements by reason of factors such as future economic conditions, legislative, regulatory and competitive developments in markets in which we and our subsidiaries operate, and other circumstances affecting anticipated revenues and costs, as more fully disclosed in our discussion of “Risk Factors” in Item 1A of Part I of this annual report. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. Additional factors that could cause such results to differ materially from those described in the forward-looking statements are set forth in connection with the forward-looking statements.

ITEM 1. BUSINESS

General

Our operating subsidiaries partner with inventors and patent owners, applying our legal and technology expertise to patent assets to unlock the financial value in their patented inventions. We are an intermediary in the patent marketplace, bridging the gap between invention and application, facilitating efficiency and delivering monetary rewards to patent owners.

Our operating subsidiaries generate revenues and related cash flows from the granting of intellectual property rights for the use of patented technologies that our operating subsidiaries control or own. Our operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation. Currently, on a consolidated basis, our operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain foreign counterparts, covering technologies used in a wide variety of industries.

We are a leader in licensing and enforcing patented technologies and have established a proven track record of licensing success with over 1,490 license agreements executed to date, across 185 patent portfolio licensing and enforcement programs. To date, we have generated gross licensing revenue of approximately $1.2 billion, and have returned more than $703 million to our patent partners.

Other

We were originally incorporated in California in January 1993 and reincorporated in Delaware in December 1999. Our website address is www.acaciaresearch.com. Reference in this annual report to this website address does not constitute incorporation by reference of the information contained on the website. We make our filings with the Securities and Exchange Commission, or the SEC, including our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, other reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, and amendments to the foregoing reports, available free of charge on or through our website as soon as reasonably practicable after we file these reports with, or furnish such reports to, the SEC. In addition, we post the following information on our website:


•	our corporate code of conduct, our code of conduct for our board of directors and our fraud policy;


•	charters for our audit committee, nominating and corporate governance committee, disclosure committee and compensation committee; and


•	applicable dividend related tax forms.

The public may read and copy any materials that we file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, D.C. 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.

Also, the SEC maintains an Internet website that contains reports, proxy and information statements, and other information regarding issuers, including us, that file electronically with the SEC. The public can obtain any documents that we file with the SEC at http://www.sec.gov.

Patent Licensing and Enforcement Business

Our operating subsidiaries invest in, license and enforce patented technologies. Our operating subsidiaries partner with inventors and patent owners, applying our legal and technology expertise to patent assets to unlock the financial value in their patented inventions. We are an intermediary in the patent marketplace, bridging the gap between invention and application, facilitating efficiency and delivering monetary rewards to patent owners.

Refer to the section entitled “Patented Technologies” below for a partial summary of patent portfolios owned or controlled by certain of our operating subsidiaries.

Patents are an important asset class worldwide. Due to legislative and regulatory changes, licensing and enforcing patents has become increasingly difficult for patent holders, necessitating an experienced, well-capitalized, licensing partner. We focus solely on the patent marketplace, and have emerged as a leading outsource patent licensing and enforcement company for patent owners that have made the important choice to outsource their patent licensing and enforcement activities.

We are a leader in patent licensing and enforcement and our operating subsidiaries have established a proven track record of licensing success with more than 1,490 license agreements executed to date. On a consolidated basis, to date, we have generated revenues from 185 patent portfolio licensing and enforcement programs. Our professional staff includes in-house patent attorneys, licensing executives, engineers and business development executives.

We partner with the disenfranchised patent owner, including individual inventors, universities, and large multi-national corporations in the technology, medical technology, energy, and industrial sectors. A disenfranchised patent owner owns patents that are being infringed by third-parties in connection with the design, manufacture, use, or distribution of products and/or services, but is not receiving fair compensation for the unauthorized use of his or her patented inventions by those third-parties. We strive to reward inventors and patent owners for their creative technological contributions. We also partner with patent owners, including individual inventors, universities, and domestic and multi-national corporations who may have limited internal resources and/or expertise to effectively address the unauthorized use of their patented technologies, and those that are seeking to effectively and efficiently monetize their portfolio of patented technologies on an outsourced basis. In a typical arrangement, our operating subsidiary will partner with a patent portfolio owner, acquiring rights in the patent portfolio or acquiring the patent portfolio outright, and in exchange, the original patent portfolio owner receives (i) a percentage of our operating subsidiary’s net recoveries from the licensing and enforcement of the patent portfolio, which we refer to as our Partnering Model, or (ii) an upfront payment for the purchase of the patent portfolio rights or the patent portfolio, which we refer to as our Purchasing Model, or (iii) a combination of the two, which we refer to as our Hybrid Partnering Model.

Under U.S. law, a patent owner has the right to exclude others from making, selling or using their patented invention. A third-party infringes a patent by making, offering for sale, selling, or using a patented invention without a license from the patent owner. Unfortunately, in the majority of cases, infringers are generally unwilling, at least initially, to negotiate or pay reasonable license fees for their unauthorized use of third-party patents and will typically fight any allegations of patent infringement. Inventors and/or patent holders without sufficient legal, financial and/or expert technical resources to bring and continue the pursuit of costly and complex patent infringement actions are often blatantly ignored.

As a result of the common reluctance of patent infringers to negotiate and ultimately take a patent license for the use of patented technologies without at least the threat of legal action, patent licensing and enforcement often begins with the filing of patent enforcement litigation. However, most patent infringement litigation settles out of court at amounts that are related to the strength of the patent and the value of the invention in the infringer’s products or services. We execute agreements that grant rights in our patents to users of our patented technologies. Our agreements can be negotiated without the filing of patent litigation, or negotiated in the shadow of ongoing patent litigation, depending on the specific facts and circumstances.

Patents are a complex and highly technical subject area. Our professionals actively seek to identify high-quality but undervalued patent portfolios in a variety of industries. We combine our legal expertise, technology expertise, and our extensive knowledge of, and experience in, the patent licensing ecosystem, to continually uncover important patent assets and bring needed proficiency to patent licensing and enforcement.

Our partnership with patent owners is the cornerstone of our operating subsidiaries’ corporate strategy. We assume all responsibility for advancing operational expenses while pursuing a patent licensing and enforcement program, and then share net licensing revenue with our patent partners as that program matures, on a pre-arranged and negotiated basis. We may also provide upfront capital to the patent owner as an advance against future licensing revenue. We are a principal in the licensing and enforcement effort, with our operating subsidiaries obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright.

Business Model and Strategy - Overview

We have the flexibility to structure arrangements in a number of ways to address the needs and specific sets of circumstances presented by each of our unique patent partners, examples of which include the following:

Partnering Model:


•	50/50 net profit sharing of revenue after legal costs and other licensing and enforcement costs. Profit sharing percentages can vary.


•	Typical partners include major corporations, research labs and universities and individual inventors.


•	Upon return of advanced costs, net profit revenue share with patent partner commences.

Hybrid Partnering Model:


•	Hybrid Partnership with up-front capital infusion to our patent partners as an advance on future licensing revenue streams.


•	Increases our total addressable market providing an advantage over competitors.


•	Typical partners include major corporations seeking to effectively and efficiently monetize their patent portfolios.


•	We maintain at least a 100% preferred rate of return until all deployed capital is returned.


•	Upon return of capital infusion, net profit revenue share with patent partner commences.

Purchasing Model:


•	We invest in 100% of the patents for 100% of the profits, with no backed participation for the patent owner.


•	Typical partners include distressed corporations and other corporations with limited success controlled by venture capitalists.

Key Elements of Business Strategy

Patent licensing and enforcement can be an effective and efficient way to maximize the profit potential of a patent. A patent license agreement grants a third-party user of an invention specific patent rights to the patented invention in exchange for patent license fees. Patent licensing is especially suitable for patents that are owned by the patent-disenfranchised. Patent disenfranchised owners of patents are those that have not successfully converted their patented invention into a profitable product or service, and therefore, are not generating revenues from their patented inventions. The patent-disenfranchised, for example, include owners of the following categories of patented inventions:


•	Inventions that were so far ahead of the technology curve that there is no existing ecosystem to support the patented products or services at the time they are introduced to market;


•	Inventions that can only be deployed in very capital-intensive industries, such as semiconductor fabrication, energy, or medical sectors, but whose owners do not have sufficient amounts of capital to deploy; and


•	Inventions that, for one reason or another, including the shifting of cost-effective manufacturing overseas, are no longer being practiced by the patent owner.

Our patent licensing business provides patent holders with an opportunity to generate income from their patented inventions being practiced by third-parties without authorization. Our patent licensing and enforcement business strategy, conducted solely by our operating subsidiaries, includes three fundamental elements, as follows:


•	Patent Discovery - Discover potentially valuable patents or patent portfolios.


•	Assessment of Economic Value - Work internally and with external experts to evaluate the use of the patented invention(s) in the relevant marketplace and assess a patents or patent portfolios’ expected economic value.


•	Licensing and Enforcement - For unauthorized users of the patented invention, enter into license negotiations and, if necessary, litigation to monetize the patent based on its assessed value.

Patent Discovery. The patent process breeds, encourages and sustains innovation and invention by granting a limited monopoly to the inventor in exchange for sharing the invention with the public. Certain technologies, including several of the technologies controlled by our operating subsidiaries, some of which are summarized below, become core technologies in the way products and services are manufactured, sold or delivered by companies across a wide array of industries. Our operating subsidiaries identify core, patented technologies that have been or are anticipated to be widely adopted by third-parties in connection with the manufacture, sale or use of products and services. Patent discovery occurs when we reach out to patent holders who may be disenfranchised, or when patent holders approach us seeking assistance with the monetization and enforcement of their patent portfolios.

Assessment of Economic Value. Subsequent to the patent discovery process, our executives work internally and/or with external industry experts in the specific technology field, to evaluate the patented invention and its adoption and implementation in the marketplace. There are several key factors to consider when analyzing a patent and determining a patent’s value: (1) Infringement, (2) Validity and (3) Enforceability.

•

Infringement. To determine infringement, we must first identify third-parties that are practicing the invention(s) covered by the patent without obtaining permission from the patent owner to do so. A key tool in determining whether or not a company is infringing a patent is a claim chart. A claim chart demonstrates how the manufacture, sale, or use of an existing product compares against the claims of the patent.


•	Invalidity. The three main factors analyzed to determine invalidity are (1) anticipation, (2) obviousness, and (3) the existence of non-patentable subject matter.


◦	Anticipation occurs when the claims of the patent are entirely revealed within a single piece of prior art. “Prior art” is a technical term that generally refers to an invention that existed prior to the grant of the patent being analyzed.


◦	Even if the claims of the patent are not entirely revealed within a single piece of prior art, the patent may still be invalid if determined to be “obvious” under the law. “Obvious” essentially means that the

differences between prior art and the patented invention are so slight such that they would have been obvious at the time of invention to one who is skilled in the subject matter being patented.


◦	Even if the patent lacks anticipation and obviousness, it may still be invalid if its subject matter is un-patentable by law. Un-patentable subject matter includes naturally occurring things, abstract concepts, or algorithms that perform an ordinary function.

•

Enforceability. A myriad of factors are analyzed to determine whether or not a patent is enforceable, including whether or not there has been patent misuse, or whether or not there are antitrust violations associated with the patent. Due to the inherently complex nature of patent law, only a court or specific administrative body, such as the International Trade Commission, can make a decision whether a patent is infringed, valid and enforceable; however, we employ our wealth of expertise to make the best assessment possible given a specific fact pattern and set of circumstances.

We estimate a patent’s economic value by evaluating the expected value of the license revenue stream based on past, present and future revenue of infringing products or services, and the risk that a court will disagree with our infringement, validity or enforcement assessments of the patent.

The processes and procedures employed in connection with the evaluation of a specific patent portfolio for future investment, licensing and enforcement are tailored and unique to each specific situation and can vary widely based on the specific facts and circumstances of a specific patent portfolio, such as the related technology, related industry and certain other factors. Some of the key components of our processes and procedures may include:


•	Utilizing our staff of in-house business development executives, patent attorneys, patent licensing executives, and technology engineers to conduct our tailored patent investment and evaluation processes and procedures. We may also leverage the expertise of external specialists and technology consultants.


•	Identifying emerging growth areas where patented technologies will play a vital role in connection with the manufacture or sale of products and services.


•	Identifying core, patented technologies that have been or are anticipated to be widely adopted by third-parties in connection with the manufacture or sale of products and services.


•	Considering the impact of subtleties in the language of a patent, recorded interactions with the patent office, evaluating prior art and literature and considering the impact on the potential licensing and enforcement revenue that can be derived from a patent or patent portfolio.


•	Evaluating the strength of a patent portfolio, including consideration of the types of claims and the number of claims potentially infringed by third-parties, and the results of any prior art searches or analysis, before the decision is made to allocate resources to a patent portfolio investment or an effective licensing and enforcement effort.


•	Identifying and considering potential problem areas, if any, and determining whether potential problem areas can be overcome prior to acquiring a patent portfolio or launching an effective licensing program.


•	Identifying potential infringers, industries within which the potential infringers exist, longevity of the patented technology, and a variety of other factors that directly impact the magnitude and potential success of a licensing and enforcement program.

Licensing and Enforcement. The final step in the patent licensing and enforcement process is to monetize the patent by securing license agreements based on the patents estimated value. While we prefer to convince unauthorized users of our patented inventions of the value of the patented invention and secure a license agreement in a non-litigious manner, many infringers refuse to take such licenses even when confronted with substantial and persuasive evidence of infringement, validity, enforceability and significant economic value. As a result, often we must resort to litigation to demonstrate and prove infringement and ultimately induce infringers to take a license. We have found it effective to negotiate licenses concurrently with litigation due to the fact that litigation necessitates and facilitates an information exchange that helps both sides assess the value of a patent and make informed decisions. Also, litigation eventually leads to a court’s judgment. When a court agrees with our assessment of a patent, this judgment stops recalcitrant infringers from indefinitely profiting from the patent they are infringing.

Our operating subsidiaries engage highly competent and experienced patent lawyers to prosecute their patent portfolio litigation. It is imperative to be persistent and patient throughout the litigation process as it typically takes 18-36 months from the filing date of a lawsuit to yield a license agreement from a potential licensee. Often, it takes longer to secure a final court judgment.

Patent license negotiations and litigation initiated by our operating subsidiaries usually lead to serious and thoughtful discussions with the unauthorized users of the patented inventions. The result can be quite favorable with the user being granted rights under the patents for the patented invention in its products and services in exchange for financial remuneration. This remuneration is typically shared between our operating subsidiary and the patent holder.

Patent Prosecution. Concurrent with our patent litigation and licensing negotiation activities, we often assist patent holders with the acquisition of additional rights associated with their inventions both in the United States and across the globe. This is referred to as “continued prosecution,” and is done to further define the boundaries of an invention. It can also be effective to correct technical deficiencies discovered within a patent that may have been identified in the negotiation and litigation process. These deficiencies, if not appropriately addressed, can limit the value of patents that are otherwise infringed, valid, enforceable.

Our specialists, along with third-party experts that we engage, are trained and skilled in the areas of patent discovery, assessment of a patent or patent portfolios expected economic value, acquiring additional patent rights via continued patent prosecution, and patent licensing and enforcement. In applying our legal and technology expertise to high quality patent assets, we bridge the gap between invention and application, facilitating efficiency and delivering monetary rewards to the patent disenfranchised and other patent owners with whom we partner.

Patented Technologies

Currently, on a consolidated basis, our operating subsidiaries own or control the rights to patent portfolios with future patent expiration dates ranging from 2016 to approximately 2033, covering technologies used in a wide variety of industries, a sample of which includes the following:



Operating Subsidiary	Industry	Description
Adaptix, Inc.	Telecommunications / Smartphones	Portfolio relates to air interface technology used in modern 4G wireless networks. The patents relate to both infrastructure and user equipment.
American Vehicular Sciences, LLC	Transportation And Automotive	Patents from Automotive Technologies International, or ATI and Intelligent Technologies International, or ITI, relating to numerous automotive safety, navigation and diagnostics technologies.
Body Science, LLC	Peripheral Vascular Devices	Patents relating to apparatus for use in wireless physiological monitoring.
Bonutti Skeletal Innovations, LLC	Orthopedic Implants And Sports Medicine Market	Issued and pending patents and applications in the orthopedic field covering, among other things, suture anchors, biologics, total knee replacements, total hip replacements, minimally invasive surgery, partial knee and hip replacement, spinal implants, and surgical instruments and methods of use.
Cellular Communications Equipment, LLC	Telecommunications / Smartphones	Portfolio covers Wireless Infrastructure and User Equipment Technology relating to second (2G), third (3G) and fourth (4G) generation wireless technologies and to air interface technology used in 2G, 3G and 4G wireless networks.
Data Engine Technologies, LLC	Software	Patent portfolio covering a wide range of Software Technology.
Endotach, LLC	Peripheral Vascular Devices	Patents relating to stent grafts.
Industrial Print Technologies, LLC	Computers/Peripherals/Printers	Patent portfolio covering ink jet printer and ink jet printing technologies and other printer and printing technologies.
Innovative Display Technologies, LLC	Telecommunications / Smartphones	Portfolio generally relates to back-lighting for displays and the patented technology covers various improvements to LCD displays.
Lambda Optical Solutions, LLC	Communications	Patents relating to Optical Switching Technology.
LifePort Sciences, LLC	Peripheral Vascular Devices	Multiple patents and applications relating to, among other things, stent grafts, stent graft delivery systems and stent placement procedures.
LifeScreen Sciences, LLC	Peripheral Vascular Devices	Portfolio consists of multiple patents and applications relating to, among other things, vena cava filters, embolic protection and associated delivery systems.
LifeShield Sciences, LLC	Peripheral Vascular Devices	Portfolio consists of multiple patents and applications relating to stent grafts, and stent graft delivery systems.



Operating Subsidiary	Industry	Description
Limestone Memory Systems LLC	Memory	This portfolio covers both DRAM and flash memory technologies used in virtually all electronic communications and computing devices.
Nexus Display Technologies, LLC	Consumer Electronics	Patent portfolio relating to high speed digital display interface technology used in industry standards such as DisplayPort and DisplayPort-related technologies and also MIPI DSI.
Optimum Content Protection, LLC and Super Interconnect Technologies, LLC	Telecommunications / Smartphones	Portfolios relate to high speed circuit interconnect, display control technology and content security used in consumer electronics, PCs and mobile devices such as smartphones, tablets, and laptops.
Parthenon Unified Memory Architecture, LLC	Semiconductor	Patents relate to the use of shared memory in multimedia processing systems such as mobile phones, tablets and other consumer electronic devices.
Power Optimized Memory Solutions LLC	Memory	This portfolio covers technologies and devices similar to those of the Limestone portfolio, as well as Solid State Drives (SSD’s).
Rapid Completions LLC	Energy Efficiency	Patents related to multi-zonal completion of horizontal wells including ball-drop, sliding sleeve and packer technology for use in the hydraulic fracturing of both tight and conventional oil and gas reservoirs. This technology has been applied in oilfields across North America and worldwide and has contributed significantly to the growth in oil and gas production from unconventional shale formations.
Saint Lawrence Communications, LLC	Wireless	Patents relating to Speech Codecs used in Wireless and Wireline Systems.
Unified Messaging Solutions, LLC	Communications	Patent for Messaging Technology.

Revenues for the periods presented include revenues generated from several of the portfolios summarized above and other technology patent portfolios owned or controlled by us. Refer to Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Overview” for a summary of patent portfolios generating revenues for the applicable periods presented.

Competition

We expect to encounter increased competition in the area of patent portfolio investments and enforcement. This includes an increase in the number of competitors seeking to invest in the same or similar patents and technologies that we may seek to invest in. Non-practicing entities such as RPX, AST, Intellectual Ventures, Wi-LAN, Conversant, Round Rock Research LLC, IPvalue Management Inc., Vringo Inc., VirnetX and Pendrell Corporation compete in acquiring rights to patents, and we expect more entities to enter the market.

We also compete with financial firms, corporate buyers and others acquiring IP. Many of these competitors may have more financial and human resources than our operating subsidiaries. As we become more successful, we may find more companies entering the market for similar technology opportunities, which may reduce our market share in one or more technology industries that we currently rely upon to generate future revenue.

Companies or other entities may develop competing technologies that offer better or less expensive alternatives to our patented technologies that we may invest in and license. Many potential competitors may have significantly greater resources than the resources that our operating subsidiaries possess. Such technological advances or entirely different approaches developed by one or more of our competitors could render certain of the technologies owned or controlled by our operating subsidiaries obsolete and/or uneconomical.

Employees

As of December 31, 2015, on a consolidated basis, we had 42 full-time employees. Neither we, nor any of our subsidiaries, are a party to any collective bargaining agreement. We consider our employee relations to be good.

ITEM 1A. RISK FACTORS

The following is a summary of certain risks we face in our business. They are not the only risks we face. Additional risks that we do not yet know of or that we currently believe are immaterial may also impair our business operations. If any of the following risks actually occur, our business, financial condition and results of operations could be materially adversely affected, and the trading price of our common stock could decline significantly. All patent portfolio investments, development, licensing and enforcement activities are conducted solely by certain of our wholly and majority-owned operating subsidiaries.

Risks Related to Our Business

We have a history of losses and may incur additional losses in the future.

We reported a net loss of $160.0 million (includes $104.9 million of noncash goodwill and patent impairment charges), $66.0 million and $56.4 million for the years ended December 31, 2015, 2014 and 2013, and on a cumulative basis, we have sustained substantial losses since our inception. As of December 31, 2015, our accumulated deficit was $288.1 million. As of December 31, 2015, we had approximately $145.9 million in cash and cash equivalents and restricted cash and working capital of $150.7 million. We expect to continue incurring significant legal, marketing and general and administrative expenses in connection with our operations. As a result, we anticipate that we may incur losses in the future. We believe, however, that our current cash and cash equivalents and investments will be sufficient to finance our anticipated capital and operating requirements for at least the next twelve months.

Our ability to use net operating losses and certain other tax attributes is uncertain and may be limited.

Our ability to use our federal and state net operating losses to offset potential future taxable income and related income taxes that would otherwise be due is dependent upon our generation of future taxable income before the expiration dates of the net operating losses, and we cannot predict with certainty when, or whether, we will generate sufficient taxable income to use all of our net operating losses. In addition, utilization of net operating losses to offset potential future taxable income and related income taxes that would otherwise be due is subject to annual limitations under the “ownership change” provisions of Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, or the Code, and similar state provisions, which may result in the expiration of net operating losses before future utilization. In general, under the Code, if a corporation undergoes an “ownership change,” generally defined as a greater than 50% change (by value) in its equity ownership over a three-year period, the corporation’s ability to use its pre-change net operating losses and other pre-change tax attributes (such as research and development credit carryforwards) to offset its post-change taxable income or taxes may be limited. Changes in our stock ownership, some of which may be outside of our control, could in the future result in an ownership change. Although we have completed studies to provide reasonable assurance that an ownership change limitation would not apply, we cannot be certain that a taxing authority would reach the same conclusion. If, after a review or audit, an ownership change limitation were to apply, utilization of our domestic net operating losses and tax credit carryforwards could be limited in future periods and a portion of the carryforwards could expire before being available to reduce future income tax liabilities.

If we encounter unforeseen difficulties with our business or operations in the future that require us to obtain additional working capital, and we cannot obtain additional working capital on favorable terms, or at all, our business may suffer.

Our consolidated cash and cash equivalents, restricted cash and short-term investments totaled $145.9 million and $193.0 million at December 31, 2015 and 2014, respectively. To date, we have relied primarily upon net cash flows from our operations and from the public and private sale of equity securities to generate the working capital needed to finance our operations.

We may encounter unforeseen difficulties with our business or operations in the future that may deplete our capital resources more rapidly than anticipated. As a result, we may be required to obtain additional working capital in the future through bank credit facilities, public or private debt or equity financings, or otherwise. If we are required to raise additional working capital in the future, such financing may be unavailable to us on favorable terms, if at all, or may be dilutive to our existing stockholders. If we fail to obtain additional working capital, as and when needed, such failure could have a material adverse impact on our business, results of operations and financial condition.

Failure to effectively manage our operational changes could place strains on our managerial, operational and financial resources and could adversely affect our business and operating results.

Our operational changes have placed, and is expected to continue to place, a strain on our managerial, operational and financial resources and systems. Further, as our subsidiary companies’ businesses grow or change, we will be required to continue to manage multiple relationships. Any further growth or change by us or our subsidiary companies, or an increase in the number of our strategic relationships, may place additional strain on our managerial, operational and financial resources and systems. Although we may not grow as we expect, if we fail to manage our growth or other operational changes effectively or to develop, expand or otherwise modify our managerial, operational and financial resources and systems, our business and financial results will be materially harmed.

Our future success depends on our ability to expand our organization to match the growth of our subsidiaries.

As our operating subsidiaries grow, the administrative demands upon us and our operating subsidiaries will grow, and our success will depend upon our ability to meet those demands. These demands include increased accounting, management, legal services, staff support, and general office services. We may need to hire additional qualified personnel to meet these demands, the cost and quality of which is dependent in part upon market factors outside of our control. Further, we will need to effectively manage the training and growth of our staff to maintain an efficient and effective workforce, and our failure to do so could adversely affect our business and operating results.

Potential patent portfolio investments may present risks, and we may be unable to achieve the financial or other goals intended at the time of any potential investment.

Our future growth depends, in part, on our ability to invest in patented technologies, patent portfolios, or companies holding such patented technologies and patent portfolios. Accordingly, we have engaged in patent portfolio investments to expand our patent portfolios and we intend to continue to explore such investments. Such investments are subject to numerous risks, including the following:


•	our inability to enter into a definitive agreement with respect to any potential patent portfolio investment, or if we are able to enter into such agreement, our inability to consummate the potential investment transaction;


•	difficulty integrating the operations, technology and personnel of the acquired entity;


•	our inability to achieve the anticipated financial and other benefits of the specific patent portfolio investment;


•	our inability to retain key personnel from the acquired company, if necessary;


•	difficulty in maintaining controls, procedures and policies during the transition and integration process;


•	diversion of our management’s attention from other business concerns; and


•	failure of our due diligence process to identify significant issues, including issues with respect to patented technologies and patent portfolios, and other legal and financial contingencies.

If we are unable to manage these risks effectively as part of any patent portfolio investment, our business could be adversely affected.

Our revenues are unpredictable, and this may harm our financial condition.

From January 2005 to the present, our operating subsidiaries have executed our business strategy of partnering with inventors and patent owners, applying our legal and technology expertise to patent assets to unlock the financial value in their patented inventions. Currently, on a consolidated basis, our operating subsidiaries own or control the rights to multiple patent portfolios which include U.S. patents and certain foreign counterparts, covering technologies used in a wide variety of industries. These patent portfolio investments continue to diversify our revenue generating opportunities. We believe that our cash and cash equivalents and short-term investment balances, anticipated cash flow from operations, proceeds from prior offerings of our common stock (refer to “Liquidity and Capital Resources” below) and other external sources of available credit, will be sufficient to meet our cash requirements through at least March 2017 and for the foreseeable future. However, due to the nature of our licensing business and uncertainties regarding the amount and timing of the receipt of license and other fees from potential infringers, stemming primarily from uncertainties regarding the outcome of enforcement actions, rates of

adoption of our patented technologies, the growth rates of our existing licensees and certain other factors, our revenues may vary significantly from quarter to quarter and period to period, which could make our business difficult to manage, adversely affect our business and operating results, cause our quarterly and periodic results to fall below market expectations and adversely affect the market price of our common stock.

Our operating subsidiaries depend upon relationships with others to provide technology-based opportunities that can develop into profitable royalty-bearing licenses, and if they are unable to maintain and generate new relationships, then they may not be able to sustain existing levels of revenue or increase revenue.

Neither we nor our operating subsidiaries invent new technologies or products; rather, we depend upon the identification and investment in new patents and inventions through our relationships with inventors, universities, research institutions, technology companies and others. If our operating subsidiaries are unable to maintain those relationships and to continue to grow new relationships, then they may not be able to identify new technology-based opportunities for sustainable revenue and growth.

Our current or future relationships may not provide the volume or quality of technologies necessary to sustain our business. In some cases, universities and other technology sources may compete against us as they seek to develop and commercialize technologies. Universities may receive financing for basic research in exchange for the exclusive right to commercialize resulting inventions. These and other strategies may reduce the number of technology sources and potential clients to whom we can market our services. If we are unable to maintain current relationships and sources of technology or to secure new relationships and sources of technology, such inability may have a material adverse effect on our operating results and financial condition.

For example, in fiscal year 2015, we obtained control of 3 new patent portfolios with applications over a wide range of technology areas, compared to 6 new patent portfolios, and 25 new patent portfolios in fiscal years 2014 and 2013, respectively. The decrease in patent portfolio intake, in part reflects a strategic decision in 2013 to shift the focus of our operating business to increasingly serve a smaller number of customers each having higher quality patent portfolios. High quality patent portfolios are typically associated with higher numbers of varied defensible claims, higher revenue potential, originating from high-pedigreed patent owners and/or possessing a relatively large number of prospective licensees. In this regard, commencing in the later portion of 2013 and early 2014, we continued the shift in our focus at our point of patent intake, from quantity to quality. As a result, our gross number of patent portfolio acquisitions has trended downward. The decrease may also be reflective, in part of industry trends impacting our ability to acquire patent portfolios. For example, legislative and legal changes have increased the complexity of patent enforcement and may be affecting the market availability of suitable patent portfolios for acquisition. If these industry trends continue, our future patent portfolio intake could be negatively impacted, resulting in a decrease in future revenue generating opportunities.

The success of our operating subsidiaries depends in part upon their ability to retain the best legal counsel to represent them in patent enforcement litigation.

The success of our licensing business depends upon our operating subsidiaries’ ability to retain the best legal counsel to prosecute patent infringement litigation. As our operating subsidiaries’ patent enforcement actions increase, it will become more difficult to find the best legal counsel to handle all of our cases because many of the best law firms may have a conflict of interest that prevents their representation of our subsidiaries.

We spend a significant amount of our financial and management resources to pursue our current litigation matters. We believe that these litigation matters and others that we may in the future determine to pursue could continue for years and continue to consume significant financial and management resources. The counterparties to our litigation are sometimes large, well-financed companies with substantially greater resources than us. We cannot assure that any of our current or future litigation matters will result in a favorable outcome for us. In addition, in part due to the appeals process and other legal processes, even if we obtain favorable interim rulings or verdicts in particular litigation matters, they may not be predictive of the ultimate resolution of the dispute. Also, we cannot assure that we will not be exposed to claims or sanctions against us which may be costly or impossible for us to defend. Unfavorable or adverse outcomes may result in losses, exhaustion of financial resources or other adverse effects which could encumber our ability to develop and commercialize products.

material, and if required to be paid by us or our operating subsidiaries, could materially harm our operating results and our financial position.

Our operating subsidiaries, in certain circumstances, rely on representations, warranties and opinions made by third-parties that, if determined to be false or inaccurate, may expose us and our operating subsidiaries to certain material liabilities.

From time to time, our operating subsidiaries may rely upon representations and warranties made by third-parties from whom our operating subsidiaries acquired patents or the exclusive rights to license and enforce patents. We also may rely upon the opinions of purported experts. In certain instances, we may not have the opportunity to independently investigate and verify the facts upon which such representations, warranties, and opinions are made. By relying on these representations, warranties and opinions, our operating subsidiaries may be exposed to liabilities in connection with the licensing and enforcement of certain patents and patent rights which could have a material adverse effect on our operating results and financial condition.

In connection with patent enforcement actions conducted by certain of our subsidiaries, a court may rule that we or our subsidiaries have violated certain statutory, regulatory, federal, local or governing rules or standards, which may expose us and our operating subsidiaries to certain material liabilities.

In connection with any of our patent enforcement actions, it is possible that a defendant may request and/or a court may rule that we have violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against us or our operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material, and if we or our operating subsidiaries are required to pay such monetary sanctions, attorneys’ fees and/or expenses, such payment could materially harm our operating results and our financial position.

In connection with patent enforcement actions conducted by certain of our subsidiaries, a court may find the patents invalid, not infringed or unenforceable and/or the U.S. Patent and Trademark Office, or the USPTO, or other relevant patent office, may either invalidate the patents or materially narrow the scope of their claims during the course of a reexamination, opposition or other such proceeding.

Patent litigation is inherently risky and the outcome is uncertain. Some of the parties that we believe infringe on our patents are large and well-financed companies with substantially greater resources than ours. We believe that these parties would devote a substantial amount of resources in an attempt to avoid or limit a finding that they are liable for infringing on our patents or, in the event liability is found, to avoid or limit the amount of associated damages. In addition, there is a risk that these parties may file reexaminations or other proceedings with the USPTO or other government agencies in the United States or abroad in an attempt to invalidate, narrow the scope or render unenforceable the patents we own or control. If this were to occur, it may have a material adverse effect on the viability of our company and our operations.

In addition, it is difficult to predict the outcome of patent enforcement litigation at any level. In the United States, there is a higher rate of appeals in patent enforcement litigation than standard business litigation. The defendant to any case we bring, may file as many appeals as allowed by right, including to the first, second and/or final courts of appeal (in the United States those courts would be the Federal Circuit and Supreme Court, respectively). Such appeals are expensive and time-consuming, and the outcomes of such appeals are sometimes unpredictable, resulting in increased costs and reduced or delayed revenue.

Our licensing cycle is lengthy and costly, and our marketing, legal and sales efforts may be unsuccessful.

We expect our operating subsidiaries to incur significant marketing, legal and sales expenses prior to entering into license agreements and generating license revenues. We will also spend considerable resources educating prospective licensees on the benefits of a license arrangement with us. As such, we may incur significant losses in any particular period before any associated revenue stream begins.

If our efforts to educate prospective licensees on the benefits of a license arrangement are unsuccessful, we may need to pursue litigation or other enforcement action to protect our patent rights. We may also need to litigate to enforce the terms of our existing license agreements, protect our trade secrets, or determine the validity and scope of the proprietary rights of others. Enforcement proceedings are typically protracted and complex. The costs are typically substantial, and the outcomes are unpredictable. Enforcement actions will divert our managerial, technical, legal and financial resources from business operations.

Risks Related to Our Industry

Our exposure to uncontrollable outside influences, including new legislation, court rulings or actions by the USPTO, could adversely affect our licensing and enforcement business and results of operations.

Our licensing and enforcement business is subject to numerous risks from outside influences, including the following:

New legislation, regulations or rules related to obtaining patents or enforcing patents could significantly increase our operating costs and decrease our revenue.

Our operating subsidiaries invest in patents with enforcement opportunities and spend a significant amount of resources to enforce those patents. If new legislation, regulations or rules are implemented by Congress, the USPTO or the courts that impact the patent application process, the patent enforcement process or the rights of patent holders, such changes could negatively affect our business. Recently, United States patent laws were amended with the enactment of the Leahy-Smith America Invents Act, or the America Invents Act, which took effect on March 16, 2013. The America Invents Act includes a number of significant changes to U.S. patent law. In general, the legislation attempts to address issues surrounding the enforceability of patents and the increase in patent litigation by, among other things, establishing new procedures for patent litigation. For example, the America Invents Act changes the way that parties may be joined in patent infringement actions, increasing the likelihood that such actions will need to be brought against individual allegedly-infringing parties by their respective individual actions or activities. In addition, the America Invents Act enacted a new inter-partes review process at the USPTO which can be, and often is, used by defendants, and other individuals and entities, to separately challenge the validity of any patent. At this time, it is not clear what, if any, overall impact the America Invents Act will have on the operation of our enforcement business. However, the America Invents Act and its implementation could increase the uncertainties and costs surrounding the enforcement of our patented technologies, which could have a material adverse effect on our business and financial condition.

The U.S. Department of Justice, or the DOJ, has conducted reviews of the patent system to evaluate the impact of patent assertion entities on industries in which those patents relate. It is possible that the findings and recommendations of the DOJ could impact the ability to effectively license and enforce standards-essential patents and could increase the uncertainties and costs surrounding the enforcement of any such patented technologies. Also, in 2014, the Federal Trade Commission, or FTC, initiated a study under Section 6(b) of the Federal Trade Commission Act to evaluate the patent assertion practice and market impact of Patent Assertion Entities, or PAEs. The FTC’s initial notice and request for public comment relating to the PAE study appeared in the Federal Register on October 3, 2013. We received and responded to a request for information as part of this FTC study. It is expected that the results of the PAE study by the FTC will be provided to Congress and other agencies, such as the DOJ, who could take action, including legislative proposals, based on the results of the study.

Finally, new rules regarding the burden of proof in patent enforcement actions could significantly increase the cost of our enforcement actions, and new standards or limitations on liability for patent infringement could negatively impact our revenue derived from such enforcement actions. In addition, recent federal court decisions have lowered the threshold for obtaining attorneys’ fees in patent infringement cases and increased the level of deference given to a district court’s fee-shifting determination. These decisions may make it easier for district courts to shift a prevailing party’s attorneys' fees to a non-prevailing party if the district court believes that the case was weak or conducted in an abusive manner. As a result, defendants in patent infringement actions brought by non-practicing entities may elect not to settle because these decisions make it much easier for defendants to get attorneys’ fees.

Changes in patent law could adversely impact our business.

Patent laws may continue to change, and may alter the historically consistent protections afforded to owners of patent rights. Such changes may not be advantageous for us and may make it more difficult to obtain adequate patent protection to enforce our patents against infringing parties. Increased focus on the growing number of patent-related lawsuits may result in legislative changes which increase our costs and related risks of asserting patent enforcement actions. For instance, the United States Congress is considering a bill that would require, among other things, non-practicing entities that bring patent infringement lawsuits to pay legal costs of the defendants, if the lawsuits are unsuccessful and certain standards are not met.

Trial judges and juries often find it difficult to understand complex patent enforcement litigation, and as a result, we may need to appeal adverse decisions by lower courts in order to successfully enforce our patents.

It is difficult to predict the outcome of patent enforcement litigation at the trial level. It is often difficult for juries and trial judges to understand complex, patented technologies, and as a result, there is a higher rate of successful appeals in patent

enforcement litigation than more standard business litigation. Such appeals are expensive and time consuming, resulting in increased costs and delayed revenue. Although we diligently pursue enforcement litigation, we cannot predict with significant reliability the decisions made by juries and trial courts.

More patent applications are filed each year resulting in longer delays in getting patents issued by the USPTO.

Certain of our operating subsidiaries hold and continue to invest in pending patents. We have identified a trend of increasing patent applications each year, which we believe is resulting in longer delays in obtaining approval of pending patent applications. The application delays could cause delays in recognizing revenue from these patents and could cause us to miss opportunities to license patents before other competing technologies are developed or introduced into the market.

Federal courts are becoming more crowded, and as a result, patent enforcement litigation is taking longer.

Our patent enforcement actions are almost exclusively prosecuted in federal court. Federal trial courts that hear our patent enforcement actions also hear criminal cases. Criminal cases always take priority over our actions. As a result, it is difficult to predict the length of time it will take to complete an enforcement action. Moreover, we believe there is a trend in increasing numbers of civil lawsuits and criminal proceedings before federal judges and, as a result, we believe that the risk of delays in our patent enforcement actions will have a greater effect on our business in the future unless this trend changes.

Any reductions in the funding of the USPTO could have an adverse impact on the cost of processing pending patent applications and the value of those pending patent applications.

The assets of our operating subsidiaries consist of patent portfolios, including pending patent applications before the USPTO. The value of our patent portfolios is dependent upon the issuance of patents in a timely manner, and any reductions in the funding of the USPTO could negatively impact the value of our assets. Further, reductions in funding from Congress could result in higher patent application filing and maintenance fees charged by the USPTO, causing an unexpected increase in our expenses.

Competition is intense in the industries in which our subsidiaries do business and as a result, we may not be able to grow or maintain our market share for our technologies and patents.

We expect to encounter competition in the area of patent portfolio investments and enforcement as the number of companies entering this market is increasing. This includes competitors seeking to invest in the same or similar patents and technologies that we may seek to invest in. Entities including RPX, AST, Intellectual Ventures, Wi-LAN, Conversant, Round Rock Research LLC, IPvalue Management Inc., Vringo Inc., VirnetX and Pendrell Corporation compete in acquiring rights to patents, and we expect more entities to enter the market. As new technological advances occur, many of our patented technologies may become obsolete before they are completely monetized. If we are unable to replace obsolete technologies with more technologically advanced patented technologies, then this obsolescence could have a negative effect on our ability to generate future revenues.

Our licensing business also competes with venture capital firms and various industry leaders for patent licensing opportunities. Many of these competitors may have more financial and human resources than we do. As we become more successful, we may find more companies entering the market for similar technology opportunities, which may reduce our market share in one or more technology industries that we currently rely upon to generate future revenue.

Our patented technologies face uncertain market value.

Our operating subsidiaries have invested in patents and technologies that may be in the early stages of adoption in the commercial and consumer markets. Demand for some of these technologies is untested and is subject to fluctuation based upon the rate at which our licensees will adopt our patents and technologies in their products and services.

Further, significant judgment is required in connection with estimates of the recoverability of the carrying value of our intangible patent assets, including estimates of market values, estimates of the amount and timing of future cash flows, and estimates of other factors that are used to determine the fair value and recoverability of the respective patent asset values. Developments with respect to ongoing patent litigation, patent challenges and re-exams, legislative and judicial decisions and other factors outside of our control, may unfavorably impact the validity, applicability, and enforceability of our patent assets, and therefore, negatively impact the future value of our patent portfolios. If certain of these unfavorable events occur, our estimates or related projections may change materially in future periods, and future intangible asset impairment tests may result in material charges to earnings.

As patent enforcement litigation becomes more prevalent, it may become more difficult for us to voluntarily license our patents.

We believe that the more prevalent patent enforcement actions become, the more difficult it will be for us to voluntarily license our patents. As a result, we may need to increase the number of our patent enforcement actions to cause infringing companies to license the patent or pay damages for lost royalties. This may increase the risks associated with an investment in our company.

Patent litigation trials and scheduled trial dates are subject to routine delay, and any such delays could adversely impact our business, results of operations and financial condition.

Patent infringement trials are components of our overall patent licensing process and are one of many factors that contribute to the existence of possible future revenue opportunities for us. Patent litigation schedules in general, and in particular trial dates, are subject to routine adjustment, and in most cases delay, as courts adjust their calendars or respond to requests from one or more parties. Trial dates often are rescheduled by the court for various reasons that are often unrelated to the underlying patent assets and typically for reasons that are beyond our control. As a result, to the extent such events are an indicator of possible future revenue opportunities for us, or other outcome determinative events, they may and often do change which can result in delay of the expected scheduled event. Any such delay could be significant and could affect the corresponding future revenue opportunities, thus adversely impacting our business, results of operations and financial condition.

The markets served by our operating subsidiaries are subject to rapid technological change, and if our operating subsidiaries are unable to develop and invest in new technologies and patents, our ability to generate revenues could be substantially impaired.

The markets served by our operating subsidiaries and their licensees frequently undergo transitions in which products rapidly incorporate new features and performance standards on an industry-wide basis. Products for communications applications and high-speed computing applications, as well as other applications covered by our operating subsidiaries’ intellectual property, are based on continually evolving industry standards. In addition, the communications industry is intensely competitive and has been impacted by price erosion, rapid technological change, short product life cycles, cyclical market patterns and increasing foreign and domestic competition. Our ability to compete in the future will depend on our ability to identify and ensure compliance with evolving industry standards. This will require our continued efforts and success in acquiring new patent portfolios with licensing and enforcement opportunities. While we expect for the foreseeable future to have sufficient liquidity and capital resources to maintain the level of patent portfolio investments necessary to keep pace with these technological advances, various factors may require us to have greater liquidity and capital resources than we currently expect. If we are unable to invest in new patented technologies and patent portfolios, or to identify and ensure compliance with evolving industry standards, our ability to generate revenues could be substantially impaired and our business and financial condition could be materially harmed.

Uncertainty in global economic conditions could negatively affect our business, results of operations and financial condition.

Our revenue-generating opportunities depend on the use of our patented technologies by existing and prospective licensees, the overall demand for the products and services of our licensees, and on the overall economic and financial health of our licensees. Although economic conditions appear to be improving, recent uncertainties in global economic conditions have resulted in the tightening of the credit markets, a low level of liquidity in many financial markets, and extreme volatility in the credit, equity and fixed income markets. If economic conditions do not continue to improve, or if they further deteriorate, many of our licensees’ customers, which may rely on credit financing, may delay or reduce their purchases of our licensees’ products and services. In addition, the use or adoption of our patented technologies is often based on current and forecasted demand for our licensees’ products and services in the marketplace and may require companies to make significant initial commitments of capital and other resources. If negative conditions in the global credit markets delay or prevent our licensees’ and their customers’ access to credit, overall consumer spending on the products and services of our licensees may decrease and the adoption or use of our patented technologies may slow, respectively. Further, if the markets in which our licensees’ participate do not continue to improve, or deteriorate further, this could negatively impact our licensees’ long-term sales and revenue generation, margins and operating expenses, which could in turn have an adverse effect on our business, results of operations and financial condition.

In addition, we have significant patent-related intangible assets recorded on our consolidated balance sheets. We will continue to evaluate the recoverability of the carrying amount of our patent-related intangible assets on an ongoing basis, and

we may incur substantial impairment charges, which would adversely affect our consolidated financial results. There can be no assurance that the outcome of such reviews in the future will not result in substantial impairment charges. Impairment assessment inherently involves judgment as to assumptions about expected future cash flows and the impact of market conditions on those assumptions. Future events and changing market conditions may impact our assumptions as to prices, costs, holding periods or other factors that may result in changes in our estimates of future cash flows. Although we believe the assumptions we used in testing for impairment are reasonable, significant changes in any one of our assumptions could produce a significantly different result.

Risks Related to Our Common Stock

The availability of shares for sale in the future could reduce the market price of our common stock.

In the future, we may issue securities to raise cash for operations and patent portfolio investments. We may also pay for interests in additional subsidiary companies by using shares of our common stock or a combination of cash and shares of our common stock. We may also issue securities convertible into our common stock. Any of these events may dilute stockholders’ ownership interests in our company and have an adverse impact on the price of our common stock.

In addition, sales of a substantial amount of our common stock in the public market, or the perception that these sales may occur, could reduce the market price of our common stock. This could also impair our ability to raise additional capital through the sale of our securities.

Delaware law and our charter documents contain provisions that could discourage or prevent a potential takeover of our company that might otherwise result in our stockholders receiving a premium over the market price of their shares.

Provisions of Delaware law and our certificate of incorporation and bylaws could make the acquisition of our company by means of a tender offer, proxy contest or otherwise, and the removal of incumbent officers and directors, more difficult. These provisions include:


•	Section 203 of the Delaware General Corporation Law, which prohibits a merger with a 15%-or-greater stockholder, such as a party that has completed a successful tender offer, until three years after that party became a 15%-or-greater stockholder;


•	amendment of our bylaws by the stockholders requires a two-thirds approval of the outstanding shares;


•	the authorization in our certificate of incorporation of undesignated preferred stock, which could be issued without stockholder approval in a manner designed to prevent or discourage a takeover;


•	provisions in our bylaws eliminating stockholders’ rights to call a special meeting of stockholders, which could make it more difficult for stockholders to wage a proxy contest for control of our board of directors or to vote to repeal any of the anti-takeover provisions contained in our certificate of incorporation and bylaws; and


•	the division of our board of directors into three classes with staggered terms for each class, which could make it more difficult for an outsider to gain control of our board of directors.

Together, these provisions may make the removal of management more difficult and may discourage transactions that could otherwise involve payment of a premium over prevailing market prices for our common stock.

We may fail to meet market expectations because of fluctuations in quarterly operating results, which could cause the price of our common stock to decline.

Our reported revenues and operating results have fluctuated in the past and may continue to fluctuate significantly from quarter to quarter in the future. It is possible that in future periods, revenues could fall below the expectations of securities analysts or investors, which could cause the market price of our common stock to decline. The following are among the factors that could cause our operating results to fluctuate significantly from period to period:


•	the dollar amount of agreements executed in each period, which is primarily driven by the nature and characteristics of the technology being licensed and the magnitude of infringement associated with a specific licensee;


•	the specific terms and conditions of agreements executed in each period and the periods of infringement contemplated by the respective payments;


•	fluctuations in the total number of agreements executed;


•	fluctuations in the sales results or other royalty-per-unit activities of our licensees that impact the calculation of license fees due;


•	the timing of the receipt of periodic license fee payments and/or reports from licensees;


•	fluctuations in the net number of active licensees period to period;


•	costs related to investments, alliances, licenses and other efforts to expand our operations;


•	the timing of payments under the terms of any customer or license agreements into which our operating subsidiaries may enter;


•	expenses related to, and the timing and results of, patent filings and other enforcement proceedings relating to intellectual property rights, as more fully described in this section; and


•	new litigation or developments in current litigation and the unpredictability of litigation results or settlements or appeals.

Technology company stock prices are especially volatile, and this volatility may depress the price of our common stock.

The stock market has experienced significant price and volume fluctuations, and the market prices of technology companies have been highly volatile. We believe that various factors may cause the market price of our common stock to fluctuate, perhaps substantially, including, among others, the following:


•	announcements of developments in our patent enforcement actions;


•	developments or disputes concerning our patents;


•	our or our competitors’ technological innovations;


•	developments in relationships with licensees;


•	variations in our quarterly operating results;


•	our failure to meet or exceed securities analysts’ expectations of our financial results;


•	a change in financial estimates or securities analysts’ recommendations;


•	changes in management’s or securities analysts’ estimates of our financial performance;


•	changes in market valuations of similar companies;


•	the current sovereign debt crises affecting several countries in the European Union and concerns about sovereign debt of the United States;


•	announcements by us or our competitors of significant contracts, investments, strategic partnerships, joint ventures, capital commitments, new technologies, or patents; and


•	failure to complete significant transactions.

For example, the NASDAQ-100 Technology Sector Index (NDXT) had a range of $1,953.85 - $2,468.15 during the 52-weeks ended December 31, 2015 and the NASDAQ Composite Index (IXIC) had a range of $4,292.14 - $5,231.94 over the same period. Over the same period, our common stock fluctuated within a range of $3.82 - $17.22.

The recent financial crisis affecting the banking system and financial markets and the uncertainty in global economic conditions have resulted in a tightening in the credit markets, a low level of liquidity in many financial markets, and extreme volatility in the credit, equity and fixed income markets. As noted above, our stock price, like many others, has fluctuated significantly in recent periods and if investors have concerns that our business, operating results and financial condition will be negatively impacted by global economic conditions, our stock price could continue to fluctuate significantly in future periods.

In addition, we believe that fluctuations in our stock price during applicable periods can also be impacted by court rulings and/or other developments in our patent licensing and enforcement actions. Court rulings in patent enforcement actions are often difficult to understand, even when favorable or neutral to the value of our patents and our overall business, and we believe that investors in the market may overreact, causing fluctuations in our stock prices that may not accurately reflect the impact of court rulings on our business operations and assets.

In the past, companies that have experienced volatility in the market price of their stock have been the objects of securities class action litigation. If our common stock was the object of securities class action litigation, it could result in substantial costs and a diversion of management’s attention and resources, which could materially harm our business and financial results.

We do not currently intend to pay dividends on our common stock in the foreseeable future, and consequently, your ability to achieve a return on your investment will depend on appreciation in the price of our common stock.

On February 23, 2016, our board of directors eliminated our dividend policy that provided for the discretionary payment of a total annual cash dividend of $0.50 per common share, payable in the amount of $0.125 per share per quarter, effective as of February 23, 2016. As a result, we do not anticipate paying any cash dividends to holders of our common stock in the foreseeable future. Consequently, investors must rely on sales of their common stock after price appreciation, which may never occur, as the only way to realize any future gains on their investments. There is no guarantee that shares of our common stock will appreciate in value or even maintain the price at which our stockholders have purchased their shares.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

ITEM 2. PROPERTIES

Our principal executive, corporate and administrative offices are located in Newport Beach, California, where we lease approximately 17,758 square feet of office space, under a lease agreement that expires in December 2019. Our primary operating subsidiary, Acacia Research Group, LLC, and its subsidiaries, are headquartered in Plano, Texas, where we lease approximately 12,137 square feet of office space, under a lease agreement that expires in June 2020. Certain of our operating subsidiaries also maintain additional leased office space in Woodcliff Lake, New Jersey, Houston, Texas, Tokyo, Japan and Munich, Germany. We believe that our facilities are adequate, suitable and of sufficient capacity to support our immediate needs.

ITEM 3. LEGAL PROCEEDINGS

In the ordinary course of business, we are the subject of, or party to, various pending or threatened legal actions, including various counterclaims in connection with our patent enforcement activities. We believe that any liability arising from these actions will not have a material adverse effect on our consolidated financial position, results of operations or cash flows.

In connection with any of our patent enforcement actions, it is possible that a defendant may claim and/or a court may rule that we have violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against us or our operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material, and if required to be paid by us or our operating subsidiaries, could materially harm our operating results and our financial position.

Our operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights. Certain of our operating subsidiaries are parties to ongoing patent enforcement related litigation, alleging infringement by third-parties of certain of the patented technologies owned or controlled by our operating subsidiaries.

ITEM 4. MINE SAFETY DISCLOSURES

None.

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

General

Our common stock trades on The NASDAQ Global Select Market under the symbol “ACTG.”

Price Range of Common Stock

The high and low sales prices for our common stock as reported by The NASDAQ Global Select Market for the periods indicated are shown in the table below. Such prices are inter-dealer prices without retail markups, markdowns or commissions and may not necessarily represent actual transactions.



	2015				2014
	Fourth Quarter	Third Quarter	Second Quarter	First Quarter	Fourth Quarter	Third Quarter	Second Quarter	First Quarter

High	$9.97	$10.63	$12.51	$17.22	$19.93	$18.74	$18.29	$16.46
Low	$3.82	$7.88	$8.61	$10.18	$13.93	$14.65	$14.68	$13.11

Dividend Policy

On April 23, 2013, we announced that our Board of Directors approved the adoption of a cash dividend policy that called for the payment of an expected total annual cash dividend of $0.50 per common share, payable in the amount of $0.125 per share per quarter. Under the policy, we paid quarterly cash dividends totaling $25.4 million, $25.0 million and $18.6 million during 2015, 2014 and 2013, respectively. On February 25, 2016, we announced that our Board of Directors terminated the company’s dividend policy effective February 23, 2016. The Board of Directors terminated the dividend policy due to a number of factors, including our financial performance and available cash resources, our cash requirements and alternative uses of capital that the Board of Directors concluded would represent an opportunity to generate a greater return on investment for us and our stockholders.

Holders of Common Stock

On March 11, 2016, there were approximately 84 owners of record of our common stock. The majority of the outstanding shares of our common stock are held by a nominee holder on behalf of an indeterminable number of ultimate beneficial owners.

Stock Price Performance Graph

The following stock price performance graph shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any of our filings under the Securities Act.

The Stock Performance Graph depicted below compares the yearly change in our cumulative total stockholder return for the last five fiscal years with the cumulative total return of The NASDAQ Stock Market (U.S.) Composite Index and the NASDAQ-100 Technology Sector Index.



	2011	2012	2013	2014	2015

Acacia Research Corporation common stock	$141	$99	$56	$65	$17
Nasdaq Composite Index (IXIC)	$98	$114	$157	$179	$189
NASDAQ-100 Technology Sector Index (NDXT)	$94	$101	$138	$171	$167

The graph covers the period from December 31, 2010 to December 31, 2015. Cumulative total returns are calculated assuming that $100 was invested on December 31, 2010, in our common stock, in the NASDAQ Composite Index, and in the NASDAQ-100 Technology Sector Index, and that all dividends, if any, were reinvested. Stockholder returns over the indicated period should not be considered indicative of future stock prices or stockholder returns.

ITEM 6. SELECTED FINANCIAL DATA

The consolidated selected balance sheet data as of December 31, 2015 and 2014 and the consolidated selected statements of operations data for the years ended December 31, 2015, 2014 and 2013 set forth below have been derived from our audited consolidated financial statements included elsewhere herein, and should be read in conjunction with those financial statements (including notes thereto). The consolidated selected balance sheet data as of December 31, 2013, 2012 and 2011 and the consolidated selected statements of operations data for the years ended December 31, 2012 and 2011 have been derived from audited consolidated financial statements not included herein, but which were previously filed with the SEC.

Consolidated Statements of Operations Data

(In thousands, except share and per share data)



	For the Years Ended December 31,
	2015			2014			2013			2012			2011

Revenues and other operating income⁽¹⁾	$	125,037		$	130,876		$	130,556		$	250,727		$	184,707
Inventor royalties and contingent legal fees expense⁽¹⁾	34,631			44,233			54,508			50,679			91,669
Litigation and licensing expenses - patents	39,373			37,614			39,335			21,591			13,005
Amortization of patents	53,067			53,745			49,039			39,019			9,745
Marketing, general and administrative expenses (excluding non-cash stock compensation expense)	27,128			30,439			31,335			28,426			22,114
Non-cash stock compensation expense (included in MG&A in the statements of operations)	11,048			18,115			27,894			25,657			13,579
Research, consulting and other expenses - business development	3,391			3,840			3,251			4,943			4,338
Impairment of patent-related intangible assets	74,731			3,497			4,619			—			—
Impairment of goodwill	30,149			—			—			—			—
Other	4,141			1,548			3,506			—			—
Operating income (loss)	$	(152,622	)	$	(62,155	)	$	(82,931	)	$	80,412		$	30,257

Income (loss) from continuing operations before (provision for) benefit from income taxes	$	(152,678	)	$	(62,750	)	$	(80,800	)	$	81,349		$	30,353
(Provision for) benefit from income taxes	(4,800		)	(3,912		)	21,958			(22,060		)	(8,708		)
Net income (loss) from continuing operations including noncontrolling interests in operating subsidiaries	$	(157,478	)	$	(66,662	)	$	(58,842	)	$	59,289		$	21,645
Net income (loss) attributable to Acacia Research Corporation	$	(160,036	)	$	(66,029	)	$	(56,434	)	$	59,453		$	21,106

Diluted income (loss) per common share	$	(3.25	)	$	(1.37	)	$	(1.18	)	$	1.21		$	0.50
Cash dividends declared per common share	$	0.500		$	0.500		$	0.375		$	—		$	—

Consolidated Balance Sheet Data (In thousands)



	At December 31,
	2015		2014		2013		2012		2011

Cash and cash equivalents and investments	$	145,948	$	193,024	$	256,702	$	311,279	$	323,286
Patents, net of accumulated amortization	162,642		286,636		288,432		313,529		25,188
Total assets	347,901		536,348		593,393		668,717		352,877
Total liabilities	33,746		47,300		31,195		50,239		30,765
Noncontrolling interests in operating subsidiaries	3,944		5,491		6,488		6,976		2,163
Acacia Research Corporation stockholders’ equity	310,211		483,557		555,710		611,502		319,949

__________________________________

⁽¹⁾ Includes verdict insurance proceeds and related costs reflected separately in the statement of operations for the year ended December 31, 2011.

Factors Affecting Comparability:


•	As of December 31, 2011, we maintained a full valuation allowance against our net deferred tax assets. Net deferred tax liabilities resulting from an acquisition in January 2012 created an additional source of income to utilize against the

majority of our existing consolidated net deferred tax assets. In addition, we estimated that certain of our other foreign tax credit and state tax related deferred tax assets were more likely than not realizable in future periods. Accordingly, the valuation allowance on the majority of our net deferred tax assets was released, resulting in a financial statement income tax benefit of $10.7 million during the year ended December 31, 2012. At December 31, 2013, we recorded a partial valuation allowance for certain tax attribute carryforwards and other deferred tax assets totaling $7.6 million, due to uncertainty regarding future realizability. We recorded a full valuation allowance for net deferred tax assets generated during fiscal year 2015 and 2014, due to uncertainty regarding future realizability.

•

For the years ended December 31, 2015, 2014, 2013, 2012 and 2011, we paid patent related investment costs totaling $19.5 million, $42.7 million, $25.1 million, $178.3 million (excluding business combinations of $150.0 million) and $14.7 million, respectively. Patent related investment costs are amortized using the straight-line method over the estimated economic useful life of the underlying patents.

•

For the years ended December 31, 2015, 2014, 2013 we recognized patent impairment charges totaling $74.7 million, $3.5 million and $4.6 million respectively. The impairment charges for the periods presented reflect the impact of reductions in expected estimated future net cash flows for certain portfolios due to adverse legal outcomes and certain patent portfolios that management determined it would no longer allocate resources to in future periods. The impairment charges consisted of the excess of the asset’s carrying value over its estimated fair value as of the applicable measurement date.


•	We conducted an annual goodwill impairment test as of December 31, 2015. Based upon the difference between the implied fair value of goodwill and the historical carrying value of goodwill, due primarily to the sustained decline in the Company's stock price and adverse litigation outcomes in the fourth quarter of 2015, we recognized a goodwill impairment charge totaling $30.1 million.

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with our consolidated financial statements included elsewhere in this Annual Report on Form 10-K. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors including the risks we discuss in Item 1A, “Risk Factors,” and elsewhere herein.

General

Our operating subsidiaries generate revenues and related cash flows from the granting of patent rights for the use of patented technologies that our operating subsidiaries control or own. Our operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation.

We are a leader in licensing patented technologies and have established a proven track record of licensing success with over 1,490 license agreements executed to date, across 185 patent portfolio licensing and enforcement programs. Currently, on a consolidated basis, our operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain foreign counterparts, covering technologies used in a wide variety of industries. To date, we have generated gross licensing revenue of approximately $1.2 billion, and have returned more than $703 million to our patent partners.

The patent portfolio investment, development, licensing and enforcement business conducted by our operating subsidiaries is described more fully in Item 1. “Business,” of this annual report.

Executive Overview

During the periods presented, we continued our business of empowering patent owners and rewarding invention by providing a path to patent monetization for the people and companies who have contributed valuable patented inventions to an industry, but who require a professional, experienced independent third-party licensing partner to get rewarded for those inventions. These people and companies are our customers, and in many cases, components of the patent disenfranchised. In so doing, we have placed ourselves at the forefront of an emerging secondary market in patent assets under which holders of high quality patents, including the patent disenfranchised, may be rewarded for the use of their patented inventions by others, even if they do not have the capital and expertise to engage in lengthy, costly and risky patent litigation.

Our operating activities for the periods presented were principally focused on the continued investment in and development of our patent licensing and enforcement business, including the continued pursuit of our ongoing patent licensing and enforcement programs and the commencement of new patent licensing and enforcement programs. In addition, we continued our focus on business development, making additional investments in existing patent portfolios and the investment in additional patent portfolios by certain of our operating subsidiaries, as described below.

Operating activities during the periods presented included the following:



	2015		2014		2013

Revenues (in thousands)	$	125,037	$	130,876	$	130,556
New agreements executed	63		88		120
Licensing and enforcement programs generating revenues - during the respective period	30		46		53
Licensing and enforcement programs with initial revenues	4		15		23
New patent portfolios	3		6		25

We measure and assess the performance and growth of the patent licensing and enforcement businesses conducted by our operating subsidiaries based on consolidated revenues (including other operating income) recognized across all of our patent licensing and enforcement programs on a trailing twelve-month basis. Trailing twelve-month revenues during the periods presented were as follows (in thousands, except percentage change values):



As of Date:	Trailing Twelve -Month Revenues		% Change

December 31, 2015	$	125,037	5	%
September 30, 2015	118,570		(17	)%
June 30, 2015	142,768		(6	)%
March 31, 2015	152,508		17	%
December 31, 2014	130,876		—	%
December 31, 2013	130,556		—

Our revenues historically have fluctuated period to period, and can vary significantly, based on a number of factors including the following:


•	the dollar amount of agreements executed each period, which can be driven by the nature and characteristics of the technology or technologies being licensed and the magnitude of infringement associated with a specific licensee;


•	the specific terms and conditions of agreements executed each period including the nature and characteristics of rights granted, and the periods of infringement or term of use contemplated by the respective payments;


•	fluctuations in the total number of agreements executed each period;


•	the number of, timing, results and uncertainties associated with patent licensing negotiations, mediations, patent infringement actions, trial dates and other enforcement proceedings relating to our patent licensing and enforcement programs;


•	the relative maturity of licensing programs during the applicable periods;


•	other external factors, including the periodic status or results of ongoing negotiations, the status or results of ongoing litigations and appeals, actual or perceived shifts in the regulatory environment, impact of unrelated patent related judicial proceedings and other macroeconomic factors; and


•	historically, based on the merits and strength of our operating subsidiary’s patent infringement claims and other factors, many prospective licensees have elected to settle significant patent infringement cases and pay reasonable license fees for the use of our patented technology, as those patent infringement cases approached a court determined trial date.

Management does not attempt to manage for smooth sequential periodic growth in revenues period to period, and therefore, periodic results can be uneven. Unlike most operating businesses and industries, licensing revenues not generated in a current period are not necessarily foregone but, depending on whether negotiations, litigation or both continue into subsequent periods, and depending on a number of other factors, such potential revenues may be pushed into subsequent fiscal periods.

Summary of Results of Operations - For Fiscal Years 2015, 2014 and 2013

(In thousands, except percentage change values)



	Fiscal Year									% Change
	2015			2014			2013			2015 vs. 2014		2014 vs. 2013

Revenues	$	125,037		$	130,876		$	130,556		(4	)%	—	%
Inventor royalties and contingent legal fees	34,631			44,233			54,508			(22	)%	(19	)%
Litigation and licensing expenses - patents	39,373			37,614			39,335			5	%	(4	)%
Amortization expense	53,067			53,745			49,039			(1	)%	10	%
Impairment of patent-related intangible assets	74,731			3,497			4,619			*		(24	)%
Impairment of goodwill	30,149			—			—			100	%	—	%
Other operating costs and expenses⁽¹⁾	45,708			53,942			65,986			(15	)%	(18	)%
Operating loss	(152,622		)	(62,155		)	(82,931		)	146	%	(25	)%
(Provision for) benefit from income taxes	(4,800		)	(3,912		)	21,958			23	%	(118	)%
Net (income) loss attributable to noncontrolling interests⁽²⁾	(2,558		)	633			2,408			*		(74	)%
Net loss attributable to Acacia Research Corporation	(160,036		)	(66,029		)	(56,434		)	142	%	17	%

____________________________________

* Percentage change in excess of 300%

⁽¹⁾ Includes non-cash stock compensation charges of $11.0 million, $18.1 million and $27.9 million in fiscal years 2015, 2014 and 2013, respectively, included in Marketing, general and administrative expense in the statements of operations.

⁽²⁾ Refer to Note 1 to the notes to consolidated financial statements included elsewhere in this annual report for additional information.

Overview - Fiscal year 2015 compared with Fiscal Year 2014


•	Revenues decreased $5.8 million, or 4% to $125.0 million for fiscal year 2015, as compared to fiscal year 2014.


•	Inventor royalties and contingent legal fees, on a combined basis, decreased $9.6 million, or 22%, due primarily to certain patent portfolios generating revenue in 2015 with a higher amount of cost recoveries and lower contingent fee rates, as compared to the portfolios generating revenues in fiscal year 2014.


•	Litigation and licensing expenses-patents increased $1.8 million, or 5%, to $39.4 million, due primarily to a net increase in litigation support and third-party technical consulting expenses associated with trials occurring in 2015 and scheduled to occur in 2016, and ongoing and new licensing and enforcement programs commenced during fiscal year 2015.

•

Impairment of patent-related intangible asset charges increased $71.2 million, or +300%, to $74.7 million, reflecting the impact of reductions in expected estimated future net cash flows for certain patent portfolios and certain patent portfolios that management determined it would no longer allocate resources to in future periods. The impairment charges consisted of the excess of the asset’s carrying value over its estimated fair value as of the applicable measurement date.

•

In the fourth quarter of fiscal 2015, we performed an impairment analysis of goodwill. Based upon the difference between the implied fair value of goodwill and the historical carrying value of goodwill, due primarily to the sustained decline in the Company's stock price and adverse litigation outcomes occurring in the fourth quarter of 2015, we recognized a goodwill impairment charge totaling $30.1 million in the fourth quarter of 2015.


•	Other Operating Expenses:


◦	Marketing, general and administrative expenses decreased $10.4 million, or 21%, to $38.2 million, due primarily to a net decrease in personnel costs in connection with the net reduction in headcount during 2014 and 2015, a decrease in variable performance-based compensation costs, and a net decrease in non-cash stock compensation expense.


◦	Fiscal year 2015 operating expenses included expenses for court ordered attorney fees totaling $4.1 million. Fiscal year 2014 operating expenses included an expense accrual for court ordered attorney fees related to matters initiated in 2010 and 2011 totaling $1.5 million.

•

Tax expense for the periods presented reflects foreign taxes withheld on revenue agreements with licensees in foreign jurisdictions and other state taxes, and the impact of full valuation allowances recorded for net operating loss and foreign tax credit related tax assets generated during the periods. As such, no tax benefit was recognized for net operating loss and foreign tax credit related tax benefits generated during the periods presented.

Overview - Fiscal year 2014 compared with Fiscal Year 2013


•	Revenues were relatively flat in fiscal year 2014, as compared to fiscal year 2013.


•	Inventor royalties and contingent legal fees, on a combined basis, decreased $10.3 million, or 19%, due primarily to a greater percentage of revenues generated in fiscal year 2014 having no inventor royalty obligations, and lower average inventor royalty rates, as compared to the portfolios generating revenues in fiscal year 2013.


•	Litigation and licensing expenses-patents decreased $1.7 million, or 4%, to $37.6 million, due primarily to a net decrease in litigation support and third-party technical consulting expenses associated with ongoing and new licensing and enforcement programs commenced during fiscal year 2014.


•	Patent amortization increased $4.7 million, or 10%, to $53.7 million, due primarily to an increase in amortization expense related to new patent portfolio investments during 2014 and accelerated patent amortization for patent portfolio dispositions, partially offset by a decrease in accelerated patent amortization related to patent portfolio impairment charges during fiscal year 2014.


•	Other Operating Expenses:

◦

Marketing, general and administrative expenses decreased $10.7 million, or 18%, to $48.6 million, due primarily to a net decrease in personnel costs in connection with the net reduction in headcount during 2014, a decrease in other non-recurring personnel severance costs including the impact of non-recurring cash and non-cash charges associated with the board approved CEO retirement package in 2013, and a net decrease in non-cash stock compensation expense.

◦

Fiscal year 2014 operating expenses included an expense accrual for court determined attorney fees related to matters initiated in 2010 and 2011 totaling $1.5 million. The respective operating subsidiaries have filed notices of appeal. Fiscal year 2013 operating expenses included a one-time, non-recurring charge related to the resolution of a dispute concerning legal fees associated with a prior matter totaling $3.5 million

•

Tax expense for fiscal year 2014 reflects the impact of a full valuation allowance recorded against our net deferred tax assets generated during the period, including a benefit from the reversal of the net deferred tax liability of $1,735,000 at the beginning of the year. As such, no tax benefit was recognized for net operating loss and foreign tax credit related tax benefits generated during the 2014 periods. Tax expense for fiscal year 2014 primarily reflects foreign taxes withheld on revenue agreements with licensees in foreign jurisdictions and other state taxes. See below for discussion of 2013 tax benefit.

Revenues for the periods presented included fees from the following licensing and enforcement programs:



•	360 Degree View Technology⁽¹⁾⁽²⁾	•	Messaging technology^(2)(3)(4)
•	3G & 4G Cellular Air Interface and Infrastructure technology⁽²⁾⁽³⁾	•	Microprocessor and Memory technology^(1)(2)(3)
•	3G & 4G Wireless technology⁽¹⁾⁽⁴⁾	•	Mobile Computer Synchronization technology^(2)(3)(4)
•	4G Wireless technology⁽²⁾⁽³⁾	•	Mobile Enhancement Solutions technology⁽⁴⁾
•	Audio Communications Fraud Detection technology^(2)(3)(4)	•	MRI technology⁽¹⁾⁽⁴⁾
•	Automotive Safety, Navigation and Diagnostics technology^(2)(3)(4)	•	Multi-Display Content Delivery and Data Aggregation technology⁽¹⁾⁽³⁾
•	Bone Wedge technology⁽²⁾	•	NOR Flash technology⁽⁴⁾
•	Broadband Communications technology^(1)(2)(3)(4)	•	Oil and Gas Production technology ^(1)(2)(3)
•	Business Process Modeling technology⁽⁴⁾	•	Online Auction Guarantee technology^(2)(3)(4)
•	Camera Support technology⁽⁴⁾	•	Online Gaming technology⁽³⁾⁽⁴⁾
•	Cardiology and Vascular Device technology^(1)(2)(3)	•	Online newsletters with links technology⁽³⁾⁽⁴⁾



•	Catheter Ablation technology⁽¹⁾	•	Optical Networking technology^(1)(2)(3)(4)
•	Computer Aided Design Tools technology^(1)(3)(4)	•	Optimized Microprocessor Operation technology^(1)(2)(3)
•	Computer Architecture and Power Management technology⁽⁴⁾	•	Power Management within Integrated Circuits technology⁽⁴⁾
•	Computer-Aided Design technology(1)(3)	•	Prescription Lens technology⁽¹⁾⁽⁴⁾
•	Core Fiber Optic Network Architectures technology^(1)(3)(4)	•	Radio Frequency Modulation technology⁽¹⁾⁽³⁾
•	Digital Imaging technology⁽¹⁾⁽⁴⁾	•	Reflective and Radiant Barrier Insulation technology^(1)(2)(3)(4)
•	Digital Signal Processing Architecture technology⁽⁴⁾	•	Semiconductor Memory and Process technology⁽¹⁾⁽⁴⁾
•	DisplayPort and MIPI DSI technology⁽¹⁾	•	Semiconductor Packaging technology^(1)(3)(4)
•	Distributed Data Management & Synchronization technology⁽¹⁾	•	Semiconductor Testing technology⁽¹⁾⁽²⁾
•	DMT® technology⁽³⁾⁽⁴⁾	•	Shared Memory for Multimedia Processing⁽¹⁾
•	Domain Name Redirection technology⁽⁴⁾	•	Software Activation technology⁽³⁾⁽⁴⁾
•	Dynamic Transmissions technology⁽¹⁾⁽⁴⁾	•	Software Technology⁽³⁾
•	Electronic Access Control technology^(1)(2)(3)	•	Speech codes used in wireless and wireline systems technology^(1)(2)(3)
•	Electronic spreadsheet, data analysis and software development technology⁽¹⁾⁽⁴⁾	•	Spinning and Jousting Toy Game technology ^(1)(2)(3)
•	Enhanced Mobile Communications technology⁽²⁾⁽³⁾	•	Super Resolutions Microscopy technology^(1)(2)(3)
•	Facilities Operation Management System technology⁽⁴⁾	•	Surgical Access technology⁽²⁾⁽⁴⁾
•	Gas Modulation Control Systems technology^(1)(2)(3)(4)	•	Suture Anchors technology^(2)(3)(4)
•	Greeting Card technology⁽¹⁾⁽⁴⁾	•	Telematics technology^(2)(3)(4)
•	High Speed Circuit Interconnect and Display Control technology^(1)(2)(3)	•	Unicondylar Knee Replacement technology⁽²⁾
•	Improved Lighting technology⁽²⁾⁽³⁾	•	User Programmable Engine Control technology⁽⁴⁾
•	Improved Memory Manufacturing technology⁽⁴⁾	•	Video Analytics for Security technology^(2)(3)(4)
•	Information Portal Software technology⁽⁴⁾	•	Video Delivery and Processing technology⁽⁴⁾
•	Information Storage, Searching & Retrieval technology⁽⁴⁾	•	Voice-Over-IP technology⁽²⁾⁽³⁾
•	Inhaler Drug Delivery technology⁽¹⁾⁽⁴⁾	•	Web Collaboration technology⁽¹⁾⁽⁴⁾
•	Innovative Display technology^(1)(2)(3)	•	Wireless Data Synchronization & Data Transfer technology^(1)(2)(3)(4)
•	Intercarrier SMS technology^(1)(2)(3)(4)	•	Wireless Infrastructure and User Equipment technology^(1)(2)(3)
•	Interstitial and Pop-Up Internet Advertising technology^(2)(3)(4)	•	Wireless Location Based Services technology⁽²⁾⁽³⁾
•	Lighting Ballast technology⁽⁴⁾	•	Wireless Location Based Services technology⁽¹⁾⁽⁴⁾
•	Location Based Services technology^(2)(3)(4)	•	Wireless Monitoring technology⁽²⁾⁽³⁾
•	Memory Circuit and Packaging technology⁽¹⁾⁽⁴⁾	•	X-Ray Powder Diffraction technology⁽¹⁾⁽⁴⁾

______________________________________



⁽¹⁾	Initial revenues recognized during the applicable period.
⁽²⁾	Licensing and enforcement program generating revenue in 2015.
⁽³⁾	Licensing and enforcement program generating revenue in 2014.
⁽⁴⁾	Licensing and enforcement program generating revenue in 2013.

Although revenues from one or more of our patents or patent portfolios may be significant in a specific reporting period, we believe that none of our individual patents or patent portfolios is individually significant to our licensing and enforcement business as a whole.

Patent Licensing and Enforcement

Patent Litigation Trial Dates and Related Trials. As of the date of this report, our operating subsidiaries have in excess of 5 pending patent infringement cases with a scheduled trial date in the next six months. Patent infringement trials are components of our overall patent licensing process and are one of many factors that contribute to possible future revenue generating opportunities for us. Scheduled trial dates, as promulgated by the respective court, merely provide an indication of when, in future periods, the trials may occur according to the court’s scheduling calendar at a specific point in time. A court may change previously scheduled trial dates. In fact, courts often reschedule trial dates for various reasons that are unrelated to the underlying patent assets and typically for reasons that are beyond our control. While scheduled trial dates provide an indication of the timing of possible future revenue generating opportunities for us, the trials themselves and the immediately preceding periods represent the possible future revenue generating opportunities. These future opportunities can result in varying outcomes. In fact, it is difficult to predict the outcome of patent enforcement litigation at the trial level since outcomes can be unfavorable. It is often difficult for juries and trial judges to understand complex patented technologies, and as a result, this may lead to a higher rate of unfavorable outcomes. Moreover, in the event of a favorable outcome, there is a higher rate of

successful appeals in patent enforcement litigation than more standard business litigation. Such appeals are expensive and time consuming, resulting in increased costs and a potential for delayed or foregone revenue opportunities in the event of modification or reversal of favorable outcomes. Although we diligently pursue enforcement litigation, we cannot predict with significant reliability the decisions made by juries and trial courts. Please refer to Item 1A. "Risk Factors" for additional information regarding trials, patent litigation and related risks.

Litigation and Licensing Expense. We expect patent-related legal expenses to continue to fluctuate from period to period based on the factors summarized herein, in connection with future trial dates, international enforcement, strategic patent portfolio prosecution and our current and future patent portfolio investment, prosecution, licensing and enforcement activities. The pursuit of enforcement actions in connection with our licensing and enforcement programs can involve certain risks and uncertainties, including the following:

•

Increases in patent-related legal expenses associated with patent infringement litigation, including, but not limited to, increases in costs billed by outside legal counsel for discovery, depositions, economic analyses, damages assessments, expert witnesses and other consultants, re-exam and inter partes review costs, case-related audio/video presentations and other litigation support and administrative costs could increase our operating costs and decrease our profit generating opportunities;


•	Our patented technologies and enforcement actions are complex and, as a result, we may be required to appeal adverse decisions by trial courts in order to successfully enforce our patents. Moreover, such appeals may not be successful;

•

New legislation, regulations or rules related to enforcement actions, including any fee or cost shifting provisions, could significantly increase our operating costs and decrease our profit generating opportunities. Increased focus on the growing number of patent-related lawsuits may result in legislative changes which increase our costs and related risks of asserting patent enforcement actions. For instance, the United States House of Representatives passed a bill that would require non-practicing entities that bring patent infringement lawsuits to pay legal costs of the defendants, if the lawsuits are unsuccessful and certain standards are not met;


•	Courts may rule that our subsidiaries have violated certain statutory, regulatory, federal, local or governing rules or standards by pursuing such enforcement actions, which may expose us and our operating subsidiaries to material liabilities, which could harm our operating results and our financial position; and


•	The complexity of negotiations and potential magnitude of exposure for potential infringers associated with higher quality patent portfolios may lead to increased intervals of time between the filing of litigation and potential revenue events (i.e. markman dates, trial dates), which may lead to increased legal expenses, consistent with the higher revenue potential of such portfolios.

In the fourth quarter of 2015, we announced that our subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, Inc., AT&T Mobility LLC, Cellco Partnership, and Sprint Spectrum L.P., lead case 6:12-cv-00022 pending in the Eastern District of Texas. The jury returned a verdict that the asserted claims of U.S. Patent No. 6,870,808 were invalid and non-infringed. Adaptix, Inc. has filed post-trial motions and is currently studying the verdict to determine whether it will be filing an appeal.

Investments in Patent Portfolios

Our operating subsidiaries continue to identify opportunities to partner with patent owners with high-quality patent assets, across a wide range of technology areas that have been, or are anticipated to be, widely adopted by third-parties in connection with the manufacture or sale of products and services.

In fiscal year 2015, we obtained control of 3 new patent portfolios with applications over a wide range of technology areas, compared to 6 new patent portfolios, and 25 new patent portfolios in fiscal years 2014 and 2013, respectively. During 2015, we partnered with a semiconductor company on a portfolio containing patents related to Flash Memory components and controllers, Solid-State Drives (SSD’s) and other systems containing Flash Memory. In addition, we expanded our partnership with Renesas of Japan, enhancing existing portfolios with nine additional groups of patents related to Microcontrollers, DRAM, Flash Memory and semiconductor packaging and fabrication processes. Patent portfolio investment costs paid in fiscal year 2015 totaled $19.5 million, compared to $42.7 million and $25.1 million in fiscal years 2014 and 2013, respectively. Accrued patent investment costs, to be paid in the subsequent year, totaled $1.0 million and $16.7 million at December 31, 2015 and 2014, respectively.

In general, the majority of patent portfolio investment costs incurred for patent portfolios with future inventor royalty obligations are subject to contractual provisions providing for higher percentage returns to our operating subsidiaries early in the licensing and enforcement program until such initial upfront patent portfolio investment costs are fully recovered.

As of December 31, 2015, certain of our operating subsidiaries continued to explore opportunities to enter into option agreements with third-party patent portfolio owners regarding the potential partnering and / or investment in additional patent portfolios for future licensing and enforcement. Future patent portfolio investments will expand and diversify our future revenue generating opportunities.

Neither we nor our operating subsidiaries invent new technologies or products; rather, we depend upon the identification and investment in new patents and inventions through our new or existing relationships with patent owners. If our operating subsidiaries are unable to maintain those relationships and to continue to grow new relationships, then they may not be able to identify new technology-based opportunities for sustainable revenue and growth. In this regard, our current or future relationships may not provide the volume or quality of technologies necessary to sustain our business. In some cases, universities and other technology sources may compete against us as they seek to develop and commercialize technologies. Universities may receive financing for basic research in exchange for the exclusive right to commercialize resulting inventions. These and other strategies may reduce the number of technology sources and potential clients to whom we can market our services. If we are unable to maintain current relationships and sources of technology or to secure new relationships and sources of technology, such inability may have a material adverse effect on our operating results and financial condition.

For example, in fiscal year 2015, we obtained control of 3 new patent portfolios with applications over a wide range of technology areas, compared to 6 new patent portfolios, and 25 new patent portfolios in fiscal years 2014 and 2013, respectively. The decrease in patent portfolio intake, in part reflects a strategic decision in 2013 to shift the focus of our operating business to increasingly serve a smaller number of customers each having higher quality patent portfolios. High quality patent portfolios are typically associated with higher numbers of varied defensible claims, higher revenue potential, originating from high-pedigreed patent owners and/or possessing a relatively large number of prospective licensees. In this regard, commencing in the later portion of 2013 and early 2014, we continued the shift in our focus at our point of patent intake, from quantity to quality. As a result, our gross number of patent portfolio acquisitions has trended downward. The decrease may also be reflective, in part, of industry trends impacting our ability to acquire patent portfolios. For example, legislative and legal changes have increased the complexity of patent enforcement and may be affecting the market availability of suitable patent portfolios for acquisition. If these industry trends continue, our future patent portfolio intake could be negatively impacted, resulting in a decrease in future revenue generating opportunities.

Critical Accounting Policies

Our consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America. In preparing these financial statements, we make assumptions, judgments and estimates that can have a significant impact on amounts reported in our consolidated financial statements. We base our assumptions, judgments and estimates on historical experience and various other factors that we believe to be reasonable under the circumstances. Actual results could differ materially from these estimates under different assumptions or conditions. On a regular basis, we evaluate our assumptions, judgments and estimates and make changes accordingly.

We believe that, of the significant accounting policies discussed in Note 2 to our notes to consolidated financial statements, the following accounting policies require our most difficult, subjective or complex judgments:


•	revenue recognition;


•	stock-based compensation expense;


•	valuation of long-lived and intangible assets including goodwill; and


•	accounting for income taxes.

We discuss below the critical accounting assumptions, judgments and estimates associated with these policies. Historically, our assumptions, judgments and estimates relative to our critical accounting policies have not differed materially from actual results. For further information on our critical accounting policies, refer to Note 2 to the notes to consolidated financial statements included herein.

Revenue Recognition

As described below, significant management judgment must be made and used in connection with the revenue recognized in any accounting period. Material differences may result in the amount and timing of revenue recognized or deferred for any period, if management made different judgments.

Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been performed pursuant to the terms of the agreement, (iii) amounts are fixed or determinable and (iv) collectibility of amounts is reasonably assured.

We make estimates and judgments when determining whether the collectibility of fees receivable from licensees is reasonably assured. We assess the collectibility of fees receivable based on a number of factors, including past transaction history and the credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectibility becomes reasonably assured, assuming all other revenue recognition criteria have been met, which is generally upon receipt of cash for transactions where collectibility may have been an issue. Management’s estimates regarding collectibility impact the actual revenues recognized each period and the timing of the recognition of revenues. Our assumptions and judgments regarding future collectibility could differ from actual events and thus materially impact our financial position and results of operations.

In general, our revenue arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by our operating subsidiaries. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by our operating subsidiaries, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined, relatively short period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for an additional minimum upfront payment. Pursuant to the terms of these agreements, our operating subsidiaries have no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on our operating subsidiaries’ part to maintain or upgrade the technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the minimum upfront payment for term agreement renewals. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectibility is reasonably assured, or upon receipt of the minimum upfront fee for term agreement renewals, and when all other revenue recognition criteria have been met.

Depending on the complexity of the underlying revenue arrangement and related terms and conditions, significant judgments, assumptions and estimates may be required to determine when substantial delivery of contract elements has occurred, whether any significant ongoing obligations exist subsequent to contract execution, whether amounts due are collectible and the appropriate period or periods in which, or during which, the completion of the earnings process occurs. Depending on the magnitude of specific revenue arrangements, if different judgments, assumptions and estimates are made regarding contracts executed in any specific period, our periodic financial results may be materially affected.

Our operating subsidiaries are responsible for the licensing and enforcement of their respective patented technologies and pursue third-parties that are utilizing their intellectual property without a license or who have under-reported the amount of royalties owed under a license agreement. As a result of these activities, from time to time, our operating subsidiaries may recognize revenues in a current period that relate to infringements by licensees that occurred in prior periods. These recoveries may cause revenues to be higher than expected during a particular reporting period and may not occur in subsequent periods. Differences between amounts initially recognized and amounts subsequently audited or reported as an adjustment to those amounts, are recognized in the period such adjustment is determined as a change in accounting estimate.

The economic terms of the inventor agreements, operating agreements and contingent legal fee arrangements associated with the patent portfolios owned or controlled by our operating subsidiaries, if any, including royalty rates, contingent fee rates and other terms, vary across the patent portfolios owned or controlled by our operating subsidiaries. Inventor royalties, noncontrolling interests and contingent legal fees expenses fluctuate period to period, based on the amount of revenues recognized each period, the terms and conditions of revenue agreements executed each period and the mix of specific patent portfolios with varying economic terms and obligations generating revenues each period. Inventor royalties, noncontrolling interests and contingent legal fees expenses will continue to fluctuate and may continue to vary significantly period to period, based primarily on these factors.

For fiscal years 2015, 2014 and 2013, the majority of our revenue agreements provided for the payment to us of one-time, paid-up license fees in consideration for the grant of certain intellectual property rights for patented technology rights owned by our operating subsidiaries. These rights were primarily granted on a perpetual basis, extending until the expiration of the underlying patents. Pursuant to the terms of these agreements, our operating subsidiaries have no further obligation with respect to the grant of the non-exclusive licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on our operating subsidiaries’ part to maintain or upgrade the technology, or provide future support or services. The agreements provided for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement. As such, the earnings process was determined to be complete and revenue was recognized upon the execution of the agreements, when all other revenue recognition criteria were met. Historically, term license agreements have not been a material component of our operating revenues, with the majority of license agreements being paid-up, perpetual license agreements.

Stock-based Compensation Expense

Stock-based compensation payments to employees and non-employee directors are recognized as expense in the statements of operations. The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the award (determined using a Black-Scholes option pricing model for stock options and intrinsic value on the date of grant for nonvested restricted stock), and is recognized as an expense over the employee’s requisite service period (generally the vesting period of the equity award). Determining the fair value of stock-based awards at the grant date requires significant estimates and judgments, including estimating the market price volatility of our common stock, future employee stock option exercise behavior and requisite service periods.

Stock-based compensation expense is recorded only for those awards expected to vest using an estimated pre-vesting forfeiture rate. As such, we are required to estimate pre-vesting option forfeitures at the time of grant and reflect the impact of estimated pre-vesting option forfeitures on compensation expense recognized. Estimates of pre-vesting forfeitures must be periodically revised in subsequent periods if actual forfeitures differ from those estimates. We consider several factors in connection with our estimate of pre-vesting forfeitures, including types of awards, employee class, and historical pre-vesting forfeiture data. The estimation of stock awards that will ultimately vest requires judgment, and to the extent that actual results differ from our estimates, such amounts will be recorded as cumulative adjustments in the period the estimates are revised. If actual results differ significantly from these estimates, stock-based compensation expense and our results of operations could be materially impacted. Refer to Notes 2 and 10 to our notes to consolidated financial statements included elsewhere herein.

Valuation of Long-lived and Intangible Assets Including Goodwill

December 31, 2015 Patent Portfolio and Goodwill Impairment Testing. Pursuant to applicable accounting standards, if goodwill and another asset group of a reporting unit are tested for impairment at the same time, the other asset group, in our case our patent portfolios, are to be tested for impairment before goodwill.

Patent Portfolio Impairment testing - December 31, 2015. Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded equal to the excess of the asset’s carrying value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows.

We performed an impairment analysis for our patents as of December 31, 2015, utilizing the assistance of a third-party valuation specialist, resulting in $74.7 million of patent portfolio impairment charges, for the following reasons:

•

In December 2015, we announced that our subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, Inc., and others. The jury returned a verdict that the asserted claims of the applicable patent at issue were invalid and non-infringed. The Adaptix trial loss resulted in a reduction in estimated cash flows for the Adaptix portfolio expected to be realized from future licensing and enforcement activities, leading to impairment charges on the portfolio in the fourth quarter of 2015.

•

Management considered the impact of the fourth quarter 2015 adverse trial outcomes on our estimates of future cash flows that could be realized from future licensing and enforcement activities for other patent portfolios. Estimates of future cash flows for certain portfolios were reduced in part, in connection with our assessment of probabilities of realization given the recent adverse trial outcomes.

•

Patent impairment charges include the carrying value of other patent portfolios for which, in the fourth quarter of 2015, we experienced adverse litigation or trial outcomes, leading to a reduction in or elimination of expected future cash flows. In addition, headcount reductions and internal staff optimization efforts led to changes with respect to which patent portfolios we intend to allocate licensing and enforcement resources to in future periods. As such, certain portfolio programs were selected for termination due to a decision to no longer pursue or allocate resources, resulting in a write-off of any remaining carrying value in the fourth quarter of 2015.

Goodwill Impairment Testing - December 31, 2015. At December 31, 2015, prior to the completion of the annual goodwill impairment test, the goodwill balance totaled $30.1 million. Goodwill is tested for impairment at our single reporting unit level on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. Factors considered important, which could trigger an impairment review, include the following:


•	significant consistent gradual decline in the Company's stock price for a sustained period;


•	significant underperformance relative to expected historical or projected future operating results;


•	significant changes in the manner of use of assets or the strategy for the Company's overall business;


•	significant negative industry or economic trends; and


•	significant adverse changes in legal factors or in the business climate, including adverse regulatory actions or assessments.

The Company considers its market capitalization and other valuation techniques, as applicable, when estimating fair value for goodwill impairment testing purposes. When conducting annual and interim goodwill impairment assessments, the Company initially performs a qualitative evaluation (considering factors described above as applicable) of whether it is more likely than not that goodwill is impaired. If it is determined by a qualitative evaluation that it is more likely than not that goodwill is impaired, a two-step impairment test is applied. The two-step impairment test first compares the estimated fair value of the Company's single reporting unit to its carrying or book value. If the estimated fair value of the reporting unit exceeds its carrying value, goodwill is not impaired and there is no requirement to perform further testing. If the carrying value of the reporting unit exceeds its estimated fair value, the Company is required to perform step-two of the impairment analysis to determine the estimated implied fair value of the reporting unit’s goodwill, and if the carrying value of the reporting unit’s goodwill exceeds its estimated implied fair value, then an impairment loss equal to the difference is recorded in the consolidated statements of operations.

In connection with our annual goodwill impairment testing for 2015, we identified several qualitative factors triggering an impairment test at December 31, 2015, as follows;

•

Adverse legal outcomes and changes in legal factors. In December 2015, we announced that our subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, et al., deciding that the claims of the applicable patent in suit were invalid and non-infringed. This adverse legal outcome and others in the fourth quarter of 2015 resulted in changes in estimates of realization related to litigation outcomes in future periods for certain patent portfolios.

•

Consistent gradual decline in the Company’s stock price: Historically, the Company's stock price has been volatile, and the volatility continued during fiscal 2015, declining from $16.72 as of January 2, 2015, to $4.29 as of December 31, 2015, a 74% decline. In addition, subsequent to December 31, 2015, the Company's stock price volatility has continued, trending downward to $3.16 as of February 29, 2016. In the fourth quarter of 2015, given the continued decline in stock price up through December 31, 2015, and the impact of the December 2015 adverse trial outcomes noted above, the gradual consistent decline in our stock price was deemed to be sustained, and hence indicative of a reduction in the estimated fair value of the Company, as reflected in our lower overall market capitalization.

•

Changes in Company Management and Resource Allocations. In connection with certain resource allocation changes within the organization given a change in management in the fourth quarter of 2015, headcount reductions and internal staff optimization efforts occurred, which led to changes with respect to estimates of which patent portfolios we intend to continue to allocate licensing and enforcement resources to in future periods. As such, certain patent portfolio programs were selected for termination due to a decision to no longer allocate resources. In addition, changes in estimates regarding the best and highest use of certain patent portfolios were made, resulting in reductions in estimated future cash flows.

At December 31, 2015, we utilized the following methods and assumptions in our annual goodwill impairment testing, which was prepared with the assistance of a third-party valuation specialist:

•

At December 31, 2015, the initial qualitative assessment included consideration of the factors described above, resulting in a conclusion that as of December 31, 2015, the consistent gradual decline in the Company’s stock price was sustained. We also considered the impact of the December 2015 adverse trial outcomes on our stock price and related estimates of fair value for remaining portfolio opportunities. Based on our assessment of these factors, we determined that it was more likely than not that goodwill was impaired, constituting a triggering event requiring a goodwill impairment test as of December 31, 2015.

•

We conducted the first step of the goodwill impairment test for our single reporting unit as of December 31, 2015. We utilized the market capitalization plus cost synergies approach to estimate the fair value of the Company. The estimated market capitalization was determined by multiplying our stock price and the common shares outstanding as of December 31, 2015. Management also considered a control premium in its estimate of fair value for our single reporting unit. The cost synergies were estimated based on the cost savings which could be achieved if the Company was acquired by a competitor in the same operating business.


•	Based on the analysis utilizing the market capitalization plus cost synergies approach, the estimated fair value of the reporting unit of $252 million was below its carrying value of $344.3 million as of December 31, 2015, and therefore, goodwill was determined to be more likely than not, impaired.

•

The purpose of step 2 of the analysis was to determine the estimated fair value of the assets and liabilities of our reporting unit, in order to determine the implied fair value of goodwill for the reporting unit. The excess, if any, of the fair value of a reporting unit over the amounts assigned to its assets and liabilities is the implied fair value of goodwill. Based upon the analysis performed, the fair value of our reporting unit did not exceed the amounts assigned to our reporting unit assets and liabilities, resulting in a difference between the implied fair value of goodwill of zero and the historical carrying value of goodwill. As a result, we recognized a goodwill impairment charge totaling $30.1 million in the fourth quarter of 2015.

Accounting for Income Taxes

As part of the process of preparing our consolidated financial statements, we are required to estimate our income taxes in each of the jurisdictions in which we operate. This process involves the estimating of our actual current tax exposure together with assessing temporary differences resulting from differing treatment of items. These differences result in deferred tax assets and liabilities, which are included within our consolidated balance sheets. We must then assess the likelihood that our deferred tax assets will be recovered from future taxable income and to the extent we believe that recovery is not likely, we must establish a valuation allowance. To the extent we establish a valuation allowance or increase this allowance in a period, we must include an expense within the tax provision in the consolidated statements of operations.

Significant management judgment is required in determining our provision for income taxes, our deferred tax assets and liabilities and our valuation allowance. Due to uncertainties related to our ability to utilize certain deferred tax assets in future periods, we have recorded a full valuation allowance against our net deferred tax assets as of December 31, 2015. These assets primarily consist of foreign tax credits, capital loss carryforwards and net operating loss carryforwards.

In assessing the need for a valuation allowance, management has considered both the positive and negative evidence available, including but not limited to, estimates of future taxable income and related probabilities, estimates surrounding the character of future income and the timing of realization, consideration of the period over which our deferred tax assets may be recoverable, our recent history of net income and prior history of losses, projected future outcomes, industry and market trends and the nature of existing deferred tax assets. In management’s estimate, any positive indicators, including forecasts of potential future profitability of our businesses, are outweighed by the uncertainties surrounding our estimates and judgments of potential future taxable income, primarily due to uncertainties surrounding the timing of realization of future taxable income and the character of such income in particular future periods (i.e. foreign or domestic). In the event that actual results differ from these estimates or we adjust these estimates should we believe we would be able to realize these deferred tax assets in the future, an adjustment to the valuation allowance would increase income in the period such determination was made.

For example, a similar analysis was performed in the first quarter of 2012, resulting in the release of the valuation allowance on the majority of our net deferred tax assets and a related tax benefit of $10.7 million recognized in the first quarter of 2012. In 2015 and 2014, based on management’s assessment, a full valuation allowance was recorded against the company’s net deferred tax assets generated during the periods and the balances as of the end of each of the periods, due to uncertainty

regarding future realizability of such tax assets pursuant to guidance set forth in ASC 740, “Income Taxes.” In future periods, if we determine that the company will more likely than not be able to realize certain of these amounts, the applicable portion of the benefit from the release of the valuation allowance will generally be recognized in the statement of operations in the period the determination is recorded.

Any changes in the judgments, assumptions and estimates associated with our analysis of the need for a valuation allowance in any future periods could materially impact our financial position and results of operations in the periods in which those determinations are made.

Consolidated Results of Operations

Comparison of the Results of Operations for Fiscal Years 2015, 2014 and 2013

Revenues



							2015 vs. 2014					2014 vs. 2013
	2015		2014		2013		$ Change			% Change		$ Change		% Change
	(in thousands, except percentage change values and number of agreements)
Revenues	$	125,037	$	130,876	$	130,556	$	(5,839	)	(4	)%	$	320	—	%
New revenue agreements executed	63		88		120
Average revenue per agreement	$	1,985	$	1,487	$	1,088

A reconciliation of the change in revenues (based on average revenue per agreement) for the periods presented, in relation to the revenues reported for the comparable prior year period, is as follows:



	2015 vs. 2014			2014 vs. 2013
	(in thousands)
Decrease in number of agreements executed	$	(37,181	)	$	(34,815	)
Increase in average revenue per agreement executed	31,342			35,135
Total	$	(5,839	)	$	320

Three licensees individually accounted for 24%, 20% and 16%, respectively, of revenues recognized in fiscal year 2015, two licensees individually accounted for 22% and 22%, respectively, of revenues recognized in fiscal year 2014, and two licensees individually accounted for 38% and 16%, respectively, of revenues recognized in fiscal year 2013. For the periods presented herein, the majority of the revenue agreements executed provided for the payment of one-time, paid-up license fees in consideration for the grant of certain intellectual property rights for patented technology rights owned by our operating subsidiaries. These rights were primarily granted on a perpetual basis, extending until the expiration of the underlying patents.

Net Loss



										2015 vs. 2014					2014 vs. 2013
	2015			2014			2013			$ Change			% Change		$ Change			% Change
	(in thousands, except percentages)
Net loss attributable to Acacia Research Corporation	$	(160,036	)	$	(66,029	)	$	(56,434	)	$	(94,007	)	142	%	$	(9,595	)	17	%

A reconciliation of the change in net income (loss) for the periods presented is as follows:



	2015 vs. 2014			%		2014 vs. 2013			%
	(in thousands, except percentage values)
Increase (decrease) in revenues	$	(5,839	)	6	%	$	320		(3	)%
Decrease in inventor royalties and contingent legal fees combined	9,602			(10	)%	10,275			(107	)%
Decrease in marketing, general and administrative expenses	10,378			(11	)%	10,675			(111	)%
(Increase) decrease in litigation and licensing expenses	(1,759		)	2	%	1,721			(18	)%
(Increase) decrease in patent amortization expenses	678			(1	)%	(4,706		)	49	%
(Increase) decrease in impairment of patent-related intangible assets	(71,234		)	76	%	1,122			(12	)%
(Increase) in impairment for goodwill	(30,149		)	32	%	—			—	%
Change in provision for income taxes	(888		)	1	%	(25,870		)	270	%
Other	(4,796		)	5	%	(3,132		)	32	%
Net change in net loss	$	(94,007	)	100	%	$	(9,595	)	100	%

Cost of Revenues



							2015 vs. 2014					2014 vs. 2013
	2015		2014		2013		$ Change			% Change		$ Change			% Change
	(in thousands, except percentages)
Inventor royalties	$	18,462	$	20,670	$	29,724	$	(2,208	)	(11	)%	$	(9,054	)	(30	)%
Contingent legal fees	16,169		23,563		24,784		(7,394		)	(31	)%	(1,221		)	(5	)%
Litigation and licensing expenses - patents	39,373		37,614		39,335		1,759			5	%	(1,721		)	(4	)%
Amortization of patents	53,067		53,745		49,039		(678		)	(1	)%	4,706			10	%

Inventor Royalties and Contingent Legal Fees Expense. The economic terms of patent partnering agreements, operating agreements and contingent legal fee arrangements, associated with the patent portfolios owned or controlled by our operating subsidiaries, if any, including royalty obligations, if any, royalty rates, contingent fee rates and other terms and conditions, vary across the patent portfolios owned or controlled by our operating subsidiaries. In certain instances, we have invested in certain patent portfolios without future inventor royalty obligations. These costs fluctuate period to period, based on the amount of revenues recognized each period, the terms and conditions of revenue agreements executed each period and the mix of specific patent portfolios with varying economic terms, conditions and obligations generating revenues each period.

A summary of the main drivers of the change in inventor royalties expense and contingent legal fees expense, in relation to the change in total revenues, for the comparable periods presented, is as follows:



	2015 vs. 2014			% of Prior Period Balance		2014 vs. 2013			% of Prior Period Balance
Inventor Royalties:	(in thousands, except percentage change values)
Decrease in inventor royalty rates	$	(3,995	)	(20	)%	$	(5,044	)	(16	)%
Increase (decrease) in total revenues	(1,214		)	(6	)%	82			—	%
Decrease (increase) in revenues without inventor royalty obligations	3,001			15	%	(4,092		)	(14	)%
Total change - inventor royalties expense	$	(2,208	)	(11	)%	$	(9,054	)	(30	)%



	2015 vs. 2014			% of Prior Period Balance		2014 vs. 2013			% of Prior Period Balance
Contingent Legal Fees:	(in thousands, except percentage change values)
Decrease in contingent legal fee rates	$	(6,400	)	(27	)%	$	(601	)	(2	)%
Increase (decrease) in total revenues	(1,096		)	(4	)%	61			—	%
Decrease (increase) in revenues without contingent legal fee obligations	102			—	%	(681		)	(3	)%
Total change - contingent legal fees	$	(7,394	)	(31	)%	$	(1,221	)	(5	)%

Litigation and Licensing Expenses - Patents. Litigation and licensing expenses-patents include patent-related litigation, enforcement and prosecution costs incurred by external patent attorneys engaged on an hourly basis and the out-of-pocket expenses incurred by law firms engaged on a contingent fee basis. Litigation and licensing expenses-patents also includes licensing and enforcement related third-party patent research, development, prosecution, re-exam and inter partes reviews, consulting, and other costs incurred in connection with the licensing and enforcement of patent portfolios. Litigation and licensing expenses-patents fluctuate from period to period based on patent enforcement and prosecution activity associated with ongoing licensing and enforcement programs and the timing of the commencement of new licensing and enforcement programs in each period.

Fiscal year 2015 litigation and licensing expenses-patents increased, as compared to fiscal year 2014, due primarily to a net increase in litigation support and third-party technical consulting expenses associated with trials occurring in 2015 and scheduled to occur in 2016, and ongoing and new licensing and enforcement programs commenced during fiscal year 2015.

Fiscal year 2014 litigation and licensing expenses-patents decreased, as compared to fiscal year 2013, due primarily to a net decrease in litigation support and third-party technical consulting expenses associated with ongoing and new licensing and enforcement programs commenced during fiscal year 2014.

We expect patent-related legal expenses to continue to fluctuate period to period as we incur increased costs related to upcoming scheduled and/or anticipated trial dates, international enforcement activities and strategic patent portfolio prosecution activities over the next several fiscal quarters, as we continue to focus on our investments in these areas.

Amortization of Patents. The change in amortization expense for the comparable periods presented was due to the following:



	2015 vs. 2014			2014 vs. 2013
	(in thousands)
Amortization of patent portfolio investments made since the end of the prior year	$	402		$	2,534
Scheduled amortization related to patent portfolios owned or controlled as of the end of the prior year	2,489			562
Accelerated amortization related to recovery of upfront advances	(1,247		)	655
Patent portfolio dispositions	(2,322		)	955
Total change in patent amortization expense	$	(678	)	$	4,706

Impairment Charges



							2015 vs. 2014				2014 vs. 2013
	2015		2014		2013		$ Change		% Change		$ Change			% Change
	(in thousands, except percentages)
Impairment of patent-related intangible assets	$	74,731	$	3,497	$	4,619	$	71,234	2,037	%	$	(1,122	)	(24	)%
Impairment of goodwill	30,149		—		—		30,149		100	%	—			—	%

Patent Impairment Charges

2015 versus 2014. Patent portfolio impairment charges totaled $74.7 million and $3.5 million in fiscal years 2015 and 2014, respectively. The impairment charges for the periods presented reflect the impact of reductions in expected estimated future net cash flows for certain portfolios due to adverse litigation outcomes and industry factors and certain patent portfolios that management determined it would no longer allocate licensing and enforcement resources to in future periods. The impairment charges consisted of the excess of the asset’s carrying value over its estimated fair value as of the applicable measurement date. Refer to Critical Accounting Policies elsewhere herein for additional information.

2014 versus 2013. Patent portfolio impairment charges totaled $3.5 million and $4.6 million in fiscal years 2014 and 2013, respectively. The impairment charges related to partial impairment of a portfolio due to a reduction in expected estimated future net cash flows (2014 only) and the impairment of certain patent portfolios that management determined it would no longer allocate future resources to in connection with the licensing and enforcement of such portfolios, due primarily to potential prior art related complexities in two of the programs (2013 only), and/or the overall determination that future resources would be allocated to other licensing and enforcement programs with higher potential return profiles.

Impairment of Goodwill

We conducted an annual goodwill impairment test as of December 31, 2015. Based upon the difference between the implied fair value of goodwill and the historical carrying value of goodwill, due primarily to the sustained decline in the Company's stock price and adverse litigation outcomes in the fourth quarter of 2015, we recognized a goodwill impairment charge totaling $30.1 million in the fourth quarter of 2015. Refer to Critical Accounting Policies elsewhere herein for additional information.

Operating Expenses



							2015 vs. 2014					2014 vs. 2013
	2015		2014		2013		$ Change			% Change		$ Change			% Change
	(in thousands, except percentages)
Marketing, general and administrative	$	27,128	$	30,439	$	31,335	$	(3,311	)	(11	)%	$	(896	)	(3	)%
Non-cash stock compensation	11,048		18,115		27,894		(7,067		)	(39	)%	(9,779		)	(35	)%
Total marketing, general and administrative expenses	$	38,176	$	48,554	$	59,229	$	(10,378	)	(21	)%	$	(10,675	)	(18	)%

Research, consulting and other expenses - business development	3,391		3,840		3,251		(449		)	(12	)%	589			18	%

Marketing, General and Administrative Expenses. Marketing, general and administrative expenses include employee compensation and related personnel costs, including variable performance based compensation and non-cash stock compensation expenses, office and facilities costs, legal and accounting professional fees, public relations, marketing, stock administration, state taxes based on gross receipts and other corporate costs. A summary of the main drivers of the change in marketing, general and administrative expenses for the periods presented, is as follows (in thousands):



	2015 vs. 2014			2014 vs. 2013
	(in thousands)
Net change in personnel costs	$	(1,264	)	$	(1,142	)
Variable performance-based compensation costs	(1,631		)	274
Corporate, general and administrative costs	(985		)	1,353
Non-cash stock compensation expense	(7,067		)	(7,956		)
Non-recurring CEO retirement and other employee severance costs	569			(165		)
Nonrecurring non-cash stock compensation - CEO retirement package	—			(1,823		)
Other	—			(1,216		)
Total change in marketing, general and administrative expenses	$	(10,378	)	$	(10,675	)

The decrease in non-cash stock compensation expense for the periods presented was due primarily to a decrease in the average grant date fair value of the shares expensed, for the periods presented, and a decrease in the number of shares expensed

resulting from a net reduction in employee headcount and a decrease in the number of shares vesting for current employees. Refer to Note 10 to the consolidated financial statements elsewhere herein.

Research, Consulting and Other Expenses - Business Development. Research, consulting and other expenses include third-party business development related research, development, consulting, and other costs incurred in connection with business development activities. These costs fluctuate period to period based on business development related activities in each period.

Other Operating Expenses

Fiscal year 2015 operating expenses included expenses for court ordered attorney fees and settlement and contingency accruals totaling $4.1 million. Fiscal year 2014 operating expenses included an expense accrual for court ordered attorney fees related to matters initiated in 2010 and 2011 totaling $1.5 million. Operating expenses for the year ended December 31, 2013 included a non-recurring charge related to the resolution of a dispute concerning legal fees associated with a prior matter totaling $3.5 million.

Income Taxes



	2015			2014			2013
(Provision for) benefit from income taxes (in thousands)	$	(4,800	)	$	(3,912	)	$	21,958
Effective tax rate	3		%	6		%	(27		)%

Fiscal Year 2015. Our effective tax rate for fiscal year 2015 was mainly comprised of foreign taxes withheld on revenue agreements with licensees in foreign jurisdictions and other state taxes, and the impact of full valuation allowances recorded for net operating loss and foreign tax credit related tax assets generated in 2015, due to uncertainty regarding future realizability. The foreign taxes withheld related to revenue agreements executed with third-party licensees domiciled in certain foreign jurisdictions totaling $4.4 million.

Fiscal Year 2014. Our effective tax rate for fiscal year 2014 was mainly comprised of foreign and state income taxes, a full valuation allowance recorded against the company’s net deferred tax assets generated in 2014, the reversal of the net deferred tax liability at the beginning of the year totaling $1.7 million and certain nondeductible permanent items. The foreign taxes withheld related to revenue agreements executed with third-party licensees domiciled in certain foreign jurisdictions totaling $5.2 million.

Fiscal Year 2013. Our effective tax rate for fiscal year 2013 was mainly comprised of U.S. federal and state income tax benefits and nondeductible permanent expenses. The benefit for income taxes for fiscal year 2013 reflects realization of net operating loss carryforward related tax benefits generated during the period. In 2013, the rate at which we recorded the tax benefit associated with the pretax loss for the period was reduced from the statutory rate primarily due to certain nondeductible permanent items and expired capital loss carryforwards. In fiscal year 2013, we recorded a valuation allowance against foreign tax credits generated in fiscal 2013 totaling $4.6 million.

Inflation

Inflation has not had a significant impact on us or any of our subsidiaries in the current or prior periods.

Liquidity and Capital Resources

General

Our primary sources of liquidity are cash, cash equivalents and investments on hand generated from our operating activities. Our management believes that our cash and cash equivalent balances, investments, and anticipated cash flow from operations, will be sufficient to meet our cash requirements through at least March 2017 and for the foreseeable future.

We may, however, encounter unforeseen difficulties that may deplete our capital resources more rapidly than anticipated, including those set forth under Item 1A, “Risk Factors”, above. Any efforts to seek additional funding could be made through issuances of equity or debt, or other external financing. However, additional funding may not be available on favorable terms, if at all. The capital and credit markets have experienced extreme volatility and disruption since late 2007 and the volatility and impact of the disruption has continued into 2015. At times during this period, the volatility and disruption has

reached unprecedented levels. In several cases, the markets have exerted downward pressure on stock prices and credit capacity for certain issuers, and there can be no assurance that the commercial paper markets will be a reliable source of short-term financing for us. If we fail to obtain additional funding when needed, we may not be able to execute our business plans and our business, conducted by our operating subsidiaries, may suffer.

Certain of our operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights. In connection with any of our operating subsidiaries’ patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against us or our operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material.

Cash, Cash Equivalents and Investments

Our consolidated cash, cash equivalents and investments on hand totaled $145.9 million at December 31, 2015, compared to $193.0 million at December 31, 2014. The net change in cash and cash equivalents for the periods presented was comprised of the following (in thousands):



	2015			2014			2013

Net cash provided by (used in):
Operating activities	$	(9,949	)	$	4,184		$	(3,509	)
Investing activities	39,307			29,297			(66,059		)
Financing activities	(28,601		)	(25,700		)	(25,551		)

Cash Flows from Operating Activities. Cash receipts from licensees totaled $111.0 million, $117.0 million and $133.5 million in fiscal years 2015, 2014 and 2013, respectively. The fluctuations in cash receipts for the periods presented primarily reflects the corresponding fluctuations in revenues recognized during the same periods, as described above, and the related timing of payments received from licensees. Cash outflows from operations totaled $120.9 million, $112.9 million and $137.0 million in fiscal years 2015, 2014 and 2013, respectively. The fluctuations in cash outflows for the periods presented reflects the fluctuations in revenue related inventor royalties and contingent legal fees and other operating costs and expenses during the same periods, as discussed above, and the impact of the timing of payments to inventors, attorneys and other vendors.

Cash Flows from Investing Activities. Cash flows from investing activities and related changes were comprised of the following for the periods presented (in thousands):



	2015			2014			2013

Patent portfolio investment costs	$	(19,504	)	$	(42,746	)	$	(25,061	)
Net sale (purchase) of available-for-sale investments	58,819			72,152			(40,323		)
Other	(8		)	(109		)	(675		)
Net cash provided by (used in) investing activities	$	39,307		$	29,297		$	(66,059	)

Cash Flows from Financing Activities. Cash flows from financing activities and related changes included the following for the periods presented (in thousands):



	2015			2014			2013

Dividends paid to stockholders	$	(25,434	)	$	(25,039	)	$	(18,633	)
Distributions to noncontrolling interests - Acacia IP Fund	(4,105		)	(867		)	—
Proceeds from the exercise of stock options	938			206			486
Repurchases of common stock	—			—			(7,926		)
Contributions from noncontrolling interests - Acacia IP Fund	—			—			1,920
Excess tax benefits (shortfalls) from stock-based compensation	—			—			(1,398		)
Net cash provided by financing activities	$	(28,601	)	$	(25,700	)	$	(25,551	)

Dividends to Stockholders. On April 23, 2013, we announced that our Board of Directors approved the adoption of a cash dividend policy that calls for the payment of an expected total annual cash dividend of $0.50 per common share, payable in the amount of $0.125 per share per quarter. Under the policy, we paid quarterly cash dividends totaling $25.4 million, $25.0 million and $18.6 million in 2015, 2014 and 2013, respectively.

On February 25, 2016, we announced that our Board of Directors terminated the company’s dividend policy effective February 23, 2016. The Board terminated the dividend policy due to a number of factors, including our financial performance and our available cash resources, our cash requirements and alternative uses of capital that the Board of Directors concluded would represent an opportunity to generate a greater return on investment for us and our stockholders.

Stock Repurchase Programs. On November 15, 2013, our Board of Directors authorized a program for repurchases of shares of our outstanding common stock. We were authorized to purchase in the aggregate up to $70.0 million of our outstanding common stock through the period ending May 14, 2014. Repurchases may be made from time to time by us in the open market or in block purchases in compliance with applicable SEC rules. In fiscal year 2013, we acquired 600,000 shares of our common stock at an average price of $13.18. Repurchases to date were made using existing cash resources and occurred in the open market.

Working Capital

The primary components of working capital are cash and cash equivalents, accounts receivable, prepaid expenses, accounts payable, accrued expenses, and royalties and contingent legal fees payable. Working capital at December 31, 2015 was $150.7 million, compared to $172.8 million at December 31, 2014.

Consolidated accounts receivable from licensees increased to $33.5 million at December 31, 2015, compared to $20.2 million at December 31, 2014. Accounts receivable balances fluctuate based on the timing, magnitude and payment terms associated with revenue agreements executed during the year, and the timing of cash receipts on accounts receivable balances recorded in previous periods. Two licensees individually represented approximately 72% and 21%, respectively, of accounts receivable at December 31, 2015. Three licensees individually represented approximately 30%, 17% and 15%, respectively, of accounts receivable at December 31, 2014.

Accounts payable and accrued expenses increased to $17.3 million at December 31, 2015, from $14.9 million at December 31, 2014, due primarily to the related timing of payments to vendors in the ordinary course.

Consolidated royalties and contingent legal fees payable increased to $14.9 million at December 31, 2015, compared to $14.4 million at December 31, 2014. Royalties and contingent legal fees payable balances fluctuate based on the magnitude and timing of the execution of related license agreements, the timing of cash receipts for the related license agreements, and the timing of payment of current and prior period royalties and contingent legal fees payable to inventor and outside attorneys, respectively.

The majority of accounts receivable from licensees at December 31, 2015 were collected or scheduled to be collected in the first quarter of 2016, in accordance with the terms of the related underlying license agreements. The majority of royalties and contingent legal fees payable are scheduled to be paid in the first and second quarter of 2016 in accordance with the underlying contractual arrangements.

Off-Balance Sheet Arrangements

We have not entered into off-balance sheet financing arrangements, other than operating leases.

Contractual Obligations

We have no significant commitments for capital expenditures in 2016. Other than our restricted cash of $10.7 million, we have no committed lines of credit or other committed funding or long-term debt. The following table lists our material known future cash commitments as of December 31, 2015, and any material known commitments arising from events subsequent to year end:



	Payments Due by Period (In thousands)
	Total		Less than 1 year		1-3 years		More than 3 years

Operating leases	$	6,463	$	1,459	$	3,169	$	1,835
Scheduled patent investment related payments	1,000		1,000		—		—
Total contractual obligations	$	7,463	$	2,459	$	3,169	$	1,835

Standby Letter of Credit and Guarantee Arrangement. In March 2015, an operating subsidiary of ours entered into a standby letter of credit and guarantee arrangement (“Guarantee”) with a bank in the amount of $10.7 million, for purposes of enforcing a court ruling in a German patent court granting an injunction against the defendants in the related patent infringement case. An injunction is an equitable remedy in the form of a court order that compels the defendant(s) to cease marketing, offering for sale or importing applicable infringing products into applicable jurisdiction(s).

Under German law, in order to enforce the injunction granted by the court, a Guarantee is required to be furnished by our operating subsidiary, the plaintiff in the case, for potential payment to the defendants of any applicable claims which may be incurred by the defendants as a result of the enforcement of the injunction, only in the event that the aforementioned court ruling is subsequently successfully appealed by the defendants or otherwise amended. The Guarantee is required to be issued unlimited with respect to time, until appropriately extinguished in accordance with German law. The Guarantee will be extinguished when a relevant extinguishment order by the court having jurisdiction takes effect, typically occurring when the related infringement case has been settled or a final non-appealable decision has been issued by the court.

The Guarantee is secured by a cash deposit at the contracting bank totaling $10.7 million, which is classified as restricted cash in accompanying balance sheet. The Guarantee expires on April 10, 2016, however, it is automatically extended without amendment for a period of one (1) year from the present or any future expiration date, unless at least 30 days prior to any expiration date, the Guarantee is extinguished in accordance with German law. The Guarantee facility fee is 1.15% per year, and the related expense is included in the statement of operations.

Uncertain Tax Positions. At December 31, 2015, we had total unrecognized tax benefits of approximately $2.1 million, including a recorded noncurrent liability of $85,000 related to unrecognized tax benefits primarily associated with state taxes. No interest and penalties have been recorded for the unrecognized tax benefits as of December 31, 2015. If recognized, approximately $2.1 million would impact our effective tax rate. We do not expect that the liability for unrecognized tax benefits will change significantly within the next 12 months.

Recent Accounting Pronouncements

Refer to Note 2 to our notes to consolidated financial statements included elsewhere herein.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The primary objective of our investment activities is to preserve principal while concurrently maximizing the income we receive from our investments without significantly increasing risk. Some of the securities that we invest in may be subject to interest rate risk and/or market risk. This means that a change in prevailing interest rates, with respect to interest rate risk, or a change in the value of the United States equity markets, with respect to market risk, may cause the principal amount or market value of the investments to fluctuate. For example, if we hold a security that was issued with a fixed interest rate at the then-prevailing rate and the prevailing interest rate later rises, the current value of the principal amount of our investment may decline. To minimize these risks in the future, we intend to maintain our portfolio of cash equivalents and short-term investments in a variety of securities, including commercial paper, money market funds, high-grade corporate bonds, government and non-government debt securities and certificates of deposit.

At December 31, 2014, our short-term investments were comprised of AAA rated money market funds that invest in first-tier only securities, which primarily include domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements (included in cash and cash equivalents in the accompanying consolidated balance sheets), and direct investments in highly liquid, AAA, U.S. government securities (included in short term investments in the accompanying consolidated balance sheets). Short-term investment balances were zero at December 31, 2015.

In general, money market funds are not subject to market risk because the interest paid on such funds fluctuates with the prevailing interest rate. Accordingly, a 100 basis point increase in interest rates or a 10% decline in the value of the United States equity markets would not be expected to have a material impact on the value of such money market funds. Investments in U.S. government fixed income securities are subject to interest rate risk and will decline in value if interest rates increase. However, due to the relatively short duration of our investment portfolio, an immediate 10% change in interest rates would have no material impact on our financial condition, results of operations or cash flows. Declines in interest rates over time will, however, reduce our interest income.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The financial statements and related financial information required to be filed hereunder are indexed under Item 15 of this report and are incorporated herein by reference.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES

(a) Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of December 31, 2015, our disclosure controls and procedures were effective to ensure that the information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure, and that such information is recorded, processed, summarized and reported within the time periods prescribed by the SEC.

(b) Management’s Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the 2013 framework in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our evaluation under the framework in Internal Control - Integrated Framework, our management concluded that our internal control over financial reporting was effective as of December 31, 2015.

Grant Thornton LLP, the independent registered public accounting firm who audited our consolidated financial statements included in this Annual Report on Form 10-K, has issued an attestation report on the effectiveness of our internal control over financial reporting as of December 31, 2015, which is included herein.

Changes in Internal Controls. There were no changes in our internal control over financial reporting during the fourth fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B. OTHER INFORMATION

None

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Except as provided below, in accordance with General Instruction G(3) to Form 10-K, certain information required by this Item is incorporated herein by reference to our definitive proxy statement to be filed with the SEC no later than April 30, 2016.

Code of Conduct.

We have adopted a Code of Conduct that applies to all employees, including our chief executive officer, chief financial and accounting officer, president and any persons performing similar functions. Our Code of Conduct is provided on our internet website at www.acaciaresearch.com.

ITEM 11. EXECUTIVE COMPENSATION

In accordance with General Instruction G(3) to Form 10-K, the information required by this Item is incorporated herein by reference to our definitive proxy statement to be filed with the SEC no later than April 30, 2016.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

In accordance with General Instruction G(3) to Form 10-K, certain information required by this Item is incorporated herein by reference to our definitive proxy statement to be filed with the SEC no later than April 30, 2016.

Equity Compensation Plan Information

The following table provides information with respect to shares of our common stock issuable under our equity compensation plans as of December 31, 2015:



Plan Category	(a) Number of securities to be issued upon exercise of outstanding options	(b) Weighted-average exercise price of outstanding options		(c) Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))

Equity compensation plans approved by security holders
2002 Acacia Technologies Stock Incentive Plan⁽¹⁾	15,000	$	13.38	—
2013 Acacia Research Stock Incentive Plan⁽²⁾	—	—		2,778,000
Subtotal	15,000	$	13.38	2,778,000
Equity compensation plans not approved by security holders
Grants to New Employees Outside of the Plans	—	—		—
Total	15,000	$	13.38	2,778,000

____________________


(1)	The 2002 Stock Plan expired in December 2012. Column (a) excludes 40,000 in nonvested restricted stock awards and restricted stock units outstanding at December 31, 2015. Refer to Note 10 to our notes to consolidated financial statements included elsewhere herein.

(2)

The initial share reserve under the 2013 Acacia Research Stock Incentive Plan, or the 2013 Plan, was 4,750,000 shares of our common stock. No new additional shares will be added to the 2013 Plan without security holder approval (except for shares subject to outstanding awards that are forfeited or otherwise returned to the 2013 Plan). Column (a) excludes 891,000 in nonvested restricted stock awards and restricted stock units outstanding at December 31, 2015. Refer to Note 10 to our notes to consolidated financial statements included elsewhere herein.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

PART IV

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES



(a)	The following documents are filed as part of this report.



(1) Financial Statements		Page

Acacia Research Corporation Consolidated Financial Statements
Reports of Independent Registered Public Accounting Firm		F- 1
Consolidated Balance Sheets as of December 31, 2015 and 2014		F- 3
Consolidated Statements of Operations for the Years Ended December 31, 2015, 2014 and 2013		F- 4
Consolidated Statements of Comprehensive Income (Loss) for the Years Ended December 31, 2015, 2014 and 2013		F- 5
Consolidated Statements of Stockholders’ Equity for the Years Ended December 31, 2015, 2014 and 2013		F- 6
Consolidated Statements of Cash Flows for the Years Ended December 31, 2015, 2014 and 2013		F- 8
Notes to Consolidated Financial Statements		F- 9

(2) Financial Statement Schedules

Financial statement schedules are omitted because they are not applicable or the required information is shown in the Financial Statements or the Notes thereto.

(3) Exhibits

Refer to Item 15(b) below.



(b)	Exhibits. The following exhibits are either filed herewith or incorporated herein by reference:



Exhibit Number	Description

2.1	Agreement and Plan of Merger, dated November 22, 2011, by and among Acacia Research Group LLC, Apollo Patent Corp., Adaptix, Inc., and Baker Communications Fund II (QP), L.P., solely in its capacity as representative for the shareholders of Adaptix, Inc.(15)
3.1	Amended and Restated Certificate of Incorporation (1)
3.2	Amended and Restated Bylaws (17)
10.1*	Acacia Research Corporation 1996 Stock Option Plan, as amended (2)
10.2*	Form of Option Agreement constituting the Acacia Research Corporation 1996 Executive Stock Bonus Plan (3)
10.3*	2002 Acacia Technologies Stock Incentive Plan (4)
10.4*	2007 Acacia Technologies Stock Incentive Plan (5)
10.5*	Form of Acacia Technologies Stock Option Agreement under the 2007 Acacia Technologies Stock Incentive Plan (6)
10.6*	Form of Acacia Technologies Stock Issuance Agreement under the 2002 Acacia Technologies Stock Incentive Plan (6)
10.7*	Form of Acacia Technologies Stock Issuance Agreement under the 2007 Acacia Technologies Stock Incentive Plan (6)
10.8	Office Space Lease dated January 28, 2002, between Acacia Research Corporation and The Irvine Company (7)
10.9	Form of Indemnification Agreement (8)



10.10	Third Amendment to Lease dated January 28, 2002 between Acacia Research Corporation and the Irvine Company (9)
10.11*	Employment Agreement, dated September 22, 2015, by and between Acacia Research Group LLC and Edward Treska (20)
10.12	Fourth Amendment to Lease dated January 28, 2002 between Acacia Research Corporation and the Irvine Company (10)
10.13	Fifth Amendment to Lease dated January 28, 2002 between Acacia Research Corporation and the Irvine Company (10)
10.15*	Employment Agreement, dated September 22, 2015, by and between Acacia Research Group LLC and Robert L. Harris (20)
10.16*	Employment Agreement, dated September 22, 2015, by and between Acacia Research Group LLC and Clayton J. Haynes (20)
10.17*	Acacia Research Corporation Amended and Restated Executive Severance Policy (12)
10.18	Sixth Amendment to Lease dated January 28, 2002 between Acacia Research Corporation and the Irvine Company (14)
10.19	Form of Purchase Agreement (16)
10.20*	2013 Acacia Research Corporation Stock Incentive Plan (18)
10.21*	Form of Stock Issuance Agreement under the 2013 Acacia Research Corporation Stock Incentive Plan (19)
10.22*	Employment Agreement, dated September 22, 2015, by and between Acacia Research Group LLC and Matthew Vella (20)
18.1	Preferability Letter dated February 25, 2010 from Grant Thornton LLP, independent registered public accounting firm, regarding change in accounting principle (13)
21.1	List of Subsidiaries
23.1	Consent of Independent Registered Public Accounting Firm
24.1	Power of Attorney (included in the signature page hereto).
31.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934
31.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934
32.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350
32.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350
101	Interactive Date Files Pursuant to Rule 405 of Regulation S-T.

___________________________


*	The referenced exhibit is a management contract, compensatory plan or arrangement required to be filed as an exhibit to this Annual Report on Form 10-K pursuant to Item 15(c) of Form 10-K.


(1)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on June 5, 2008 (File No. 000-26068).


(2)	Incorporated by reference to Appendix A to Acacia Research Corporation’s Definitive Proxy Statement on Schedule 14A filed on April 20, 2000 (File No. 000-26068).


(3)	Incorporated by reference to Appendix A to Acacia Research Corporation’s Definitive Proxy Statement on Schedule 14A filed on April 26, 1996 (File No. 000-26068).


(4)	Incorporated by reference to Annex E to the Proxy Statement/Prospectus which formed part of Acacia Research Corporation’s Registration Statement on Form S-4 (File No. 333-87654) which became effective on November 8, 2002.


(5)	Incorporated by reference to Acacia Research Corporation’s Registration Statement on Form S-8 (File No. 333-144754) which became effective on July 20, 2007.


(6)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q for the period ended September 30, 2007, filed on November 2, 2007 (File No. 000-26068).


(7)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10‑K for the year ended December 31, 2001, filed on March 27, 2002 (File No. 000‑26068).


(8)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q for the period ended June 30, 2012, filed on July 30, 2012 (File No. 000-26068).


(9)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q for the period ended March 31, 2006, filed on May 10, 2006 (File No. 000‑26068).


(10)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2007, filed on March 14, 2008 (File No. 000-26068).


(11)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on April 2, 2008 ( File No. 000-26068).


(12)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2008, filed on February 26, 2009 (File No. 000-26068).


(13)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2009, filed on February 26, 2010, as amended on March 1, 2010 (File No. 000-26068)


(14)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2010, filed on February 28, 2011, as amended on March 24, 2011 (File No. 000-26068).


(15)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K/A filed on January 19, 2012 (File No. 000-26068). Portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24-b-2 of the Securities Exchange Act of 1934, as amended. The omitted material has been separately filed with the Securities and Exchange Commission.


(16)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on February 16, 2012 (File No. 000-26068).


(17)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2012, filed on February 28, 2013 (File No. 000-26068).


(18)	Incorporated by reference to Appendix A to Acacia Research Corporation’s Definitive Proxy Statement on Schedule 14A filed on April 24, 2013 (File No. 000-26068).


(19)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on May 22, 2013 (File No. 000-26068).


(20)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q filed on November 9, 2015 (File No. 000-26068).

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



			ACACIA RESEARCH CORPORATION

Dated:	March 15, 2016	By:	/s/ Marvin Key
			Marvin Key
			Interim Chief Executive Officer (Authorized Signatory)

POWER OF ATTORNEY

We, the undersigned directors and officers of Acacia Research Corporation, do hereby constitute and appoint Marvin Key and Clayton J. Haynes, and each of them, as our true and lawful attorneys-in-fact and agents with power of substitution, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorney-in-fact and agent may deem necessary or advisable to enable said corporation to comply with the Securities Exchange Act of 1934, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with this Annual Report on Form 10-K, including specifically but without limitation, power and authority to sign for us or any of us in our names in the capacities indicated below, any and all amendments hereto; and we do hereby ratify and confirm all that said attorney-in-fact and agent, shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities and Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and the capacities and on the dates indicated.



Signature		Title	Date

/s/	Marvin Key	Interim Chief Executive Officer	March 15, 2016
	Marvin Key	(Principal Executive Officer)

/s/	Clayton J. Haynes	Chief Financial Officer and Treasurer	March 15, 2016
	Clayton J. Haynes	(Principal Financial and Accounting Officer)

/s/	Robert L. Harris, II	Director	March 15, 2016
	Robert L. Harris, II

/s/	Fred A. de Boom	Director	March 15, 2016
	Fred A. de Boom

/s/	Edward W. Frykman	Director	March 15, 2016
	Edward W. Frykman

/s/	G. Louis Graziadio, III	Director	March 15, 2016
	G. Louis Graziadio, III

/s/	William S. Anderson	Director	March 15, 2016
	William S. Anderson

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors and Stockholders

Acacia Research Corporation

We have audited the accompanying consolidated balance sheets of Acacia Research Corporation (the “Company”) as of December 31, 2015 and 2014, and the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2015. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Acacia Research Corporation as of December 31, 2015 and 2014, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2015, in conformity with accounting principles generally accepted in the United States of America.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the Company’s internal control over financial reporting as of December 31, 2015, based on criteria established in the 2013 Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), and our report dated March 15, 2016 expressed an unqualified opinion.

/s/ GRANT THORNTON LLP

Los Angeles, California

March 15, 2016

F- 1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors and Stockholders

Acacia Research Corporation

We have audited the internal control over financial reporting of Acacia Research Corporation (the “Company”) as of December 31, 2015, based on criteria established in the 2013 Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2015, based on criteria established in the 2013 Internal Control-Integrated Framework issued by COSO.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated financial statements of the Company as of and for the year ended December 31, 2015, and our report dated March 15, 2016 expressed an unmodified on those financial statements.

/s/ GRANT THORNTON LLP

Los Angeles, California

March 15, 2016

F- 2

ACACIA RESEARCH CORPORATION

CONSOLIDATED BALANCE SHEETS

As of December 31, 2015 and 2014

(In thousands, except share and per share information)



	2015			2014
ASSETS
Current assets:
Cash and cash equivalents	$	135,223		$	134,466
Restricted cash	10,725			—
Short-term investments	—			58,558
Accounts receivable	33,500			20,168
Deferred income tax	210			1,161
Prepaid expenses and other current assets	4,219			4,355
Total current assets	183,877			218,708
Furniture and equipment, net of accumulated depreciation and amortization	272			500
Patents, net of accumulated amortization	162,642			286,636
Goodwill	—			30,149
Other assets	1,110			355
	$	347,901		$	536,348
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued expenses	$	17,347		$	14,860
Accrued patent investment costs	1,000			16,700
Royalties and contingent legal fees payable	14,878			14,351
Total current liabilities	33,225			45,911
Deferred income taxes	210			1,161
Other liabilities	311			228
Total liabilities	33,746			47,300
Commitments and contingencies (Note 11)
Stockholders’ equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding	—			—
Common stock, par value $0.001 per share; 100,000,000 shares authorized; 50,651,239 shares issued and outstanding as of December 31, 2015 and 50,065,382 shares issued and outstanding as of December 31, 2014	51			50
Treasury stock, at cost, 1,729,408 shares as of December 31, 2015 and December 31, 2014	(34,640		)	(34,640		)
Additional paid-in capital	633,146			646,595
Accumulated comprehensive loss	(215		)	(353		)
Accumulated deficit	(288,131		)	(128,095		)
Total Acacia Research Corporation stockholders’ equity	310,211			483,557
Noncontrolling interests in operating subsidiaries	3,944			5,491
Total stockholders’ equity	314,155			489,048
	$	347,901		$	536,348

The accompanying notes are an integral part of these consolidated financial statements.

F- 3

ACACIA RESEARCH CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

For the Years Ended December 31, 2015, 2014 and 2013

(In thousands, except share and per share information)



	2015			2014			2013

Revenues	$	125,037		$	130,876		$	130,556
Operating costs and expenses:
Cost of revenues:
Inventor royalties	18,462			20,670			29,724
Contingent legal fees	16,169			23,563			24,784
Litigation and licensing expenses - patents	39,373			37,614			39,335
Amortization of patents	53,067			53,745			49,039
Marketing, general and administrative expenses (including non-cash stock compensation expense of $11,048 in 2015, $18,115 in 2014 and $27,894 in 2013)	38,176			48,554			59,229
Research, consulting and other expenses - business development	3,391			3,840			3,251
Impairment of patent-related intangible assets	74,731			3,497			4,619
Impairment of goodwill	30,149			—			—
Other	4,141			1,548			3,506

Total operating costs and expenses	277,659			193,031			213,487

Operating loss	(152,622		)	(62,155		)	(82,931		)

Total other income (expense)	(56		)	(595		)	2,131

Loss from operations before (provision for) benefit from income taxes	(152,678		)	(62,750		)	(80,800		)
(Provision for) benefit from income taxes	(4,800		)	(3,912		)	21,958
Net loss including noncontrolling interests in operating subsidiaries	(157,478		)	(66,662		)	(58,842		)
Net (income) loss attributable to noncontrolling interests in operating subsidiaries	(2,558		)	633			2,408
Net loss attributable to Acacia Research Corporation	$	(160,036	)	$	(66,029	)	$	(56,434	)

Net loss attributable to common stockholders - basic and diluted	$	(160,730	)	$	(66,755	)	$	(56,945	)

Basic and diluted loss per common share	$	(3.25	)	$	(1.37	)	$	(1.18	)

Weighted-average number of shares outstanding, basic and diluted	49,505,817			48,658,088			48,155,832

Cash dividends declared per common share	$	0.50		$	0.50		$	0.375

The accompanying notes are an integral part of these consolidated financial statements.

F- 4

ACACIA RESEARCH CORPORATION

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

For the Years Ended December 31, 2015, 2014 and 2013

(In thousands)



	2015			2014			2013
Net loss including noncontrolling interests in operating subsidiaries	$	(157,478	)	$	(66,662	)	$	(58,842	)
Other comprehensive income (loss):
Unrealized gain (loss) on short-term investments, net of tax of $0	(356		)	(1,488		)	26
Unrealized loss on foreign currency translation, net of tax of $0	(123		)	(128		)	—
Add: reclassification adjustment for losses included in net income	617			2,210			193
Total other comprehensive loss	(157,340		)	(66,068		)	(58,623		)
Comprehensive income (loss) attributable to noncontrolling interests	(2,558		)	633			2,408
Comprehensive loss attributable to Acacia Research Corporation	$	(159,898	)	$	(65,435	)	$	(56,215	)

The accompanying notes are an integral part of these consolidated financial statements.

F- 5

ACACIA RESEARCH CORPORATION

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

For the Years Ended December 31, 2015, 2014 and 2013

(In thousands, except share information)



	Common Shares		Common Stock			Treasury Stock			Additional Paid-in Capital			Other Comprehensive (Loss) Income			Accumulated Deficit			Noncontrolling Interests in Operating Subsidiaries			Total

Balance at December 31, 2012	49,160,844		$	49		$	(26,731	)	$	644,982		$	(1,166	)	$	(5,632	)	$	6,976		$	618,478
Net loss attributable to Acacia Research Corporation	—		—			—			—			—			(56,434		)	—			(56,434		)
Dividends paid to stockholders	—		—			—			(18,633		)	—			—			—			(18,633		)
Repurchase of common stock	(600,000	)	(1		)	(7,909		)	—			—			—			—			(7,910		)
Repurchase of restricted common stock	(666	)	—			—			(16		)	—			—			—			(16		)
Stock options exercised	115,346		—			—			486			—			—			—			486
Compensation expense relating to restricted stock awards	709,533		1			—			27,893			—			—			—			27,894
Excess tax benefits from stock-based compensation	—		—			—			(1,398		)	—			—			—			(1,398		)
Net loss attributable to noncontrolling interests in operating subsidiaries	—		—			—			—			—			—			(2,408		)	(2,408		)
Contributions from noncontrolling interests in operating subsidiary, net	—		—			—			—			—			—			1,920			1,920
Unrealized gain on short-term investments	—		—			—			—			219			—			—			219
Balance at December 31, 2013	49,385,057		49			(34,640		)	653,314			(947		)	(62,066		)	6,488			562,198
Net loss attributable to Acacia Research Corporation	—		—			—			—			—			(66,029		)	—			(66,029		)
Dividends paid to stockholders	—		—			—			(25,039		)	—			—			—			(25,039		)
Stock options exercised	44,506		—			—			206			—			—			—			206
Compensation expense relating to restricted stock awards	635,819		1			—			18,114			—			—			—			18,115
Net loss attributable to noncontrolling interests in operating subsidiaries	—		—			—			—			—			—			(633		)	(633		)
Distributions to noncontrolling interests in operating subsidiary	—		—			—			—			—			—			(364		)	(364		)
Unrealized loss on foreign currency translation	—		—			—			—			(99		)	—			—			(99		)
Unrealized gain on short-term investments	—		—			—			—			693			—			—			693
Balance at December 31, 2014	50,065,382		$	50		$	(34,640	)	$	646,595		$	(353	)	$	(128,095	)	$	5,491		$	489,048



(Continued on next page)

F- 6



ACACIA RESEARCH CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Continued)
For the Years Ended December 31, 2015, 2014 and 2013
(In thousands, except share information)

	Common Shares	Common Stock		Treasury Stock			Additional Paid-in Capital			Other Comprehensive (Loss) Income			Accumulated Deficit			Noncontrolling Interests in Operating Subsidiaries			Total
Balance at December 31, 2014	50,065,382	$	50	$	(34,640	)	$	646,595		$	(353	)	$	(128,095	)	$	5,491		$	489,048
Net loss attributable to Acacia Research Corporation	—	—		—			—			—			(160,036		)	—			(160,036		)
Dividends paid to stockholders	—	—		—			(25,434		)	—			—			—			(25,434		)
Stock options exercised	135,000	—		—			938			—			—			—			938
Compensation expense relating to restricted stock awards	450,857	1		—			11,047			—			—			—			11,048
Net income attributable to noncontrolling interests in operating subsidiaries	—	—		—			—			—			—			2,558			2,558
Distributions to noncontrolling interests in operating subsidiary	—	—		—			—			—			—			(4,105		)	(4,105		)
Unrealized loss on foreign currency translation	—	—		—			—			(123		)	—			—			(123		)
Unrealized gain on short-term investments	—	—		—			—			261			—			—			261
Balance at December 31, 2015	50,651,239	$	51	$	(34,640	)	$	633,146		$	(215	)	$	(288,131	)	$	3,944		$	314,155

The accompanying notes are an integral part of these consolidated financial statements.

F- 7

ACACIA RESEARCH CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Years Ended December 31, 2015, 2014 and 2013

(In thousands)



	2015			2014			2013

Cash flows from operating activities:
Net loss including noncontrolling interests in operating subsidiaries	$	(157,478	)	$	(66,662	)	$	(58,842	)
Adjustments to reconcile net loss including noncontrolling interests in operating subsidiaries to net cash provided by (used in) operating activities:
Depreciation and amortization	53,289			54,049			49,275
Non-cash stock compensation	11,048			18,115			27,894
Excess tax benefits from stock-based compensation	—			—			1,398
Deferred income taxes	—			(1,736		)	(26,746		)
Impairment of patent-related intangible assets	74,731			3,497			4,619
Impairment of goodwill	30,149			—			—
Other	(109		)	(28		)	12
Changes in assets and liabilities:
Restricted cash	(10,725		)	—			—
Accounts receivable	(13,332		)	(13,827		)	3,502
Prepaid expenses and other assets	(619		)	3,154			(5,300		)
Accounts payable and accrued expenses / patent costs	2,570			3,718			2,740
Royalties and contingent legal fees payable	527			3,904			(2,061		)

Net cash provided by (used in) operating activities	(9,949		)	4,184			(3,509		)

Cash flows from investing activities:
Purchases of furniture and equipment	(8		)	(109		)	(675		)
Purchases of available-for-sale investments	(23,296		)	(109,963		)	(279,693		)
Sales and maturities of available-for-sale investments	82,115			182,115			239,370
Patent portfolio investment costs	(19,504		)	(42,746		)	(25,061		)

Net cash provided by (used in) investing activities	39,307			29,297			(66,059		)

Cash flows from financing activities:
Dividends paid to stockholders	(25,434		)	(25,039		)	(18,633		)
Distributions to noncontrolling interests in operating subsidiary	(4,105		)	(867		)	—
Proceeds from the exercise of stock options	938			206			486
Repurchases of common stock	—			—			(7,926		)
Contributions from noncontrolling interests in operating subsidiary, net of issuance costs	—			—			1,920
Excess tax benefits (shortfalls) from stock-based compensation	—			—			(1,398		)

Net cash used in financing activities	(28,601		)	(25,700		)	(25,551		)

Increase (decrease) in cash and cash equivalents	757			7,781			(95,119		)

Cash and cash equivalents, beginning	134,466			126,685			221,804

Cash and cash equivalents, ending	$	135,223		$	134,466		$	126,685

Supplemental schedule of noncash investing activities:
Patent portfolio investment costs included in accrued expenses / costs	$	1,000		$	16,700		$	4,000

The accompanying notes are an integral part of these consolidated financial statements.

F- 8

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1. DESCRIPTION OF BUSINESS

Description of Business. As used herein, “Acacia” and the “Company” refer to Acacia Research Corporation and/or its wholly and majority-owned and controlled operating subsidiaries, and/or where applicable, its management. All patent investment, prosecution, licensing and enforcement activities are conducted solely by certain of Acacia’s wholly and majority-owned and controlled operating subsidiaries.

Acacia’s operating subsidiaries invest in, license and enforce patented technologies. Acacia’s operating subsidiaries partner with inventors and patent owners, applying their legal and technology expertise to patent assets to unlock the financial value in their patented inventions. Acacia is an intermediary in the patent marketplace, bridging the gap between invention and application, facilitating efficiency and delivering monetary rewards to patent owners.

Acacia’s operating subsidiaries generate revenues and related cash flows from the granting of intellectual property rights for the use of patented technologies that its operating subsidiaries control or own. Acacia’s operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation.

Acacia’s operating subsidiaries are principals in the licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright. Acacia’s operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain foreign counterparts, covering technologies used in a wide variety of industries.

Acacia was incorporated on January 25, 1993 under the laws of the State of California. In December 1999, Acacia changed its state of incorporation from California to Delaware.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Accounting Principles and Fiscal Year End. The consolidated financial statements and accompanying notes are prepared on the accrual basis of accounting in accordance with generally accepted accounting principles in the United States of America.

Principles of Consolidation. The accompanying consolidated financial statements include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. Material intercompany transactions and balances have been eliminated in consolidation.

Noncontrolling interests in Acacia’s majority-owned and controlled operating subsidiaries (“noncontrolling interests”) are separately presented as a component of stockholders’ equity. Consolidated net income or (loss) is adjusted to include the net (income) or loss attributed to noncontrolling interests in the consolidated statements of operations. Refer to the accompanying consolidated statements of stockholders’ equity for total noncontrolling interests.

A wholly owned subsidiary of Acacia is the general partner of the Acacia Intellectual Property Fund, L.P. (the “Acacia IP Fund”), which was formed in August 2010. The Acacia IP Fund is included in the Company’s consolidated financial statements since 2010, as Acacia’s wholly owned subsidiary, as the general partner, has the ability to control the operations and activities of the Acacia IP Fund. Refer to Note 11 to these consolidated financial statements.

Revenue Recognition. Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectibility of amounts is reasonably assured.

In general, revenue arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by Acacia’s operating subsidiaries. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by Acacia’s operating subsidiaries, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined, relatively short period of time, with the licensee possessing the right to renew the agreement at the end

F- 9

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

of each contractual term for an additional minimum upfront payment. Pursuant to the terms of these agreements, Acacia’s operating subsidiaries have no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on Acacia’s operating subsidiaries’ part to maintain or upgrade the technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the minimum upfront payment for term agreement renewals. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectibility is reasonably assured, or upon receipt of the minimum upfront fee for term agreement renewals, and when all other revenue recognition criteria have been met.

For the periods presented herein, the majority of the revenue agreements executed by the Company provided for the payment of one-time, paid-up license fees in consideration for the grant of certain intellectual property rights for patented technology rights owned by our operating subsidiaries. These rights were primarily granted on a perpetual basis, extending until the expiration of the underlying patents.

Certain of the Company’s revenue arrangements provide for future royalties or additional required payments based on future licensee activities. Additional royalties are recognized in revenue upon resolution of the related contingency provided that all revenue recognition criteria, as described above, have been met. Amounts of additional royalties due under these license agreements, if any, cannot be reasonably estimated by management.

Certain of the Company’s revenue arrangements provide for the calculation of fees based on a licensee’s actual quarterly sales or actual per unit activity, applied to a contractual royalty rate. Licensees that pay fees on a quarterly basis generally report actual quarterly sales or actual per unit activity information and related quarterly fees due within 30 days to 45 days after the end of the quarter in which such sales or activity takes place. The amount of fees due under these revenue arrangements each quarter cannot be reasonably estimated by management. Consequently, Acacia’s operating subsidiaries recognize revenue from these revenue arrangements on a three-month lag basis, in the quarter following the quarter of sales or per unit activity, provided amounts are fixed or determinable and collectibility is reasonably assured. The lag method described above allows for the receipt of licensee royalty reports prior to the recognition of revenue.

Amounts related to revenue arrangements that do not meet the revenue recognition criteria described above are deferred until the revenue recognition criteria are met.

Acacia assesses the collectibility of fees receivable based on a number of factors, including past transaction history and credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectibility becomes reasonably assured, assuming all other revenue recognition criteria have been met, which is generally upon receipt of cash.

Cost of Revenues. Cost of revenues include the costs and expenses incurred in connection with Acacia’s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment costs. These costs are included under the caption “Cost of revenues” in the accompanying consolidated statements of operations.

Inventor Royalties and Contingent Legal Expenses. Inventor royalties are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In certain instances, pursuant to the terms of the underlying inventor agreements, upfront advances paid to patent owners by Acacia’s operating subsidiaries are recoverable from future net revenues. Patent costs that are recoverable from future net revenues are amortized over the estimated economic useful life of the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense in the consolidated statements of operations. Any unamortized upfront advances recovered from net revenues are expensed in the period recovered, and included in amortization expense in the consolidated statements of operations. Refer to Note 11 for additional information.

Contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal fees are paid; however, Acacia’s operating subsidiaries may be liable for certain out of pocket legal costs incurred pursuant to the underlying legal services agreement.

Fair Value Measurements. U.S. generally accepted accounting principles define fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date, and also establishes a fair value hierarchy which

F- 10

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

requires an entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value is defined as follows:



●	Level 1 -	Observable Inputs: Quoted prices in active markets for identical investments;
●	Level 2 -	Pricing Models with Significant Observable Inputs: Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and
●	Level 3 -	Unobservable Inputs: Significant unobservable inputs, including the entity’s own assumptions in determining the fair value of investments.

Whenever possible, the Company is required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value. Acacia has not elected the fair value option for recording non-financial assets and liabilities, and therefore no fair value measurements are performed on a recurring basis.

Cash and Cash Equivalents. Acacia considers all highly liquid, short-term investments with original maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia’s cash equivalents are comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements. Acacia’s cash equivalents are measured at fair value using quoted prices that represent Level 1 inputs.

Investments in Marketable Securities. Investments in securities with original maturities of greater than three months and less than one year and other investments representing amounts that are available for current operations are classified as short-term investments, unless there are indications that such investments may not be readily sold in the short term. The fair values of these investments approximate their carrying values. As of December 31, 2015, the balance of short term investments was zero. At December 31, 2014, all of Acacia’s investments were classified as available-for-sale, which are reported at fair value on a recurring basis using significant observable inputs (Level 1), with related unrealized gains and losses in the value of such securities recorded as a separate component of other comprehensive income (loss) in stockholders’ equity until realized. Realized and unrealized gains and losses are recorded based on the specific identification method. Interest on all securities is included in interest and other investment income (loss).

Impairment of Marketable Securities. Acacia evaluates its investments in marketable securities for potential impairment, employing a systematic methodology on a quarterly basis that considers available quantitative and qualitative evidence. If the cost or carrying value of an investment exceeds its estimated fair value, the Company evaluates, among other factors, general market conditions, credit quality of instrument issuers, the duration and extent to which the fair value is less than cost, and the Company’s intent and ability to hold, or plans or ability to sell. Fair value is estimated based on publicly available market information or other estimates determined by management. Investments are considered to be impaired when a decline in fair value is estimated to be other-than-temporary. Acacia reviews impairments associated with its investments in marketable securities and determines the classification of any impairment as temporary or other-than-temporary. An impairment is deemed other-than-temporary unless (a) Acacia has the ability and intent to hold an investment for a period of time sufficient for recovery of its carrying amount and (b) positive evidence indicating that the investment’s carrying amount is recoverable within a reasonable period of time outweighs any evidence to the contrary. All available evidence, both positive and negative, is considered to determine whether, based on the weight of such evidence, the carrying amount of the investment is recoverable within a reasonable period of time. For investments classified as available-for-sale, unrealized losses that are other-than-temporary are recognized in the consolidated statements of operations.

Concentration of Credit Risks. Financial instruments that potentially subject Acacia to concentrations of credit risk are cash equivalents, investments and accounts receivable. Acacia places its cash equivalents and investments primarily in highly rated money market funds and investment grade marketable securities. Cash equivalents are also invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not experienced any significant losses on its deposits of cash and cash equivalents.

Three licensees individually accounted for 24%, 20% and 16% respectively, of revenues recognized during the year ended December 31, 2015. Two licensees individually accounted for 22% and 22%, respectively, of revenues recognized during the year ended December 31, 2014. Two licensees individually accounted for 38% and 16%, respectively, of revenues recognized during the year ended December 31, 2013. Two licensees individually represented approximately 72% and 21% respectively, of accounts receivable at December 31, 2015. Three licensees individually represented approximately 30%, 17% and 15%, respectively, of accounts receivable at December 31, 2014. For 2015, 2014 and 2013, 49%, 43% and 24%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity

F- 11

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. The Company does not have any material foreign operations.

Acacia performs credit evaluations of its licensees with significant receivable balances, if any, and has not experienced any significant credit losses. Accounts receivable are recorded at the executed contract amount and generally do not bear interest. Collateral is not required. An allowance for doubtful accounts may be established to reflect the Company’s best estimate of probable losses inherent in the accounts receivable balance, and is reflected as a contra-asset account on the balance sheet and a charge to operating expenses in the statement of operations for the applicable period. The allowance is determined based on known troubled accounts, historical experience, and other currently available evidence. There was no allowance for doubtful accounts established for the periods presented.

Furniture and Equipment. Furniture and equipment are recorded at cost. Major additions and improvements that materially extend useful lives of furniture and equipment are capitalized. Maintenance and repairs are charged against the results of operations as incurred. When these assets are sold or otherwise disposed of, the asset and related depreciation are relieved, and any gain or loss is included in the consolidated statements of operations for the period of sale or disposal. Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives of the assets:



Furniture and fixtures	3 to 5 years
Computer hardware and software	3 to 5 years
Leasehold improvements	2 to 5 years (Lesser of lease term or useful life of improvement)

Rental payments on operating leases are charged to expense in the consolidated statements of operations on a straight-line basis over the lease term.

Patents. Patents include the cost of patents or patent rights (hereinafter, collectively “patents”) acquired from third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from one to ten years. Certain patent application and prosecution costs incurred to secure additional patent claims, that based on management’s estimates are deemed to be recoverable, are capitalized and amortized over the remaining estimated economic useful life of the related patent portfolio.

Goodwill. Goodwill is tested for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis (December 31) and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. Acacia considers its market capitalization and the carrying value of its assets and liabilities, including goodwill, when performing its goodwill impairment test. When conducting its annual goodwill impairment assessment, the Company initially performs a qualitative evaluation of whether it is more likely than not that goodwill is impaired. If it is determined by a qualitative evaluation that it is more likely than not that goodwill is impaired, the Company then applies a two-step impairment test. The two-step impairment test first compares the fair value of the Company’s reporting unit to its carrying or book value. If the fair value of the reporting unit exceeds its carrying value, goodwill is not impaired and the Company is not required to perform further testing. If the carrying value of the reporting unit exceeds its fair value, the Company determines the implied fair value of the reporting unit’s goodwill and if the carrying value of the reporting unit’s goodwill exceeds its implied fair value, then an impairment loss equal to the difference is recorded in the consolidated statement of operations. Refer to Note 7 for additional information.

Impairment of Long-lived Assets. Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded equal to the excess of the asset’s carrying value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows. Refer to Note 7 for additional information.

Fair value is generally estimated using the “Income Approach,” focusing on the estimated future net income-producing capability of the patent portfolios over the estimated remaining economic useful life. Estimates of future after-tax cash flows are converted to present value through “discounting,” including an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market share data. Estimated cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied to estimated license fee revenues, in addition

F- 12

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

to other estimates of out-of-pocket expenses associated with a specific patent portfolio’s licensing and enforcement program. The analysis also contemplates consideration of current information about the patent portfolio including, status and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent information that could impact future net cash flows.

Fair Value of Financial Instruments. The carrying value of cash and cash equivalents, investments, accounts receivables, and accounts payable approximates their fair values due to their short-term maturities.

Contingent Liabilities. The Company, from time to time, is involved in certain legal proceedings. Based upon consultation with outside counsel handling its defense in these matters and the Company’s analysis of potential outcomes, if the Company determines that a loss arising from such matters is probable and can be reasonably estimated, an estimate of the contingent liability is recorded in its consolidated financial statements. If only a range of estimated loss can be determined, an amount within the range that, based on estimates, assumptions and judgments, reflects the most likely outcome, is recorded as a contingent liability in the consolidated financial statements. In situations where none of the estimates within the estimated range is a better estimate of probable loss than any other amount, the Company records the low end of the range. Any such accrual would be charged to expense in the appropriate period. Litigation expenses for these types of contingencies are recognized in the period in which the litigation services were provided.

Stock-Based Compensation. The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee’s requisite service period (generally the vesting period of the equity award) which is generally two to four years. The fair value of restricted stock and restricted stock unit awards is determined by the product of the number of shares or units granted and the grant date market price of the underlying common stock. The fair value of each option award is estimated on the date of grant using a Black-Scholes option valuation model. Stock-based compensation expense is recorded only for those awards expected to vest using an estimated forfeiture rate. Refer to Note 10 to these notes to consolidated financial statements for information on stock-based awards granted for the periods presented.

Income Taxes. Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in Acacia’s consolidated financial statements or consolidated income tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized, or if it is determined that there is uncertainty regarding future realizability of such assets.

Under U.S. generally accepted accounting principles, a tax position is a position in a previously filed tax return or a position expected to be taken in a future tax filing that is reflected in measuring current or deferred income tax assets and liabilities. Tax positions are recognized only when it is more likely than not (likelihood of greater than 50%), based on technical merits, that the position will be sustained upon examination. Tax positions that meet the more likely than not threshold are measured using a probability weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.

If a deduction reported on a tax return for an equity-based incentive award exceeds the cumulative compensation cost for those instruments recognized for financial reporting purposes, any resulting realized tax benefit that exceeds the previously calculated deferred tax asset for those instruments is considered an excess tax benefit, and is recognized as additional paid-in capital. If the tax deduction is less than the cumulative book compensation cost, the tax effect of the resulting difference is charged first to APIC, to the extent of the available pool of windfall tax benefits, with any remainder recognized in income tax expense.

Segment Reporting. Acacia uses the management approach, which designates the internal organization that is used by management for making operating decisions and assessing performance as the basis of Acacia’s reportable segments. Acacia’s patent licensing and enforcement business constitutes its single reportable segment.

Use of Estimates. The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, stock-based compensation expense, impairment of marketable securities and intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets

F- 13

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

and the application of the acquisition method of accounting for business combinations, require its most difficult, subjective or complex judgments.

Income (Loss) Per Share. The Company computes net income (loss) attributable to common stockholders using the two-class method required for capital structures that include participating securities. Under the two-class method, securities that participate in non-forfeitable dividends, such as the Company’s outstanding unvested restricted stock, are considered “participating securities.”

In applying the two-class method, (i) basic net income (loss) per share is computed by dividing net income (loss) (less any dividends paid on participating securities) by the weighted average number of shares of common stock and participating securities outstanding for the period and (ii) diluted earnings per share may include the additional effect of other securities, if dilutive, in which case the dilutive effect of such securities is calculated by applying the two-class method and the treasury stock method to the assumed exercise or vesting of potentially dilutive common shares. The method yielding the more dilutive result is ultimately reported for the applicable period. Potentially dilutive common stock equivalents primarily consist of employee stock options, and restricted stock units for calculations utilizing the two-class method, and also include unvested restricted stock, when utilizing the treasury method.

The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted income per share:



	2015			2014			2013
Numerator (in thousands):
Basic and Diluted
Net loss	$	(160,036	)	$	(66,029	)	$	(56,434	)
Total dividends declared / paid	(25,434		)	(25,039		)	(18,633		)
Dividends attributable to common stockholders	24,740			24,313			18,122
Net loss attributable to common stockholders – basic and diluted	$	(160,730	)	$	(66,755	)	$	(56,945	)

Weighted-average shares used in computing net loss per share attributable to common stockholders – basic and diluted	49,505,817			48,658,088			48,155,832

Basic and diluted net loss per common share	$	(3.25	)	$	(1.37	)	$	(1.18	)
Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share	71,468			27,760			27,760

Treasury Stock. Repurchases of the Company’s outstanding common stock are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock on the consolidated balance sheets.

Recent Accounting Pronouncements - Not Yet Adopted. In June 2014, the Financial Accounting Standards Board (the “FASB”) issued a new accounting standard which requires that a performance target that affects vesting and could be achieved after the requisite service period shall be treated as a performance condition. Adoption of this standard is required for annual periods beginning after December 15, 2015. Early adoption is permitted. The Company is currently evaluating the impact the pronouncement will have on its consolidated financial statements and related disclosures.

In May 2014, the FASB issued a new accounting standards update addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. The amendments for this standard update are effective for interim and annual reporting periods beginning after December 15, 2016, and are to be applied

retrospectively or the cumulative effect as of the date of adoption, with early application not permitted. The Company is currently evaluating the impact and method of adoption the pronouncement will have on its consolidated financial statements and related disclosures.

In August 2014, the FASB issued a new accounting standard which requires management to assess an entity’s ability to continue as a going concern every reporting period including interim periods, and to provide related footnote disclosure in certain circumstances. Adoption of this standard is required for annual periods beginning after December 15, 2016 and are to be

F- 14

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

applied retrospectively or the cumulative effect as of the date of adoption. Early adoption is permitted. The Company is currently evaluating the impact the pronouncement will have on its consolidated financial statements and related disclosures.

In September 2015, the FASB issued an accounting standard update to simplify the accounting for measurement- period adjustments in a business combination by requiring the acquirer to recognize adjustments to provisional amounts

identified during the measurement period in the reporting period in which the adjustments are determined. The acquirer is also

required to record in the reporting period in which the adjustments are determined the effect on earnings of changes in

depreciation, amortization, and other items resulting from the change to the provisional amounts. The new guidance is effective

for fiscal years beginning after December 15, 2015, including interim periods within those fiscal years. Management is

currently evaluating the effect that implementation of this update will have on its consolidated financial position and results of

operations upon adoption.

In November 2015, the FASB issued an accounting standard update to simplify the presentation of deferred income taxes by requiring that deferred tax liabilities and assets be classified as noncurrent on the balance sheet. This update is effective for annual reporting periods beginning after December 31, 2016, including interim periods within those annual periods, and early adoption is permitted. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

In February 2016, the FASB issued an accounting standard update which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. The requirements of this standard include a significant increase in required disclosures. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

Recently Adopted Accounting Pronouncements - Adopted Effective January 1, 2014. In July 2013, the FASB issued a new accounting standard addressing when unrecognized tax benefits should be presented as reductions to deferred tax assets for net operating loss carryforwards in the financial statements. This standard was adopted effective January 1, 2014. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements and related disclosures.

In March 2013, the FASB issued a new accounting standard addressing the accounting for the cumulative translation adjustment when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. This standard was adopted effective January 1, 2014. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements and related disclosures.

3. SHORT-TERM INVESTMENTS

Short-term marketable securities for the periods presented were comprised of the following (in thousands):



	December 31, 2014
Security Type	Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
U.S. government fixed income securities	$	58,819	$	2	$	(263	)	$	58,558
Total short-term investments	$	58,819	$	2	$	(263	)	$	58,558

Short-term investments at December 31, 2014 were comprised of investments in highly liquid, AAA, U.S. government fixed income securities with maturity dates in 2015. Short-term marketable securities in unrealized loss positions at December 31, 2014 were in continuous unrealized loss positions for less than one year. There were no short-term investments at December 31, 2015.

U.S. government fixed income securities. The gross unrealized loss can be primarily attributed to a combination of market conditions as well as the demand for and duration of the U.S. government fixed income securities. The Company has the ability to hold these securities until maturity, currently has no intent to sell, there is no requirement to sell and the Company believes that it can recover the amortized cost of these investments. The Company has found no evidence of impairment due to

F- 15

credit losses in its portfolio. Therefore, these unrealized losses were recorded in other comprehensive income (loss). However, the Company cannot provide any assurance that its portfolio of short-term marketable securities will not be impacted by adverse conditions in the financial markets, which may require the Company in the future to record an impairment charge for credit losses which could adversely impact its financial results.

For the year ended December 31, 2015, proceeds from the sale of short-term marketable securities classified as available-for-sale were $82,115,000 and gross realized losses were $617,000. Gross realized losses are recorded in the statements of operations in other income (expense). For the year ended December 31, 2014, proceeds from the sale of short-term marketable securities classified as available-for-sale were $182,115,000 and gross realized losses were $2,188,000. For the year ended December 31, 2013, proceeds from the sale of short-term marketable securities classified as available-for-sale were $239,370,000, gross realized gains were $1,174,000 and gross realized losses were $981,000.

4. FURNITURE AND EQUIPMENT

Furniture and equipment consists of the following at December 31, 2015 and 2014 (in thousands):



	2015			2014

Furniture and fixtures	$	739		$	761
Computer hardware and software	649			650
Leasehold improvements	145			144
	1,533			1,555
Less: accumulated depreciation and amortization	(1,261		)	(1,055		)
	$	272		$	500

Depreciation expense was $222,000, $304,000 and $236,000 for the years ended December 31, 2015, 2014 and 2013, respectively. In 2015 and 2014, the Company retired $30,000 and $330,000, respectively, of items held in furniture and equipment and recorded a $14,000 and $71,000, respectively, loss on disposal.

5. ACCOUNTS PAYABLE AND ACCRUED EXPENSES

Accounts payable and accrued expenses consist of the following at December 31, 2015 and 2014 (in thousands):



	2015		2014

Payroll and other employee benefits	$	576	$	1,481
Accrued vacation	701		806
Accrued legal expenses - patent	10,135		8,410
Accrued attorney's fees	—		1,548
Foreign taxes payable ⁽¹⁾	3,960		—
Accrued consulting and other professional fees	1,592		1,530
Other accrued liabilities	383		1,085
	$	17,347	$	14,860

⁽¹⁾ - Included in "Accounts Payable and Accrued Expenses/Patent Costs" line item on the consolidated statement of cash flows included elsewhere herein.

6. PATENTS

Acacia’s only identifiable intangible assets are patents and patent rights, with estimated remaining economic useful lives ranging from one to eight years. For all periods presented, all of Acacia’s identifiable intangible assets were subject to amortization. The gross carrying amounts and accumulated amortization related to investments in intangible assets as of December 31, 2015 and 2014 are as follows (in thousands):

F- 16

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS



	2015			2014

Gross carrying amount - patents	$	444,137		$	453,201
Accumulated amortization - patents⁽¹⁾	(281,495		)	(166,565		)
Patents, net	$	162,642		$	286,636

(1) Includes patent impairment charges for the applicable periods.

The weighted-average remaining estimated economic useful life of Acacia’s patents and patent rights is 5 years. Scheduled annual aggregate amortization expense is estimated to be $43,218,000 in 2016, $40,577,000 in 2017, $35,777,000 in 2018, $19,410,000 in 2019, $6,787,000 in 2020 and $16,873,000 thereafter.

For the years ended December 31, 2015, 2014 and 2013, Acacia paid patent investment costs totaling $19,504,000, $42,746,000 and $25,061,000, respectively. The patents have initial estimated economic useful lives ranging from two to ten years. Included in net additions to capitalized patent costs during the years ended December 31, 2015 and 2014 are accrued patent investment costs totaling $1,000,000 and $16,700,000, respectively, which are amortized over the estimated economic useful life of the related patents.

During the periods presented, certain operating subsidiaries recovered up-front patent portfolio advances from applicable net licensing proceeds prior to the scheduled amortization of such up-front patent portfolio advances, resulting in the acceleration of amortization expense for the applicable patent-related assets. For the years ended December 31, 2014 and 2013, accelerated amortization expense related to the recovery of up-front patent portfolio advances totaled $1,247,000 and $592,000, respectively.

For the years ended December 31, 2015, 2014 and 2013, pursuant to the terms of the respective inventor agreements, certain Acacia operating subsidiaries elected to terminate or sell their rights to patent portfolios, resulting in the acceleration of amortization expense for the patent-related assets totaling $380,000, $2,702,000 and $1,747,000, respectively.

Acacia recorded impairment of patent-related intangible asset charges totaling $74,731,000, $3,497,000 and $4,619,000 for the years ended December 31, 2015, 2014 and 2013, respectively. The impairment charges related to impairments of patent portfolios due to a reduction in expected estimated future net cash flows and certain patent portfolios that management determined it would no longer allocate future resources to in connection with the licensing and enforcement of such portfolios, due primarily to potential prior art related complexities and/or the overall determination that future resources would be allocated to other licensing and enforcement programs with higher potential return profiles. The impairment charges consisted of the excess of the asset’s carrying value over its estimated fair value. Refer to Note 7 for additional information regarding impairment charges for the year ended December 31, 2015.

For the years ended December 31, 2015, 2014 and 2013, capitalized patent costs, accumulated amortization, and sales proceeds related to patent-related sales and disposals are as follows (in thousands):



	2015		2014		2013

Capitalized patent costs	$	500	$	3,000	$	3,500
Accumulated amortization	120		298		1,753
Sales proceeds	750		3,500		1,000

7. GOODWILL AND PATENT IMPAIRMENT CHARGES

Pursuant to applicable accounting standards, if goodwill and another asset group of a reporting unit are tested for impairment at the same time, the other asset group, the Company's patent portfolios, are to be tested for impairment before goodwill.

Patent Portfolio Impairment Testing - December 31, 2015. Acacia performed an impairment analysis for its patent assets as of December 31, 2015, utilizing the assistance of a third-party valuation specialist, resulting in $74.7 million of patent portfolio impairment charges, for the following reasons:


•	In December 2015, Acacia announced that its subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, Inc., and others. The jury returned a verdict that the asserted claims of the patent at issue were

F- 17

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

invalid and non-infringed. The Adaptix trial loss resulted in a reduction in estimated cash flows for the Adaptix portfolio expected to be realized from future licensing and enforcement activities, leading to impairment charges on the portfolio in the fourth quarter of 2015.

•

Management considered the impact of the fourth quarter 2015 adverse trial outcomes on its estimates of future cash flows that could be realized from future licensing and enforcement activities for other patent portfolios. Estimates of future cash flows for these portfolios were reduced in part in connection with the Company's assessment of probabilities of realization given the recent adverse trial outcomes.

•

Patent impairment charges include the carrying value of other patent portfolios for which, in the fourth quarter of 2015, the Company experienced adverse litigation or trial outcomes, leading to a reduction in or elimination of expected future cash flows. In addition, headcount reductions and internal staff optimization efforts led to changes with respect to which patent portfolios the Company intends to allocate licensing and enforcement resources to in future periods. As such, certain portfolio programs were selected for termination due to a decision to no longer pursue or allocate resources, resulting in a write-off any remaining carrying value in the fourth quarter of 2015.

Goodwill Impairment Testing - December 31, 2015. At December 31, 2015, prior to the completion of the annual goodwill impairment test, the goodwill balance totaled $30.1 million. Goodwill is tested for impairment at the Company's single reporting unit level on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. Factors considered important, which could trigger an impairment review, include the following:


•	significant consistent gradual decline in the Company's stock price for a sustained period;


•	significant underperformance relative to expected historical or projected future operating results;


•	significant changes in the manner of use of assets or the strategy for the Company's overall business;


•	significant negative industry or economic trends; and


•	significant adverse changes in legal factors or in the business climate, including adverse regulatory actions or assessments.

In connection with Acacia's annual goodwill impairment testing for 2015, the Company identified several qualitative factors triggering an impairment test at December 31, 2015, as follows:

•

Adverse legal outcomes and changes in legal factors. In December 2015, Acacia announced that its subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, et al., deciding that the claims of the applicable patents in suit were invalid and non-infringed. This adverse legal outcome and others in the fourth quarter of 2015 resulted in changes in estimates of realization related to litigation outcomes in future periods for certain patent portfolios.

•

Significant consistent gradual decline in the Company’s stock price: Historically, the Company's stock price has been volatile, and the volatility continued during fiscal 2015, declining from $16.72 as of January 2, 2015, to $4.29 as of December 31, 2015, a 74% decline. In addition, subsequent to December 31, 2015, the Company's stock price volatility has continued, trending downward to $3.16 as of February 29, 2016. In the fourth quarter of 2015, given the continued decline in stock price up through December 31, 2015, and the impact of the December 2015 adverse trial outcomes noted above, the gradual consistent decline in the Company's stock price was deemed to be sustained, and hence indicative of a reduction in the estimated fair value of the Company, as reflected in its lower overall market capitalization.

•

Changes in Company Management and Resource Allocations. In connection with certain resource allocation changes within the organization given a change in management in the fourth quarter of 2015, headcount reductions and internal staff optimization efforts occurred, which led to changes with respect to estimates of which patent portfolios the Company intends to continue to allocate licensing and enforcement resources to in future periods. As such, certain patent portfolio programs were selected for termination due to a decision to no longer allocate resources. In addition, changes in estimates regarding the best and highest use of certain patent portfolios were made, resulting in reductions in estimated future cash flows.

At December 31, 2015, the Company utilized the following methods and assumptions in its annual goodwill impairment testing, which was prepared with the assistance of a third-party valuation specialist:


•	At December 31, 2015, the initial qualitative assessment included consideration of the factors described above, resulting in a conclusion that as of December 31, 2015, the consistent gradual decline in the Company’s stock price

F- 18

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

was sustained. The Company also considered the impact of the December 2015 adverse trial outcomes on the Company's stock price and related estimates of fair value for remaining portfolio opportunities. Based on the Company's assessment of these factors, the Company determined that it was more likely than not that goodwill was impaired, constituting a triggering event requiring a goodwill impairment test as of December 31, 2015.

•

The Company conducted the first step of the goodwill impairment test for its single reporting unit as of December 31, 2015. The Company utilized the market capitalization plus cost synergies approach to estimate the fair value of the Company. The estimated market capitalization was determined by multiplying the Company's stock price and the common shares outstanding as of December 31, 2015. Management also considered a control premium in its estimate of fair value for the Company's single reporting unit. The cost synergies were estimated based on the cost savings which could be achieved if the Company was acquired by a competitor in the same operating business.


•	Based on the analysis utilizing the market capitalization plus cost synergies approach, the estimated fair value of the reporting unit of $252 million was below its carrying value of $344.3 million as of December 31, 2015, and therefore, goodwill was determined to be more likely than not, impaired.

•

The purpose of step 2 of the analysis was to determine the estimated fair value of the assets and liabilities of the Company's reporting unit, in order to determine the implied fair value of goodwill for the reporting unit. The excess, if any, of the fair value of a reporting unit over the amounts assigned to its assets and liabilities is the implied fair value of goodwill. Based upon the analysis performed, the fair value of the Company's single reporting unit did not exceed the amounts assigned to its reporting unit assets and liabilities, resulting in a difference between the implied fair value of goodwill of zero and the historical carrying value of goodwill. As a result, the Company recognized a goodwill impairment charge totaling $30.1 million in the fourth quarter of 2015.

8. STOCKHOLDERS’ EQUITY

Repurchases of Common Stock. On November 15, 2013, Acacia’s Board of Directors authorized a program for repurchases of shares of Acacia’s outstanding common stock. Under the stock repurchase program, effective November 15, 2013, Acacia was authorized to purchase in the aggregate up to $70,000,000 of its of its outstanding common stock through the period ending May 14, 2014.

Repurchases were made from time to time by Acacia in the open market or in block purchases in compliance with applicable Securities and Exchange Commission rules. Repurchases to date were made using existing cash resources and occurred in the open market. The authorization to repurchase shares presented an opportunity to reduce the outstanding share count and enhance stockholder value. The following is the monthly stock repurchases for the periods presented, all of which were purchased as part of publicly announced plans or programs:



	Total Number of Shares Purchased	Average Price paid per Share		Approximate Dollar Value of Shares that May Yet be Purchased under the Program		Plan Expiration

December 4, 2013 - December 11, 2013	600,000	$	13.18	$	—	May 14, 2014
Totals for 2013	600,000

Cash Dividends. On April 23, 2013, Acacia announced that its Board of Directors approved the adoption of a cash dividend policy that calls for the payment of an expected total annual cash dividend of $0.50 per common share, payable in the amount of $0.125 per share per quarter. Under the policy, the Company paid four quarterly cash dividends totaling $25,434,000 and $25,039,000 in 2015 and 2014 and three quarterly cash dividends totaling $18,633,000 in 2013.

On February 25, 2016, Acacia announced that its Board of Directors terminated the company’s dividend policy effective February 23, 2016. The Board of Directors terminated the dividend policy due to a number of factors, including the Company’s financial performance and its available cash resources, the Company’s cash requirements and alternative uses of capital that the Board of Directors concluded would represent an opportunity to generate a greater return on investment for the Company and its stockholders.

F- 19

9. INCOME TAXES

Acacia’s provision for income taxes for the fiscal periods presented consisted of the following (in thousands):



	2015		2014			2013

Current:
Federal	$	—	$	—		$	—
State taxes	379		289			113
Foreign taxes	4,421		5,359			4,405
Total current	4,800		5,648			4,518
Deferred:
Federal	—		(1,867		)	(26,151		)
State taxes	—		131			(325		)
Total deferred	—		(1,736		)	(26,476		)
Provision for (benefit from) income taxes	$	4,800	$	3,912		$	(21,958	)

The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities consist of the following at December 31, 2015 and 2014 (in thousands):



	2015			2014

Deferred tax assets:
Net operating loss and capital loss carryforwards and credits	$	71,494		$	59,427
Stock compensation	1,385			1,800
Fixed assets and intangibles	1,359			—
Basis of investments in affiliates	499			1,437
Accrued liabilities and other	442			409
Unrealized loss on short-term investments	—			92
State taxes	81			26
Total deferred tax assets	75,260			63,191
Valuation allowance	(75,179		)	(35,927		)
Total deferred tax assets, net of valuation allowance	81			27,264

Deferred tax liabilities:
Fixed assets and intangibles	—			(27,157		)
Other	(81		)	(107		)
Total deferred tax liabilities	(81		)	(27,264		)

Net deferred tax assets (liabilities)	$	—		$	—

F- 20

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

A reconciliation of the federal statutory income tax rate and the effective income tax rate is as follows:



	2015		2014		2013

Statutory federal tax rate - (benefit) expense	(35	)%	(35	)%	(35	)%
State income and foreign taxes, net of federal tax effect	3	%	9	%	5	%
Foreign tax credit	(3	)%	(8	)%	(6	)%
Noncontrolling interests in operating subsidiaries	(1	)%	—	%	1	%
Goodwill	7	%	—	%	—	%
Nondeductible permanent items	—	%	1	%	2	%
Expired capital loss carryforwards	1	%	—	%	2	%
Valuation allowance	31	%	39	%	4	%
	3	%	6	%	(27	)%

For the fiscal years ended December 31, 2015 and 2014, the Company recorded full valuation allowances against its net deferred tax assets due to uncertainty regarding future realizability pursuant to guidance set forth in ASC 740, “Income Taxes.” In future periods, if the Company determines it will more likely than not be able to realize certain of these amounts, the applicable portion of the benefit from the release of the valuation allowance will generally be recognized in the statement of operations in the period the determination is made.

At December 31, 2015, Acacia had U.S. federal and state income tax net operating loss carryforwards (“NOLs”) totaling approximately $160,840,000 and $55,215,000, expiring between 2025 and 2035, and 2016 and 2035, respectively, for which $0 and $441,000 of federal and state net operating losses are included as a deferred tax asset related to the tax benefits of stock option deductions and which will be credited to additional paid-in capital when realized as a reduction of taxes payable on Acacia’s tax return. In addition, $1,928,000 and $37,771,000 of federal and state net operating losses are not included as a deferred tax asset and will be credited to additional paid-in capital when realized as a reduction of taxes payable on Acacia’s tax return as they relate to unrecognized excess tax benefits (see additional information regarding the ordering of windfall tax benefits and use of the “with-and-without” approach below). Capital loss carryovers totaled $3,423,000 at December 31, 2015, expiring between 2017 and 2020.

At December 31, 2015, approximately $29,318,000 of the U.S. federal NOLs, acquired in connection with the acquisition of ADAPTIX, Inc. in 2012, are subject to an annual utilization limitation of approximately $14,100,000, pursuant to the “change in ownership” provisions under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”).

As of December 31, 2015, Acacia had approximately $34,298,000 of foreign tax credits, expiring between 2016 and 2025, of which $20,313,000 has been utilized for financial statement purposes. Future realization of the credits as a reduction of taxes payable on Acacia’s tax return will result in an income tax benefit recognizable through additional paid in capital since the entire amount of the credits have been utilized for financial statement purposes under the “with-and-without approach.” In general, foreign taxes withheld may be claimed as a deduction on future U.S. corporate income tax returns, or as a credit against future U.S. income tax liabilities, subject to certain limitations.

Tax expense for the periods presented, primarily reflects foreign taxes withheld on revenue agreements with licensees in foreign jurisdictions, a benefit totaling $1,735,000 from the reversal of the net deferred tax liability that existed at the beginning of the year (2014 only) and other state taxes. Excluding the impact of the change in valuation allowance, annual effective tax rates were (28)%, (33)%, and (31%) for fiscal years 2015, 2014, and 2013, respectively. In 2013, the rate at which the Company recorded the tax benefit associated with the pre-tax loss for the period was reduced from the statutory rate primarily due to certain nondeductible permanent items and expired capital loss carryforwards. The Company recorded a valuation allowance on foreign tax credits generated in fiscal year 2013 totaling $4,605,000, and therefore, did not recognize the related tax benefit for these tax assets in fiscal year 2013.

The Company has elected to utilize the “with-and-without approach” regarding ordering of windfall tax benefits to determine whether the windfall tax benefit has reduced taxes payable. Under this approach, the windfall tax benefits would be recognized in additional paid in capital only if an incremental tax benefit is realized after considering all other tax benefits presently available to the Company. The deductions related to the exercise and vesting of equity-based incentive awards during the periods presented are, in general, available to offset taxable income on Acacia’s consolidated tax returns. Accordingly, the

F- 21

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

excess tax benefit related to the exercise and vesting of equity-based incentive awards for the periods presented was credited to additional paid-in capital, not taxes payable. For the year ended December 31, 2013, the Company incurred approximately $1,398,000 of net short falls from the exercise and vesting of equity-based incentive awards, of which $1,398,000 was recorded against its additional paid-in capital pool with no impact to the income statement. For the years ended December 31, 2015 and 2014, the Company incurred approximately $1,917,000 and $2,713,000, respectively, of net short falls from the exercise and vesting of equity-based incentive awards, of which $1,917,000 and $2,713,000, respectively, was recorded against its additional paid-in capital, subject to a full valuation allowance, with no impact to the income statement.

Acacia is subject to taxation in the U.S. and in various state jurisdictions and incurs foreign tax withholdings on revenue agreements with licensees in certain foreign jurisdictions. With no material exceptions, Acacia is no longer subject to U.S. federal or state examinations by tax authorities for years before 2000. The California Franchise Tax Board is auditing the 2011 and 2012 California combined income tax returns. The audit is in process and no findings or adjustments have been proposed.

At December 31, 2015, the Company had total unrecognized tax benefits of approximately $2,127,000, including a recorded noncurrent liability of $85,000, related to unrecognized tax benefits primarily associated with state taxes. No interest and penalties have been recorded for the unrecognized tax benefits as of December 31, 2015. If recognized, approximately $2,127,000, net of valuation analysis, would impact the Company’s effective tax rate. The Company does not expect that the liability for unrecognized tax benefits will change significantly within the next 12 months.

Acacia recognizes interest and penalties with respect to unrecognized tax benefits in income tax expense. Acacia has identified no uncertain tax position for which it is reasonably possible that the total amount of unrecognized tax benefits will significantly increase or decrease within 12 months.

10. STOCK-BASED INCENTIVE PLANS

The 2007 Acacia Technologies Stock Incentive Plan (“2007 Plan”) and the 2013 Acacia Research Corporation Stock Incentive Plan (“2013 Plan”) (collectively, the “Plans”) were approved by the stockholders of Acacia in May 2007 and May 2013, respectively. All Plans allow grants of stock options, stock awards and performance shares with respect to Acacia common stock to eligible individuals, which generally includes directors, officers, employees and consultants. Except as noted below, the terms and provisions of the Plans are identical in all material respects.

Acacia’s compensation committee administers the discretionary option grant and stock issuance programs. The compensation committee determines which eligible individuals are to receive option grants or stock issuances under those programs, the time or times when the grants or issuances are to be made, the number of shares subject to each grant or issuance, the status of any granted option as either an incentive stock option or a non-statutory stock option under the federal tax laws, the vesting schedule to be in effect for the option grant or stock issuance and the maximum term for which any granted option is to remain outstanding. The exercise price of options is generally equal to the fair market value of Acacia’s common stock on the date of grant. Options generally begin to be exercisable six months to one year after grant and generally expire ten years after grant. Stock options generally vest over two to three years and restricted shares generally vest in full after two to three years (generally representing the requisite service period). The Plans terminate no later than the tenth anniversary of the approval of the incentive plans by Acacia’s stockholders.

The Plans provide for the following separate programs:

•

Discretionary Option Grant Program. Under the discretionary option grant program, Acacia’s compensation committee may grant (1) non-statutory options to purchase shares of common stock to eligible individuals in the employ or service of Acacia or its subsidiaries (including employees, non-employee board members and consultants) at an exercise price not less than 85% of the fair market value of those shares on the grant date, and (2) incentive stock options to purchase shares of common stock to eligible employees at an exercise price not less than 100% of the fair market value of those shares on the grant date (not less than 110% of fair market value if such employee actually or constructively owns more than 10% of Acacia’s voting stock or the voting stock of any of its subsidiaries).

•

Stock Issuance Program. Under the stock issuance program, eligible individuals may be issued shares of common stock directly, upon the attainment of performance milestones or the completion of a specified period of service or as a bonus for past services. Under this program, the purchase price for the shares shall not be less than 100% of the fair market value of the shares on the date of issuance, and payment may be in the form of cash or past services

F- 22

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

rendered. The eligible individuals shall have full stockholder rights with respect to any shares of Common Stock issued to them under the Stock Issuance Program, whether or not their interest in those shares is vested. Accordingly, the eligible individuals shall have the right to vote such shares and to receive any regular cash dividends paid on such shares.

•

Automatic Option Grant Program (2013Plan only). Each non-employee director will receive restricted stock units for the number of shares determined by dividing the annual retainer by the closing price of Acacia’s common stock on the grant date, provided that such individual has served as a non-employee director for at least 6 months. In addition, each new non-employee director will receive restricted stock units for the number of shares determined by dividing the annual board of directors retainer by the closing price of Acacia’s common stock on the commencement date. Restricted stock units vest in a series of twelve quarterly installments over the three year period following the grant date, subject to immediate acceleration upon a change in control. Acacia will deliver shares corresponding to the vested restricted stock units within thirty (30) days after the first to occur of the following events: (i) the fifth (5th) anniversary of the grant date; or (ii) termination of the non-employee director’s service as a member of the Company’s Board of Directors. The non-employee directors do not have any rights, benefits or entitlements with respect to any shares unless and until the shares have been delivered.

The initial share reserve under the 2007 Plan was 560,000 shares. The number of shares of common stock available for issuance under the 2007 Plan automatically increased on January 1, 2008 and 2009, by an amount equal to two percent (2%) of the total number of shares of common stock outstanding on the last trading day of December in the prior calendar year. After January 1, 2009, no new additional shares will be added to the 2007 Plan without stockholder approval (except for shares subject to outstanding awards that are forfeited or otherwise returned to the 2007 Plan). At December 31, 2015, there were no shares available for grant under the 2007 Plan.

The number of shares of Common Stock initially reserved for issuance under the 2013 Plan was 4,750,000 shares. No new additional shares will be added to the 2013 Plan without security holder approval (except for shares subject to outstanding awards that are forfeited or otherwise returned to the 2013 Plan). The stock issuable under the 2013 Plan shall be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market. At December 31, 2015, there were 2,778,000 shares available for grant under the 2013 Plan.

Upon the exercise of stock options, the granting of restricted stock, or the delivery of shares pursuant to vested restricted stock units, it is Acacia’s policy to issue new shares of common stock. Acacia’s board of directors may amend or modify the Plans at any time, subject to any required stockholder approval.

The following table summarizes stock option activity for the Plans for the year ended December 31, 2015:



			Weighted-Average
	Options		Exercise Price		Remaining Contractual Term	Aggregate Intrinsic Value

Outstanding at December 31, 2014	150,000		$	7.59
Exercised	(135,000	)	$	6.95
Outstanding at December 31, 2015	15,000		$	13.38	1 year	$	—
Vested	15,000		$	13.38	1 year	$	—
Exercisable at December 31, 2015	15,000		$	13.38	1 year	$	—

The aggregate intrinsic value of options exercised during the years ended December 31, 2015, 2014 and 2013 was $751,000, $518,000, and $2,024,000, respectively. No options vested during the years ended December 31, 2015, 2014 and 2013.

F- 23

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The following table summarizes nonvested restricted share activity for the year ended December 31, 2015:



	Nonvested Restricted Shares		Weighted Average Grant Date Fair Value

Nonvested restricted stock at December 31, 2014	1,018,000		$	18.71
Granted	894,000		$	12.83
Vested	(615,000	)	$	18.69
Canceled	(468,000	)	$	15.13
Nonvested restricted stock at December 31, 2015	829,000		$	14.41

The weighted-average grant date fair value of nonvested restricted stock granted during the years ended December 31, 2015, 2014 and 2013 was $12.83, $14.41, and $24.31, respectively. The aggregate fair value of restricted stock that vested during the years ended December 31, 2015, 2014 and 2013 was $11,494,000, $21,490,000, $22,317,000, respectively. As of December 31, 2015, the total unrecognized compensation expense related to nonvested restricted stock awards was $9,264,000, which is expected to be recognized over a weighted-average period of approximately 1.6 years.

The following table summarizes restricted stock unit activity for the year ended December 31, 2015:



	Restricted Stock Units		Weighted Average Grant Date Fair Value

Nonvested restricted stock units outstanding at December 31, 2014	33,000		$	17.10
Granted	28,000		$	16.72
Vested	(26,000	)	$	18.48
Nonvested restricted stock units outstanding at December 31, 2015	35,000		$	15.78
Vested restricted stock units outstanding at December 31, 2015	75,000		$	23.32

The weighted-average grant date fair value of restricted stock units granted during the years ended December 31, 2015 and 2014 was $16.72 and $14.33, respectively. There were no restricted units granted during the year ended December 31, 2013. The aggregate fair value of restricted stock units that vested during the years ended December 31, 2015, 2014 and 2013 was $480,000, $460,000 and $469,000, respectively. As of December 31, 2015, the total unrecognized compensation expense related to restricted stock unit awards was $482,000, which is expected to be recognized over a weighted-average period of approximately 1.7 years.

As of December 31, 2015, there are 2,903,000 shares of common stock reserved for issuance under the Plans.

11. COMMITMENTS AND CONTINGENCIES

Operating Leases

Acacia leases certain office space under various operating lease agreements expiring at various dates from 2016 through 2020. Minimum annual rental commitments for operating leases of continuing operations having initial or remaining noncancellable lease terms in excess of one year are as follows (in thousands):



Years ending December 31,
2016	$	1,459
2017	1,557
2018	1,612
2019	1,669
2020	166
Total minimum lease payments	$	6,463

F- 24

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Rent expense for the years ended December 31, 2015, 2014 and 2013 approximated $1,926,000, $1,523,000 and $1,312,000, respectively. Rental payments are expensed in the statements of operations in the period to which they relate. Scheduled rent increases are amortized on a straight-line basis over the lease term.

Inventor Royalties and Contingent Legal Expenses

In connection with the investment in certain patents and patent rights, certain of Acacia’s operating subsidiaries executed related agreements which grant to the former owners of the respective patents or patent rights, the right to receive inventor royalties based on future net revenues (as defined in the respective agreements) generated as a result of licensing and otherwise enforcing the respective patents or patent portfolios.

Acacia’s operating subsidiaries may retain the services of law firms that specialize in patent licensing and enforcement and patent law in connection with their licensing and enforcement activities. These law firms may be retained on a contingent fee basis whereby such law firms are paid on a scaled percentage of any negotiated fees, settlements or judgments awarded based on how and when the fees, settlements or judgments are obtained.

The economic terms of the inventor agreements, operating agreements and contingent legal fee arrangements associated with the patent portfolios owned or controlled by Acacia’s operating subsidiaries, if any, including royalty rates, contingent fee rates and other terms, vary across the patent portfolios owned or controlled by such operating subsidiaries. Inventor royalties, payments to noncontrolling interests and contingent legal fees expenses fluctuate period to period, based on the amount of revenues recognized each period, the terms and conditions of revenue agreements executed each period and the mix of specific patent portfolios with varying economic terms and obligations generating revenues each period. Inventor royalties and contingent legal fees expenses will continue to fluctuate and may continue to vary significantly period to period, based primarily on these factors.

Patent Enforcement and Other Litigation

Acacia is subject to claims, counterclaims and legal actions that arise in the ordinary course of business. Management believes that the ultimate liability with respect to these claims and legal actions, if any, will not have a material effect on Acacia’s consolidated financial position, results of operations or cash flows.

Certain of Acacia’s operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights. In connection with any of Acacia’s operating subsidiaries’ patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against Acacia or its operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material, and if required to be paid by Acacia or its operating subsidiaries, could materially harm the Company’s operating results and financial position.

Fiscal year 2015 operating expenses included expenses for court ordered attorney fees and settlement and contingency accruals totaling $4,141,000. Fiscal year 2014 operating expenses included an expense accrual for court ordered attorney fees related to matters initiated in 2010 and 2011 totaling $1,548,000. Operating expenses for the year ended December 31, 2013 included a one-time, non-recurring charge related to the resolution of a dispute concerning legal fees associated with a prior matter totaling $3,506,000.

Guarantees and Indemnifications

Certain of Acacia’s operating subsidiaries have made guarantees and indemnities under which they may be required to make payments to a guaranteed or indemnified party, in relation to certain transactions, including revenue transactions in the ordinary course of business. In connection with certain facility leases, Acacia and certain of its operating subsidiaries have indemnified lessors for certain claims arising from the facilities or the leases. Acacia indemnifies its directors and officers to the maximum extent permitted under the laws of the State of Delaware. However, Acacia has a directors and officers insurance policy that may reduce its exposure in certain circumstances and may enable it to recover a portion of future amounts that may be payable, if any. The duration of the guarantees and indemnities varies and, in many cases is indefinite but subject to statute of limitations. The majority of guarantees and indemnities do not provide any limitations of the maximum potential future payments that Acacia could be obligated to make. To date, Acacia has made no payments related to these guarantees and indemnities. Acacia estimates the fair value of its indemnification obligations to be insignificant based on this history and

F- 25

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

therefore, have not recorded any liability for these guarantees and indemnities in the accompanying consolidated balance sheets. Additionally, no events or transactions have occurred that would result in a material liability at December 31, 2015.

Bank Guarantee

In March 2015, an operating subsidiary of Acacia entered into a standby letter of credit and guarantee arrangement (“Guarantee”) with a bank in the amount of $10,721,000, for purposes of enforcing a court ruling in a German patent court granting an injunction against the defendants in the related patent infringement case. An injunction is an equitable remedy in the form of a court order that compels the defendant(s) to cease marketing, offering for sale or importing applicable infringing products into applicable jurisdiction(s).

Under German law, in order to enforce the injunction granted by the court, a Guarantee is required to be furnished by the operating subsidiary, the plaintiff in the case, for potential payment to the defendants of any applicable claims which may be incurred by the defendants as a result of the enforcement of the injunction, only in the event that the aforementioned court ruling is subsequently successfully appealed by the defendants or otherwise amended. The Guarantee is required to be issued unlimited with respect to time, until appropriately extinguished in accordance with German law. The Guarantee will be extinguished when a relevant extinguishment order by the court having jurisdiction takes effect, typically occurring when the related infringement case has been settled or a final non-appealable decision has been issued by the court.

The Guarantee is secured by a cash deposit at the contracting bank totaling $10,721,000, which is classified as restricted cash in the accompanying balance sheet. The Guarantee expires on April 10, 2016, however, it is automatically extended without amendment for a period of one (1) year from the present or any future expiration date, unless at least 30 days prior to any expiration date, the Guarantee is extinguished in accordance with German law. The Guarantee facility fee is 1.15% per year, and the related expense is included in the consolidated statement of operations.

Other

In August 2010, a wholly owned subsidiary of Acacia became the general partner of the Acacia IP Fund, which was formed in August 2010. The Acacia IP Fund is authorized to raise up to $250,000,000. The Acacia IP Fund invests in, licenses and enforces intellectual property consisting primarily of patents, patent rights, and patented technologies. Refer to Note 2 to these notes to consolidated financial statements for information regarding the consolidation of majority-owned subsidiaries and the presentation of related noncontrolling interests. At December 31, 2015 and 2014, the Acacia IP Fund net assets and net loss were primarily comprised of the following (in thousands):



	2015		2014
Cash and other assets	$	7,740	$	2,823
Patents, net of accumulated amortization	147		967
Investments - noncurrent	5,829		8,281
Total assets	$	13,716	$	12,071

Accrued expenses and contributions	$	7,436	$	1,876
Total liabilities	7,436		1,876
Net assets	$	6,280	$	10,195



	2015			2014
Revenues	$	18		$	1,560
Operating expenses	1,617			1,724
Gain from operations	(1,599		)	(164		)
Net gain (loss) in equity method investments	6,922			(1,807		)
Net income (loss)	$	5,323		$	(1,971	)

12. RETIREMENT SAVINGS PLAN AND EXECUTIVE SEVERANCE POLICY

F- 26

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Retirement Savings Plan. Acacia has an employee savings and retirement plan under section 401(k) of the Code (the “Plan”). The Plan is a defined contribution plan in which eligible employees may elect to have a percentage of their compensation contributed to the Plan, subject to certain guidelines issued by the Internal Revenue Service. Acacia may contribute to the Plan at the discretion of the board of directors. There were no contributions made by Acacia during the periods presented.

Executive Severance Policy. Under Acacia’s Amended Executive Severance Policy, full-time employees with the title of Senior Vice President and higher (“SVP and higher”) are entitled to receive certain benefits upon termination of employment. If employment of an SVP and higher employee is terminated for other than cause or other than on account of death or disability, Acacia will (i) promptly pay to the SVP and higher employee a lump sum amount equal to the aggregate of (a) accrued obligations (i.e., annual base salary through the date of termination to the extent not theretofore paid and any compensation previously deferred (together with any accrued interest or earnings thereon) and any accrued vacation pay, and reimbursable expenses, in each case to the extent not theretofore paid) and (b) three (3) months of base salary for each full year that the SVP and higher employee was employed by the Company (the “Severance Period”), up to a maximum of twelve (12) months (eighteen (18) months for executive officers of Acacia Research Corporation) of base salary, and (ii) provide to the SVP and higher employee, Acacia paid COBRA coverage for the medical and dental benefits selected in the year in which the termination occurs, for the duration of the Severance Period.

13. SUPPLEMENTAL CASH FLOW INFORMATION

Federal taxes paid totaled $0, $0 and $3,000,000 for the years ended December 31, 2015, 2014 and 2013, respectively. At December 31, 2013, prepaid expenses and other current assets included federal and state income taxes receivable totaling $3,251,000. Cash paid for state income taxes totaled $211,000, $172,000 and $516,000 for the years ended December 31, 2015, 2014 and 2013, respectively. Foreign taxes withheld totaled $4,421,000, $5,159,000 and $4,605,000 for the years ended December 31, 2015, 2014 and 2013.

Refer to Note 6 to these notes to consolidated financial statements for information regarding noncash investing activity related to the investment in patent portfolios for the periods presented.

F- 27

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

14. QUARTERLY FINANCIAL DATA (unaudited)

The following table sets forth unaudited consolidated statements of operations data for the eight quarters in the period ended December 31, 2015. This information has been derived from Acacia’s unaudited condensed consolidated financial statements that have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the audited consolidated financial statements and related notes thereto. Acacia’s quarterly results have been, and may in the future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should not be relied upon as any indication of the results to be expected in any future periods.



	Quarter Ended
	Mar. 31,			Jun. 30,			Sept. 30,			Dec. 31,			Mar. 31,			Jun. 30,			Sept. 30,			Dec. 31,
	2015			2015			2015			2015			2014			2014			2014			2014
	(Unaudited, in thousands, except share and per share information)
Revenues	$	34,210		$	40,336		$	12,994		$	37,497		$	12,578		$	50,076		$	37,192		$	31,030
Operating costs and expenses:
Cost of revenues:
Inventor royalties	9,325			1,265			116			7,756			951			10,694			4,667			4,358
Contingent legal fees	4,784			5,512			1,972			3,901			1,527			7,077			7,663			7,296
Litigation and licensing expenses - patents	8,675			9,012			10,345			11,341			8,994			10,820			9,592			8,208
Amortization of patents	13,038			13,228			13,688			13,113			11,906			15,532			13,511			12,796
Marketing, general and administrative expenses (including non-cash stock compensation expense)	10,575			9,587			9,442			8,572			11,693			13,181			11,636			12,044
Research, consulting and other expenses - business development	997			732			802			860			992			1,003			1,208			637
Impairment of patent-related intangible assets	—			—			—			74,731			2,566			—			—			931
Impairment of goodwill	—			—			—			30,149			—			—			—			—
Other	426			—			3,465			250			—			—			1,548			—
Total operating costs and expenses	47,820			39,336			39,830			150,673			38,629			58,307			49,825			46,270
Operating income (loss)	(13,610		)	1,000			(26,836		)	(113,176		)	(26,051		)	(8,231		)	(12,633		)	(15,240		)
Total other income (expense)	228			(104		)	(180		)	—			109			(196		)	(57		)	(451		)
Income (loss) before (provision for) benefit from income taxes	(13,382		)	896			(27,016		)	(113,176		)	(25,942		)	(8,427		)	(12,690		)	(15,691		)
Benefit from (provision for) income taxes	(170		)	(119		)	(337		)	(4,174		)	1,372			(4,689		)	(145		)	(450		)
Net income (loss) including noncontrolling interests	(13,552		)	777			(27,353		)	(117,350		)	(24,570		)	(13,116		)	(12,835		)	(16,141		)
Net (income) loss attributable to noncontrolling interests in operating subsidiaries	422			(4,463		)	43			1,440			149			167			420			(103		)
Net loss attributable to Acacia Research Corporation	$	(13,130	)	$	(3,686	)	$	(27,310	)	$	(115,910	)	$	(24,421	)	$	(12,949	)	$	(12,415	)	$	(16,244	)
Net loss per common share attributable to Acacia Research Corporation:
Basic and diluted income (loss) per share	$	(0.27	)	$	(0.08	)	$	(0.55	)	$	(2.33	)	$	(0.51	)	$	(0.27	)	$	(0.26	)	$	(0.34	)
Weighted-average number of shares outstanding, basic and diluted	49,212,207			49,423,472			49,630,369			49,749,941			48,329,375			48,543,334			48,806,334			48,944,914

F- 28

EXHIBIT INDEX



Exhibit Number	Description

2.1	Agreement and Plan of Merger, dated November 22, 2011, by and among Acacia Research Group LLC, Apollo Patent Corp., Adaptix, Inc., and Baker Communications Fund II (QP), L.P., solely in its capacity as representative for the shareholders of Adaptix, Inc.(15)
3.1	Amended and Restated Certificate of Incorporation (1)
3.2	Amended and Restated Bylaws
10.1*	Acacia Research Corporation 1996 Stock Option Plan, as amended (2)
10.2*	Form of Option Agreement constituting the Acacia Research Corporation 1996 Executive Stock Bonus Plan (3)
10.3*	2002 Acacia Technologies Stock Incentive Plan (4)
10.4*	2007 Acacia Technologies Stock Incentive Plan (5)
10.5*	Form of Acacia Technologies Stock Option Agreement under the 2007 Acacia Technologies Stock Incentive Plan (6)
10.6*	Form of Acacia Technologies Stock Issuance Agreement under the 2002 Acacia Technologies Stock Incentive Plan (6)
10.7*	Form of Acacia Technologies Stock Issuance Agreement under the 2007 Acacia Technologies Stock Incentive Plan (6)
10.8	Office Space Lease dated January 28, 2002, between Acacia Research Corporation and The Irvine Company (7)
10.9	Form of Indemnification Agreement (8)
10.10	Third Amendment to Lease dated January 28, 2002 between Acacia Research Corporation and the Irvine Company (9)
10.11*	Employment Agreement, dated September 22, 2015, by and between Acacia Research Group LLC and Edward Treska (10)
10.12	Fourth Amendment to Lease dated January 28, 2002 between Acacia Research Corporation and the Irvine Company (10)
10.13	Fifth Amendment to Lease dated January 28, 2002 between Acacia Research Corporation and the Irvine Company (10)
10.15*	Employment Agreement, dated September 22, 2015, by and between Acacia Research Group LLC and Robert L. Harris (20)
10.16*	Employment Agreement, dated September 22, 2015, by and between Acacia Research Group LLC and Clayton J. Haynes (20)
10.17*	Acacia Research Corporation Amended and Restated Executive Severance Policy (12)
10.18	Sixth Amendment to Lease dated January 28, 2002 between Acacia Research Corporation and the Irvine Company (14)
10.19	Form of Purchase Agreement (16)
10.20*	2013 Acacia Research Corporation Stock Incentive Plan (18)
10.21*	Form of Stock Issuance Agreement under the 2013 Acacia Research Corporation Stock Incentive Plan (19)
10.22*	Employment Agreement, dated September 22, 2015, by and between Acacia Research Group LLC and Matthew Vella (20)
18.1	Preferability Letter dated February 25, 2010 from Grant Thornton LLP, independent registered public accounting firm, regarding change in accounting principle (13)
21.1	List of Subsidiaries
23.1	Consent of Independent Registered Public Accounting Firm
24.1	Power of Attorney (included in the signature page hereto).
31.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934
31.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934



32.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350
32.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350
101	Interactive Date Files Pursuant to Rule 405 of Regulation S-T.

___________________________


*	The referenced exhibit is a management contract, compensatory plan or arrangement required to be filed as an exhibit to this Annual Report on Form 10-K pursuant to Item 15(c) of Form 10-K.


(1)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on June 5, 2008 (File No. 000-26068).


(2)	Incorporated by reference to Appendix A to Acacia Research Corporation’s Definitive Proxy Statement on Schedule 14A filed on April 20, 2000 (File No. 000-26068).


(3)	Incorporated by reference to Appendix A to Acacia Research Corporation’s Definitive Proxy Statement on Schedule 14A filed on April 26, 1996 (File No. 000-26068).


(4)	Incorporated by reference to Annex E to the Proxy Statement/Prospectus which formed part of Acacia Research Corporation’s Registration Statement on Form S-4 (File No. 333-87654) which became effective on November 8, 2002.


(5)	Incorporated by reference to Acacia Research Corporation’s Registration Statement on Form S-8 (File No. 333-144754) which became effective on July 20, 2007.


(6)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q for the period ended September 30, 2007, filed on November 2, 2007 (File No. 000-26068).


(7)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10‑K for the year ended December 31, 2001, filed on March 27, 2002 (File No. 000‑26068).


(8)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q for the period ended June 30, 2012, filed on July 30, 2012 (File No. 000-26068).


(9)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q for the period ended March 31, 2006, filed on May 10, 2006 (File No. 000‑26068).


(10)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2007, filed on March 14, 2008 (File No. 000-26068).


(11)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on April 2, 2008 ( File No. 000-26068).


(12)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2008, filed on February 26, 2009 (File No. 000-26068).


(13)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2009, filed on February 26, 2010, as amended on March 1, 2010 (File No. 000-26068)


(14)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2010, filed on February 28, 2011, as amended on March 24, 2011 (File No. 000-26068).


(15)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K/A filed on January 19, 2012 (File No. 000-26068). Portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24-b-2 of the Securities Exchange Act of 1934, as amended. The omitted material has been separately filed with the Securities and Exchange Commission.


(16)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on February 16, 2012 (File No. 000-26068).


(17)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2012, filed on February 28, 2013 (File No. 000-26068).


(18)	Incorporated by reference to Appendix A to Acacia Research Corporation’s Definitive Proxy Statement on Schedule 14A filed on April 24, 2013 (File No. 000-26068).


(19)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on May 22, 2013 (File No. 000-26068).


(20)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q filed on November 9, 2015 (File No. 000-26068).

EX-21.1 2 actgex211123115.htm EXHIBIT 21.1 Exhibit

EXHIBIT 21.1

SUBSIDIARIES OF THE REGISTRANT

The following is a listing of the significant subsidiaries of Acacia Research Corporation:



	Jurisdiction of Incorporation

Acacia Global Acquisition LLC and subsidiaries	Delaware

Acacia Research Group, LLC, formerly Acacia Patent Acquisition, LLC and subsidiaries	Delaware

Acacia Global Acquisition LLC and Acacia Research Group, LLC, wholly own multiple consolidated operating subsidiaries, that are included in Acacia Research Corporation's consolidated financial statements included elsewhere herein, each of which are separate and distinct legal entities, and all of which are in the patent acquisition, development, licensing and enforcement business. All of the operating subsidiaries wholly owned by Acacia Global Acquisition LLC and Acacia Research Group, LLC operate in the United States.

EX-23.1 3 actgex231123115.htm EXHIBIT 23.1 Exhibit

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We have issued our reports dated March 15, 2016, with respect to the consolidated financial statements and internal control over financial reporting included in the Annual Report of Acacia Research Corporation on Form 10-K for the year ended December 31, 2015. We hereby consent to the incorporation by reference of said reports in the Registration Statements of Acacia Research Corporation on Forms S-3 (File No. 333-122452, effective February 1, 2005, File No. 333-157623, effective April 27, 2010, File No. 333-173045, effective March 24, 2011, File No. 333-180858, effective April 20, 2012) and on Forms S-8 (File No. 333-102181, effective December 23, 2002, File No. 333-109352, effective October 1, 2003, File No. 333-119811, effective October 19, 2004, File No. 333-127583, effective August 16, 2005, File No. 333-131463, effective February 1, 2006, File No. 333-140280, effective January 29, 2007, File No. 333-144754, effective July 20, 2007, File No. 333-149849, effective March 21, 2008, File No. 333-157626, effective March 2, 2009, File No. 333-165110, effective March 1, 2010, File No. 333-172538, effective March 1, 2011, File No. 333-179010, effective January 13, 2012, File No. 333-189135, effective June 6, 2013).

/s/ GRANT THORNTON LLP

Los Angeles, California

March 15, 2016

EX-31.1 4 actgex311123115.htm EXHIBIT 31.1 Exhibit

EXHIBIT 31.1

CERTIFICATION

I, Marvin Key, certify that:


1.	I have reviewed this Annual Report on Form 10-K of Acacia Research Corporation;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c.	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d.	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and


5.	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):


a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and


b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



Dated:	March 15, 2016	/s/ Marvin Key
		Marvin Key Interim Chief Executive Officer (Principal Executive Officer)

EX-31.2 5 actgex312123115.htm EXHIBIT 31.2 Exhibit

EXHIBIT 31.2

CERTIFICATION

I, Clayton J. Haynes, certify that:


1.	I have reviewed this Annual Report on Form 10-K of Acacia Research Corporation;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c.	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d.	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and


5.	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):


a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and


b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



Dated:	March 15, 2016	/s/ Clayton J. Haynes
		Clayton J. Haynes Chief Financial Officer (Principal Financial Officer)

EX-32.1 6 actgex321123115.htm EXHIBIT 32.1 Exhibit

EXHIBIT 32.1

CERTIFICATION

In connection with the Annual Report of Acacia Research Corporation (the “Company”) on Form 10-K for the fiscal year ended December 31, 2015, as filed with the Securities and Exchange Commission on March 15, 2016 (the “Report”), I, Marvin Key, Interim Chief Executive Officer of the Company, certify, pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)) and 18 U.S.C. Section 1350, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



	By:	/s/ Marvin Key
		Marvin Key
		Interim Chief Executive Officer
		March 15, 2016

This certification accompanies this Report pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934.

EX-32.2 7 actgex322123115.htm EXHIBIT 32.2 Exhibit

EXHIBIT 32.2

CERTIFICATION

In connection with the Annual Report of Acacia Research Corporation (the “Company”) on Form 10-K for the fiscal year ended December 31, 2015, as filed with the Securities and Exchange Commission on March 15, 2016 (the “Report”), I, Clayton J. Haynes, Chief Financial Officer of the Company, certify, pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)) and 18 U.S.C. Section 1350, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



	By:	/s/ Clayton J. Haynes
		Clayton J. Haynes
		Chief Financial Officer
		March 15, 2016

EX-101.INS 8 actg-20151231.xml XBRL INSTANCE DOCUMENT 0000934549 2015-01-01 2015-12-31 0000934549 2016-03-11 0000934549 2015-06-30 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee1Member 2015-01-01 2015-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee2Member 2014-01-01 2014-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee2Member 2013-01-01 2013-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee1Member 2014-01-01 2014-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee1Member 2013-01-01 2013-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee2Member 2015-01-01 2015-12-31 0000934549 2013-01-01 2013-12-31 0000934549 2014-01-01 2014-12-31 0000934549 us-gaap:RetainedEarningsMember 2015-01-01 2015-12-31 0000934549 2014-12-31 0000934549 2015-12-31 0000934549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-01-01 2015-12-31 0000934549 us-gaap:CommonStockMember 2014-01-01 2014-12-31 0000934549 us-gaap:NoncontrollingInterestMember 2015-12-31 0000934549 us-gaap:NoncontrollingInterestMember 2014-01-01 2014-12-31 0000934549 us-gaap:AdditionalPaidInCapitalMember 2013-12-31 0000934549 us-gaap:AdditionalPaidInCapitalMember 2013-01-01 2013-12-31 0000934549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-12-31 0000934549 us-gaap:CommonStockMember 2014-12-31 0000934549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-12-31 0000934549 us-gaap:CommonStockMember 2013-01-01 2013-12-31 0000934549 2013-12-31 0000934549 2012-12-31 0000934549 us-gaap:CommonStockMember 2012-12-31 0000934549 us-gaap:TreasuryStockMember 2014-12-31 0000934549 us-gaap:AdditionalPaidInCapitalMember 2014-01-01 2014-12-31 0000934549 us-gaap:TreasuryStockMember 2015-12-31 0000934549 us-gaap:RetainedEarningsMember 2014-12-31 0000934549 us-gaap:NoncontrollingInterestMember 2012-12-31 0000934549 us-gaap:RetainedEarningsMember 2014-01-01 2014-12-31 0000934549 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0000934549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-01-01 2014-12-31 0000934549 us-gaap:CommonStockMember 2013-12-31 0000934549 us-gaap:NoncontrollingInterestMember 2014-12-31 0000934549 us-gaap:NoncontrollingInterestMember 2013-12-31 0000934549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-12-31 0000934549 us-gaap:CommonStockMember 2015-01-01 2015-12-31 0000934549 us-gaap:TreasuryStockMember 2012-12-31 0000934549 us-gaap:RetainedEarningsMember 2013-12-31 0000934549 us-gaap:RetainedEarningsMember 2012-12-31 0000934549 us-gaap:AdditionalPaidInCapitalMember 2015-01-01 2015-12-31 0000934549 us-gaap:NoncontrollingInterestMember 2015-01-01 2015-12-31 0000934549 us-gaap:CommonStockMember 2015-12-31 0000934549 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0000934549 us-gaap:RetainedEarningsMember 2015-12-31 0000934549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-01-01 2013-12-31 0000934549 us-gaap:TreasuryStockMember 2013-12-31 0000934549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-12-31 0000934549 us-gaap:NoncontrollingInterestMember 2013-01-01 2013-12-31 0000934549 us-gaap:AdditionalPaidInCapitalMember 2012-12-31 0000934549 us-gaap:RetainedEarningsMember 2013-01-01 2013-12-31 0000934549 us-gaap:TreasuryStockMember 2013-01-01 2013-12-31 0000934549 us-gaap:AccountsReceivableMember actg:Licensee2Member 2015-01-01 2015-12-31 0000934549 us-gaap:AccountsReceivableMember actg:Licensee1Member 2015-01-01 2015-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:LicenseesInForeignJurisdictionsMember 2015-01-01 2015-12-31 0000934549 us-gaap:AccountsReceivableMember actg:Licensee1Member 2014-01-01 2014-12-31 0000934549 us-gaap:MinimumMember 2015-01-01 2015-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee3Member 2015-01-01 2015-12-31 0000934549 us-gaap:AccountsReceivableMember actg:Licensee2Member 2014-01-01 2014-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:LicenseesInForeignJurisdictionsMember 2013-01-01 2013-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:LicenseesInForeignJurisdictionsMember 2014-01-01 2014-12-31 0000934549 us-gaap:MaximumMember 2015-01-01 2015-12-31 0000934549 us-gaap:AccountsReceivableMember actg:Licensee3Member 2014-01-01 2014-12-31 0000934549 actg:ComputerHardwareAndSoftwareMember us-gaap:MaximumMember 2015-01-01 2015-12-31 0000934549 actg:ComputerHardwareAndSoftwareMember us-gaap:MinimumMember 2015-01-01 2015-12-31 0000934549 us-gaap:FurnitureAndFixturesMember us-gaap:MinimumMember 2015-01-01 2015-12-31 0000934549 us-gaap:LeaseholdImprovementsMember us-gaap:MaximumMember 2015-01-01 2015-12-31 0000934549 us-gaap:FurnitureAndFixturesMember us-gaap:MaximumMember 2015-01-01 2015-12-31 0000934549 us-gaap:LeaseholdImprovementsMember us-gaap:MinimumMember 2015-01-01 2015-12-31 0000934549 us-gaap:PatentsMember us-gaap:MinimumMember 2015-01-01 2015-12-31 0000934549 us-gaap:PatentsMember us-gaap:MaximumMember 2015-01-01 2015-12-31 0000934549 us-gaap:PatentsMember 2014-12-31 0000934549 us-gaap:PatentsMember 2015-12-31 0000934549 2016-02-29 0000934549 2015-01-02 0000934549 2013-12-03 2013-12-11 0000934549 2013-11-15 0000934549 us-gaap:InternalRevenueServiceIRSMember actg:CapitalLossCarryforwardRelatedToBusinessAcquisitionMember 2015-12-31 0000934549 us-gaap:StateAndLocalJurisdictionMember 2015-12-31 0000934549 us-gaap:DomesticCountryMember 2015-12-31 0000934549 us-gaap:RestrictedStockUnitsRSUMember 2015-01-01 2015-12-31 0000934549 us-gaap:RestrictedStockUnitsRSUMember 2015-12-31 0000934549 us-gaap:RestrictedStockUnitsRSUMember 2014-12-31 0000934549 us-gaap:RestrictedStockMember 2015-12-31 0000934549 us-gaap:RestrictedStockMember 2014-12-31 0000934549 us-gaap:RestrictedStockMember 2015-01-01 2015-12-31 0000934549 us-gaap:RestrictedStockMember 2013-01-01 2013-12-31 0000934549 actg:StockIssuanceProgramMember 2015-01-01 2015-12-31 0000934549 us-gaap:RestrictedStockUnitsRSUMember 2014-01-01 2014-12-31 0000934549 us-gaap:RestrictedStockMember 2014-01-01 2014-12-31 0000934549 actg:A2013PlanMember 2015-12-31 0000934549 us-gaap:RestrictedStockUnitsRSUMember 2013-01-01 2013-12-31 0000934549 actg:NonstatutoryOptionsMember actg:DiscretionaryOptionGrantProgramMember 2015-01-01 2015-12-31 0000934549 actg:A2007PlanMember 2008-12-31 0000934549 actg:LessThan10Member actg:IncentiveStockOptionsMember actg:DiscretionaryOptionGrantProgramMember 2015-01-01 2015-12-31 0000934549 actg:A2007PlanMember 2009-01-01 2009-12-31 0000934549 actg:A10OrMoreMember actg:IncentiveStockOptionsMember actg:DiscretionaryOptionGrantProgramMember 2015-01-01 2015-12-31 0000934549 actg:A2007PlanMember 2015-12-31 0000934549 2011-01-01 2011-12-31 0000934549 2014-01-01 2014-03-31 0000934549 2015-07-01 2015-09-30 0000934549 2014-10-01 2014-12-31 0000934549 2014-07-01 2014-09-30 0000934549 2015-04-01 2015-06-30 0000934549 2014-04-01 2014-06-30 0000934549 2015-10-01 2015-12-31 0000934549 2015-01-01 2015-03-31 iso4217:USD xbrli:shares xbrli:shares xbrli:pure iso4217:USD 592000 1247000 1747000 2702000 380000 1548000 0 1876000 7436000 8410000 10135000 16700000 1000000 16700000 1000000 1753000 298000 120000 P10Y P2Y 3423000 2823000 7740000 516000 172000 211000 0.125 650000 649000 24784000 1527000 7077000 7663000 7296000 23563000 4784000 5512000 1972000 3901000 16169000 59427000 71494000 27157000 0 0 0 0 1359000 18122000 24313000 24740000 0.02 0.00 0.01 0.00 0.00 0.07 0.31 -0.33 -0.28 344300000 252000000 3000000 0 0 14100000 34298000 4605000 5159000 4421000 20313000 0 3960000 164000 1599000 -1971000 5323000 -1807000 6922000 -1724000 -1617000 -2061000 3904000 527000 8281000 5829000 P3M 39335000 8994000 10820000 9592000 8208000 37614000 8675000 9012000 10345000 11341000 39373000 10195000 6280000 1928000 37771000 160840000 55215000 0.10 250000000 4000000 16700000 1000000 3500000 3000000 500000 166565000 281495000 453201000 444137000 286636000 286636000 162642000 162642000 967000 147000 -16000 -16000 P45D P30D 3251000 992000 1003000 1208000 637000 3840000 997000 732000 802000 860000 3391000 -1560000 -18000 14351000 14878000 75000 23.32 0.02 1735000 12071000 13716000 1876000 7436000 85000 4605000 false --12-31 FY 2015 2015-12-31 10-K 0000934549 50458905 Yes Large Accelerated Filer 437867000 ACACIA RESEARCH CORP No No 2015-12-31

14860000

17347000

20168000

33500000

1530000

1592000

806000

701000

1055000

1261000

-353000

-215000

P5Y

646595000

633146000

1398000

2713000

1917000

49039000

11906000

15532000

13511000

12796000

53745000

13038000

13228000

13688000

13113000

53067000

27760

71468

536348000

347901000

218708000

183877000

58558000

58819000

1174000

981000

2188000

617000

2000

263000

221804000

126685000

134466000

135223000

-95119000

7781000

757000

2903000

2778000

0.375

0.500

0.50

0.001

100000000

50065382

50651239

49160844

49385057

50065382

50651239

50000

51000

-56215000

-65435000

-159898000

-58623000

-66068000

-157340000

0.38

0.16

0.24

0.30

0.17

0.15

0.22

0.43

0.72

0.21

0.24

0.20

0.16

0.49

4405000

5359000

4421000

4518000

5648000

4800000

113000

289000

379000

-26151000

-1867000

-26476000

-1736000

27264000

81000

-325000

131000

63191000

75260000

1437000

499000

1161000

210000

27264000

81000

441000

92000

26000

81000

1800000

1385000

409000

442000

35927000

75179000

1161000

210000

107000

81000

236000

304000

222000

49275000

54049000

53289000

-1.18

-0.51

-0.27

-0.26

-0.34

-1.37

-0.27

-0.08

-0.55

-2.33

-3.25

-0.27

0.06

0.03

-0.35

0.04

0.39

0.31

0.01

0.00

-0.01

0.02

0.01

0.00

0.05

0.09

0.03

-0.06

-0.08

-0.03

1481000

576000

9264000

482000

P1Y7M

P1Y8M

-1398000

1398000

P8Y

P1Y

P10Y

P1Y

16873000

43218000

6787000

19410000

35777000

40577000

-99000

-123000

761000

739000

71000

14000

59229000

11693000

13181000

11636000

12044000

48554000

10575000

9587000

9442000

8572000

38176000

30149000

4619000

2566000

931000

3497000

74731000

-80800000

-25942000

-8427000

-12690000

-15691000

-62750000

-13382000

896000

-27016000

-113176000

-152678000

-21958000

-1372000

4689000

145000

450000

3912000

170000

119000

337000

4174000

4800000

3251000

2740000

3718000

2570000

3502000

-13827000

-13332000

-5300000

3154000

-619000

-10725000

1312000

1523000

1926000

144000

145000

47300000

33746000

536348000

347901000

45911000

33225000

130556000

130876000

125037000

0.0115

5491000

3944000

-364000

-4105000

-25551000

-25700000

-28601000

-66059000

29297000

39307000

-3509000

4184000

-9949000

-56434000

-24421000

-12949000

-12415000

-16244000

-66029000

-13130000

-3686000

-27310000

-115910000

-160036000

-2408000

-149000

-167000

-420000

103000

-633000

-422000

4463000

-43000

-1440000

2558000

-56945000

-66755000

-160730000

213487000

38629000

58307000

49825000

46270000

193031000

47820000

39336000

39830000

150673000

277659000

-82931000

-26051000

-8231000

-12633000

-15240000

-62155000

-13610000

1000000

-26836000

-113176000

-152622000

6463000

1459000

166000

1669000

1612000

1557000

29318000

1085000

383000

355000

1110000

-128000

-123000

-193000

-2210000

-617000

26000

-1488000

-356000

3506000

1548000

426000

3465000

250000

4141000

228000

311000

2131000

109000

-196000

-57000

-451000

-595000

228000

-104000

-180000

-56000

12000

-28000

-109000

7926000

18633000

25039000

25434000

279693000

109963000

23296000

25061000

42746000

19504000

675000

109000

8000

867000

4105000

0.001

10000000

4355000

4219000

1920000

239370000

182115000

82115000

239370000

182115000

82115000

1000000

3500000

750000

486000

206000

938000

-58842000

-24570000

-13116000

-12835000

-16141000

-66662000

-13552000

777000

-27353000

-117350000

-157478000

330000

30000

1555000

1533000

500000

272000

10725000

-128095000

-288131000

12578000

50076000

37192000

31030000

34210000

40336000

12994000

37497000

29724000

951000

10694000

4667000

4358000

20670000

9325000

1265000

116000

7756000

18462000

27894000

27893000

1000

18115000

18114000

1000

11048000

11047000

1000

468000

15.13

894000

28000

24.31

14.33

14.41

0.00

12.83

16.72

1018000

33000

829000

35000

18.71

17.10

14.41

15.78

615000

26000

22317000

469000

21490000

460000

11494000

480000

18.69

18.48

4750000

560000

15000

13.38

2024000

518000

751000

150000

15000

7.59

13.38

15000

13.38

6.95

4.29

16.72

3.16

P1Y

1.10

1.00

0.85

1.00

58558000

709533

635819

450857

115346

44506

135000

-18633000

-25039000

486000

206000

938000

70000000

-666

-1000

483557000

310211000

618478000

-1166000

644982000

49000

6976000

-5632000

-26731000

562198000

-947000

653314000

49000

6488000

-62066000

-34640000

489048000

-353000

646595000

50000

5491000

-128095000

-34640000

314155000

-215000

633146000

51000

3944000

-288131000

-34640000

13.18

1729408

600000

-600000

34640000

-7910000

-7909000

219000

693000

261000

2127000

-26746000

-1736000

48155832

48329375

48543334

48806334

48944914

48658088

49212207

49423472

49630369

49749941

49505817

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingent Liabilities.</font><font style="font-family:inherit;font-size:10pt;"> The Company, from time to time, is involved in certain legal proceedings. Based upon consultation with outside counsel handling its defense in these matters and the Company’s analysis of potential outcomes, if the Company determines that a loss arising from such matters is probable and can be reasonably estimated, an estimate of the contingent liability is recorded in its consolidated financial statements. If only a range of estimated loss can be determined, an amount within the range that, based on estimates, assumptions and judgments, reflects the most likely outcome, is recorded as a contingent liability in the consolidated financial statements. In situations where none of the estimates within the estimated range is a better estimate of probable loss than any other amount, the Company records the low end of the range. Any such accrual would be charged to expense in the appropriate period. Litigation expenses for these types of contingencies are recognized in the period in which the litigation services were provided.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cost of Revenues</font><font style="font-family:inherit;font-size:10pt;">.  Cost of revenues include the costs and expenses incurred in connection with Acacia’s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment costs. These costs are included under the caption “Cost of revenues” in the accompanying consolidated statements of operations. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Goodwill. </font><font style="font-family:inherit;font-size:10pt;">Goodwill is tested for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis (December 31) and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. Acacia considers its market capitalization and the carrying value of its assets and liabilities, including goodwill, when performing its goodwill impairment test. When conducting its annual goodwill impairment assessment, the Company initially performs a qualitative evaluation of whether it is more likely than not that goodwill is impaired. If it is determined by a qualitative evaluation that it is more likely than not that goodwill is impaired, the Company then applies a two-step impairment test. The two-step impairment test first compares the fair value of the Company’s reporting unit to its carrying or book value. If the fair value of the reporting unit exceeds its carrying value, goodwill is not impaired and the Company is not required to perform further testing. If the carrying value of the reporting unit exceeds its fair value, the Company determines the implied fair value of the reporting unit’s goodwill and if the carrying value of the reporting unit’s goodwill exceeds its implied fair value, then an impairment loss equal to the difference is recorded in the consolidated statement of operations. Refer to Note </font><font style="font-family:inherit;font-size:10pt;">7</font><font style="font-family:inherit;font-size:10pt;"> for additional information.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Inventor Royalties and Contingent Legal Expenses. </font><font style="font-family:inherit;font-size:10pt;">Inventor royalties are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In certain instances, pursuant to the terms of the underlying inventor agreements, upfront advances paid to patent owners by Acacia’s operating subsidiaries are recoverable from future net revenues. Patent costs that are recoverable from future net revenues are amortized over the estimated economic useful life of the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense in the consolidated statements of operations. Any unamortized upfront advances recovered from net revenues are expensed in the period recovered, and included in amortization expense in the consolidated statements of operations. Refer to Note 11 for additional information.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal fees are paid; however, Acacia’s operating subsidiaries may be liable for certain out of pocket legal costs incurred pursuant to the underlying legal services agreement. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015 and 2014</font><font style="font-family:inherit;font-size:10pt;">, the Acacia IP Fund net assets and net loss were primarily comprised of the following (in thousands):</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:81.25%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="50%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="22%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="22%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and other assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,740</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,823</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents, net of accumulated amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">967</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments - noncurrent</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,829</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,281</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,716</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,071</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses and contributions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,436</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,876</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,436</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,876</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,280</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,195</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:81.25%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="50%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="22%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="22%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,560</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,617</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,724</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain from operations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,599</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(164</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net gain (loss) in equity method investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,922</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,807</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,323</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,971</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncontrolling interests in Acacia’s majority-owned and controlled operating subsidiaries (“noncontrolling interests”) are separately presented as a component of stockholders’ equity. Consolidated net income or (loss) is adjusted to include the net (income) or loss attributed to noncontrolling interests in the consolidated statements of operations. Refer to the accompanying consolidated statements of stockholders’ equity for total noncontrolling interests. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A wholly owned subsidiary of Acacia is the general partner of the Acacia Intellectual Property Fund, L.P. (the “Acacia IP Fund”), which was formed in August 2010. The Acacia IP Fund is included in the Company’s consolidated financial statements since 2010, as Acacia’s wholly owned subsidiary, as the general partner, has the ability to control the operations and activities of the Acacia IP Fund. Refer to Note </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;text-decoration:none;">11</font><font style="font-family:inherit;font-size:10pt;"> to these consolidated financial statements.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015, 2014 and 2013</font><font style="font-family:inherit;font-size:10pt;">, capitalized patent costs, accumulated amortization, and sales proceeds related to patent-related sales and disposals are as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.3359375%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="48%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capitalized patent costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">298</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,753</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales proceeds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Patents.</font><font style="font-family:inherit;font-size:10pt;">  Patents include the cost of patents or patent rights (hereinafter, collectively “patents”) acquired from third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">ten</font><font style="font-family:inherit;font-size:10pt;"> years. Certain patent application and prosecution costs incurred to secure additional patent claims, that based on management’s estimates are deemed to be recoverable, are capitalized and amortized over the remaining estimated economic useful life of the related patent portfolio.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The gross carrying amounts and accumulated amortization related to investments in intangible assets as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015 and 2014</font><font style="font-family:inherit;font-size:10pt;"> are as follows (in thousands): </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="76%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross carrying amount - patents                                                                             </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">444,137</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">453,201</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization - patents</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;">                                                                         </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(281,495</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(166,565</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents, net                                                                             </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162,642</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">286,636</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives of the assets:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:91.015625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="56%" rowspan="1" colspan="1"></td><td width="44%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixtures</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:60px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3 to 5 years</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer hardware and software</font></div></td><td style="vertical-align:top;padding-left:60px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3 to 5 years</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:60px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2 to 5 years (Lesser of lease term or useful life of improvement)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Adopted Accounting Pronouncements - Adopted Effective January 1, 2014. </font><font style="font-family:inherit;font-size:10pt;">In July 2013, the FASB issued a new accounting standard addressing when unrecognized tax benefits should be presented as reductions to deferred tax assets for net operating loss carryforwards in the financial statements. This standard was adopted effective January 1, 2014. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements and related disclosures.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2013, the FASB issued a new accounting standard addressing the accounting for the cumulative translation adjustment when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. This standard was adopted effective January 1, 2014. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements and related disclosures.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Treasury Stock</font><font style="font-family:inherit;font-size:10pt;">. Repurchases of the Company’s outstanding common stock are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock on the consolidated balance sheets.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cash and Cash Equivalents</font><font style="font-family:inherit;font-size:10pt;">.  Acacia considers all highly liquid, short-term investments with original maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia’s cash equivalents are comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements. Acacia’s cash equivalents are measured at fair value using quoted prices that represent Level 1 inputs.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentration of Credit Risks.  </font><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject Acacia to concentrations of credit risk are cash equivalents, investments and accounts receivable. Acacia places its cash equivalents and investments primarily in highly rated money market funds and investment grade marketable securities. Cash equivalents are also invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not experienced any significant losses on its deposits of cash and cash equivalents.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">24%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">20%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">16%</font><font style="font-family:inherit;font-size:10pt;"> respectively, of revenues recognized during the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">. Two licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">22%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">22%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues recognized during the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2014</font><font style="font-family:inherit;font-size:10pt;">. Two licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">38%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">16%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues recognized during the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2013</font><font style="font-family:inherit;font-size:10pt;">. Two licensees individually represented approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">72%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">21%</font><font style="font-family:inherit;font-size:10pt;"> respectively, of accounts receivable at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">. Three licensees individually represented approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">30%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">17%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of accounts receivable at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2014</font><font style="font-family:inherit;font-size:10pt;">. For </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015, 2014 and 2013</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">49%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">43%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">24%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. The Company does not have any material foreign operations. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia performs credit evaluations of its licensees with significant receivable balances, if any, and has not experienced any significant credit losses. Accounts receivable are recorded at the executed contract amount and generally do not bear interest. Collateral is not required. An allowance for doubtful accounts may be established to reflect the Company’s best estimate of probable losses inherent in the accounts receivable balance, and is reflected as a contra-asset account on the balance sheet and a charge to operating expenses in the statement of operations for the applicable period. The allowance is determined based on known troubled accounts, historical experience, and other currently available evidence. There was no allowance for doubtful accounts established for the periods presented. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Principles of Consolidation.  </font><font style="font-family:inherit;font-size:10pt;">The accompanying consolidated financial statements include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. Material intercompany transactions and balances have been eliminated in consolidation.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income (Loss) Per Share.  </font><font style="font-family:inherit;font-size:10pt;">The Company computes net income (loss) attributable to common stockholders using the two-class method required for capital structures that include participating securities. Under the two-class method, securities that participate in non-forfeitable dividends, such as the Company’s outstanding unvested restricted stock, are considered “participating securities.” </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In applying the two-class method, (i) basic net income (loss) per share is computed by dividing net income (loss) (less any dividends paid on participating securities) by the weighted average number of shares of common stock and participating securities outstanding for the period and (ii) diluted earnings per share may include the additional effect of other securities, if dilutive, in which case the dilutive effect of such securities is calculated by applying the two-class method and the treasury stock method to the assumed exercise or vesting of potentially dilutive common shares. The method yielding the more dilutive result is ultimately reported for the applicable period. Potentially dilutive common stock equivalents primarily consist of employee stock options, and restricted stock units for calculations utilizing the two-class method, and also include unvested restricted stock, when utilizing the treasury method.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted income per share:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="61%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Numerator (in thousands):</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basic and Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160,036</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(66,029</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(56,434</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total dividends declared / paid</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,434</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,039</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18,633</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dividends attributable to common stockholders</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,740</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,313</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,122</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss attributable to common stockholders – basic and diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160,730</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(66,755</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(56,945</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average shares used in computing net loss per share attributable to common stockholders – basic and diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,505,817</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,658,088</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,155,832</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic and diluted net loss per common share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.25</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.37</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.18</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,468</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,760</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,760</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements.</font><font style="font-family:inherit;font-size:10pt;"> U.S. generally accepted accounting principles define fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value is defined as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.4375%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="5%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="82%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">●</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 1 -</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Observable Inputs:  Quoted prices in active markets for identical investments;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">●</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 2 -</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pricing Models with Significant Observable Inputs:  Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">●</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 3 -</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unobservable Inputs:  Significant unobservable inputs, including the entity’s own assumptions in determining the fair value of investments.</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Whenever possible, the Company is required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value. Acacia has not elected the fair value option for recording non-financial assets and liabilities, and therefore no fair value measurements are performed on a recurring basis.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value of Financial Instruments.  </font><font style="font-family:inherit;font-size:10pt;">The carrying value of cash and cash equivalents, investments, accounts receivables, and accounts payable approximates their fair values due to their short-term maturities.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accounting Principles and Fiscal Year End.  </font><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements and accompanying notes are prepared on the accrual basis of accounting in accordance with generally accepted accounting principles in the United States of America. </font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">GOODWILL AND PATENT IMPAIRMENT CHARGES</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to applicable accounting standards, if goodwill and another asset group of a reporting unit are tested for impairment at the same time, the other asset group, the Company's patent portfolios, are to be tested for impairment before goodwill. </font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Patent Portfolio Impairment Testing - December 31, 2015.</font><font style="font-family:inherit;font-size:10pt;"> Acacia performed an impairment analysis for its patent assets as of December 31, 2015, utilizing the assistance of a third-party valuation specialist, resulting in </font><font style="font-family:inherit;font-size:10pt;">$74.7 million</font><font style="font-family:inherit;font-size:10pt;"> of patent portfolio impairment charges, for the following reasons: </font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2015, Acacia announced that its subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, Inc., and others. The jury returned a verdict that the asserted claims of the patent at issue were invalid and non-infringed. The Adaptix trial loss resulted in a reduction in estimated cash flows for the Adaptix portfolio expected to be realized from future licensing and enforcement activities, leading to impairment charges on the portfolio in the fourth quarter of 2015. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management considered the impact of the fourth quarter 2015 adverse trial outcomes on its estimates of future cash flows that could be realized from future licensing and enforcement activities for other patent portfolios. Estimates of future cash flows for these portfolios were reduced in part in connection with the Company's assessment of probabilities of realization given the recent adverse trial outcomes.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patent impairment charges include the carrying value of other patent portfolios for which, in the fourth quarter of 2015, the Company experienced adverse litigation or trial outcomes, leading to a reduction in or elimination of expected future cash flows. In addition, headcount reductions and internal staff optimization efforts led to changes with respect to which patent portfolios the Company intends to allocate licensing and enforcement resources to in future periods. As such, certain portfolio programs were selected for termination due to a decision to no longer pursue or allocate resources, resulting in a write-off any remaining carrying value in the fourth quarter of 2015. </font></div></td></tr></table><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Goodwill Impairment Testing - December 31, 2015.</font><font style="font-family:inherit;font-size:10pt;"> At December 31, 2015, prior to the completion of the annual goodwill impairment test, the goodwill balance totaled </font><font style="font-family:inherit;font-size:10pt;">$30.1 million</font><font style="font-family:inherit;font-size:10pt;">. Goodwill is tested for impairment at the Company's single reporting unit level on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. Factors considered important, which could trigger an impairment review, include the following:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">significant consistent gradual decline in the Company's stock price for a sustained period;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">significant underperformance relative to expected historical or projected future operating results;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">significant changes in the manner of use of assets or the strategy for the Company's overall business;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">significant negative industry or economic trends; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">significant adverse changes in legal factors or in the business climate, including adverse regulatory actions or assessments.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">     In connection with Acacia's annual goodwill impairment testing for 2015, the Company identified several qualitative factors triggering an impairment test at December 31, 2015, as follows: </font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Adverse legal outcomes and changes in legal factors.</font><font style="font-family:inherit;font-size:10pt;"> In December 2015, Acacia announced that its subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, et al., deciding that the claims of the applicable patents in suit were invalid and non-infringed. This adverse legal outcome and others in the fourth quarter of 2015 resulted in changes in estimates of realization related to litigation outcomes in future periods for certain patent portfolios. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Significant consistent gradual decline in the Company’s stock price: </font><font style="font-family:inherit;font-size:10pt;">Historically, the Company's stock price has been volatile, and the volatility continued during fiscal 2015, declining from </font><font style="font-family:inherit;font-size:10pt;">$16.72</font><font style="font-family:inherit;font-size:10pt;"> as of January 2, 2015, to </font><font style="font-family:inherit;font-size:10pt;">$4.29</font><font style="font-family:inherit;font-size:10pt;"> as of December 31, 2015, a 74% decline. In addition, subsequent to December 31, 2015, the Company's stock price volatility has continued, trending downward to </font><font style="font-family:inherit;font-size:10pt;">$3.16</font><font style="font-family:inherit;font-size:10pt;"> as of February 29, 2016. In the fourth quarter of 2015, given the continued decline in stock price up through December 31, 2015, and the impact of the December 2015 adverse trial outcomes noted above, the gradual consistent decline in the Company's stock price was deemed to be sustained, and hence indicative of a reduction in the estimated fair value of the Company, as reflected in its lower overall market capitalization.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Changes in Company Management and Resource Allocations.</font><font style="font-family:inherit;font-size:10pt;"> In connection with certain resource allocation changes within the organization given a change in management in the fourth quarter of 2015, headcount reductions and internal staff optimization efforts occurred, which led to changes with respect to estimates of which patent portfolios the Company intends to continue to allocate licensing and enforcement resources to in future periods. As such, certain patent portfolio programs were selected for termination due to a decision to no longer allocate resources. In addition, changes in estimates regarding the best and highest use of certain patent portfolios were made, resulting in reductions in estimated future cash flows.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2015, the Company utilized the following methods and assumptions in its annual goodwill impairment testing, which was prepared with the assistance of a third-party valuation specialist: </font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2015, the initial qualitative assessment included consideration of the factors described above, resulting in a conclusion that as of December 31, 2015, the consistent gradual decline in the Company’s stock price was sustained. The Company also considered the impact of the December 2015 adverse trial outcomes on the Company's stock price and related estimates of fair value for remaining portfolio opportunities. Based on the Company's assessment of these factors, the Company determined that it was more likely than not that goodwill was impaired, constituting a triggering event requiring a goodwill impairment test as of December 31, 2015.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company conducted the first step of the goodwill impairment test for its single reporting unit as of December 31, 2015. The Company utilized the market capitalization plus cost synergies approach to estimate the fair value of the Company. The estimated market capitalization was determined by multiplying the Company's stock price and the common shares outstanding as of December 31, 2015. Management also considered a control premium in its estimate of fair value for the Company's single reporting unit. The cost synergies were estimated based on the cost savings which could be achieved if the Company was acquired by a competitor in the same operating business.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on the analysis utilizing the market capitalization plus cost synergies approach, the estimated fair value of the reporting unit of </font><font style="font-family:inherit;font-size:10pt;">$252 million</font><font style="font-family:inherit;font-size:10pt;"> was below its carrying value of </font><font style="font-family:inherit;font-size:10pt;">$344.3 million</font><font style="font-family:inherit;font-size:10pt;"> as of December 31, 2015, and therefore, goodwill was determined to be more likely than not, impaired.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The purpose of step 2 of the analysis was to determine the estimated fair value of the assets and liabilities of the Company's reporting unit, in order to determine the implied fair value of goodwill for the reporting unit. The excess, if any, of the fair value of a reporting unit over the amounts assigned to its assets and liabilities is the implied fair value of goodwill. Based upon the analysis performed, the fair value of the Company's single reporting unit did not exceed the amounts assigned to its reporting unit assets and liabilities, resulting in a difference between the implied fair value of goodwill of zero and the historical carrying value of goodwill. As a result, the Company recognized a goodwill impairment charge totaling </font><font style="font-family:inherit;font-size:10pt;">$30.1 million</font><font style="font-family:inherit;font-size:10pt;"> in the fourth quarter of 2015.</font></div></td></tr></table></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Impairment of Long-lived Assets.</font><font style="font-family:inherit;font-size:10pt;"> Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded equal to the excess of the asset’s carrying value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows. Refer to Note </font><font style="font-family:inherit;font-size:10pt;">7</font><font style="font-family:inherit;font-size:10pt;"> for additional information.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value is generally estimated using the “Income Approach,” focusing on the estimated future net income-producing capability of the patent portfolios over the estimated remaining economic useful life. Estimates of future after-tax cash flows are converted to present value through “discounting,” including an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market share data. Estimated cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio’s licensing and enforcement program. The analysis also contemplates consideration of current information about the patent portfolio including, status and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent information that could impact future net cash flows.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INCOME TAXES</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia’s provision for income taxes for the fiscal periods presented consisted of the following (in thousands): </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="64%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State taxes                                                      </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">379</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">289</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,421</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,359</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,405</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,800</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,648</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,518</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,867</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26,151</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State taxes                                                      </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">131</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(325</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,736</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26,476</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provision for (benefit from) income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,800</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,912</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,958</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities consist of the following at </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">December 31, 2015 and 2014</font><font style="font-family:inherit;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="76%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net operating loss and capital loss carryforwards and credits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,494</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,427</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,385</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,800</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed assets and intangibles</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,359</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basis of investments in affiliates</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">499</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,437</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued liabilities and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">442</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">409</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized loss on short-term investments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,260</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63,191</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(75,179</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35,927</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax assets, net of valuation allowance</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,264</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed assets and intangibles</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(27,157</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(81</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(107</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(81</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(27,264</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net deferred tax assets (liabilities)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of the federal statutory income tax rate and the effective income tax rate is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td width="64%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Statutory federal tax rate - (benefit) expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State income and foreign taxes, net of federal tax effect</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign tax credit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncontrolling interests in operating subsidiaries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nondeductible permanent items</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired capital loss carryforwards</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(27</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the fiscal years ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;"> and 2014, the Company recorded full valuation allowances against its net deferred tax assets due to uncertainty regarding future realizability pursuant to guidance set forth in ASC 740, “Income Taxes.” In future periods, if the Company determines it will more likely than not be able to realize certain of these amounts, the applicable portion of the benefit from the release of the valuation allowance will generally be recognized in the statement of operations in the period the determination is made.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, Acacia had U.S. federal and state income tax net operating loss carryforwards (“NOLs”) totaling approximately </font><font style="font-family:inherit;font-size:10pt;">$160,840,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$55,215,000</font><font style="font-family:inherit;font-size:10pt;">, expiring between 2025 and 2035, and 2016 and 2035, respectively, for which </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$441,000</font><font style="font-family:inherit;font-size:10pt;"> of federal and state net operating losses are included as a deferred tax asset related to the tax benefits of stock option deductions and which will be credited to additional paid-in capital when realized as a reduction of taxes payable on Acacia’s tax return. In addition, </font><font style="font-family:inherit;font-size:10pt;">$1,928,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$37,771,000</font><font style="font-family:inherit;font-size:10pt;"> of federal and state net operating losses are not included as a deferred tax asset and will be credited to additional paid-in capital when realized as a reduction of taxes payable on Acacia’s tax return as they relate to unrecognized excess tax benefits (see additional information regarding the ordering of windfall tax benefits and use of the “with-and-without” approach below). Capital loss carryovers totaled </font><font style="font-family:inherit;font-size:10pt;">$3,423,000</font><font style="font-family:inherit;font-size:10pt;"> at December 31, 2015, expiring between 2017 and 2020. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, approximately </font><font style="font-family:inherit;font-size:10pt;">$29,318,000</font><font style="font-family:inherit;font-size:10pt;"> of the U.S. federal NOLs, acquired in connection with the acquisition of ADAPTIX, Inc. in 2012, are subject to an annual utilization limitation of approximately </font><font style="font-family:inherit;font-size:10pt;">$14,100,000</font><font style="font-family:inherit;font-size:10pt;">, pursuant to the “change in ownership” provisions under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”). </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, Acacia had approximately </font><font style="font-family:inherit;font-size:10pt;">$34,298,000</font><font style="font-family:inherit;font-size:10pt;"> of foreign tax credits, expiring between 2016 and 2025, of which </font><font style="font-family:inherit;font-size:10pt;">$20,313,000</font><font style="font-family:inherit;font-size:10pt;"> has been utilized for financial statement purposes. Future realization of the credits as a reduction of taxes payable on Acacia’s tax return will result in an income tax benefit recognizable through additional paid in capital since the entire amount of the credits have been utilized for financial statement purposes under the “with-and-without approach.” In general, foreign taxes withheld may be claimed as a deduction on future U.S. corporate income tax returns, or as a credit against future U.S. income tax liabilities, subject to certain limitations. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">      </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax expense for the periods presented, primarily reflects foreign taxes withheld on revenue agreements with licensees in foreign jurisdictions, a benefit totaling </font><font style="font-family:inherit;font-size:10pt;">$1,735,000</font><font style="font-family:inherit;font-size:10pt;"> from the reversal of the net deferred tax liability that existed at the beginning of the year (2014 only) and other state taxes. Excluding the impact of the change in valuation allowance, annual effective tax rates were </font><font style="font-family:inherit;font-size:10pt;">(28)%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">(33)%</font><font style="font-family:inherit;font-size:10pt;">, and (</font><font style="font-family:inherit;font-size:10pt;">31%</font><font style="font-family:inherit;font-size:10pt;">) for fiscal years 2015, 2014, and 2013, respectively. In 2013, the rate at which the Company recorded the tax benefit associated with the pre-tax loss for the period was reduced from the statutory rate primarily due to certain nondeductible permanent items and expired capital loss carryforwards.  The Company recorded a valuation allowance on foreign tax credits generated in fiscal year 2013 totaling </font><font style="font-family:inherit;font-size:10pt;">$4,605,000</font><font style="font-family:inherit;font-size:10pt;">, and therefore, did not recognize the related tax benefit for these tax assets in fiscal year 2013.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has elected to utilize the “with-and-without approach” regarding ordering of windfall tax benefits to determine whether the windfall tax benefit has reduced taxes payable. Under this approach, the windfall tax benefits would be recognized in additional paid in capital only if an incremental tax benefit is realized after considering all other tax benefits presently available to the Company. The deductions related to the exercise and vesting of equity-based incentive awards during the periods presented are, in general, available to offset taxable income on Acacia’s consolidated tax returns. Accordingly, the excess tax benefit related to the exercise and vesting of equity-based incentive awards for the periods presented was credited to additional paid-in capital, not taxes payable. For the year ended December 31, 2013, the Company incurred approximately </font><font style="font-family:inherit;font-size:10pt;">$1,398,000</font><font style="font-family:inherit;font-size:10pt;"> of net short falls from the exercise and vesting of equity-based incentive awards, of which </font><font style="font-family:inherit;font-size:10pt;">$1,398,000</font><font style="font-family:inherit;font-size:10pt;"> was recorded against its additional paid-in capital pool with no impact to the income statement. For the years ended December 31, 2015 and 2014, the Company incurred approximately </font><font style="font-family:inherit;font-size:10pt;">$1,917,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2,713,000</font><font style="font-family:inherit;font-size:10pt;">, respectively, of net short falls from the exercise and vesting of equity-based incentive awards, of which </font><font style="font-family:inherit;font-size:10pt;">$1,917,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2,713,000</font><font style="font-family:inherit;font-size:10pt;">, respectively, was recorded against its additional paid-in capital, subject to a full valuation allowance, with no impact to the income statement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia is subject to taxation in the U.S. and in various state jurisdictions and incurs foreign tax withholdings on revenue agreements with licensees in certain foreign jurisdictions. With no material exceptions, Acacia is no longer subject to U.S. federal or state examinations by tax authorities for years before 2000. The California Franchise Tax Board is auditing the 2011 and 2012 California combined income tax returns. The audit is in process and no findings or adjustments have been proposed.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company had total unrecognized tax benefits of approximately </font><font style="font-family:inherit;font-size:10pt;">$2,127,000</font><font style="font-family:inherit;font-size:10pt;">, including a recorded noncurrent liability of </font><font style="font-family:inherit;font-size:10pt;">$85,000</font><font style="font-family:inherit;font-size:10pt;">, related to unrecognized tax benefits primarily associated with state taxes. No interest and penalties have been recorded for the unrecognized tax benefits as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">. If recognized, approximately </font><font style="font-family:inherit;font-size:10pt;">$2,127,000</font><font style="font-family:inherit;font-size:10pt;">, net of valuation analysis, would impact the Company’s effective tax rate. The Company does not expect that the liability for unrecognized tax benefits will change significantly within the next 12 months. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia recognizes interest and penalties with respect to unrecognized tax benefits in income tax expense. Acacia has identified no uncertain tax position for which it is reasonably possible that the total amount of unrecognized tax benefits will significantly increase or decrease within 12 months.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes.  </font><font style="font-family:inherit;font-size:10pt;">Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in Acacia’s consolidated financial statements or consolidated income tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized, or if it is determined that there is uncertainty regarding future realizability of such assets.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under U.S. generally accepted accounting principles, a tax position is a position in a previously filed tax return or a position expected to be taken in a future tax filing that is reflected in measuring current or deferred income tax assets and liabilities. Tax positions are recognized only when it is more likely than not (likelihood of greater than 50%), based on technical merits, that the position will be sustained upon examination. Tax positions that meet the more likely than not threshold are measured using a probability weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If a deduction reported on a tax return for an equity-based incentive award exceeds the cumulative compensation cost for those instruments recognized for financial reporting purposes, any resulting realized tax benefit that exceeds the previously calculated deferred tax asset for those instruments is considered an excess tax benefit, and is recognized as additional paid-in capital. If the tax deduction is less than the cumulative book compensation cost, the tax effect of the resulting difference is charged first to APIC, to the extent of the available pool of windfall tax benefits, with any remainder recognized in income tax expense.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia’s only identifiable intangible assets are patents and patent rights, with estimated remaining economic useful lives ranging from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">eight years</font><font style="font-family:inherit;font-size:10pt;">. For all periods presented, all of Acacia’s identifiable intangible assets were subject to amortization. The gross carrying amounts and accumulated amortization related to investments in intangible assets as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015 and 2014</font><font style="font-family:inherit;font-size:10pt;"> are as follows (in thousands): </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="76%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross carrying amount - patents                                                                             </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">444,137</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">453,201</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization - patents</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;">                                                                         </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(281,495</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(166,565</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents, net                                                                             </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162,642</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">286,636</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> (1) Includes patent impairment charges for the applicable periods.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The weighted-average remaining estimated economic useful life of Acacia’s patents and patent rights is </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">5 years</font><font style="font-family:inherit;font-size:10pt;">. Scheduled annual aggregate amortization expense is estimated to be </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$43,218,000</font><font style="font-family:inherit;font-size:10pt;"> in 2016, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$40,577,000</font><font style="font-family:inherit;font-size:10pt;"> in 2017, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$35,777,000</font><font style="font-family:inherit;font-size:10pt;"> in 2018, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$19,410,000</font><font style="font-family:inherit;font-size:10pt;"> in 2019, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$6,787,000</font><font style="font-family:inherit;font-size:10pt;"> in 2020 and </font><font style="font-family:inherit;font-size:10pt;">$16,873,000</font><font style="font-family:inherit;font-size:10pt;"> thereafter.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015, 2014 and 2013</font><font style="font-family:inherit;font-size:10pt;">, Acacia paid patent investment costs totaling </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$19,504,000</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$42,746,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$25,061,000</font><font style="font-family:inherit;font-size:10pt;">, respectively. The patents have initial estimated economic useful lives ranging from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">ten years</font><font style="font-family:inherit;font-size:10pt;">. Included in net additions to capitalized patent costs during the years ended December 31, 2015 and 2014 are accrued patent investment costs totaling </font><font style="font-family:inherit;font-size:10pt;">$1,000,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$16,700,000</font><font style="font-family:inherit;font-size:10pt;">, respectively, which are amortized over the estimated economic useful life of the related patents.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the periods presented, certain operating subsidiaries recovered up-front patent portfolio advances from applicable net licensing proceeds prior to the scheduled amortization of such up-front patent portfolio advances, resulting in the acceleration of amortization expense for the applicable patent-related assets. For the years ended December 31, 2014 and 2013, accelerated amortization expense related to the recovery of up-front patent portfolio advances totaled </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1,247,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$592,000</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015, 2014 and 2013</font><font style="font-family:inherit;font-size:10pt;">, pursuant to the terms of the respective inventor agreements, certain Acacia operating subsidiaries elected to terminate or sell their rights to patent portfolios, resulting in the acceleration of amortization expense for the patent-related assets totaling </font><font style="font-family:inherit;font-size:10pt;">$380,000</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$2,702,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1,747,000</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia recorded impairment of patent-related intangible asset charges totaling $</font><font style="font-family:inherit;font-size:10pt;">74,731,000</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$3,497,000</font><font style="font-family:inherit;font-size:10pt;"> and $4,619,000 for the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015, 2014 and 2013</font><font style="font-family:inherit;font-size:10pt;">, respectively. The impairment charges related to impairments of patent portfolios due to a reduction in expected estimated future net cash flows and certain patent portfolios that management determined it would no longer allocate future resources to in connection with the licensing and enforcement of such portfolios, due primarily to potential prior art related complexities and/or the overall determination that future resources would be allocated to other licensing and enforcement programs with higher potential return profiles. The impairment charges consisted of the excess of the asset’s carrying value over its estimated fair value. Refer to Note 7 for additional information regarding impairment charges for the year ended December 31, 2015.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">    </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015, 2014 and 2013</font><font style="font-family:inherit;font-size:10pt;">, capitalized patent costs, accumulated amortization, and sales proceeds related to patent-related sales and disposals are as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.3359375%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="48%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capitalized patent costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">298</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,753</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales proceeds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Investments in Marketable Securities.  </font><font style="font-family:inherit;font-size:10pt;">Investments in securities with original maturities of greater than three months and less than one year and other investments representing amounts that are available for current operations are classified as short-term investments, unless there are indications that such investments may not be readily sold in the short term. The fair values of these investments approximate their carrying values. As of December 31, 2015, the balance of short term investments was zero. At December 31, 2014, all of Acacia’s investments were classified as available-for-sale, which are reported at fair value on a recurring basis using significant observable inputs (Level 1), with related unrealized gains and losses in the value of such securities recorded as a separate component of other comprehensive income (loss) in stockholders’ equity until realized. Realized and unrealized gains and losses are recorded based on the specific identification method. Interest on all securities is included in interest and other investment income (loss).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Impairment of Marketable Securities. </font><font style="font-family:inherit;font-size:10pt;">Acacia evaluates its investments in marketable securities for potential impairment, employing a systematic methodology on a quarterly basis that considers available quantitative and qualitative evidence. If the cost or carrying value of an investment exceeds its estimated fair value, the Company evaluates, among other factors, general market conditions, credit quality of instrument issuers, the duration and extent to which the fair value is less than cost, and the Company’s intent and ability to hold, or plans or ability to sell. Fair value is estimated based on publicly available market information or other estimates determined by management. Investments are considered to be impaired when a decline in fair value is estimated to be other-than-temporary. Acacia reviews impairments associated with its investments in marketable securities and determines the classification of any impairment as temporary or other-than-temporary. An impairment is deemed other-than-temporary unless (a) Acacia has the ability and intent to hold an investment for a period of time sufficient for recovery of its carrying amount and (b) positive evidence indicating that the investment’s carrying amount is recoverable within a reasonable period of time outweighs any evidence to the contrary. All available evidence, both positive and negative, is considered to determine whether, based on the weight of such evidence, the carrying amount of the investment is recoverable within a reasonable period of time. For investments classified as available-for-sale, unrealized losses that are other-than-temporary are recognized in the consolidated statements of operations.   </font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term marketable securities for the periods presented were comprised of the following (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.96875%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="43%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Security Type</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Unrealized Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government fixed income securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">58,819</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(263</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">58,558</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total short-term investments</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">58,819</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(263</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">58,558</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recent Accounting Pronouncements - Not Yet Adopted. </font><font style="font-family:inherit;font-size:10pt;">In June 2014, the Financial Accounting Standards Board (the “FASB”) issued a new accounting standard which requires that a performance target that affects vesting and could be achieved after the requisite service period shall be treated as a performance condition. Adoption of this standard is required for annual periods beginning after December 15, 2015. Early adoption is permitted. The Company is currently evaluating the impact the pronouncement will have on its consolidated financial statements and related disclosures.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued a new accounting standards update addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue.  Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services.  The amendments for this standard update are effective for interim and annual reporting periods beginning after December 15, 2016, and are to be applied </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">retrospectively or the cumulative effect as of the date of adoption, with early application not permitted.  The Company is currently evaluating the impact and method of adoption the pronouncement will have on its consolidated financial statements and related disclosures.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2014, the FASB issued a new accounting standard which requires management to assess an entity’s ability to continue as a going concern every reporting period including interim periods, and to provide related footnote disclosure in certain circumstances. Adoption of this standard is required for annual periods beginning after December 15, 2016 and are to be applied retrospectively or the cumulative effect as of the date of adoption. Early adoption is permitted. The Company is currently evaluating the impact the pronouncement will have on its consolidated financial statements and related disclosures.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">     </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In September 2015, the FASB issued an accounting standard update to simplify the accounting for measurement- period adjustments in a business combination by requiring the acquirer to recognize adjustments to provisional amounts</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">identified during the measurement period in the reporting period in which the adjustments are determined. The acquirer is also</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">required to record in the reporting period in which the adjustments are determined the effect on earnings of changes in</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">depreciation, amortization, and other items resulting from the change to the provisional amounts. The new guidance is effective</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">for fiscal years beginning after December 15, 2015, including interim periods within those fiscal years. Management is</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">currently evaluating the effect that implementation of this update will have on its consolidated financial position and results of</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">operations upon adoption.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2015, the FASB issued an accounting standard update to simplify the presentation of deferred income taxes by requiring that deferred tax liabilities and assets be classified as noncurrent on the balance sheet. This update is effective for annual reporting periods beginning after December 31, 2016, including interim periods within those annual periods, and early adoption is permitted. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued an accounting standard update which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. The requirements of this standard include a significant increase in required disclosures. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">FURNITURE AND EQUIPMENT</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and equipment consists of the following at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015 and 2014</font><font style="font-family:inherit;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="76%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixtures</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">739</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">761</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer hardware and software</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">649</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">650</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">144</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,533</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,555</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less:  accumulated depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,261</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,055</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">272</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation expense was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$222,000</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$304,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$236,000</font><font style="font-family:inherit;font-size:10pt;"> for the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015, 2014 and 2013</font><font style="font-family:inherit;font-size:10pt;">, respectively. In 2015 and 2014, the Company retired </font><font style="font-family:inherit;font-size:10pt;">$30,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$330,000</font><font style="font-family:inherit;font-size:10pt;">, respectively, of items held in furniture and equipment and recorded a </font><font style="font-family:inherit;font-size:10pt;">$14,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$71,000</font><font style="font-family:inherit;font-size:10pt;">, respectively, loss on disposal.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Furniture and Equipment.  </font><font style="font-family:inherit;font-size:10pt;">Furniture and equipment are recorded at cost. Major additions and improvements that materially extend useful lives of furniture and equipment are capitalized. Maintenance and repairs are charged against the results of operations as incurred. When these assets are sold or otherwise disposed of, the asset and related depreciation are relieved, and any gain or loss is included in the consolidated statements of operations for the period of sale or disposal. Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives of the assets:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:91.015625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="56%" rowspan="1" colspan="1"></td><td width="44%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixtures</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:60px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3 to 5 years</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer hardware and software</font></div></td><td style="vertical-align:top;padding-left:60px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3 to 5 years</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:60px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2 to 5 years (Lesser of lease term or useful life of improvement)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rental payments on operating leases are charged to expense in the consolidated statements of operations on a straight-line basis over the lease term.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and equipment consists of the following at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015 and 2014</font><font style="font-family:inherit;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="76%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixtures</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">739</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">761</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer hardware and software</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">649</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">650</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">144</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,533</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,555</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less:  accumulated depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,261</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,055</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">272</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">QUARTERLY FINANCIAL DATA (unaudited)</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth unaudited consolidated statements of operations data for the eight quarters in the period ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">. This information has been derived from Acacia’s unaudited condensed consolidated financial statements that have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the audited consolidated financial statements and related notes thereto. Acacia’s quarterly results have been, and may in the future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should not be relied upon as any indication of the results to be expected in any future periods.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="33" rowspan="1"></td></tr><tr><td width="31%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="31" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Quarter Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Mar. 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Jun. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Sept. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dec. 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Mar. 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Jun. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Sept. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dec. 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="31" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Unaudited, in thousands, except share and per share information)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34,210</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40,336</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,994</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">37,497</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,578</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,076</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">37,192</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31,030</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating costs and expenses:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cost of revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Inventor royalties</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,325</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,265</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">116</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,756</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">951</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,694</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,667</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,358</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Contingent legal fees</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,784</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,512</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,972</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,901</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,527</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,077</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,663</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,296</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Litigation and licensing expenses - patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,675</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,012</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,345</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,341</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,994</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,820</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,592</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,208</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of patents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,038</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,228</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,688</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,113</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,906</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15,532</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,511</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,796</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Marketing, general and administrative expenses (including non-cash stock compensation expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,575</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,587</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,442</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,572</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,693</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,181</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,636</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,044</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Research, consulting and other expenses - business development</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">997</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">732</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">802</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">860</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">992</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,003</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,208</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">637</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Impairment of patent-related intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">74,731</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,566</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">931</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Impairment of goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">30,149</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">426</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,465</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">250</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,548</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total operating costs and expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">47,820</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">39,336</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">39,830</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">150,673</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">38,629</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">58,307</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,825</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46,270</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating income (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,610</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(26,836</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(113,176</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(26,051</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8,231</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,633</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,240</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total other income (expense)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">228</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(104</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(180</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">109</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(196</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(57</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(451</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income (loss) before (provision for) benefit from income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,382</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">896</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(27,016</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(113,176</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(25,942</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8,427</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,690</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,691</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Benefit from (provision for) income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(170</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(119</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(337</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,174</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,372</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,689</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(145</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(450</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income (loss) including noncontrolling interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,552</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">777</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(27,353</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(117,350</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(24,570</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,116</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,835</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(16,141</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net (income) loss attributable to noncontrolling interests in operating subsidiaries</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">422</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,463</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">43</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,440</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">149</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">167</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">420</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(103</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss attributable to Acacia Research Corporation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,130</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,686</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(27,310</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(115,910</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(24,421</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,949</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,415</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(16,244</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss per common share attributable to Acacia Research Corporation:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic and diluted income (loss) per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.27</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.08</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.55</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.33</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.51</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.27</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.26</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.34</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average number of shares outstanding, basic and diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,212,207</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,423,472</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,630,369</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,749,941</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,329,375</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,543,334</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,806,334</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,944,914</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition.  </font><font style="font-family:inherit;font-size:10pt;">Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectibility of amounts is reasonably assured.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In general, revenue arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by Acacia’s operating subsidiaries. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by Acacia’s operating subsidiaries, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined, relatively short period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for an additional minimum upfront payment. Pursuant to the terms of these agreements, Acacia’s operating subsidiaries have no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on Acacia’s operating subsidiaries’ part to maintain or upgrade the technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the minimum upfront payment for term agreement renewals. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectibility is reasonably assured, or upon receipt of the minimum upfront fee for term agreement renewals, and when all other revenue recognition criteria have been met.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the periods presented herein, the majority of the revenue agreements executed by the Company provided for the payment of one-time, paid-up license fees in consideration for the grant of certain intellectual property rights for patented technology rights owned by our operating subsidiaries. These rights were primarily granted on a perpetual basis, extending until the expiration of the underlying patents.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain of the Company’s revenue arrangements provide for future royalties or additional required payments based on future licensee activities. Additional royalties are recognized in revenue upon resolution of the related contingency provided that all revenue recognition criteria, as described above, have been met. Amounts of additional royalties due under these license agreements, if any, cannot be reasonably estimated by management.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain of the Company’s revenue arrangements provide for the calculation of fees based on a licensee’s actual quarterly sales or actual per unit activity, applied to a contractual royalty rate. Licensees that pay fees on a quarterly basis generally report actual quarterly sales or actual per unit activity information and related quarterly fees due within </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">30 days</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">45 days</font><font style="font-family:inherit;font-size:10pt;"> after the end of the quarter in which such sales or activity takes place. The amount of fees due under these revenue arrangements each quarter cannot be reasonably estimated by management. Consequently, Acacia’s operating subsidiaries recognize revenue from these revenue arrangements on a </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;">-month lag basis, in the quarter following the quarter of sales or per unit activity, provided amounts are fixed or determinable and collectibility is reasonably assured. The lag method described above allows for the receipt of licensee royalty reports prior to the recognition of revenue.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts related to revenue arrangements that do not meet the revenue recognition criteria described above are deferred until the revenue recognition criteria are met.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia assesses the collectibility of fees receivable based on a number of factors, including past transaction history and credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectibility becomes reasonably assured, assuming all other revenue recognition criteria have been met, which is generally upon receipt of cash.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable and accrued expenses consist of the following at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015 and 2014</font><font style="font-family:inherit;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="76%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payroll and other employee benefits</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">576</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,481</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued vacation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">701</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">806</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued legal expenses - patent</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,135</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,410</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued attorney's fees</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,548</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign taxes payable </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,960</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued consulting and other professional fees</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,592</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,530</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accrued liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">383</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,085</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,347</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,860</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:9pt;">- Included in "Accounts Payable and Accrued Expenses/Patent Costs" line item on the consolidated statement of cash flows included elsewhere herein.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia’s provision for income taxes for the fiscal periods presented consisted of the following (in thousands): </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="64%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State taxes                                                      </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">379</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">289</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,421</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,359</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,405</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,800</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,648</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,518</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,867</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26,151</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State taxes                                                      </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">131</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(325</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,736</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26,476</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provision for (benefit from) income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,800</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,912</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,958</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities consist of the following at </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">December 31, 2015 and 2014</font><font style="font-family:inherit;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="76%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net operating loss and capital loss carryforwards and credits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,494</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,427</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,385</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,800</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed assets and intangibles</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,359</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basis of investments in affiliates</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">499</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,437</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued liabilities and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">442</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">409</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized loss on short-term investments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,260</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63,191</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(75,179</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35,927</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax assets, net of valuation allowance</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,264</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed assets and intangibles</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(27,157</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(81</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(107</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(81</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(27,264</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net deferred tax assets (liabilities)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted income per share:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="61%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Numerator (in thousands):</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basic and Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160,036</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(66,029</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(56,434</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total dividends declared / paid</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,434</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,039</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18,633</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dividends attributable to common stockholders</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,740</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,313</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,122</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss attributable to common stockholders – basic and diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160,730</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(66,755</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(56,945</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average shares used in computing net loss per share attributable to common stockholders – basic and diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,505,817</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,658,088</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,155,832</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic and diluted net loss per common share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.25</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.37</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.18</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,468</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,760</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,760</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of the federal statutory income tax rate and the effective income tax rate is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td width="64%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Statutory federal tax rate - (benefit) expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State income and foreign taxes, net of federal tax effect</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign tax credit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncontrolling interests in operating subsidiaries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nondeductible permanent items</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired capital loss carryforwards</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(27</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Minimum annual rental commitments for operating leases of continuing operations having initial or remaining noncancellable lease terms in excess of one year are as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:70.703125%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="85%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Years ending December 31,</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,459</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,557</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,612</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,669</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">166</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total minimum lease payments</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,463</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes nonvested restricted share activity for the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nonvested</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average Grant Date Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested restricted stock at December 31, 2014</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,018,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.71</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">894,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.83</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(615,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.69</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canceled</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(468,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested restricted stock at December 31, 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">829,000</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.41</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth unaudited consolidated statements of operations data for the eight quarters in the period ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">. This information has been derived from Acacia’s unaudited condensed consolidated financial statements that have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the audited consolidated financial statements and related notes thereto. Acacia’s quarterly results have been, and may in the future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should not be relied upon as any indication of the results to be expected in any future periods.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="33" rowspan="1"></td></tr><tr><td width="31%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="31" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Quarter Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Mar. 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Jun. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Sept. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dec. 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Mar. 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Jun. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Sept. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dec. 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="31" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Unaudited, in thousands, except share and per share information)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34,210</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40,336</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,994</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">37,497</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,578</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,076</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">37,192</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31,030</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating costs and expenses:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cost of revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Inventor royalties</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,325</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,265</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">116</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,756</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">951</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,694</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,667</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,358</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Contingent legal fees</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,784</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,512</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,972</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,901</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,527</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,077</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,663</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,296</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Litigation and licensing expenses - patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,675</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,012</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,345</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,341</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,994</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,820</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,592</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,208</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of patents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,038</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,228</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,688</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,113</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,906</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15,532</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,511</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,796</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Marketing, general and administrative expenses (including non-cash stock compensation expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,575</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,587</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,442</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,572</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,693</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,181</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,636</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,044</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Research, consulting and other expenses - business development</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">997</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">732</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">802</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">860</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">992</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,003</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,208</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">637</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Impairment of patent-related intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">74,731</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,566</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">931</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Impairment of goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">30,149</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">426</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,465</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">250</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,548</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total operating costs and expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">47,820</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">39,336</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">39,830</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">150,673</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">38,629</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">58,307</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,825</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46,270</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating income (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,610</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(26,836</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(113,176</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(26,051</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8,231</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,633</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,240</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total other income (expense)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">228</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(104</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(180</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">109</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(196</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(57</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(451</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income (loss) before (provision for) benefit from income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,382</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">896</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(27,016</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(113,176</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(25,942</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8,427</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,690</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,691</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Benefit from (provision for) income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(170</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(119</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(337</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,174</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,372</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,689</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(145</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(450</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income (loss) including noncontrolling interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,552</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">777</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(27,353</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(117,350</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(24,570</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,116</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,835</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(16,141</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net (income) loss attributable to noncontrolling interests in operating subsidiaries</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">422</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,463</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">43</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,440</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">149</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">167</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">420</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(103</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss attributable to Acacia Research Corporation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,130</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,686</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(27,310</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(115,910</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(24,421</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,949</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,415</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(16,244</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss per common share attributable to Acacia Research Corporation:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic and diluted income (loss) per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.27</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.08</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.55</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.33</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.51</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.27</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.26</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.34</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average number of shares outstanding, basic and diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,212,207</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,423,472</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,630,369</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,749,941</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,329,375</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,543,334</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,806,334</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,944,914</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes restricted stock unit activity for the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock Units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average Grant Date Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested restricted stock units outstanding at December 31, 2014</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.72</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26,000</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested restricted stock units outstanding at December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,000</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.78</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested restricted stock units outstanding at December 31, 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.32</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes stock option activity for the Plans for the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td width="56%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted-Average</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Exercise</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Remaining</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Contractual Term</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Aggregate</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Intrinsic Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December 31, 2014</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">150,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(135,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.95</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December 31, 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.38</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1 year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,000</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.38</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1 year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable at December 31, 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,000</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.38</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1 year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ollowing is the monthly stock repurchases for the periods presented, all of which were purchased as part of publicly announced plans or programs:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.0703125%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td width="34%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="18%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="23%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Number of Shares Purchased</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average Price paid per Share</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Approximate Dollar Value of</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Shares that May Yet be</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Purchased under the Program</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Plan Expiration</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 4, 2013 - December 11, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">600,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.18</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 14, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Totals for 2013</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">600,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Segment Reporting.</font><font style="font-family:inherit;font-size:10pt;">  Acacia uses the management approach, which designates the internal organization that is used by management for making operating decisions and assessing performance as the basis of Acacia’s reportable segments. Acacia’s patent licensing and enforcement business constitutes its single reportable segment.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Stock-Based Compensation.</font><font style="font-family:inherit;font-size:10pt;"> The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee’s requisite service period (generally the vesting period of the equity award) which is generally two to four years. The fair value of restricted stock and restricted stock unit awards is determined by the product of the number of shares or units granted and the grant date market price of the underlying common stock. The fair value of each option award is estimated on the date of grant using a Black-Scholes option valuation model. Stock-based compensation expense is recorded only for those awards expected to vest using an estimated forfeiture rate. Refer to Note </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;text-decoration:none;">10</font><font style="font-family:inherit;font-size:10pt;"> to these notes to consolidated financial statements for information on stock-based awards granted for the periods presented.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font><font style="font-family:inherit;font-size:10pt;">.  The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, stock-based compensation expense, impairment of marketable securities and intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets and the application of the acquisition method of accounting for business combinations, require its most difficult, subjective or complex judgments.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

EX-101.SCH 9 actg-20151231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2106100 - Disclosure - Accounts Payable and Accrued Expenses link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Accounts Payable and Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Accounts Payable and Accrued Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 2416403 - Disclosure - Commitments and Contingencies Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2316301 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1001001 - Statement - Consolidated Balance Sheets Parentheticals link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Consolidated Statements of Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 1002001 - Statement - Consolidated Statements of Operations Parentheticals link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 1004001 - Statement - Consolidated Statements of Stockholders' Equity Parentheticals link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Description of Business link:presentationLink link:calculationLink link:definitionLink 2401401 - Disclosure - Description of Business (Details) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information Document link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Furniture and Equipment link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Furniture and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - Furniture and Equipment Summary of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Furniture and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - Goodwill and Patent Impairment Charges (Details) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Goodwill and Patent Impairment Charges (Notes) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - Goodwill and Patent Impairment Charges (Tables) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2414404 - Disclosure - Income Taxes Deferred Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2414405 - Disclosure - Income Taxes Income Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 2414403 - Disclosure - Income Taxes Provision for Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 2414406 - Disclosure - Income Taxes Valuation allowance (Details) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Patents link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - Patents Cost and Accumulated Amortization (Details) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Patents (Details) link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - Patents Future Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Patents (Tables) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - Quarterly Financial Data link:presentationLink link:calculationLink link:definitionLink 2419402 - Disclosure - Quarterly Financial Data (Details) link:presentationLink link:calculationLink link:definitionLink 2319301 - Disclosure - Quarterly Financial Data (Tables) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Retirement Savings Plan and Executive Severance Policy link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Short-term Investments link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Short-term Investments (Details) link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Short-term Investments Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Short-term Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - Stock-Based Incentive Plans link:presentationLink link:calculationLink link:definitionLink 2415402 - Disclosure - Stock-Based Incentive Plans (Details) link:presentationLink link:calculationLink link:definitionLink 2415404 - Disclosure - Stock-Based Incentive Plans Nonvested Restriced Stock (Details) link:presentationLink link:calculationLink link:definitionLink 2415405 - Disclosure - Stock-Based Incentive Plans Nonvested Restricted Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 2415403 - Disclosure - Stock-Based Incentive Plans Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 2315301 - Disclosure - Stock-Based Incentive Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 2413403 - Disclosure - Stockholders' Equity Repurchases of Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2402404 - Disclosure - Summary of Significant Accounting Policies Concentrations (Details) link:presentationLink link:calculationLink link:definitionLink 2402403 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 2402406 - Disclosure - Summary of Significant Accounting Policies Earnings per share (Details) link:presentationLink link:calculationLink link:definitionLink 2402407 - Disclosure - Summary of Significant Accounting Policies Impact of revision (Details) link:presentationLink link:calculationLink link:definitionLink 2202201 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2402405 - Disclosure - Summary of Significant Accounting Policies Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 2302302 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Supplemental Cash Flow Information link:presentationLink link:calculationLink link:definitionLink 2418401 - Disclosure - Supplemental Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 actg-20151231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 11 actg-20151231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 12 actg-20151231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Accounting Policies [Abstract] Schedule of Property and Equipment [Table] Property, Plant and Equipment [Table] Property and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Furniture and Fixtures [Member] Furniture and Fixtures [Member] Computer Hardware and Software [Member] Computer Hardware and Software [Member] Computer Hardware and Software [Member] Leasehold Improvements [Member] Leasehold Improvements [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] Property and Equipment [Line Items] Property, Plant and Equipment [Line Items] Estimated useful lives, years Property, Plant and Equipment, Estimated Useful Lives Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common Stock [Member] Common Stock [Member] Treasury Stock [Member] Treasury Stock [Member] Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Accumulated Other Comprehensive Income (Loss) [Member] Accumulated Other Comprehensive Income (Loss) [Member] Accumulated Deficit [Member] Retained Earnings [Member] Noncontrolling Interests [Member] Noncontrolling Interest [Member] Statement [Line Items] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Common stock, shares outstanding Common Stock, Shares, Outstanding Net income (loss) attributable to Acacia Research Corporation Net Income (Loss) Attributable to Parent Payments of Dividends Payments of Dividends Stock Issued During Period, Value, New Issues Stock Issued During Period, Value, New Issues Treasury stock, shares acquired Treasury Stock, Shares, Acquired Stock Repurchased During Period, Shares Stock Repurchased During Period, Shares Treasury stock, cost of shares acquired Treasury Stock, Value, Acquired, Cost Method payments to repurchase restricted common stock payments to repurchase restricted common stock payments to repurchase restricted common stock Stock options exercised, shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Stock options exercised, value Stock Issued During Period, Value, Stock Options Exercised Stock issued during period, shares, share-based compensation, net of forfeitures Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Compensation expense related to stock options and restricted stock awards Share-based Compensation Excess tax benefits from stock-based compensation Excess Tax Benefit from Share-based Compensation, Financing Activities Net (income) loss attributable to noncontrolling interests in operating subsidiaries Net Income (Loss) Attributable to Noncontrolling Interest Contributions from noncontrolling interests in operating subsidiary, net Proceeds from (Payments to) Noncontrolling Interests Foreign Currency Transaction Gain (Loss), Unrealized Foreign Currency Transaction Gain (Loss), Unrealized Unrealized Gain (Loss) on Investments Unrealized Gain (Loss) on Investments Distributions to noncontrolling interests in operating subsidiary Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Balance Common stock, shares outstanding Patents [Abstract] Patents [Abstract] Patents Patents [Table Text Block] Patents [Table Text Block] Patent costs and accumulated amortization related to patent sales and disposals [Table Text Block] Patent costs and accumulated amortization, and sales proceeds and other costs related to patent sales and disposals [Table Text Block] Patent costs and accumulated amortization, and sales proceeds and other costs related to patent sales and disposals [Table Text Block] Period after quarter end licensees report activity Period after quarter end licensees report activity Period after quarter end licensees report activity Lag time in recognizing revenues from licensee's quarter Lag time in recognizing revenues from licensees' quarter Lag time in recognizing revenues from licensees' quarter Patents, useful life Finite-Lived Intangible Asset, Useful Life Goodwill and Patent Impairment Charges [Abstract] Goodwill and Patent Impairment Charges [Abstract] Subsequent Event [Table] Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event [Line Items] Subsequent Event [Line Items] Goodwill Goodwill Share Price Share Price Estimated Fair Value of the Reporting Unit Estimated Fair Value of the Reporting Unit Estimated Fair Value of the Reporting Unit, Cost Synergies Approach Estimated Carrying Value of Reporting Unit, Market Capitalization Plus Cost Synergies Approach Estimated Carrying Value of Reporting Unit, Market Capitalization Plus Cost Synergies Approach Estimated Carrying Value of Reporting Unit, Market Capitalization Plus Cost Synergies Approach Assets Assets Impairment of Goodwill Goodwill, Impairment Loss Income Tax Disclosure [Abstract] Current: Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Federal Current Federal Tax Expense (Benefit) State taxes Current State and Local Tax Expense (Benefit) Foreign taxes Current Foreign Tax Expense (Benefit) Total current Current Income Tax Expense (Benefit) Deferred: Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Federal Deferred Federal Income Tax Expense (Benefit) State taxes Deferred State and Local Income Tax Expense (Benefit) Total deferred Deferred Income Tax Expense (Benefit) (Provision) benefit for income taxes Income Tax Expense (Benefit) Share-based Compensation [Abstract] Outstanding at December 31, 2012 Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Exercised Outstanding at December 31, 2013 Vested Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Exercisable at December 31, 2013 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Outstanding at December 31, 2012, weighted average exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Exercised, weighted average exercise price Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Outstanding at December 31, 2013, weighted average exercise price Vested, weighted average exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Exercisable, weighted average exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Outstanding at December 31, 2013, aggregate, intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Vested, aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Exercisable, aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Goodwill and Intangible Assets Disclosure [Text Block] Goodwill and Intangible Assets Disclosure [Text Block] Statement of Cash Flows [Abstract] Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net income (loss) including noncontrolling interests in operating subsidiaries Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Adjustments to reconcile net income (loss) including noncontrolling interests in operating subsidiaries to net cash provided by (used in) operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Non-cash stock compensation Excess tax benefits from stock-based compensation Excess Tax Benefit from Share-based Compensation, Operating Activities Provision for deferred income taxes Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Impairment of Patent-Related Intangible Assets Impairment of Intangible Assets, Finite-lived Other Other Operating Activities, Cash Flow Statement Changes in assets and liabilities: Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract] Increase (Decrease) in Restricted Cash Increase (Decrease) in Restricted Cash Accounts receivable Increase (Decrease) in Accounts Receivable Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Accounts payable and accrued expenses / costs Increase (Decrease) in Accounts Payable and Accrued Liabilities Royalties and contingent legal fees payable Increase (decrease) in royalties and contingent legal fees payable Increase (decrease) in royalties and contingent legal fees payable Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Purchase of available-for-sale investments Payments to Acquire Available-for-sale Securities Sale of available-for-sale investments Proceeds from Sale of Available-for-sale Securities Patent acquisition costs Payments to Acquire Intangible Assets Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Payments of Dividends Distributions to noncontrolling interests in operating subsidiary Payments to Noncontrolling Interests Proceeds from the exercise of stock options Proceeds from Stock Options Exercised Repurchases of common stock Payments for Repurchase of Common Stock Contributions from noncontrolling interests in operating subsidiary, net of issuance costs Proceeds from Noncontrolling Interests Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Increase in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents, beginning Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents, ending Patent acquisition costs included in accrued expenses Patent acquisition costs included in accrued expenses Patent Acquisition Costs Included in Accrued Expenses DESCRIPTION OF BUSINESS [Abstract] DESCRIPTION OF BUSINESS [Abstract] Description of Business Business Description and Basis of Presentation [Text Block] Stock Options Activity Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Nonvested Restricted Stock Activity Schedule of Nonvested Share Activity [Table Text Block] Restricted Stock Units Activity Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block] Income Statement [Abstract] Income Taxes [Table] Income Taxes [Table] Income Taxes [Table] Tax Credit Carryforward [Axis] Tax Credit Carryforward [Axis] Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name [Domain] Capital Loss Carryforward Related to Business Acquisition [Member] Capital Loss Carryforward Related to Business Acquisition [Member] Capital Loss Carryforward Related to Business Acquisition [Member] Valuation Allowance by Deferred Tax Asset [Axis] Valuation Allowance by Deferred Tax Asset [Axis] Deferred Tax Asset [Domain] Deferred Tax Asset [Domain] Income Tax Authority [Axis] Income Tax Authority [Axis] Income Tax Authority [Domain] Income Tax Authority [Domain] Domestic Tax Authority [Member] Domestic Tax Authority [Member] State and Local Jurisdiction [Member] State and Local Jurisdiction [Member] Internal Revenue Service (IRS) [Member] Internal Revenue Service (IRS) [Member] Income Taxes [Line Items] Income Taxes [Line Items] [Line Items] for Income Taxes [Table] Operating loss carryforwards, federal Operating loss carryforwards, federal Operating loss carryforwards, federal Operating loss carryforwards, state Operating loss carryforwards, state Operating loss carryforwards, state Deferred tax assets, valuation allowance Deferred Tax Assets, Valuation Allowance Federal NOL annual utilization limit Federal NOL Annual Utilization Limit Federal NOL Annual Utilization Limit Net operating losses included in deferred tax assets Deferred Tax Assets, Operating Loss Carryforwards Net operating losses, unrecognized excess tax benefits, federal Net operating losses, unrecognized excess tax benefits, federal Net operating losses, unrecognized excess tax benefits, federal Net operating losses, unrecognized excess tax benefits, state Net operating losses, unrecognized tax benefits, state Net operating losses, unrecognized tax benefits, state Capital loss carryovers Capital loss carryovers Capital loss carryovers Deferred Tax Asset, Operating and Capital Loss Carryforwards and Credits Deferred Tax Asset, Operating and Capital Loss Carryforwards and Credits Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss and capital loss carryforwards and credits Tax benefit from stock options exercised, federal Tax Benefit from Stock Options Exercised, Federal Tax Benefit from Stock Options Exercised, Federal Tax fenefit from stock options exercised, state Tax Benefit from Stock Options Exercised, State Tax Benefit from Stock Options Exercised, State Operating Loss Carryforwards Operating Loss Carryforwards Foreign withholding taxes Valuation Allowance on Foreign Tax Credits Valuation Allowance on Foreign Tax Credits Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation Foreign tax credits, additional paid in capital benefit Foreign tax credits, additional paid in capital benefit Foreign tax credits that have not been recorded as a deferred tax asset as the benefit will be credited to additional paid in capital when realized as a reduction of tax payable on the tax return. Foreign tax credits utilized for financial statement purposes Foreign tax credits utilized for financial statement purposes Foreign tax credits utilized for financial statement purposes Tax Benefit From Reversal of the Net Deferred Tax Liability Tax Benefit From Reversal of the Net Deferred Tax Liability Tax Benefit From Reversal of the Net Deferred Tax Liability Effective Income Tax Rate Reconciliation, Percent Effective Income Tax Rate Reconciliation, Percent Effective tax rate excluding valuation allowance Effective tax rate excluding valuation allowance Effective tax rate excluding valuation allowance Unrecognized tax benefits Unrecognized Tax Benefits unrecognized tax benefits primarily associated with state taxes unrecognized tax benefits primarily associated with state taxes Unrecognized tax benefits primarily associated with state taxes Income Taxes Income Tax Disclosure [Text Block] Stockholders' Equity Note [Abstract] Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Net income (loss) attributable to Acacia Research Corporation Dividends attributable to common stockholders under the two class method Dividends attributable to common stockholders under the two class method Add Back of Dividends attributable to common stockholders under the two class method Net Loss Available to Common Stockholders, Basic and Diluted Net Income (Loss) Available to Common Stockholders, Basic Weighted Average Number of Shares Outstanding, Basic and Diluted Weighted Average Number of Shares Outstanding, Basic and Diluted Earnings Per Share, Basic and Diluted Earnings Per Share, Basic and Diluted Anti-dilutive equity-based incentive awards excluded from the computation of diluted income (loss) per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Property, Plant and Equipment [Abstract] Furniture and fixtures Furniture and Fixtures, Gross Computer hardware and software Computer Hardware and Software Computer Hardware and Software Leasehold improvements Leasehold Improvements, Gross Property and equipment, gross Property, Plant and Equipment, Gross Less: accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Furniture and equipment, net Property, Plant and Equipment, Net Short-term Investments [Abstract] Short-term Investments Marketable Securities [Table Text Block] Document and Entity Information [Abstract] Document and Entity Information [Abstract] Entities [Table] Entities [Table] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Entity Information [Line Items] Entity Information [Line Items] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key EX-101.PRE 13 actg-20151231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 14 acaciaresearchcorp03.jpg begin 644 acaciaresearchcorp03.jpg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businessmodeloptionsv4a03.jpg begin 644 businessmodeloptionsv4a03.jpg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�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end GRAPHIC 16 stockperformancegraph2015v2.jpg begin 644 stockperformancegraph2015v2.jpg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end XML 17 R1.htm IDEA: XBRL DOCUMENT v3.3.1.900

Document and Entity Information Document - USD ($)
12 Months Ended

Dec. 31, 2015

Mar. 11, 2016

Jun. 30, 2015

Entity Information [Line Items]

Entity Registrant Name ACACIA RESEARCH CORP

Entity Central Index Key 0000934549

Current Fiscal Year End Date --12-31

Entity Filer Category Large Accelerated Filer

Document Type 10-K

Document Period End Date Dec. 31, 2015

Document Fiscal Year Focus 2015

Document Fiscal Period Focus FY

Amendment Flag false

Entity Common Stock, Shares Outstanding 50,458,905

Entity Well-known Seasoned Issuer No

Entity Voluntary Filers No

Entity Current Reporting Status Yes

Entity Public Float $ 437,867,000

X

- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12b
-Subsection 1
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: dei_EntityInformationLineItems

Namespace Prefix: dei_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.
+ References
No definition available.
+ Details

Name: dei_EntityPublicFloat

Namespace Prefix: dei_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12b
-Subsection 1
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
+ References
No definition available.
+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.
+ References
No definition available.
+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

XML 18 R2.htm IDEA: XBRL DOCUMENT v3.3.1.900

Consolidated Balance Sheets - USD ($)
$ in Thousands

Dec. 31, 2015

Dec. 31, 2014

Current assets:

Cash and cash equivalents $ 135,223 $ 134,466

Restricted cash 10,725 0

Short-term investments 0 58,558

Accounts receivable 33,500 20,168

Deferred income tax 210 1,161

Prepaid expenses and other current assets 4,219 4,355

Total current assets 183,877 218,708

Furniture and equipment, net of accumulated depreciation and amortization 272 500

Patents, net of accumulated amortization 162,642 286,636

Goodwill 0 30,149

Other assets 1,110 355

Total assets 347,901 536,348

Current liabilities:

Accounts payable and accrued expenses 17,347 14,860

Accrued patent investment costs 1,000 16,700

Royalties and contingent legal fees payable 14,878 14,351

Total current liabilities 33,225 45,911

Deferred income taxes 210 1,161

Other liabilities 311 228

Total liabilities $ 33,746 $ 47,300

Commitments and contingencies (Note 11)

Stockholders' equity:

Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding $ 0 $ 0

Common stock, par value $0.001 per share; 100,000,000 shares authorized; 50,651,239 shares issued and outstanding as of December 31, 2015 and 50,065,382 shares issued and outstanding as of December 31, 2014 51 50

Treasury stock, at cost, 1,729,408 shares as of December 31, 2015 and December 31, 2014 (34,640) (34,640)

Additional paid-in capital 633,146 646,595

Accumulated comprehensive loss (215) (353)

Accumulated deficit (288,131) (128,095)

Total Acacia Research Corporation stockholders’ equity 310,211 483,557

Noncontrolling interests in operating subsidiaries 3,944 5,491

Total stockholders’ equity 314,155 489,048

Total liabilities and stockholders' equity $ 347,901 $ 536,348

X

- Definition
Accrued Patent Acquisition Related Payments, Current
+ References
No definition available.
+ Details

Name: actg_AccruedPatentAcquisitionRelatedPaymentsCurrent

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value for patents, net of accumulated amortization.
+ References
No definition available.
+ Details

Name: actg_PatentsNetOfAccumulatedAmortization

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Royalties and contingent legal fees payable
+ References
No definition available.
+ Details

Name: actg_RoyaltiesAndContingentLegalFeesPayable

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 20
-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 19
-Article 5
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.3-4)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 3
-Subparagraph a(1)
-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 4
-Article 5
+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e681-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669686-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 31
-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.30(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 31
-Article 5
+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.18)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 12
-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 18
-Article 5
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 9
-Article 5
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 1
-Article 5
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.(a),19)
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.17)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 19
-Article 7

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 25
-Article 5

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 17
-Article 9
+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards, net of deferred tax liability attributable to taxable temporary differences.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsLiabilitiesNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences, net of deferred tax asset attributable to deductible temporary differences and carryforwards net of valuation allowances expected to be realized or consumed after one year (or the normal operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31931-109318

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31958-109318

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31917-109318
+ Details

Name: us-gaap_DeferredTaxLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266
+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.32)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 25
-Article 7

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 32
-Article 5
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 21
-Article 5
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 27
-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 20
-Article 7
+ Details

Name: us-gaap_MinorityInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 17
-Article 5
+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The aggregate carrying amount, as of the balance sheet date, of liabilities not separately disclosed in the balance sheet.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 15
-Article 9
+ Details

Name: us-gaap_OtherLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29
-Article 5
+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 8
-Article 5
+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 13
-Subparagraph a
-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 8
-Article 7
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The carrying amounts of cash and cash equivalent items which are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. For a classified balance sheet represents the current portion only (the noncurrent portion has a separate concept); there is a separate and distinct element for unclassified presentations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 1
-Article 5
+ Details

Name: us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.31(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 31
-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Investments which are intended to be sold in the short term (usually less than one year or the normal operating cycle, whichever is longer) including trading securities, available-for-sale securities, held-to-maturity securities, and other short-term investments not otherwise listed in the existing taxonomy.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.2)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 1
-Subparagraph g
-Article 7
+ Details

Name: us-gaap_ShortTermInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30, 31
-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4590271-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4568740-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4568447-111683
+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656
+ Details

Name: us-gaap_TreasuryStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 19 R3.htm IDEA: XBRL DOCUMENT v3.3.1.900

Consolidated Balance Sheets Parentheticals - $ / shares

Dec. 31, 2015

Dec. 31, 2014

Preferred stock, shares authorized 10,000,000 10,000,000

Preferred stock, par value per share $ 0.001 $ 0.001

Preferred stock, shares issued 0 0

Preferred stock, shares outstanding 0 0

Common stock, par value per share $ 0.001 $ 0.001

Common stock, shares authorized 100,000,000 100,000,000

Common stock, shares issued 50,651,239 50,065,382

Common stock, shares outstanding 50,651,239 50,065,382

Treasury stock, shares 1,729,408 1,729,408

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29
-Article 5
+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29
-Article 5
+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29
-Article 5
+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29
-Article 5
+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28,29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30
-Article 5
+ Details

Name: us-gaap_TreasuryStockShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 20 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900

Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Income Statement [Abstract]

Revenues $ 125,037 $ 130,876 $ 130,556

Cost of revenues:

Inventor royalties 18,462 20,670 29,724

Contingent legal fees 16,169 23,563 24,784

Litigation and licensing expenses - patents 39,373 37,614 39,335

Amortization of patents 53,067 53,745 49,039

Marketing, general and administrative expenses (including non-cash stock compensation expense of $11,048 in 2015, $18,115 in 2014 and $27,894 in 2013) 38,176 48,554 59,229

Research, consulting and other expenses - business development 3,391 3,840 3,251

Impairment of Patent-Related Intangible Assets 74,731 3,497 4,619

Impairment of Goodwill 30,149 0 0

Other 4,141 1,548 3,506

Total operating costs and expenses 277,659 193,031 213,487

Operating loss (152,622) (62,155) (82,931)

Total other income (expense) (56) (595) 2,131

Loss from operations before (provision for) benefit from income taxes (152,678) (62,750) (80,800)

(Provision for) benefit from income taxes (4,800) (3,912) 21,958

Net loss including noncontrolling interests in operating subsidiaries (157,478) (66,662) (58,842)

Net (income) loss attributable to noncontrolling interests in operating subsidiaries (2,558) 633 2,408

Net loss attributable to Acacia Research Corporation (160,036) (66,029) (56,434)

Net Loss Available to Common Stockholders, Basic and Diluted $ (160,730) $ (66,755) $ (56,945)

Earnings Per Share, Basic and Diluted $ (3.25) $ (1.37) $ (1.18)

Weighted Average Number of Shares Outstanding, Basic and Diluted 49,505,817 48,658,088 48,155,832

Common Stock, Dividends, Per Share, Cash Paid $ 0.500 $ 0.500 $ 0.375

X

- Definition
Contingent legal fees paid or payable to external counsel.
+ References
No definition available.
+ Details

Name: actg_ContingentLegalFees

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Expenses incurred directly related to litigation and licensing of patents.
+ References
No definition available.
+ Details

Name: actg_LitigationAndLicensingExpensesPatents

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Expenses incurred directly related to business development research, consulting and other expenses.
+ References
No definition available.
+ Details

Name: actg_ResearchConsultingAndOtherExpensesBusinessDevelopment

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275
+ Details

Name: us-gaap_AmortizationOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Aggregate dividends paid during the period for each share of common stock outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_CommonStockDividendsPerShareCashPaid

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CostOfRevenueAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688
+ Details

Name: us-gaap_GeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillImpairmentLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16373-109275
+ Details

Name: us-gaap_ImpairmentOfIntangibleAssetsFinitelived

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 20
-Section 25
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35710027&loc=d3e41242-110953

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 10
-Article 5
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeStatementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Income Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6515339

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(e))
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688
+ Details

Name: us-gaap_LicensesRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=6518256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.18)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.22)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=6519514

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 19
-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 20
-Article 9
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of Net Income (Loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684
+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1377-109256
+ Details

Name: us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingCostsAndExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 3
-Article 5
+ Details

Name: us-gaap_OtherCostAndExpenseOperating

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.9)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 9
-Article 5
+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a),(c)
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688
+ Details

Name: us-gaap_RoyaltyExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
+ References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 21 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900

Consolidated Statements of Operations Parentheticals - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Non-cash stock compensation $ 11,048 $ 18,115 $ 27,894

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 22 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900

Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Statement of Comprehensive Income [Abstract]

Net income (loss) including noncontrolling interests in operating subsidiaries $ (157,478) $ (66,662) $ (58,842)

Other comprehensive income (loss):

Unrealized loss on short-term investments (356) (1,488) 26

Unrealized gain on foreign currency translation (123) (128) 0

Add: reclassification adjustment for losses included in net income 617 2,210 193

Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest (157,340) (66,068) (58,623)

Net (income) loss attributable to noncontrolling interests in operating subsidiaries 2,558 (633) (2,408)

Comprehensive income $ (159,898) $ (65,435) $ (56,215)

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=6519514

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=35737396

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e557-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=6518256
+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686
+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of Net Income (Loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684
+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32211-110900

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (a-c)
-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669646-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32022-110900

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32157-110900
+ Details

Name: us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27357-111563

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e689-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669646-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a),(c)
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 23 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900

Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands

Total

Common Stock [Member]

Treasury Stock [Member]

Additional Paid-in Capital [Member]

Accumulated Other Comprehensive Income (Loss) [Member]

Accumulated Deficit [Member]

Noncontrolling Interests [Member]

Balance at Dec. 31, 2012 $ 618,478 $ 49 $ (26,731) $ 644,982 $ (1,166) $ (5,632) $ 6,976

Common stock, shares outstanding at Dec. 31, 2012 49,160,844

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income (loss) attributable to Acacia Research Corporation (56,434) (56,434)

Payments of Dividends (18,633) (18,633)

Stock Issued During Period, Value, New Issues (18,633)

Treasury stock, shares acquired (600,000)

Stock Repurchased During Period, Shares (666)

Treasury stock, cost of shares acquired (7,910) (7,909)

payments to repurchase restricted common stock (16) (16)

Stock options exercised, shares 115,346

Stock options exercised, value 486 486

Stock issued during period, shares, share-based compensation, net of forfeitures 709,533

Compensation expense related to stock options and restricted stock awards 27,894 $ 1 27,893

Excess tax benefits from stock-based compensation (1,398) (1,398)

Net (income) loss attributable to noncontrolling interests in operating subsidiaries (2,408) (2,408)

Contributions from noncontrolling interests in operating subsidiary, net 1,920 1,920

Unrealized Gain (Loss) on Investments 219 219

Balance at Dec. 31, 2013 562,198 $ 49 (34,640) 653,314 (947) (62,066) 6,488

Common stock, shares outstanding at Dec. 31, 2013 49,385,057

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income (loss) attributable to Acacia Research Corporation (66,029) (66,029)

Payments of Dividends (25,039) (25,039)

Stock Issued During Period, Value, New Issues (25,039)

Stock options exercised, shares 44,506

Stock options exercised, value 206 206

Stock issued during period, shares, share-based compensation, net of forfeitures 635,819

Compensation expense related to stock options and restricted stock awards 18,115 $ 1 18,114

Excess tax benefits from stock-based compensation 0

Net (income) loss attributable to noncontrolling interests in operating subsidiaries (633) (633)

Foreign Currency Transaction Gain (Loss), Unrealized (99) (99)

Unrealized Gain (Loss) on Investments 693 693

Distributions to noncontrolling interests in operating subsidiary 364 364

Balance at Dec. 31, 2014 $ 489,048 $ 50 (34,640) 646,595 (353) (128,095) 5,491

Common stock, shares outstanding at Dec. 31, 2014 50,065,382 50,065,382

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income (loss) attributable to Acacia Research Corporation $ (160,036) (160,036)

Payments of Dividends $ (25,434) (25,434)

Stock options exercised, shares 135,000 135,000

Stock options exercised, value $ 938 938

Stock issued during period, shares, share-based compensation, net of forfeitures 450,857

Compensation expense related to stock options and restricted stock awards 11,048 $ 1 11,047

Excess tax benefits from stock-based compensation 0

Net (income) loss attributable to noncontrolling interests in operating subsidiaries 2,558 2,558

Foreign Currency Transaction Gain (Loss), Unrealized (123) (123)

Unrealized Gain (Loss) on Investments 261 261

Distributions to noncontrolling interests in operating subsidiary 4,105 4,105

Balance at Dec. 31, 2015 $ 314,155 $ 51 $ (34,640) $ 633,146 $ (215) $ (288,131) $ 3,944

Common stock, shares outstanding at Dec. 31, 2015 50,651,239 50,651,239

X

- Definition
payments to repurchase restricted common stock
+ References
No definition available.
+ Details

Name: actg_Paymentstorepurchaserestrictedcommonstock

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of cash inflow from realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11374-113907
+ Details

Name: us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450189&loc=d3e30690-110894

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6450189&loc=d3e30700-110894

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895
+ Details

Name: us-gaap_ForeignCurrencyTransactionGainLossUnrealized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInStockholdersEquityRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=6518256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.18)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.22)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=6519514

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 19
-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 20
-Article 9
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of Net Income (Loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684
+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfDividends

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585
+ Details

Name: us-gaap_ProceedsFromPaymentsToMinorityShareholders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30
-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28,29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30
-Article 5

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30, 31
-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value of stock issued as a result of the exercise of stock options.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30, 31
-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30
-Article 5
+ Details

Name: us-gaap_StockRepurchasedDuringPeriodShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4590271-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4568740-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4568447-111683
+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Number of shares that have been repurchased during the period and are being held in treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30
-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_TreasuryStockSharesAcquired

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_TreasuryStockValueAcquiredCostMethod

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of investments, not including unrealized gains or losses on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, held at each balance sheet date and included in earnings for the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585
+ Details

Name: us-gaap_UnrealizedGainLossOnInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 24 R8.htm IDEA: XBRL DOCUMENT v3.3.1.900

Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Cash flows from operating activities:

Net income (loss) including noncontrolling interests in operating subsidiaries $ (157,478) $ (66,662) $ (58,842)

Adjustments to reconcile net income (loss) including noncontrolling interests in operating subsidiaries to net cash provided by (used in) operating activities:

Depreciation and amortization 53,289 54,049 49,275

Non-cash stock compensation 11,048 18,115 27,894

Excess tax benefits from stock-based compensation 0 0 1,398

Provision for deferred income taxes 0 (1,736) (26,746)

Impairment of Patent-Related Intangible Assets 74,731 3,497 4,619

Impairment of Goodwill 30,149 0 0

Other (109) (28) 12

Changes in assets and liabilities:

Increase (Decrease) in Restricted Cash (10,725) 0 0

Accounts receivable (13,332) (13,827) 3,502

Prepaid expenses and other assets (619) 3,154 (5,300)

Accounts payable and accrued expenses / costs 2,570 3,718 2,740

Royalties and contingent legal fees payable 527 3,904 (2,061)

Net cash provided by (used in) operating activities (9,949) 4,184 (3,509)

Cash flows from investing activities:

Purchase of property and equipment (8) (109) (675)

Purchase of available-for-sale investments (23,296) (109,963) (279,693)

Sale of available-for-sale investments 82,115 182,115 239,370

Patent acquisition costs (19,504) (42,746) (25,061)

Net cash provided by (used in) investing activities 39,307 29,297 (66,059)

Cash flows from financing activities:

Payments of Dividends (25,434) (25,039) (18,633)

Distributions to noncontrolling interests in operating subsidiary (4,105) (867) 0

Proceeds from the exercise of stock options 938 206 486

Repurchases of common stock 0 0 (7,926)

Contributions from noncontrolling interests in operating subsidiary, net of issuance costs 0 0 1,920

Excess tax benefits from stock-based compensation 0 0 (1,398)

Net cash provided by (used in) financing activities (28,601) (25,700) (25,551)

Increase in cash and cash equivalents 757 7,781 (95,119)

Cash and cash equivalents, beginning 134,466 126,685 221,804

Cash and cash equivalents, ending 135,223 134,466 126,685

Patent acquisition costs included in accrued expenses $ 1,000 $ 16,700 $ 4,000

X

- Definition
Increase (decrease) in royalties and contingent legal fees payable
+ References
No definition available.
+ Details

Name: actg_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Patent Acquisition Costs Included in Accrued Expenses
+ References
No definition available.
+ Details

Name: actg_PatentAcquisitionCostsIncludedInAccruedExpenses

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 1
-Article 5
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 230
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450594&loc=d3e33268-110906
+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585
+ Details

Name: us-gaap_DepreciationDepletionAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow from realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11374-113907
+ Details

Name: us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash outflow for realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11374-113907
+ Details

Name: us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillImpairmentLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16373-109275
+ Details

Name: us-gaap_ImpairmentOfIntangibleAssetsFinitelived

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The net cash inflow or outflow for the increase (decrease) associated with funds that are not available for withdrawal or use (such as funds held in escrow) and are associated with underlying transactions that are classified as investing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133
+ Details

Name: us-gaap_IncreaseDecreaseInRestrictedCash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).
+ References
No definition available.
+ Details

Name: us-gaap_OtherOperatingActivitiesCashFlowStatement

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow to reacquire common stock during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_PaymentsForRepurchaseOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfDividends

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow to acquire debt and equity securities not classified as either held-to-maturity securities or trading securities which would be classified as available-for-sale securities and reported at fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of shareholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26853-111562
+ Details

Name: us-gaap_PaymentsToAcquireAvailableForSaleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133
+ Details

Name: us-gaap_PaymentsToAcquireIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_PaymentsToMinorityShareholders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromMinorityShareholders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26853-111562

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585
+ Details

Name: us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (j)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_ProceedsFromStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a),(c)
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e32123-109318
+ Details

Name: us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 25 R9.htm IDEA: XBRL DOCUMENT v3.3.1.900

Description of Business
12 Months Ended

Dec. 31, 2015

DESCRIPTION OF BUSINESS [Abstract]

Description of Business
DESCRIPTION OF BUSINESS

Description of Business. As used herein, “Acacia” and the “Company” refer to Acacia Research Corporation and/or its wholly and majority-owned and controlled operating subsidiaries, and/or where applicable, its management. All patent investment, prosecution, licensing and enforcement activities are conducted solely by certain of Acacia’s wholly and majority-owned and controlled operating subsidiaries.

Acacia’s operating subsidiaries invest in, license and enforce patented technologies. Acacia’s operating subsidiaries partner with inventors and patent owners, applying their legal and technology expertise to patent assets to unlock the financial value in their patented inventions. Acacia is an intermediary in the patent marketplace, bridging the gap between invention and application, facilitating efficiency and delivering monetary rewards to patent owners.

Acacia’s operating subsidiaries generate revenues and related cash flows from the granting of intellectual property rights for the use of patented technologies that its operating subsidiaries control or own. Acacia’s operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation.

Acacia’s operating subsidiaries are principals in the licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright. Acacia’s operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain foreign counterparts, covering technologies used in a wide variety of industries.

Acacia was incorporated on January 25, 1993 under the laws of the State of California. In December 1999, Acacia changed its state of incorporation from California to Delaware.

X

- Definition
DESCRIPTION OF BUSINESS [Abstract]
+ References
No definition available.
+ Details

Name: actg_DescriptionOfBusinessAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 26 R10.htm IDEA: XBRL DOCUMENT v3.3.1.900

Summary of Significant Accounting Policies
12 Months Ended

Dec. 31, 2015

Accounting Policies [Abstract]

Summary of Significant Accounting Policies
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Accounting Principles and Fiscal Year End.  The consolidated financial statements and accompanying notes are prepared on the accrual basis of accounting in accordance with generally accepted accounting principles in the United States of America.

Principles of Consolidation.  The accompanying consolidated financial statements include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. Material intercompany transactions and balances have been eliminated in consolidation.

Noncontrolling interests in Acacia’s majority-owned and controlled operating subsidiaries (“noncontrolling interests”) are separately presented as a component of stockholders’ equity. Consolidated net income or (loss) is adjusted to include the net (income) or loss attributed to noncontrolling interests in the consolidated statements of operations. Refer to the accompanying consolidated statements of stockholders’ equity for total noncontrolling interests.

A wholly owned subsidiary of Acacia is the general partner of the Acacia Intellectual Property Fund, L.P. (the “Acacia IP Fund”), which was formed in August 2010. The Acacia IP Fund is included in the Company’s consolidated financial statements since 2010, as Acacia’s wholly owned subsidiary, as the general partner, has the ability to control the operations and activities of the Acacia IP Fund. Refer to Note 11 to these consolidated financial statements.

Revenue Recognition.  Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectibility of amounts is reasonably assured.

In general, revenue arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by Acacia’s operating subsidiaries. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by Acacia’s operating subsidiaries, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined, relatively short period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for an additional minimum upfront payment. Pursuant to the terms of these agreements, Acacia’s operating subsidiaries have no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on Acacia’s operating subsidiaries’ part to maintain or upgrade the technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the minimum upfront payment for term agreement renewals. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectibility is reasonably assured, or upon receipt of the minimum upfront fee for term agreement renewals, and when all other revenue recognition criteria have been met.
For the periods presented herein, the majority of the revenue agreements executed by the Company provided for the payment of one-time, paid-up license fees in consideration for the grant of certain intellectual property rights for patented technology rights owned by our operating subsidiaries. These rights were primarily granted on a perpetual basis, extending until the expiration of the underlying patents.

Certain of the Company’s revenue arrangements provide for future royalties or additional required payments based on future licensee activities. Additional royalties are recognized in revenue upon resolution of the related contingency provided that all revenue recognition criteria, as described above, have been met. Amounts of additional royalties due under these license agreements, if any, cannot be reasonably estimated by management.

Certain of the Company’s revenue arrangements provide for the calculation of fees based on a licensee’s actual quarterly sales or actual per unit activity, applied to a contractual royalty rate. Licensees that pay fees on a quarterly basis generally report actual quarterly sales or actual per unit activity information and related quarterly fees due within 30 days to 45 days after the end of the quarter in which such sales or activity takes place. The amount of fees due under these revenue arrangements each quarter cannot be reasonably estimated by management. Consequently, Acacia’s operating subsidiaries recognize revenue from these revenue arrangements on a three-month lag basis, in the quarter following the quarter of sales or per unit activity, provided amounts are fixed or determinable and collectibility is reasonably assured. The lag method described above allows for the receipt of licensee royalty reports prior to the recognition of revenue.

Amounts related to revenue arrangements that do not meet the revenue recognition criteria described above are deferred until the revenue recognition criteria are met.

Acacia assesses the collectibility of fees receivable based on a number of factors, including past transaction history and credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectibility becomes reasonably assured, assuming all other revenue recognition criteria have been met, which is generally upon receipt of cash.

Cost of Revenues.  Cost of revenues include the costs and expenses incurred in connection with Acacia’s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment costs. These costs are included under the caption “Cost of revenues” in the accompanying consolidated statements of operations.

Inventor Royalties and Contingent Legal Expenses. Inventor royalties are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In certain instances, pursuant to the terms of the underlying inventor agreements, upfront advances paid to patent owners by Acacia’s operating subsidiaries are recoverable from future net revenues. Patent costs that are recoverable from future net revenues are amortized over the estimated economic useful life of the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense in the consolidated statements of operations. Any unamortized upfront advances recovered from net revenues are expensed in the period recovered, and included in amortization expense in the consolidated statements of operations. Refer to Note 11 for additional information.

Contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal fees are paid; however, Acacia’s operating subsidiaries may be liable for certain out of pocket legal costs incurred pursuant to the underlying legal services agreement.

Fair Value Measurements. U.S. generally accepted accounting principles define fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value is defined as follows:

●
Level 1 -
Observable Inputs:  Quoted prices in active markets for identical investments;

●
Level 2 -
Pricing Models with Significant Observable Inputs:  Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and

●
Level 3 -
Unobservable Inputs:  Significant unobservable inputs, including the entity’s own assumptions in determining the fair value of investments.
Whenever possible, the Company is required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value. Acacia has not elected the fair value option for recording non-financial assets and liabilities, and therefore no fair value measurements are performed on a recurring basis.

Cash and Cash Equivalents.  Acacia considers all highly liquid, short-term investments with original maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia’s cash equivalents are comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements. Acacia’s cash equivalents are measured at fair value using quoted prices that represent Level 1 inputs.

Investments in Marketable Securities.  Investments in securities with original maturities of greater than three months and less than one year and other investments representing amounts that are available for current operations are classified as short-term investments, unless there are indications that such investments may not be readily sold in the short term. The fair values of these investments approximate their carrying values. As of December 31, 2015, the balance of short term investments was zero. At December 31, 2014, all of Acacia’s investments were classified as available-for-sale, which are reported at fair value on a recurring basis using significant observable inputs (Level 1), with related unrealized gains and losses in the value of such securities recorded as a separate component of other comprehensive income (loss) in stockholders’ equity until realized. Realized and unrealized gains and losses are recorded based on the specific identification method. Interest on all securities is included in interest and other investment income (loss).

Impairment of Marketable Securities. Acacia evaluates its investments in marketable securities for potential impairment, employing a systematic methodology on a quarterly basis that considers available quantitative and qualitative evidence. If the cost or carrying value of an investment exceeds its estimated fair value, the Company evaluates, among other factors, general market conditions, credit quality of instrument issuers, the duration and extent to which the fair value is less than cost, and the Company’s intent and ability to hold, or plans or ability to sell. Fair value is estimated based on publicly available market information or other estimates determined by management. Investments are considered to be impaired when a decline in fair value is estimated to be other-than-temporary. Acacia reviews impairments associated with its investments in marketable securities and determines the classification of any impairment as temporary or other-than-temporary. An impairment is deemed other-than-temporary unless (a) Acacia has the ability and intent to hold an investment for a period of time sufficient for recovery of its carrying amount and (b) positive evidence indicating that the investment’s carrying amount is recoverable within a reasonable period of time outweighs any evidence to the contrary. All available evidence, both positive and negative, is considered to determine whether, based on the weight of such evidence, the carrying amount of the investment is recoverable within a reasonable period of time. For investments classified as available-for-sale, unrealized losses that are other-than-temporary are recognized in the consolidated statements of operations.

Concentration of Credit Risks.  Financial instruments that potentially subject Acacia to concentrations of credit risk are cash equivalents, investments and accounts receivable. Acacia places its cash equivalents and investments primarily in highly rated money market funds and investment grade marketable securities. Cash equivalents are also invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not experienced any significant losses on its deposits of cash and cash equivalents.

Three licensees individually accounted for 24%, 20% and 16% respectively, of revenues recognized during the year ended December 31, 2015. Two licensees individually accounted for 22% and 22%, respectively, of revenues recognized during the year ended December 31, 2014. Two licensees individually accounted for 38% and 16%, respectively, of revenues recognized during the year ended December 31, 2013. Two licensees individually represented approximately 72% and 21% respectively, of accounts receivable at December 31, 2015. Three licensees individually represented approximately 30%, 17% and 15%, respectively, of accounts receivable at December 31, 2014. For 2015, 2014 and 2013, 49%, 43% and 24%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. The Company does not have any material foreign operations.

Acacia performs credit evaluations of its licensees with significant receivable balances, if any, and has not experienced any significant credit losses. Accounts receivable are recorded at the executed contract amount and generally do not bear interest. Collateral is not required. An allowance for doubtful accounts may be established to reflect the Company’s best estimate of probable losses inherent in the accounts receivable balance, and is reflected as a contra-asset account on the balance sheet and a charge to operating expenses in the statement of operations for the applicable period. The allowance is determined based on known troubled accounts, historical experience, and other currently available evidence. There was no allowance for doubtful accounts established for the periods presented.

Furniture and Equipment.  Furniture and equipment are recorded at cost. Major additions and improvements that materially extend useful lives of furniture and equipment are capitalized. Maintenance and repairs are charged against the results of operations as incurred. When these assets are sold or otherwise disposed of, the asset and related depreciation are relieved, and any gain or loss is included in the consolidated statements of operations for the period of sale or disposal. Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives of the assets:
Furniture and fixtures
3 to 5 years
Computer hardware and software
3 to 5 years
Leasehold improvements
2 to 5 years (Lesser of lease term or useful life of improvement)

Rental payments on operating leases are charged to expense in the consolidated statements of operations on a straight-line basis over the lease term.

Patents.  Patents include the cost of patents or patent rights (hereinafter, collectively “patents”) acquired from third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from one to ten years. Certain patent application and prosecution costs incurred to secure additional patent claims, that based on management’s estimates are deemed to be recoverable, are capitalized and amortized over the remaining estimated economic useful life of the related patent portfolio.

Goodwill. Goodwill is tested for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis (December 31) and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. Acacia considers its market capitalization and the carrying value of its assets and liabilities, including goodwill, when performing its goodwill impairment test. When conducting its annual goodwill impairment assessment, the Company initially performs a qualitative evaluation of whether it is more likely than not that goodwill is impaired. If it is determined by a qualitative evaluation that it is more likely than not that goodwill is impaired, the Company then applies a two-step impairment test. The two-step impairment test first compares the fair value of the Company’s reporting unit to its carrying or book value. If the fair value of the reporting unit exceeds its carrying value, goodwill is not impaired and the Company is not required to perform further testing. If the carrying value of the reporting unit exceeds its fair value, the Company determines the implied fair value of the reporting unit’s goodwill and if the carrying value of the reporting unit’s goodwill exceeds its implied fair value, then an impairment loss equal to the difference is recorded in the consolidated statement of operations. Refer to Note 7 for additional information.

Impairment of Long-lived Assets. Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded equal to the excess of the asset’s carrying value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows. Refer to Note 7 for additional information.

Fair value is generally estimated using the “Income Approach,” focusing on the estimated future net income-producing capability of the patent portfolios over the estimated remaining economic useful life. Estimates of future after-tax cash flows are converted to present value through “discounting,” including an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market share data. Estimated cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio’s licensing and enforcement program. The analysis also contemplates consideration of current information about the patent portfolio including, status and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent information that could impact future net cash flows.

Fair Value of Financial Instruments.  The carrying value of cash and cash equivalents, investments, accounts receivables, and accounts payable approximates their fair values due to their short-term maturities.

Contingent Liabilities. The Company, from time to time, is involved in certain legal proceedings. Based upon consultation with outside counsel handling its defense in these matters and the Company’s analysis of potential outcomes, if the Company determines that a loss arising from such matters is probable and can be reasonably estimated, an estimate of the contingent liability is recorded in its consolidated financial statements. If only a range of estimated loss can be determined, an amount within the range that, based on estimates, assumptions and judgments, reflects the most likely outcome, is recorded as a contingent liability in the consolidated financial statements. In situations where none of the estimates within the estimated range is a better estimate of probable loss than any other amount, the Company records the low end of the range. Any such accrual would be charged to expense in the appropriate period. Litigation expenses for these types of contingencies are recognized in the period in which the litigation services were provided.
Stock-Based Compensation. The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee’s requisite service period (generally the vesting period of the equity award) which is generally two to four years. The fair value of restricted stock and restricted stock unit awards is determined by the product of the number of shares or units granted and the grant date market price of the underlying common stock. The fair value of each option award is estimated on the date of grant using a Black-Scholes option valuation model. Stock-based compensation expense is recorded only for those awards expected to vest using an estimated forfeiture rate. Refer to Note 10 to these notes to consolidated financial statements for information on stock-based awards granted for the periods presented.

Income Taxes.  Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in Acacia’s consolidated financial statements or consolidated income tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized, or if it is determined that there is uncertainty regarding future realizability of such assets.

Under U.S. generally accepted accounting principles, a tax position is a position in a previously filed tax return or a position expected to be taken in a future tax filing that is reflected in measuring current or deferred income tax assets and liabilities. Tax positions are recognized only when it is more likely than not (likelihood of greater than 50%), based on technical merits, that the position will be sustained upon examination. Tax positions that meet the more likely than not threshold are measured using a probability weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.

If a deduction reported on a tax return for an equity-based incentive award exceeds the cumulative compensation cost for those instruments recognized for financial reporting purposes, any resulting realized tax benefit that exceeds the previously calculated deferred tax asset for those instruments is considered an excess tax benefit, and is recognized as additional paid-in capital. If the tax deduction is less than the cumulative book compensation cost, the tax effect of the resulting difference is charged first to APIC, to the extent of the available pool of windfall tax benefits, with any remainder recognized in income tax expense.

Segment Reporting.  Acacia uses the management approach, which designates the internal organization that is used by management for making operating decisions and assessing performance as the basis of Acacia’s reportable segments. Acacia’s patent licensing and enforcement business constitutes its single reportable segment.

Use of Estimates.  The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, stock-based compensation expense, impairment of marketable securities and intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets and the application of the acquisition method of accounting for business combinations, require its most difficult, subjective or complex judgments.

Income (Loss) Per Share.  The Company computes net income (loss) attributable to common stockholders using the two-class method required for capital structures that include participating securities. Under the two-class method, securities that participate in non-forfeitable dividends, such as the Company’s outstanding unvested restricted stock, are considered “participating securities.”

In applying the two-class method, (i) basic net income (loss) per share is computed by dividing net income (loss) (less any dividends paid on participating securities) by the weighted average number of shares of common stock and participating securities outstanding for the period and (ii) diluted earnings per share may include the additional effect of other securities, if dilutive, in which case the dilutive effect of such securities is calculated by applying the two-class method and the treasury stock method to the assumed exercise or vesting of potentially dilutive common shares. The method yielding the more dilutive result is ultimately reported for the applicable period. Potentially dilutive common stock equivalents primarily consist of employee stock options, and restricted stock units for calculations utilizing the two-class method, and also include unvested restricted stock, when utilizing the treasury method.

The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted income per share:

2015

2014

2013
Numerator (in thousands):

Basic and Diluted

Net loss

$
(160,036
)

$
(66,029
)

$
(56,434
)
Total dividends declared / paid

(25,434
)

(25,039
)

(18,633
)
Dividends attributable to common stockholders

24,740

24,313

18,122

Net loss attributable to common stockholders – basic and diluted

$
(160,730
)

$
(66,755
)

$
(56,945
)

Weighted-average shares used in computing net loss per share attributable to common stockholders – basic and diluted

49,505,817

48,658,088

48,155,832

Basic and diluted net loss per common share

$
(3.25
)

$
(1.37
)

$
(1.18
)
Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share

71,468

27,760

27,760


Treasury Stock. Repurchases of the Company’s outstanding common stock are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock on the consolidated balance sheets.

Recent Accounting Pronouncements - Not Yet Adopted. In June 2014, the Financial Accounting Standards Board (the “FASB”) issued a new accounting standard which requires that a performance target that affects vesting and could be achieved after the requisite service period shall be treated as a performance condition. Adoption of this standard is required for annual periods beginning after December 15, 2015. Early adoption is permitted. The Company is currently evaluating the impact the pronouncement will have on its consolidated financial statements and related disclosures.

In May 2014, the FASB issued a new accounting standards update addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. The amendments for this standard update are effective for interim and annual reporting periods beginning after December 15, 2016, and are to be applied
retrospectively or the cumulative effect as of the date of adoption, with early application not permitted. The Company is currently evaluating the impact and method of adoption the pronouncement will have on its consolidated financial statements and related disclosures.

In August 2014, the FASB issued a new accounting standard which requires management to assess an entity’s ability to continue as a going concern every reporting period including interim periods, and to provide related footnote disclosure in certain circumstances. Adoption of this standard is required for annual periods beginning after December 15, 2016 and are to be applied retrospectively or the cumulative effect as of the date of adoption. Early adoption is permitted. The Company is currently evaluating the impact the pronouncement will have on its consolidated financial statements and related disclosures.

In September 2015, the FASB issued an accounting standard update to simplify the accounting for measurement- period adjustments in a business combination by requiring the acquirer to recognize adjustments to provisional amounts
identified during the measurement period in the reporting period in which the adjustments are determined. The acquirer is also
required to record in the reporting period in which the adjustments are determined the effect on earnings of changes in
depreciation, amortization, and other items resulting from the change to the provisional amounts. The new guidance is effective
for fiscal years beginning after December 15, 2015, including interim periods within those fiscal years. Management is
currently evaluating the effect that implementation of this update will have on its consolidated financial position and results of
operations upon adoption.

In November 2015, the FASB issued an accounting standard update to simplify the presentation of deferred income taxes by requiring that deferred tax liabilities and assets be classified as noncurrent on the balance sheet. This update is effective for annual reporting periods beginning after December 31, 2016, including interim periods within those annual periods, and early adoption is permitted. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

In February 2016, the FASB issued an accounting standard update which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. The requirements of this standard include a significant increase in required disclosures. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

Recently Adopted Accounting Pronouncements - Adopted Effective January 1, 2014. In July 2013, the FASB issued a new accounting standard addressing when unrecognized tax benefits should be presented as reductions to deferred tax assets for net operating loss carryforwards in the financial statements. This standard was adopted effective January 1, 2014. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements and related disclosures.

In March 2013, the FASB issued a new accounting standard addressing the accounting for the cumulative translation adjustment when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. This standard was adopted effective January 1, 2014. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements and related disclosures.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all significant accounting policies of the reporting entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18861-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18726-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18743-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18854-107790
+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 27 R11.htm IDEA: XBRL DOCUMENT v3.3.1.900

Short-term Investments
12 Months Ended

Dec. 31, 2015

Short-term Investments [Abstract]

Short-Term Investments
SHORT-TERM INVESTMENTS

Short-term marketable securities for the periods presented were comprised of the following (in thousands):

December 31, 2014
Security Type
Cost

Gross Unrealized Gains

Gross Unrealized Losses

Fair Value
U.S. government fixed income securities
$
58,819

$
2

$
(263
)

$
58,558

Total short-term investments
$
58,819

$
2

$
(263
)

$
58,558

Short-term investments at December 31, 2014 were comprised of investments in highly liquid, AAA, U.S. government fixed income securities with maturity dates in 2015. Short-term marketable securities in unrealized loss positions at December 31, 2014 were in continuous unrealized loss positions for less than one year. There were no short-term investments at December 31, 2015.

U.S. government fixed income securities. The gross unrealized loss can be primarily attributed to a combination of market conditions as well as the demand for and duration of the U.S. government fixed income securities. The Company has the ability to hold these securities until maturity, currently has no intent to sell, there is no requirement to sell and the Company believes that it can recover the amortized cost of these investments. The Company has found no evidence of impairment due to credit losses in its portfolio. Therefore, these unrealized losses were recorded in other comprehensive income (loss). However, the Company cannot provide any assurance that its portfolio of short-term marketable securities will not be impacted by adverse conditions in the financial markets, which may require the Company in the future to record an impairment charge for credit losses which could adversely impact its financial results.

For the year ended December 31, 2015, proceeds from the sale of short-term marketable securities classified as available-for-sale were $82,115,000 and gross realized losses were $617,000. Gross realized losses are recorded in the statements of operations in other income (expense). For the year ended December 31, 2014, proceeds from the sale of short-term marketable securities classified as available-for-sale were $182,115,000 and gross realized losses were $2,188,000. For the year ended December 31, 2013, proceeds from the sale of short-term marketable securities classified as available-for-sale were $239,370,000, gross realized gains were $1,174,000 and gross realized losses were $981,000.

X

- Definition
The entire disclosure for investments in certain debt and equity securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-Glossary Debt Security
-URI http://asc.fasb.org/extlink&oid=6509901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27290-111563

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6379141&loc=d3e15032-111544

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27232-111563

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-Glossary Equity Security
-URI http://asc.fasb.org/extlink&oid=6511694

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 320
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62557-112803

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27357-111563

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27405-111563
+ Details

Name: us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_ShortTermInvestmentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 28 R12.htm IDEA: XBRL DOCUMENT v3.3.1.900

Furniture and Equipment
12 Months Ended

Dec. 31, 2015

Property, Plant and Equipment [Abstract]

Property and Equipment
FURNITURE AND EQUIPMENT

Furniture and equipment consists of the following at December 31, 2015 and 2014 (in thousands):

2015

2014

Furniture and fixtures

$
739

$
761

Computer hardware and software

649

650

Leasehold improvements

145

144

1,533

1,555

Less:  accumulated depreciation and amortization

(1,261
)

(1,055
)

$
272

$
500

Depreciation expense was $222,000, $304,000 and $236,000 for the years ended December 31, 2015, 2014 and 2013, respectively. In 2015 and 2014, the Company retired $30,000 and $330,000, respectively, of items held in furniture and equipment and recorded a $14,000 and $71,000, respectively, loss on disposal.

X

- References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13-14)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2921-110230

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 29 R13.htm IDEA: XBRL DOCUMENT v3.3.1.900

Accounts Payable and Accrued Expenses
12 Months Ended

Dec. 31, 2015

Accounts Payable and Accrued Liabilities, Current [Abstract]

Accounts Payable and Accrued Expenses / Costs
ACCOUNTS PAYABLE AND ACCRUED EXPENSES

Accounts payable and accrued expenses consist of the following at December 31, 2015 and 2014 (in thousands):

2015

2014

Payroll and other employee benefits

$
576

$
1,481

Accrued vacation

701

806

Accrued legal expenses - patent

10,135

8,410

Accrued attorney's fees

—

1,548

Foreign taxes payable ⁽¹⁾

3,960

—

Accrued consulting and other professional fees

1,592

1,530

Other accrued liabilities

383

1,085

$
17,347

$
14,860

⁽¹⁾ - Included in "Accounts Payable and Accrued Expenses/Patent Costs" line item on the consolidated statement of cash flows included elsewhere herein.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a),20,24)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 19
-Subparagraph a
-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 20, 24
-Article 5
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 30 R14.htm IDEA: XBRL DOCUMENT v3.3.1.900

Patents
12 Months Ended

Dec. 31, 2015

Patents [Abstract]

Patents

Acacia’s only identifiable intangible assets are patents and patent rights, with estimated remaining economic useful lives ranging from one to eight years. For all periods presented, all of Acacia’s identifiable intangible assets were subject to amortization. The gross carrying amounts and accumulated amortization related to investments in intangible assets as of December 31, 2015 and 2014 are as follows (in thousands):

2015

2014

Gross carrying amount - patents

$
444,137

$
453,201

Accumulated amortization - patents⁽¹⁾

(281,495
)

(166,565
)
Patents, net

$
162,642

$
286,636

(1) Includes patent impairment charges for the applicable periods.

The weighted-average remaining estimated economic useful life of Acacia’s patents and patent rights is 5 years. Scheduled annual aggregate amortization expense is estimated to be $43,218,000 in 2016, $40,577,000 in 2017, $35,777,000 in 2018, $19,410,000 in 2019, $6,787,000 in 2020 and $16,873,000 thereafter.

For the years ended December 31, 2015, 2014 and 2013, Acacia paid patent investment costs totaling $19,504,000, $42,746,000 and $25,061,000, respectively. The patents have initial estimated economic useful lives ranging from two to ten years. Included in net additions to capitalized patent costs during the years ended December 31, 2015 and 2014 are accrued patent investment costs totaling $1,000,000 and $16,700,000, respectively, which are amortized over the estimated economic useful life of the related patents.

During the periods presented, certain operating subsidiaries recovered up-front patent portfolio advances from applicable net licensing proceeds prior to the scheduled amortization of such up-front patent portfolio advances, resulting in the acceleration of amortization expense for the applicable patent-related assets. For the years ended December 31, 2014 and 2013, accelerated amortization expense related to the recovery of up-front patent portfolio advances totaled $1,247,000 and $592,000, respectively.

For the years ended December 31, 2015, 2014 and 2013, pursuant to the terms of the respective inventor agreements, certain Acacia operating subsidiaries elected to terminate or sell their rights to patent portfolios, resulting in the acceleration of amortization expense for the patent-related assets totaling $380,000, $2,702,000 and $1,747,000, respectively.

Acacia recorded impairment of patent-related intangible asset charges totaling $74,731,000, $3,497,000 and $4,619,000 for the years ended December 31, 2015, 2014 and 2013, respectively. The impairment charges related to impairments of patent portfolios due to a reduction in expected estimated future net cash flows and certain patent portfolios that management determined it would no longer allocate future resources to in connection with the licensing and enforcement of such portfolios, due primarily to potential prior art related complexities and/or the overall determination that future resources would be allocated to other licensing and enforcement programs with higher potential return profiles. The impairment charges consisted of the excess of the asset’s carrying value over its estimated fair value. Refer to Note 7 for additional information regarding impairment charges for the year ended December 31, 2015.

For the years ended December 31, 2015, 2014 and 2013, capitalized patent costs, accumulated amortization, and sales proceeds related to patent-related sales and disposals are as follows (in thousands):

2015

2014

2013

Capitalized patent costs

$
500

$
3,000

$
3,500

Accumulated amortization

120

298

1,753

Sales proceeds

750

3,500

1,000

X

- Definition
Patents [Abstract]
+ References
No definition available.
+ Details

Name: actg_PatentsAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all or part of the information related to intangible assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16373-109275
+ Details

Name: us-gaap_IntangibleAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R15.htm IDEA: XBRL DOCUMENT v3.3.1.900

Goodwill and Patent Impairment Charges (Notes)
12 Months Ended

Dec. 31, 2015

Goodwill and Patent Impairment Charges [Abstract]

Goodwill and Intangible Assets Disclosure [Text Block]
GOODWILL AND PATENT IMPAIRMENT CHARGES
Pursuant to applicable accounting standards, if goodwill and another asset group of a reporting unit are tested for impairment at the same time, the other asset group, the Company's patent portfolios, are to be tested for impairment before goodwill.
Patent Portfolio Impairment Testing - December 31, 2015. Acacia performed an impairment analysis for its patent assets as of December 31, 2015, utilizing the assistance of a third-party valuation specialist, resulting in $74.7 million of patent portfolio impairment charges, for the following reasons:
•
In December 2015, Acacia announced that its subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, Inc., and others. The jury returned a verdict that the asserted claims of the patent at issue were invalid and non-infringed. The Adaptix trial loss resulted in a reduction in estimated cash flows for the Adaptix portfolio expected to be realized from future licensing and enforcement activities, leading to impairment charges on the portfolio in the fourth quarter of 2015.
•
Management considered the impact of the fourth quarter 2015 adverse trial outcomes on its estimates of future cash flows that could be realized from future licensing and enforcement activities for other patent portfolios. Estimates of future cash flows for these portfolios were reduced in part in connection with the Company's assessment of probabilities of realization given the recent adverse trial outcomes.
•
Patent impairment charges include the carrying value of other patent portfolios for which, in the fourth quarter of 2015, the Company experienced adverse litigation or trial outcomes, leading to a reduction in or elimination of expected future cash flows. In addition, headcount reductions and internal staff optimization efforts led to changes with respect to which patent portfolios the Company intends to allocate licensing and enforcement resources to in future periods. As such, certain portfolio programs were selected for termination due to a decision to no longer pursue or allocate resources, resulting in a write-off any remaining carrying value in the fourth quarter of 2015.
Goodwill Impairment Testing - December 31, 2015. At December 31, 2015, prior to the completion of the annual goodwill impairment test, the goodwill balance totaled $30.1 million. Goodwill is tested for impairment at the Company's single reporting unit level on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. Factors considered important, which could trigger an impairment review, include the following:
•
significant consistent gradual decline in the Company's stock price for a sustained period;
•
significant underperformance relative to expected historical or projected future operating results;
•
significant changes in the manner of use of assets or the strategy for the Company's overall business;
•
significant negative industry or economic trends; and
•
significant adverse changes in legal factors or in the business climate, including adverse regulatory actions or assessments.

     In connection with Acacia's annual goodwill impairment testing for 2015, the Company identified several qualitative factors triggering an impairment test at December 31, 2015, as follows:
•
Adverse legal outcomes and changes in legal factors. In December 2015, Acacia announced that its subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, et al., deciding that the claims of the applicable patents in suit were invalid and non-infringed. This adverse legal outcome and others in the fourth quarter of 2015 resulted in changes in estimates of realization related to litigation outcomes in future periods for certain patent portfolios.
•
Significant consistent gradual decline in the Company’s stock price: Historically, the Company's stock price has been volatile, and the volatility continued during fiscal 2015, declining from $16.72 as of January 2, 2015, to $4.29 as of December 31, 2015, a 74% decline. In addition, subsequent to December 31, 2015, the Company's stock price volatility has continued, trending downward to $3.16 as of February 29, 2016. In the fourth quarter of 2015, given the continued decline in stock price up through December 31, 2015, and the impact of the December 2015 adverse trial outcomes noted above, the gradual consistent decline in the Company's stock price was deemed to be sustained, and hence indicative of a reduction in the estimated fair value of the Company, as reflected in its lower overall market capitalization.
•
Changes in Company Management and Resource Allocations. In connection with certain resource allocation changes within the organization given a change in management in the fourth quarter of 2015, headcount reductions and internal staff optimization efforts occurred, which led to changes with respect to estimates of which patent portfolios the Company intends to continue to allocate licensing and enforcement resources to in future periods. As such, certain patent portfolio programs were selected for termination due to a decision to no longer allocate resources. In addition, changes in estimates regarding the best and highest use of certain patent portfolios were made, resulting in reductions in estimated future cash flows.
At December 31, 2015, the Company utilized the following methods and assumptions in its annual goodwill impairment testing, which was prepared with the assistance of a third-party valuation specialist:
•
At December 31, 2015, the initial qualitative assessment included consideration of the factors described above, resulting in a conclusion that as of December 31, 2015, the consistent gradual decline in the Company’s stock price was sustained. The Company also considered the impact of the December 2015 adverse trial outcomes on the Company's stock price and related estimates of fair value for remaining portfolio opportunities. Based on the Company's assessment of these factors, the Company determined that it was more likely than not that goodwill was impaired, constituting a triggering event requiring a goodwill impairment test as of December 31, 2015.
•
The Company conducted the first step of the goodwill impairment test for its single reporting unit as of December 31, 2015. The Company utilized the market capitalization plus cost synergies approach to estimate the fair value of the Company. The estimated market capitalization was determined by multiplying the Company's stock price and the common shares outstanding as of December 31, 2015. Management also considered a control premium in its estimate of fair value for the Company's single reporting unit. The cost synergies were estimated based on the cost savings which could be achieved if the Company was acquired by a competitor in the same operating business.
•
Based on the analysis utilizing the market capitalization plus cost synergies approach, the estimated fair value of the reporting unit of $252 million was below its carrying value of $344.3 million as of December 31, 2015, and therefore, goodwill was determined to be more likely than not, impaired.
•
The purpose of step 2 of the analysis was to determine the estimated fair value of the assets and liabilities of the Company's reporting unit, in order to determine the implied fair value of goodwill for the reporting unit. The excess, if any, of the fair value of a reporting unit over the amounts assigned to its assets and liabilities is the implied fair value of goodwill. Based upon the analysis performed, the fair value of the Company's single reporting unit did not exceed the amounts assigned to its reporting unit assets and liabilities, resulting in a difference between the implied fair value of goodwill of zero and the historical carrying value of goodwill. As a result, the Company recognized a goodwill impairment charge totaling $30.1 million in the fourth quarter of 2015.

X

- Definition
Goodwill and Patent Impairment Charges [Abstract]
+ References
No definition available.
+ Details

Name: actg_GoodwillandPatentImpairmentChargesAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16373-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 32 R16.htm IDEA: XBRL DOCUMENT v3.3.1.900

Stockholders' Equity
12 Months Ended

Dec. 31, 2015

Stockholders' Equity Note [Abstract]

Stockholders' Equity
STOCKHOLDERS’ EQUITY
Repurchases of Common Stock. On November 15, 2013, Acacia’s Board of Directors authorized a program for repurchases of shares of Acacia’s outstanding common stock. Under the stock repurchase program, effective November 15, 2013, Acacia was authorized to purchase in the aggregate up to $70,000,000 of its of its outstanding common stock through the period ending May 14, 2014.

Repurchases were made from time to time by Acacia in the open market or in block purchases in compliance with applicable Securities and Exchange Commission rules. Repurchases to date were made using existing cash resources and occurred in the open market. The authorization to repurchase shares presented an opportunity to reduce the outstanding share count and enhance stockholder value. The following is the monthly stock repurchases for the periods presented, all of which were purchased as part of publicly announced plans or programs:

Total Number of Shares Purchased
Average Price paid per Share
Approximate Dollar Value of
Shares that May Yet be
Purchased under the Program
Plan Expiration

December 4, 2013 - December 11, 2013
600,000

$
13.18

$
—

May 14, 2014
Totals for 2013
600,000

Cash Dividends. On April 23, 2013, Acacia announced that its Board of Directors approved the adoption of a cash dividend policy that calls for the payment of an expected total annual cash dividend of $0.50 per common share, payable in the amount of $0.125 per share per quarter. Under the policy, the Company paid four quarterly cash dividends totaling $25,434,000 and $25,039,000 in 2015 and 2014 and three quarterly cash dividends totaling $18,633,000 in 2013.

On February 25, 2016, Acacia announced that its Board of Directors terminated the company’s dividend policy effective February 23, 2016. The Board of Directors terminated the dividend policy due to a number of factors, including the Company’s financial performance and its available cash resources, the Company’s cash requirements and alternative uses of capital that the Board of Directors concluded would represent an opportunity to generate a greater return on investment for the Company and its stockholders.

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityNoteAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d),(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB TOPIC 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph d
-Article 4

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30, 31
-Article 5

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Article 4

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section C

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 R17.htm IDEA: XBRL DOCUMENT v3.3.1.900

Income Taxes
12 Months Ended

Dec. 31, 2015

Income Tax Disclosure [Abstract]

Income Taxes
INCOME TAXES

Acacia’s provision for income taxes for the fiscal periods presented consisted of the following (in thousands):

2015

2014

2013

Current:

Federal

$
—

$
—

$
—

State taxes

379

289

113

Foreign taxes

4,421

5,359

4,405

Total current

4,800

5,648

4,518

Deferred:

Federal

—

(1,867
)

(26,151
)
State taxes

—

131

(325
)
Total deferred

—

(1,736
)

(26,476
)
Provision for (benefit from) income taxes

$
4,800

$
3,912

$
(21,958
)

The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities consist of the following at December 31, 2015 and 2014 (in thousands):

2015

2014

Deferred tax assets:

Net operating loss and capital loss carryforwards and credits

$
71,494

$
59,427

Stock compensation

1,385

1,800

Fixed assets and intangibles

1,359

—

Basis of investments in affiliates

499

1,437

Accrued liabilities and other

442

409

Unrealized loss on short-term investments

—

92

State taxes

81

26

Total deferred tax assets

75,260

63,191

Valuation allowance

(75,179
)

(35,927
)
Total deferred tax assets, net of valuation allowance

81

27,264

Deferred tax liabilities:

Fixed assets and intangibles

—

(27,157
)
Other

(81
)

(107
)
Total deferred tax liabilities

(81
)

(27,264
)

Net deferred tax assets (liabilities)

$
—

$
—

A reconciliation of the federal statutory income tax rate and the effective income tax rate is as follows:

2015

2014

2013

Statutory federal tax rate - (benefit) expense

(35
)%

(35
)%

(35
)%
State income and foreign taxes, net of federal tax effect

3
%

9
%

5
%
Foreign tax credit

(3
)%

(8
)%

(6
)%
Noncontrolling interests in operating subsidiaries

(1
)%

—
%

1
%
Goodwill

7
%

—
%

—
%
Nondeductible permanent items

—
%

1
%

2
%
Expired capital loss carryforwards

1
%

—
%

2
%
Valuation allowance

31
%

39
%

4
%

3
%

6
%

(27
)%

For the fiscal years ended December 31, 2015 and 2014, the Company recorded full valuation allowances against its net deferred tax assets due to uncertainty regarding future realizability pursuant to guidance set forth in ASC 740, “Income Taxes.” In future periods, if the Company determines it will more likely than not be able to realize certain of these amounts, the applicable portion of the benefit from the release of the valuation allowance will generally be recognized in the statement of operations in the period the determination is made.

At December 31, 2015, Acacia had U.S. federal and state income tax net operating loss carryforwards (“NOLs”) totaling approximately $160,840,000 and $55,215,000, expiring between 2025 and 2035, and 2016 and 2035, respectively, for which $0 and $441,000 of federal and state net operating losses are included as a deferred tax asset related to the tax benefits of stock option deductions and which will be credited to additional paid-in capital when realized as a reduction of taxes payable on Acacia’s tax return. In addition, $1,928,000 and $37,771,000 of federal and state net operating losses are not included as a deferred tax asset and will be credited to additional paid-in capital when realized as a reduction of taxes payable on Acacia’s tax return as they relate to unrecognized excess tax benefits (see additional information regarding the ordering of windfall tax benefits and use of the “with-and-without” approach below). Capital loss carryovers totaled $3,423,000 at December 31, 2015, expiring between 2017 and 2020.

At December 31, 2015, approximately $29,318,000 of the U.S. federal NOLs, acquired in connection with the acquisition of ADAPTIX, Inc. in 2012, are subject to an annual utilization limitation of approximately $14,100,000, pursuant to the “change in ownership” provisions under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”).

As of December 31, 2015, Acacia had approximately $34,298,000 of foreign tax credits, expiring between 2016 and 2025, of which $20,313,000 has been utilized for financial statement purposes. Future realization of the credits as a reduction of taxes payable on Acacia’s tax return will result in an income tax benefit recognizable through additional paid in capital since the entire amount of the credits have been utilized for financial statement purposes under the “with-and-without approach.” In general, foreign taxes withheld may be claimed as a deduction on future U.S. corporate income tax returns, or as a credit against future U.S. income tax liabilities, subject to certain limitations.

Tax expense for the periods presented, primarily reflects foreign taxes withheld on revenue agreements with licensees in foreign jurisdictions, a benefit totaling $1,735,000 from the reversal of the net deferred tax liability that existed at the beginning of the year (2014 only) and other state taxes. Excluding the impact of the change in valuation allowance, annual effective tax rates were (28)%, (33)%, and (31%) for fiscal years 2015, 2014, and 2013, respectively. In 2013, the rate at which the Company recorded the tax benefit associated with the pre-tax loss for the period was reduced from the statutory rate primarily due to certain nondeductible permanent items and expired capital loss carryforwards. The Company recorded a valuation allowance on foreign tax credits generated in fiscal year 2013 totaling $4,605,000, and therefore, did not recognize the related tax benefit for these tax assets in fiscal year 2013.

The Company has elected to utilize the “with-and-without approach” regarding ordering of windfall tax benefits to determine whether the windfall tax benefit has reduced taxes payable. Under this approach, the windfall tax benefits would be recognized in additional paid in capital only if an incremental tax benefit is realized after considering all other tax benefits presently available to the Company. The deductions related to the exercise and vesting of equity-based incentive awards during the periods presented are, in general, available to offset taxable income on Acacia’s consolidated tax returns. Accordingly, the excess tax benefit related to the exercise and vesting of equity-based incentive awards for the periods presented was credited to additional paid-in capital, not taxes payable. For the year ended December 31, 2013, the Company incurred approximately $1,398,000 of net short falls from the exercise and vesting of equity-based incentive awards, of which $1,398,000 was recorded against its additional paid-in capital pool with no impact to the income statement. For the years ended December 31, 2015 and 2014, the Company incurred approximately $1,917,000 and $2,713,000, respectively, of net short falls from the exercise and vesting of equity-based incentive awards, of which $1,917,000 and $2,713,000, respectively, was recorded against its additional paid-in capital, subject to a full valuation allowance, with no impact to the income statement.

Acacia is subject to taxation in the U.S. and in various state jurisdictions and incurs foreign tax withholdings on revenue agreements with licensees in certain foreign jurisdictions. With no material exceptions, Acacia is no longer subject to U.S. federal or state examinations by tax authorities for years before 2000. The California Franchise Tax Board is auditing the 2011 and 2012 California combined income tax returns. The audit is in process and no findings or adjustments have been proposed.

At December 31, 2015, the Company had total unrecognized tax benefits of approximately $2,127,000, including a recorded noncurrent liability of $85,000, related to unrecognized tax benefits primarily associated with state taxes. No interest and penalties have been recorded for the unrecognized tax benefits as of December 31, 2015. If recognized, approximately $2,127,000, net of valuation analysis, would impact the Company’s effective tax rate. The Company does not expect that the liability for unrecognized tax benefits will change significantly within the next 12 months.

Acacia recognizes interest and penalties with respect to unrecognized tax benefits in income tax expense. Acacia has identified no uncertain tax position for which it is reasonably possible that the total amount of unrecognized tax benefits will significantly increase or decrease within 12 months.

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4
+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 34 R18.htm IDEA: XBRL DOCUMENT v3.3.1.900

Stock-Based Incentive Plans
12 Months Ended

Dec. 31, 2015

Share-based Compensation [Abstract]

Stock-based Incentive Plans
STOCK-BASED INCENTIVE PLANS

The 2007 Acacia Technologies Stock Incentive Plan (“2007 Plan”) and the 2013 Acacia Research Corporation Stock Incentive Plan (“2013 Plan”) (collectively, the “Plans”) were approved by the stockholders of Acacia in May 2007 and May 2013, respectively. All Plans allow grants of stock options, stock awards and performance shares with respect to Acacia common stock to eligible individuals, which generally includes directors, officers, employees and consultants. Except as noted below, the terms and provisions of the Plans are identical in all material respects.

Acacia’s compensation committee administers the discretionary option grant and stock issuance programs. The compensation committee determines which eligible individuals are to receive option grants or stock issuances under those programs, the time or times when the grants or issuances are to be made, the number of shares subject to each grant or issuance, the status of any granted option as either an incentive stock option or a non-statutory stock option under the federal tax laws, the vesting schedule to be in effect for the option grant or stock issuance and the maximum term for which any granted option is to remain outstanding. The exercise price of options is generally equal to the fair market value of Acacia’s common stock on the date of grant. Options generally begin to be exercisable six months to one year after grant and generally expire ten years after grant. Stock options generally vest over two to three years and restricted shares generally vest in full after two to three years (generally representing the requisite service period). The Plans terminate no later than the tenth anniversary of the approval of the incentive plans by Acacia’s stockholders.

The Plans provide for the following separate programs:

•
Discretionary Option Grant Program. Under the discretionary option grant program, Acacia’s compensation committee may grant (1) non-statutory options to purchase shares of common stock to eligible individuals in the employ or service of Acacia or its subsidiaries (including employees, non-employee board members and consultants) at an exercise price not less than 85% of the fair market value of those shares on the grant date, and (2) incentive stock options to purchase shares of common stock to eligible employees at an exercise price not less than 100% of the fair market value of those shares on the grant date (not less than 110% of fair market value if such employee actually or constructively owns more than 10% of Acacia’s voting stock or the voting stock of any of its subsidiaries).

•
Stock Issuance Program. Under the stock issuance program, eligible individuals may be issued shares of common stock directly, upon the attainment of performance milestones or the completion of a specified period of service or as a bonus for past services. Under this program, the purchase price for the shares shall not be less than 100% of the fair market value of the shares on the date of issuance, and payment may be in the form of cash or past services rendered. The eligible individuals shall have full stockholder rights with respect to any shares of Common Stock issued to them under the Stock Issuance Program, whether or not their interest in those shares is vested. Accordingly, the eligible individuals shall have the right to vote such shares and to receive any regular cash dividends paid on such shares.

•
Automatic Option Grant Program (2013Plan only). Each non-employee director will receive restricted stock units for the number of shares determined by dividing the annual retainer by the closing price of Acacia’s common stock on the grant date, provided that such individual has served as a non-employee director for at least 6 months. In addition, each new non-employee director will receive restricted stock units for the number of shares determined by dividing the annual board of directors retainer by the closing price of Acacia’s common stock on the commencement date. Restricted stock units vest in a series of twelve quarterly installments over the three year period following the grant date, subject to immediate acceleration upon a change in control. Acacia will deliver shares corresponding to the vested restricted stock units within thirty (30) days after the first to occur of the following events: (i) the fifth (5th) anniversary of the grant date; or (ii) termination of the non-employee director’s service as a member of the Company’s Board of Directors. The non-employee directors do not have any rights, benefits or entitlements with respect to any shares unless and until the shares have been delivered.

The initial share reserve under the 2007 Plan was 560,000 shares. The number of shares of common stock available for issuance under the 2007 Plan automatically increased on January 1, 2008 and 2009, by an amount equal to two percent (2%) of the total number of shares of common stock outstanding on the last trading day of December in the prior calendar year. After January 1, 2009, no new additional shares will be added to the 2007 Plan without stockholder approval (except for shares subject to outstanding awards that are forfeited or otherwise returned to the 2007 Plan). At December 31, 2015, there were no shares available for grant under the 2007 Plan.

The number of shares of Common Stock initially reserved for issuance under the 2013 Plan was 4,750,000 shares. No new additional shares will be added to the 2013 Plan without security holder approval (except for shares subject to outstanding awards that are forfeited or otherwise returned to the 2013 Plan). The stock issuable under the 2013 Plan shall be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market. At December 31, 2015, there were 2,778,000 shares available for grant under the 2013 Plan.

Upon the exercise of stock options, the granting of restricted stock, or the delivery of shares pursuant to vested restricted stock units, it is Acacia’s policy to issue new shares of common stock. Acacia’s board of directors may amend or modify the Plans at any time, subject to any required stockholder approval.

The following table summarizes stock option activity for the Plans for the year ended December 31, 2015:

Weighted-Average

Options

Exercise
Price

Remaining
Contractual Term

Aggregate
Intrinsic Value

Outstanding at December 31, 2014

150,000

$
7.59

Exercised

(135,000
)

$
6.95

Outstanding at December 31, 2015

15,000

$
13.38

1 year

$
—

Vested

15,000

$
13.38

1 year

$
—

Exercisable at December 31, 2015

15,000

$
13.38

1 year

$
—

The aggregate intrinsic value of options exercised during the years ended December 31, 2015, 2014 and 2013 was $751,000, $518,000, and $2,024,000, respectively. No options vested during the years ended December 31, 2015, 2014 and 2013.

The following table summarizes nonvested restricted share activity for the year ended December 31, 2015:

Nonvested
Restricted Shares

Weighted
Average Grant Date Fair Value

Nonvested restricted stock at December 31, 2014

1,018,000

$
18.71

Granted

894,000

$
12.83

Vested

(615,000
)

$
18.69

Canceled

(468,000
)

$
15.13

Nonvested restricted stock at December 31, 2015

829,000

$
14.41

The weighted-average grant date fair value of nonvested restricted stock granted during the years ended December 31, 2015, 2014 and 2013 was $12.83, $14.41, and $24.31, respectively. The aggregate fair value of restricted stock that vested during the years ended December 31, 2015, 2014 and 2013 was $11,494,000, $21,490,000, $22,317,000, respectively. As of December 31, 2015, the total unrecognized compensation expense related to nonvested restricted stock awards was $9,264,000, which is expected to be recognized over a weighted-average period of approximately 1.6 years.

The following table summarizes restricted stock unit activity for the year ended December 31, 2015:

Restricted
Stock Units

Weighted
Average Grant Date Fair Value

Nonvested restricted stock units outstanding at December 31, 2014

33,000

$
17.10

Granted

28,000

$
16.72

Vested

(26,000
)

$
18.48

Nonvested restricted stock units outstanding at December 31, 2015

35,000

$
15.78

Vested restricted stock units outstanding at December 31, 2015

75,000

$
23.32

The weighted-average grant date fair value of restricted stock units granted during the years ended December 31, 2015 and 2014 was $16.72 and $14.33, respectively. There were no restricted units granted during the year ended December 31, 2013. The aggregate fair value of restricted stock units that vested during the years ended December 31, 2015, 2014 and 2013 was $480,000, $460,000 and $469,000, respectively. As of December 31, 2015, the total unrecognized compensation expense related to restricted stock unit awards was $482,000, which is expected to be recognized over a weighted-average period of approximately 1.7 years.

As of December 31, 2015, there are 2,903,000 shares of common stock reserved for issuance under the Plans.

X

- Definition
The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 40
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 14
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 35 R19.htm IDEA: XBRL DOCUMENT v3.3.1.900

Commitments and Contingencies
12 Months Ended

Dec. 31, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies
COMMITMENTS AND CONTINGENCIES

Operating Leases

Acacia leases certain office space under various operating lease agreements expiring at various dates from 2016 through 2020. Minimum annual rental commitments for operating leases of continuing operations having initial or remaining noncancellable lease terms in excess of one year are as follows (in thousands):

Years ending December 31,

2016
$
1,459

2017
1,557

2018
1,612

2019
1,669

2020
166

Total minimum lease payments
$
6,463

Rent expense for the years ended December 31, 2015, 2014 and 2013 approximated $1,926,000, $1,523,000 and $1,312,000, respectively. Rental payments are expensed in the statements of operations in the period to which they relate. Scheduled rent increases are amortized on a straight-line basis over the lease term.

Inventor Royalties and Contingent Legal Expenses

In connection with the investment in certain patents and patent rights, certain of Acacia’s operating subsidiaries executed related agreements which grant to the former owners of the respective patents or patent rights, the right to receive inventor royalties based on future net revenues (as defined in the respective agreements) generated as a result of licensing and otherwise enforcing the respective patents or patent portfolios.

Acacia’s operating subsidiaries may retain the services of law firms that specialize in patent licensing and enforcement and patent law in connection with their licensing and enforcement activities. These law firms may be retained on a contingent fee basis whereby such law firms are paid on a scaled percentage of any negotiated fees, settlements or judgments awarded based on how and when the fees, settlements or judgments are obtained.

The economic terms of the inventor agreements, operating agreements and contingent legal fee arrangements associated with the patent portfolios owned or controlled by Acacia’s operating subsidiaries, if any, including royalty rates, contingent fee rates and other terms, vary across the patent portfolios owned or controlled by such operating subsidiaries. Inventor royalties, payments to noncontrolling interests and contingent legal fees expenses fluctuate period to period, based on the amount of revenues recognized each period, the terms and conditions of revenue agreements executed each period and the mix of specific patent portfolios with varying economic terms and obligations generating revenues each period. Inventor royalties and contingent legal fees expenses will continue to fluctuate and may continue to vary significantly period to period, based primarily on these factors.

Patent Enforcement and Other Litigation

Acacia is subject to claims, counterclaims and legal actions that arise in the ordinary course of business. Management believes that the ultimate liability with respect to these claims and legal actions, if any, will not have a material effect on Acacia’s consolidated financial position, results of operations or cash flows.

Certain of Acacia’s operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights. In connection with any of Acacia’s operating subsidiaries’ patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against Acacia or its operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material, and if required to be paid by Acacia or its operating subsidiaries, could materially harm the Company’s operating results and financial position.

Fiscal year 2015 operating expenses included expenses for court ordered attorney fees and settlement and contingency accruals totaling $4,141,000. Fiscal year 2014 operating expenses included an expense accrual for court ordered attorney fees related to matters initiated in 2010 and 2011 totaling $1,548,000. Operating expenses for the year ended December 31, 2013 included a one-time, non-recurring charge related to the resolution of a dispute concerning legal fees associated with a prior matter totaling $3,506,000.

Guarantees and Indemnifications

Certain of Acacia’s operating subsidiaries have made guarantees and indemnities under which they may be required to make payments to a guaranteed or indemnified party, in relation to certain transactions, including revenue transactions in the ordinary course of business. In connection with certain facility leases, Acacia and certain of its operating subsidiaries have indemnified lessors for certain claims arising from the facilities or the leases. Acacia indemnifies its directors and officers to the maximum extent permitted under the laws of the State of Delaware. However, Acacia has a directors and officers insurance policy that may reduce its exposure in certain circumstances and may enable it to recover a portion of future amounts that may be payable, if any. The duration of the guarantees and indemnities varies and, in many cases is indefinite but subject to statute of limitations. The majority of guarantees and indemnities do not provide any limitations of the maximum potential future payments that Acacia could be obligated to make. To date, Acacia has made no payments related to these guarantees and indemnities. Acacia estimates the fair value of its indemnification obligations to be insignificant based on this history and therefore, have not recorded any liability for these guarantees and indemnities in the accompanying consolidated balance sheets. Additionally, no events or transactions have occurred that would result in a material liability at December 31, 2015.

Bank Guarantee
In March 2015, an operating subsidiary of Acacia entered into a standby letter of credit and guarantee arrangement (“Guarantee”) with a bank in the amount of $10,721,000, for purposes of enforcing a court ruling in a German patent court granting an injunction against the defendants in the related patent infringement case. An injunction is an equitable remedy in the form of a court order that compels the defendant(s) to cease marketing, offering for sale or importing applicable infringing products into applicable jurisdiction(s).
Under German law, in order to enforce the injunction granted by the court, a Guarantee is required to be furnished by the operating subsidiary, the plaintiff in the case, for potential payment to the defendants of any applicable claims which may be incurred by the defendants as a result of the enforcement of the injunction, only in the event that the aforementioned court ruling is subsequently successfully appealed by the defendants or otherwise amended. The Guarantee is required to be issued unlimited with respect to time, until appropriately extinguished in accordance with German law. The Guarantee will be extinguished when a relevant extinguishment order by the court having jurisdiction takes effect, typically occurring when the related infringement case has been settled or a final non-appealable decision has been issued by the court.
The Guarantee is secured by a cash deposit at the contracting bank totaling $10,721,000, which is classified as restricted cash in the accompanying balance sheet. The Guarantee expires on April 10, 2016, however, it is automatically extended without amendment for a period of one (1) year from the present or any future expiration date, unless at least 30 days prior to any expiration date, the Guarantee is extinguished in accordance with German law. The Guarantee facility fee is 1.15% per year, and the related expense is included in the consolidated statement of operations.
Other

In August 2010, a wholly owned subsidiary of Acacia became the general partner of the Acacia IP Fund, which was formed in August 2010. The Acacia IP Fund is authorized to raise up to $250,000,000. The Acacia IP Fund invests in, licenses and enforces intellectual property consisting primarily of patents, patent rights, and patented technologies. Refer to Note 2 to these notes to consolidated financial statements for information regarding the consolidation of majority-owned subsidiaries and the presentation of related noncontrolling interests. At December 31, 2015 and 2014, the Acacia IP Fund net assets and net loss were primarily comprised of the following (in thousands):

2015

2014
Cash and other assets

$
7,740

$
2,823

Patents, net of accumulated amortization

147

967

Investments - noncurrent

5,829

8,281

Total assets

$
13,716

$
12,071

Accrued expenses and contributions

$
7,436

$
1,876

Total liabilities

7,436

1,876

Net assets

$
6,280

$
10,195

2015

2014
Revenues

$
18

$
1,560

Operating expenses

1,617

1,724

Gain from operations

(1,599
)

(164
)
Net gain (loss) in equity method investments

6,922

(1,807
)
Net income (loss)

$
5,323

$
(1,971
)

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R20.htm IDEA: XBRL DOCUMENT v3.3.1.900

Retirement Savings Plan and Executive Severance Policy
12 Months Ended

Dec. 31, 2015

RETIREMENT SAVINGS PLAN AND EXECUTIVE SEVERANCE POLICY [Abstract]

Retirement Savings Plan and Executive Severance Policy
RETIREMENT SAVINGS PLAN AND EXECUTIVE SEVERANCE POLICY

Retirement Savings Plan.  Acacia has an employee savings and retirement plan under section 401(k) of the Code (the “Plan”). The Plan is a defined contribution plan in which eligible employees may elect to have a percentage of their compensation contributed to the Plan, subject to certain guidelines issued by the Internal Revenue Service. Acacia may contribute to the Plan at the discretion of the board of directors. There were no contributions made by Acacia during the periods presented.

Executive Severance Policy.  Under Acacia’s Amended Executive Severance Policy, full-time employees with the title of Senior Vice President and higher (“SVP and higher”) are entitled to receive certain benefits upon termination of employment. If employment of an SVP and higher employee is terminated for other than cause or other than on account of death or disability, Acacia will (i) promptly pay to the SVP and higher employee a lump sum amount equal to the aggregate of (a) accrued obligations (i.e., annual base salary through the date of termination to the extent not theretofore paid and any compensation previously deferred (together with any accrued interest or earnings thereon) and any accrued vacation pay, and reimbursable expenses, in each case to the extent not theretofore paid) and (b) three (3) months of base salary for each full year that the SVP and higher employee was employed by the Company (the “Severance Period”), up to a maximum of twelve (12) months (eighteen (18) months for executive officers of Acacia Research Corporation) of base salary, and (ii) provide to the SVP and higher employee, Acacia paid COBRA coverage for the medical and dental benefits selected in the year in which the termination occurs, for the duration of the Severance Period.

X

- Definition
RETIREMENT SAVINGS PLAN AND EXECUTIVE SEVERANCE POLICY [Abstract]
+ References
No definition available.
+ Details

Name: actg_RetirementSavingsPlanAndExecutiveSeverancePolicyAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for pension and other postretirement benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 80
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=35742057&loc=SL14450702-114947

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35743120&loc=d3e2410-114920

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39675-114964

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 70
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6414718&loc=d3e28014-114942

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6414199&loc=d3e39622-114963
+ Details

Name: us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 37 R21.htm IDEA: XBRL DOCUMENT v3.3.1.900

Supplemental Cash Flow Information
12 Months Ended

Dec. 31, 2014

Supplemental Cash Flow Information [Abstract]

Supplemental Cash Flow Information
SUPPLEMENTAL CASH FLOW INFORMATION

Federal taxes paid totaled $0, $0 and $3,000,000 for the years ended December 31, 2015, 2014 and 2013, respectively. At December 31, 2013, prepaid expenses and other current assets included federal and state income taxes receivable totaling $3,251,000. Cash paid for state income taxes totaled $211,000, $172,000 and $516,000 for the years ended December 31, 2015, 2014 and 2013, respectively. Foreign taxes withheld totaled $4,421,000, $5,159,000 and $4,605,000 for the years ended December 31, 2015, 2014 and 2013.

Refer to Note 6 to these notes to consolidated financial statements for information regarding noncash investing activity related to the investment in patent portfolios for the periods presented.

X

- Definition
The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586
+ Details

Name: us-gaap_CashFlowSupplementalDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 38 R22.htm IDEA: XBRL DOCUMENT v3.3.1.900

Quarterly Financial Data
12 Months Ended

Dec. 31, 2015

Quarterly Financial Data [Abstract]

Quarterly Financial Data
QUARTERLY FINANCIAL DATA (unaudited)
The following table sets forth unaudited consolidated statements of operations data for the eight quarters in the period ended December 31, 2015. This information has been derived from Acacia’s unaudited condensed consolidated financial statements that have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the audited consolidated financial statements and related notes thereto. Acacia’s quarterly results have been, and may in the future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should not be relied upon as any indication of the results to be expected in any future periods.

Quarter Ended

Mar. 31,

Jun. 30,

Sept. 30,

Dec. 31,

Mar. 31,

Jun. 30,

Sept. 30,

Dec. 31,

2015

2015

2015

2015

2014

2014

2014

2014

(Unaudited, in thousands, except share and per share information)
Revenues

$
34,210

$
40,336

$
12,994

$
37,497

$
12,578

$
50,076

$
37,192

$
31,030

Operating costs and expenses:

Cost of revenues:

Inventor royalties

9,325

1,265

116

7,756

951

10,694

4,667

4,358

Contingent legal fees

4,784

5,512

1,972

3,901

1,527

7,077

7,663

7,296

Litigation and licensing expenses - patents

8,675

9,012

10,345

11,341

8,994

10,820

9,592

8,208

Amortization of patents

13,038

13,228

13,688

13,113

11,906

15,532

13,511

12,796

Marketing, general and administrative expenses (including non-cash stock compensation expense)

10,575

9,587

9,442

8,572

11,693

13,181

11,636

12,044

Research, consulting and other expenses - business development

997

732

802

860

992

1,003

1,208

637

Impairment of patent-related intangible assets

—

—

—

74,731

2,566

—

—

931

Impairment of goodwill

—

—

—

30,149

—

—

—

—

Other

426

—

3,465

250

—

—

1,548

—

Total operating costs and expenses

47,820

39,336

39,830

150,673

38,629

58,307

49,825

46,270

Operating income (loss)

(13,610
)

1,000

(26,836
)

(113,176
)

(26,051
)

(8,231
)

(12,633
)

(15,240
)
Total other income (expense)

228

(104
)

(180
)

—

109

(196
)

(57
)

(451
)
Income (loss) before (provision for) benefit from income taxes

(13,382
)

896

(27,016
)

(113,176
)

(25,942
)

(8,427
)

(12,690
)

(15,691
)
Benefit from (provision for) income taxes

(170
)

(119
)

(337
)

(4,174
)

1,372

(4,689
)

(145
)

(450
)
Net income (loss) including noncontrolling interests

(13,552
)

777

(27,353
)

(117,350
)

(24,570
)

(13,116
)

(12,835
)

(16,141
)
Net (income) loss attributable to noncontrolling interests in operating subsidiaries

422

(4,463
)

43

1,440

149

167

420

(103
)
Net loss attributable to Acacia Research Corporation

$
(13,130
)

$
(3,686
)

$
(27,310
)

$
(115,910
)

$
(24,421
)

$
(12,949
)

$
(12,415
)

$
(16,244
)
Net loss per common share attributable to Acacia Research Corporation:

Basic and diluted income (loss) per share

$
(0.27
)

$
(0.08
)

$
(0.55
)

$
(2.33
)

$
(0.51
)

$
(0.27
)

$
(0.26
)

$
(0.34
)
Weighted-average number of shares outstanding, basic and diluted

49,212,207

49,423,472

49,630,369

49,749,941

48,329,375

48,543,334

48,806,334

48,944,914

X

- References
No definition available.
+ Details

Name: us-gaap_QuarterlyFinancialDataAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the quarterly financial data in the annual financial statements. The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6372559&loc=d3e765-108305

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)-(j)
-URI http://asc.fasb.org/extlink&oid=35737889&loc=d3e1280-108306

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6372559&loc=d3e725-108305

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 6
-Section G
-Subsection 1

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K (SK)
-Number 229
-Section 302
-Paragraph a
+ Details

Name: us-gaap_QuarterlyFinancialInformationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R23.htm IDEA: XBRL DOCUMENT v3.3.1.900

Summary of Significant Accounting Policies (Policies)
12 Months Ended

Dec. 31, 2015

Accounting Policies [Abstract]

Fiscal Period
Accounting Principles and Fiscal Year End.  The consolidated financial statements and accompanying notes are prepared on the accrual basis of accounting in accordance with generally accepted accounting principles in the United States of America.

Consolidation, Subsidiaries or Other Investments, Consolidated Entities
Principles of Consolidation.  The accompanying consolidated financial statements include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. Material intercompany transactions and balances have been eliminated in consolidation.

Net income (loss) attributable to noncontrolling interest
Noncontrolling interests in Acacia’s majority-owned and controlled operating subsidiaries (“noncontrolling interests”) are separately presented as a component of stockholders’ equity. Consolidated net income or (loss) is adjusted to include the net (income) or loss attributed to noncontrolling interests in the consolidated statements of operations. Refer to the accompanying consolidated statements of stockholders’ equity for total noncontrolling interests.

A wholly owned subsidiary of Acacia is the general partner of the Acacia Intellectual Property Fund, L.P. (the “Acacia IP Fund”), which was formed in August 2010. The Acacia IP Fund is included in the Company’s consolidated financial statements since 2010, as Acacia’s wholly owned subsidiary, as the general partner, has the ability to control the operations and activities of the Acacia IP Fund. Refer to Note 11 to these consolidated financial statements.

Revenue Recognition
Revenue Recognition.  Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectibility of amounts is reasonably assured.

In general, revenue arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by Acacia’s operating subsidiaries. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by Acacia’s operating subsidiaries, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined, relatively short period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for an additional minimum upfront payment. Pursuant to the terms of these agreements, Acacia’s operating subsidiaries have no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on Acacia’s operating subsidiaries’ part to maintain or upgrade the technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the minimum upfront payment for term agreement renewals. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectibility is reasonably assured, or upon receipt of the minimum upfront fee for term agreement renewals, and when all other revenue recognition criteria have been met.
For the periods presented herein, the majority of the revenue agreements executed by the Company provided for the payment of one-time, paid-up license fees in consideration for the grant of certain intellectual property rights for patented technology rights owned by our operating subsidiaries. These rights were primarily granted on a perpetual basis, extending until the expiration of the underlying patents.

Certain of the Company’s revenue arrangements provide for future royalties or additional required payments based on future licensee activities. Additional royalties are recognized in revenue upon resolution of the related contingency provided that all revenue recognition criteria, as described above, have been met. Amounts of additional royalties due under these license agreements, if any, cannot be reasonably estimated by management.

Certain of the Company’s revenue arrangements provide for the calculation of fees based on a licensee’s actual quarterly sales or actual per unit activity, applied to a contractual royalty rate. Licensees that pay fees on a quarterly basis generally report actual quarterly sales or actual per unit activity information and related quarterly fees due within 30 days to 45 days after the end of the quarter in which such sales or activity takes place. The amount of fees due under these revenue arrangements each quarter cannot be reasonably estimated by management. Consequently, Acacia’s operating subsidiaries recognize revenue from these revenue arrangements on a three-month lag basis, in the quarter following the quarter of sales or per unit activity, provided amounts are fixed or determinable and collectibility is reasonably assured. The lag method described above allows for the receipt of licensee royalty reports prior to the recognition of revenue.

Amounts related to revenue arrangements that do not meet the revenue recognition criteria described above are deferred until the revenue recognition criteria are met.

Acacia assesses the collectibility of fees receivable based on a number of factors, including past transaction history and credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectibility becomes reasonably assured, assuming all other revenue recognition criteria have been met, which is generally upon receipt of cash.

Cost of Revenues

Cost of Revenues.  Cost of revenues include the costs and expenses incurred in connection with Acacia’s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment costs. These costs are included under the caption “Cost of revenues” in the accompanying consolidated statements of operations.

Inventor Royalties and Contingent Legal Expenses
Inventor Royalties and Contingent Legal Expenses. Inventor royalties are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In certain instances, pursuant to the terms of the underlying inventor agreements, upfront advances paid to patent owners by Acacia’s operating subsidiaries are recoverable from future net revenues. Patent costs that are recoverable from future net revenues are amortized over the estimated economic useful life of the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense in the consolidated statements of operations. Any unamortized upfront advances recovered from net revenues are expensed in the period recovered, and included in amortization expense in the consolidated statements of operations. Refer to Note 11 for additional information.

Contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal fees are paid; however, Acacia’s operating subsidiaries may be liable for certain out of pocket legal costs incurred pursuant to the underlying legal services agreement.

Fair Value Measurements
Fair Value Measurements. U.S. generally accepted accounting principles define fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value is defined as follows:

●
Level 1 -
Observable Inputs:  Quoted prices in active markets for identical investments;

●
Level 2 -
Pricing Models with Significant Observable Inputs:  Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and

●
Level 3 -
Unobservable Inputs:  Significant unobservable inputs, including the entity’s own assumptions in determining the fair value of investments.
Whenever possible, the Company is required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value. Acacia has not elected the fair value option for recording non-financial assets and liabilities, and therefore no fair value measurements are performed on a recurring basis.

Cash and Cash Equivalents

Cash and Cash Equivalents.  Acacia considers all highly liquid, short-term investments with original maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia’s cash equivalents are comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements. Acacia’s cash equivalents are measured at fair value using quoted prices that represent Level 1 inputs.

Marketable Securities
Investments in Marketable Securities.  Investments in securities with original maturities of greater than three months and less than one year and other investments representing amounts that are available for current operations are classified as short-term investments, unless there are indications that such investments may not be readily sold in the short term. The fair values of these investments approximate their carrying values. As of December 31, 2015, the balance of short term investments was zero. At December 31, 2014, all of Acacia’s investments were classified as available-for-sale, which are reported at fair value on a recurring basis using significant observable inputs (Level 1), with related unrealized gains and losses in the value of such securities recorded as a separate component of other comprehensive income (loss) in stockholders’ equity until realized. Realized and unrealized gains and losses are recorded based on the specific identification method. Interest on all securities is included in interest and other investment income (loss).

Impairment of Marketable Securities. Acacia evaluates its investments in marketable securities for potential impairment, employing a systematic methodology on a quarterly basis that considers available quantitative and qualitative evidence. If the cost or carrying value of an investment exceeds its estimated fair value, the Company evaluates, among other factors, general market conditions, credit quality of instrument issuers, the duration and extent to which the fair value is less than cost, and the Company’s intent and ability to hold, or plans or ability to sell. Fair value is estimated based on publicly available market information or other estimates determined by management. Investments are considered to be impaired when a decline in fair value is estimated to be other-than-temporary. Acacia reviews impairments associated with its investments in marketable securities and determines the classification of any impairment as temporary or other-than-temporary. An impairment is deemed other-than-temporary unless (a) Acacia has the ability and intent to hold an investment for a period of time sufficient for recovery of its carrying amount and (b) positive evidence indicating that the investment’s carrying amount is recoverable within a reasonable period of time outweighs any evidence to the contrary. All available evidence, both positive and negative, is considered to determine whether, based on the weight of such evidence, the carrying amount of the investment is recoverable within a reasonable period of time. For investments classified as available-for-sale, unrealized losses that are other-than-temporary are recognized in the consolidated statements of operations.

Concentrations of Credit Risk

Concentration of Credit Risks.  Financial instruments that potentially subject Acacia to concentrations of credit risk are cash equivalents, investments and accounts receivable. Acacia places its cash equivalents and investments primarily in highly rated money market funds and investment grade marketable securities. Cash equivalents are also invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not experienced any significant losses on its deposits of cash and cash equivalents.

Three licensees individually accounted for 24%, 20% and 16% respectively, of revenues recognized during the year ended December 31, 2015. Two licensees individually accounted for 22% and 22%, respectively, of revenues recognized during the year ended December 31, 2014. Two licensees individually accounted for 38% and 16%, respectively, of revenues recognized during the year ended December 31, 2013. Two licensees individually represented approximately 72% and 21% respectively, of accounts receivable at December 31, 2015. Three licensees individually represented approximately 30%, 17% and 15%, respectively, of accounts receivable at December 31, 2014. For 2015, 2014 and 2013, 49%, 43% and 24%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. The Company does not have any material foreign operations.

Acacia performs credit evaluations of its licensees with significant receivable balances, if any, and has not experienced any significant credit losses. Accounts receivable are recorded at the executed contract amount and generally do not bear interest. Collateral is not required. An allowance for doubtful accounts may be established to reflect the Company’s best estimate of probable losses inherent in the accounts receivable balance, and is reflected as a contra-asset account on the balance sheet and a charge to operating expenses in the statement of operations for the applicable period. The allowance is determined based on known troubled accounts, historical experience, and other currently available evidence. There was no allowance for doubtful accounts established for the periods presented.

Furniture and Equipment
Furniture and Equipment.  Furniture and equipment are recorded at cost. Major additions and improvements that materially extend useful lives of furniture and equipment are capitalized. Maintenance and repairs are charged against the results of operations as incurred. When these assets are sold or otherwise disposed of, the asset and related depreciation are relieved, and any gain or loss is included in the consolidated statements of operations for the period of sale or disposal. Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives of the assets:
Furniture and fixtures
3 to 5 years
Computer hardware and software
3 to 5 years
Leasehold improvements
2 to 5 years (Lesser of lease term or useful life of improvement)

Rental payments on operating leases are charged to expense in the consolidated statements of operations on a straight-line basis over the lease term.

Patents
Patents.  Patents include the cost of patents or patent rights (hereinafter, collectively “patents”) acquired from third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from one to ten years. Certain patent application and prosecution costs incurred to secure additional patent claims, that based on management’s estimates are deemed to be recoverable, are capitalized and amortized over the remaining estimated economic useful life of the related patent portfolio.

Goodwill
Goodwill. Goodwill is tested for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis (December 31) and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. Acacia considers its market capitalization and the carrying value of its assets and liabilities, including goodwill, when performing its goodwill impairment test. When conducting its annual goodwill impairment assessment, the Company initially performs a qualitative evaluation of whether it is more likely than not that goodwill is impaired. If it is determined by a qualitative evaluation that it is more likely than not that goodwill is impaired, the Company then applies a two-step impairment test. The two-step impairment test first compares the fair value of the Company’s reporting unit to its carrying or book value. If the fair value of the reporting unit exceeds its carrying value, goodwill is not impaired and the Company is not required to perform further testing. If the carrying value of the reporting unit exceeds its fair value, the Company determines the implied fair value of the reporting unit’s goodwill and if the carrying value of the reporting unit’s goodwill exceeds its implied fair value, then an impairment loss equal to the difference is recorded in the consolidated statement of operations. Refer to Note 7 for additional information.

Impairment of Long-Lived Assets
Impairment of Long-lived Assets. Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded equal to the excess of the asset’s carrying value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows. Refer to Note 7 for additional information.

Fair value is generally estimated using the “Income Approach,” focusing on the estimated future net income-producing capability of the patent portfolios over the estimated remaining economic useful life. Estimates of future after-tax cash flows are converted to present value through “discounting,” including an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market share data. Estimated cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio’s licensing and enforcement program. The analysis also contemplates consideration of current information about the patent portfolio including, status and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent information that could impact future net cash flows.

Fair Value of Financial Instruments
Fair Value of Financial Instruments.  The carrying value of cash and cash equivalents, investments, accounts receivables, and accounts payable approximates their fair values due to their short-term maturities.

Contingent liabilities [Policy Text Block]
Contingent Liabilities. The Company, from time to time, is involved in certain legal proceedings. Based upon consultation with outside counsel handling its defense in these matters and the Company’s analysis of potential outcomes, if the Company determines that a loss arising from such matters is probable and can be reasonably estimated, an estimate of the contingent liability is recorded in its consolidated financial statements. If only a range of estimated loss can be determined, an amount within the range that, based on estimates, assumptions and judgments, reflects the most likely outcome, is recorded as a contingent liability in the consolidated financial statements. In situations where none of the estimates within the estimated range is a better estimate of probable loss than any other amount, the Company records the low end of the range. Any such accrual would be charged to expense in the appropriate period. Litigation expenses for these types of contingencies are recognized in the period in which the litigation services were provided.

Stock-based Compensation
Stock-Based Compensation. The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee’s requisite service period (generally the vesting period of the equity award) which is generally two to four years. The fair value of restricted stock and restricted stock unit awards is determined by the product of the number of shares or units granted and the grant date market price of the underlying common stock. The fair value of each option award is estimated on the date of grant using a Black-Scholes option valuation model. Stock-based compensation expense is recorded only for those awards expected to vest using an estimated forfeiture rate. Refer to Note 10 to these notes to consolidated financial statements for information on stock-based awards granted for the periods presented.

Income Taxes
Income Taxes.  Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in Acacia’s consolidated financial statements or consolidated income tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized, or if it is determined that there is uncertainty regarding future realizability of such assets.

Under U.S. generally accepted accounting principles, a tax position is a position in a previously filed tax return or a position expected to be taken in a future tax filing that is reflected in measuring current or deferred income tax assets and liabilities. Tax positions are recognized only when it is more likely than not (likelihood of greater than 50%), based on technical merits, that the position will be sustained upon examination. Tax positions that meet the more likely than not threshold are measured using a probability weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.

If a deduction reported on a tax return for an equity-based incentive award exceeds the cumulative compensation cost for those instruments recognized for financial reporting purposes, any resulting realized tax benefit that exceeds the previously calculated deferred tax asset for those instruments is considered an excess tax benefit, and is recognized as additional paid-in capital. If the tax deduction is less than the cumulative book compensation cost, the tax effect of the resulting difference is charged first to APIC, to the extent of the available pool of windfall tax benefits, with any remainder recognized in income tax expense.

Segment Reporting
Segment Reporting.  Acacia uses the management approach, which designates the internal organization that is used by management for making operating decisions and assessing performance as the basis of Acacia’s reportable segments. Acacia’s patent licensing and enforcement business constitutes its single reportable segment.

Use of Estimates
Use of Estimates.  The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, stock-based compensation expense, impairment of marketable securities and intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets and the application of the acquisition method of accounting for business combinations, require its most difficult, subjective or complex judgments.

Earnings Per Share
Income (Loss) Per Share.  The Company computes net income (loss) attributable to common stockholders using the two-class method required for capital structures that include participating securities. Under the two-class method, securities that participate in non-forfeitable dividends, such as the Company’s outstanding unvested restricted stock, are considered “participating securities.”

In applying the two-class method, (i) basic net income (loss) per share is computed by dividing net income (loss) (less any dividends paid on participating securities) by the weighted average number of shares of common stock and participating securities outstanding for the period and (ii) diluted earnings per share may include the additional effect of other securities, if dilutive, in which case the dilutive effect of such securities is calculated by applying the two-class method and the treasury stock method to the assumed exercise or vesting of potentially dilutive common shares. The method yielding the more dilutive result is ultimately reported for the applicable period. Potentially dilutive common stock equivalents primarily consist of employee stock options, and restricted stock units for calculations utilizing the two-class method, and also include unvested restricted stock, when utilizing the treasury method.

The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted income per share:

2015

2014

2013
Numerator (in thousands):

Basic and Diluted

Net loss

$
(160,036
)

$
(66,029
)

$
(56,434
)
Total dividends declared / paid

(25,434
)

(25,039
)

(18,633
)
Dividends attributable to common stockholders

24,740

24,313

18,122

Net loss attributable to common stockholders – basic and diluted

$
(160,730
)

$
(66,755
)

$
(56,945
)

Weighted-average shares used in computing net loss per share attributable to common stockholders – basic and diluted

49,505,817

48,658,088

48,155,832

Basic and diluted net loss per common share

$
(3.25
)

$
(1.37
)

$
(1.18
)
Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share

71,468

27,760

27,760



Treasury Stock [Policy Text Block]
Treasury Stock. Repurchases of the Company’s outstanding common stock are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock on the consolidated balance sheets.


Recently Adopted Accounting Policies
Recent Accounting Pronouncements - Not Yet Adopted. In June 2014, the Financial Accounting Standards Board (the “FASB”) issued a new accounting standard which requires that a performance target that affects vesting and could be achieved after the requisite service period shall be treated as a performance condition. Adoption of this standard is required for annual periods beginning after December 15, 2015. Early adoption is permitted. The Company is currently evaluating the impact the pronouncement will have on its consolidated financial statements and related disclosures.

In May 2014, the FASB issued a new accounting standards update addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. The amendments for this standard update are effective for interim and annual reporting periods beginning after December 15, 2016, and are to be applied
retrospectively or the cumulative effect as of the date of adoption, with early application not permitted. The Company is currently evaluating the impact and method of adoption the pronouncement will have on its consolidated financial statements and related disclosures.

In August 2014, the FASB issued a new accounting standard which requires management to assess an entity’s ability to continue as a going concern every reporting period including interim periods, and to provide related footnote disclosure in certain circumstances. Adoption of this standard is required for annual periods beginning after December 15, 2016 and are to be applied retrospectively or the cumulative effect as of the date of adoption. Early adoption is permitted. The Company is currently evaluating the impact the pronouncement will have on its consolidated financial statements and related disclosures.

In September 2015, the FASB issued an accounting standard update to simplify the accounting for measurement- period adjustments in a business combination by requiring the acquirer to recognize adjustments to provisional amounts
identified during the measurement period in the reporting period in which the adjustments are determined. The acquirer is also
required to record in the reporting period in which the adjustments are determined the effect on earnings of changes in
depreciation, amortization, and other items resulting from the change to the provisional amounts. The new guidance is effective
for fiscal years beginning after December 15, 2015, including interim periods within those fiscal years. Management is
currently evaluating the effect that implementation of this update will have on its consolidated financial position and results of
operations upon adoption.

In November 2015, the FASB issued an accounting standard update to simplify the presentation of deferred income taxes by requiring that deferred tax liabilities and assets be classified as noncurrent on the balance sheet. This update is effective for annual reporting periods beginning after December 31, 2016, including interim periods within those annual periods, and early adoption is permitted. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

In February 2016, the FASB issued an accounting standard update which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. The requirements of this standard include a significant increase in required disclosures. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

Recently adopted accounting policies [Policy Text Block]
Recently Adopted Accounting Pronouncements - Adopted Effective January 1, 2014. In July 2013, the FASB issued a new accounting standard addressing when unrecognized tax benefits should be presented as reductions to deferred tax assets for net operating loss carryforwards in the financial statements. This standard was adopted effective January 1, 2014. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements and related disclosures.

In March 2013, the FASB issued a new accounting standard addressing the accounting for the cumulative translation adjustment when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. This standard was adopted effective January 1, 2014. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements and related disclosures.

X

- Definition
Contingent liabilities [Policy Text Block]
+ References
No definition available.
+ Details

Name: actg_ContingentliabilitiesPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for costs of revenues recognized during the period.
+ References
No definition available.
+ Details

Name: actg_CostOfRevenuesPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Goodwill [Policy Text Block]
+ References
No definition available.
+ Details

Name: actg_GoodwillPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Inventor royalties and contingent legal expenses [Policy Text Block]
+ References
No definition available.
+ Details

Name: actg_InventorRoyaltiesAndContingentLegalExpensesPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Net income (loss) attributable to noncontrolling interest
+ References
No definition available.
+ Details

Name: actg_NetincomelossattributabletononcontrollinginterestPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Patents [Policy Text Block]
+ References
No definition available.
+ Details

Name: actg_PatentsPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Recently adopted accounting policies [Policy Text Block]
+ References
No definition available.
+ Details

Name: actg_RecentlyAdoptedAccountingPoliciesPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Treasury Stock [Policy Text Block]
+ References
No definition available.
+ Details

Name: actg_TreasuryStockPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 305
-SubTopic 10
-Section 05
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6375392&loc=d3e26790-107797

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4273-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Financial Reporting Release (FRR)
-Number 203
-Paragraph 02-03

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 1
-Article 5
+ Details

Name: us-gaap_CashAndCashEquivalentsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for credit risk.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 55
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6875567&loc=d3e14489-108613

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 825
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6480020&loc=d3e61082-112788

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 825
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=28088331&loc=SL29635902-196195

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=35750535&loc=d3e13537-108611

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=35750535&loc=d3e13531-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 825
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6480020&loc=d3e61044-112788
+ Details

Name: us-gaap_ConcentrationRiskCreditRisk

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=18733093&loc=d3e5614-111684

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.3A-02)
-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355033-122828

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph a
-Article 4

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02, 03, 04
-Article 3A
+ Details

Name: us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790
+ Details

Name: us-gaap_EarningsPerSharePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.
+ References
No definition available.
+ Details

Name: us-gaap_FairValueMeasurementPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for determining the fair value of financial instruments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35750535&loc=d3e13279-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 60
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260
+ Details

Name: us-gaap_FairValueOfFinancialInstrumentsPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=7656940&loc=d3e5291-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.3A-03.(b))
-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355100-122828

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.3A-02.(b))
-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355033-122828

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph b
-Article 3A

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph k
-Article 1

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 06
-Article 3

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph b
-Article 3A
+ Details

Name: us-gaap_FiscalPeriod

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 05
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6390181&loc=d3e202-110218

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 5
-Section CC
-Subsection 3
+ Details

Name: us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32840-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 05
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6423966&loc=d3e40913-109327

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 954
-SubTopic 740
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32809-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e32247-109318

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e32280-109318
+ Details

Name: us-gaap_IncomeTaxPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for investments in debt and equity securities that have readily determinable fair values (marketable securities). At a minimum, the disclosure might address accounting policies for investments classified as trading, available for sale, or held to maturity and may include how the entity determines whether impairments of available for sale or held to maturity investments are other than temporary, how the fair values of the entity's securities are determined, and the entity's accounting treatment for transfers between investment categories.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section S50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6381980&loc=d3e87707-122711

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 320
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62652-112803

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 5
-Section M

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 2, 12
-Article 5
+ Details

Name: us-gaap_MarketableSecuritiesPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 13
-Subparagraph a
-Article 5
+ Details

Name: us-gaap_PropertyPlantAndEquipmentPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18823-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18726-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 13.B.Q1)
-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 13
-Section B
-Paragraph Question 1
+ Details

Name: us-gaap_RevenueRecognitionPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for segment reporting.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790
+ Details

Name: us-gaap_SegmentReportingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b),(f)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6061-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6143-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6132-108592
+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 40 R24.htm IDEA: XBRL DOCUMENT v3.3.1.900

Summary of Significant Accounting Policies (Tables)
12 Months Ended

Dec. 31, 2015

Accounting Policies [Abstract]

Property and Equipment, Useful Lives
Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives of the assets:
Furniture and fixtures
3 to 5 years
Computer hardware and software
3 to 5 years
Leasehold improvements
2 to 5 years (Lesser of lease term or useful life of improvement)

Schedule of Earnings Per Share, Basic and Diluted

The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted income per share:

2015

2014

2013
Numerator (in thousands):

Basic and Diluted

Net loss

$
(160,036
)

$
(66,029
)

$
(56,434
)
Total dividends declared / paid

(25,434
)

(25,039
)

(18,633
)
Dividends attributable to common stockholders

24,740

24,313

18,122

Net loss attributable to common stockholders – basic and diluted

$
(160,730
)

$
(66,755
)

$
(56,945
)

Weighted-average shares used in computing net loss per share attributable to common stockholders – basic and diluted

49,505,817

48,658,088

48,155,832

Basic and diluted net loss per common share

$
(3.25
)

$
(1.37
)

$
(1.18
)
Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share

71,468

27,760

27,760



X

- Definition
Property and Equipment, Useful Lives [Table Text Block]
+ References
No definition available.
+ Details

Name: actg_PropertyAndEquipmentUsefulLivesTableTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1311-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258
+ Details

Name: us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 41 R25.htm IDEA: XBRL DOCUMENT v3.3.1.900

Short-term Investments (Tables)
12 Months Ended

Dec. 31, 2015

Short-term Investments [Abstract]

Short-term Investments
Short-term marketable securities for the periods presented were comprised of the following (in thousands):

December 31, 2014
Security Type
Cost

Gross Unrealized Gains

Gross Unrealized Losses

Fair Value
U.S. government fixed income securities
$
58,819

$
2

$
(263
)

$
58,558

Total short-term investments
$
58,819

$
2

$
(263
)

$
58,558

X

- Definition
Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26626-111562

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.4)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 5
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27232-111563

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26610-111562

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.2,12)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_MarketableSecuritiesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_ShortTermInvestmentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 42 R26.htm IDEA: XBRL DOCUMENT v3.3.1.900

Furniture and Equipment (Tables)
12 Months Ended

Dec. 31, 2015

Property, Plant and Equipment [Abstract]

Property and Equipment

Furniture and equipment consists of the following at December 31, 2015 and 2014 (in thousands):

2015

2014

Furniture and fixtures

$
739

$
761

Computer hardware and software

649

650

Leasehold improvements

145

144

1,533

1,555

Less:  accumulated depreciation and amortization

(1,261
)

(1,055
)

$
272

$
500

X

- References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 13
-Subparagraph b
-Article 5
+ Details

Name: us-gaap_PropertyPlantAndEquipmentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 43 R27.htm IDEA: XBRL DOCUMENT v3.3.1.900

Accounts Payable and Accrued Expenses (Tables)
12 Months Ended

Dec. 31, 2015

Accounts Payable and Accrued Liabilities, Current [Abstract]

Accounts Payable and Accrued Expenses / Costs
Accounts payable and accrued expenses consist of the following at December 31, 2015 and 2014 (in thousands):

2015

2014

Payroll and other employee benefits

$
576

$
1,481

Accrued vacation

701

806

Accrued legal expenses - patent

10,135

8,410

Accrued attorney's fees

—

1,548

Foreign taxes payable ⁽¹⁾

3,960

—

Accrued consulting and other professional fees

1,592

1,530

Other accrued liabilities

383

1,085

$
17,347

$
14,860

⁽¹⁾ - Included in "Accounts Payable and Accrued Expenses/Patent Costs" line item on the consolidated statement of cash flows included elsewhere herein.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 44 R28.htm IDEA: XBRL DOCUMENT v3.3.1.900

Patents (Tables)
12 Months Ended

Dec. 31, 2015

Patents [Abstract]

Patents
The gross carrying amounts and accumulated amortization related to investments in intangible assets as of December 31, 2015 and 2014 are as follows (in thousands):

2015

2014

Gross carrying amount - patents

$
444,137

$
453,201

Accumulated amortization - patents⁽¹⁾

(281,495
)

(166,565
)
Patents, net

$
162,642

$
286,636

Patent costs and accumulated amortization related to patent sales and disposals [Table Text Block]
For the years ended December 31, 2015, 2014 and 2013, capitalized patent costs, accumulated amortization, and sales proceeds related to patent-related sales and disposals are as follows (in thousands):

2015

2014

2013

Capitalized patent costs

$
500

$
3,000

$
3,500

Accumulated amortization

120

298

1,753

Sales proceeds

750

3,500

1,000

X

- Definition
Patent costs and accumulated amortization, and sales proceeds and other costs related to patent sales and disposals [Table Text Block]
+ References
No definition available.
+ Details

Name: actg_PatentcostsandaccumulatedamortizationandsalesproceedsandothercostsrelatedtopatentsalesanddisposalsTableTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Patents [Abstract]
+ References
No definition available.
+ Details

Name: actg_PatentsAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Patents [Table Text Block]
+ References
No definition available.
+ Details

Name: actg_PatentsTableTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 45 R29.htm IDEA: XBRL DOCUMENT v3.3.1.900

Stockholders' Equity (Tables)
12 Months Ended

Dec. 31, 2015

Stockholders' Equity Note [Abstract]

Schedule of Treasury Stock by Class
ollowing is the monthly stock repurchases for the periods presented, all of which were purchased as part of publicly announced plans or programs:

Total Number of Shares Purchased
Average Price paid per Share
Approximate Dollar Value of
Shares that May Yet be
Purchased under the Program
Plan Expiration

December 4, 2013 - December 11, 2013
600,000

$
13.18

$
—

May 14, 2014
Totals for 2013
600,000

X

- Definition
Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656
+ Details

Name: us-gaap_ScheduleOfTreasuryStockByClassTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityNoteAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 46 R30.htm IDEA: XBRL DOCUMENT v3.3.1.900

Income Taxes (Tables)
12 Months Ended

Dec. 31, 2015

Income Tax Disclosure [Abstract]

Schedule of Components of Income Tax Expense (Benefit)
Acacia’s provision for income taxes for the fiscal periods presented consisted of the following (in thousands):

2015

2014

2013

Current:

Federal

$
—

$
—

$
—

State taxes

379

289

113

Foreign taxes

4,421

5,359

4,405

Total current

4,800

5,648

4,518

Deferred:

Federal

—

(1,867
)

(26,151
)
State taxes

—

131

(325
)
Total deferred

—

(1,736
)

(26,476
)
Provision for (benefit from) income taxes

$
4,800

$
3,912

$
(21,958
)

Schedule of Deferred Tax Assets and Liabilities
The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities consist of the following at December 31, 2015 and 2014 (in thousands):

2015

2014

Deferred tax assets:

Net operating loss and capital loss carryforwards and credits

$
71,494

$
59,427

Stock compensation

1,385

1,800

Fixed assets and intangibles

1,359

—

Basis of investments in affiliates

499

1,437

Accrued liabilities and other

442

409

Unrealized loss on short-term investments

—

92

State taxes

81

26

Total deferred tax assets

75,260

63,191

Valuation allowance

(75,179
)

(35,927
)
Total deferred tax assets, net of valuation allowance

81

27,264

Deferred tax liabilities:

Fixed assets and intangibles

—

(27,157
)
Other

(81
)

(107
)
Total deferred tax liabilities

(81
)

(27,264
)

Net deferred tax assets (liabilities)

$
—

$
—

Schedule of Effective Income Tax Rate Reconciliation
A reconciliation of the federal statutory income tax rate and the effective income tax rate is as follows:

2015

2014

2013

Statutory federal tax rate - (benefit) expense

(35
)%

(35
)%

(35
)%
State income and foreign taxes, net of federal tax effect

3
%

9
%

5
%
Foreign tax credit

(3
)%

(8
)%

(6
)%
Noncontrolling interests in operating subsidiaries

(1
)%

—
%

1
%
Goodwill

7
%

—
%

—
%
Nondeductible permanent items

—
%

1
%

2
%
Expired capital loss carryforwards

1
%

—
%

2
%
Valuation allowance

31
%

39
%

4
%

3
%

6
%

(27
)%

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319
+ Details

Name: us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319
+ Details

Name: us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319
+ Details

Name: us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 47 R31.htm IDEA: XBRL DOCUMENT v3.3.1.900

Stock-Based Incentive Plans (Tables)
12 Months Ended

Dec. 31, 2015

Share-based Compensation [Abstract]

Stock Options Activity
The following table summarizes stock option activity for the Plans for the year ended December 31, 2015:

Weighted-Average

Options

Exercise
Price

Remaining
Contractual Term

Aggregate
Intrinsic Value

Outstanding at December 31, 2014

150,000

$
7.59

Exercised

(135,000
)

$
6.95

Outstanding at December 31, 2015

15,000

$
13.38

1 year

$
—

Vested

15,000

$
13.38

1 year

$
—

Exercisable at December 31, 2015

15,000

$
13.38

1 year

$
—

Nonvested Restricted Stock Activity
The following table summarizes nonvested restricted share activity for the year ended December 31, 2015:

Nonvested
Restricted Shares

Weighted
Average Grant Date Fair Value

Nonvested restricted stock at December 31, 2014

1,018,000

$
18.71

Granted

894,000

$
12.83

Vested

(615,000
)

$
18.69

Canceled

(468,000
)

$
15.13

Nonvested restricted stock at December 31, 2015

829,000

$
14.41

Restricted Stock Units Activity
The following table summarizes restricted stock unit activity for the year ended December 31, 2015:

Restricted
Stock Units

Weighted
Average Grant Date Fair Value

Nonvested restricted stock units outstanding at December 31, 2014

33,000

$
17.10

Granted

28,000

$
16.72

Vested

(26,000
)

$
18.48

Nonvested restricted stock units outstanding at December 31, 2015

35,000

$
15.78

Vested restricted stock units outstanding at December 31, 2015

75,000

$
23.32

X

- Definition
Tabular disclosure of the changes in outstanding nonvested shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 48 R32.htm IDEA: XBRL DOCUMENT v3.3.1.900

Commitments and Contingencies (Tables)
12 Months Ended

Dec. 31, 2015

Commitments and Contingencies Disclosure [Abstract]

Schedule of Future Minimum Rental Payments for Operating Leases
Minimum annual rental commitments for operating leases of continuing operations having initial or remaining noncancellable lease terms in excess of one year are as follows (in thousands):

Years ending December 31,

2016
$
1,459

2017
1,557

2018
1,612

2019
1,669

2020
166

Total minimum lease payments
$
6,463

Net assets of IP Fund [Table Text Block]
At December 31, 2015 and 2014, the Acacia IP Fund net assets and net loss were primarily comprised of the following (in thousands):

2015

2014
Cash and other assets

$
7,740

$
2,823

Patents, net of accumulated amortization

147

967

Investments - noncurrent

5,829

8,281

Total assets

$
13,716

$
12,071

Accrued expenses and contributions

$
7,436

$
1,876

Total liabilities

7,436

1,876

Net assets

$
6,280

$
10,195

2015

2014
Revenues

$
18

$
1,560

Operating expenses

1,617

1,724

Gain from operations

(1,599
)

(164
)
Net gain (loss) in equity method investments

6,922

(1,807
)
Net income (loss)

$
5,323

$
(1,971
)

X

- Definition
Financial statements of IP Fund [Table Text Block]
+ References
No definition available.
+ Details

Name: actg_NetAssetsOfIpFundTableTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717
+ Details

Name: us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 49 R33.htm IDEA: XBRL DOCUMENT v3.3.1.900

Quarterly Financial Data (Tables)
12 Months Ended

Dec. 31, 2015

QUARTERLY FINANCIAL DATA (unaudited) [Abstract]

Quarterly Financial Data
The following table sets forth unaudited consolidated statements of operations data for the eight quarters in the period ended December 31, 2015. This information has been derived from Acacia’s unaudited condensed consolidated financial statements that have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the audited consolidated financial statements and related notes thereto. Acacia’s quarterly results have been, and may in the future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should not be relied upon as any indication of the results to be expected in any future periods.

Quarter Ended

Mar. 31,

Jun. 30,

Sept. 30,

Dec. 31,

Mar. 31,

Jun. 30,

Sept. 30,

Dec. 31,

2015

2015

2015

2015

2014

2014

2014

2014

(Unaudited, in thousands, except share and per share information)
Revenues

$
34,210

$
40,336

$
12,994

$
37,497

$
12,578

$
50,076

$
37,192

$
31,030

Operating costs and expenses:

Cost of revenues:

Inventor royalties

9,325

1,265

116

7,756

951

10,694

4,667

4,358

Contingent legal fees

4,784

5,512

1,972

3,901

1,527

7,077

7,663

7,296

Litigation and licensing expenses - patents

8,675

9,012

10,345

11,341

8,994

10,820

9,592

8,208

Amortization of patents

13,038

13,228

13,688

13,113

11,906

15,532

13,511

12,796

Marketing, general and administrative expenses (including non-cash stock compensation expense)

10,575

9,587

9,442

8,572

11,693

13,181

11,636

12,044

Research, consulting and other expenses - business development

997

732

802

860

992

1,003

1,208

637

Impairment of patent-related intangible assets

—

—

—

74,731

2,566

—

—

931

Impairment of goodwill

—

—

—

30,149

—

—

—

—

Other

426

—

3,465

250

—

—

1,548

—

Total operating costs and expenses

47,820

39,336

39,830

150,673

38,629

58,307

49,825

46,270

Operating income (loss)

(13,610
)

1,000

(26,836
)

(113,176
)

(26,051
)

(8,231
)

(12,633
)

(15,240
)
Total other income (expense)

228

(104
)

(180
)

—

109

(196
)

(57
)

(451
)
Income (loss) before (provision for) benefit from income taxes

(13,382
)

896

(27,016
)

(113,176
)

(25,942
)

(8,427
)

(12,690
)

(15,691
)
Benefit from (provision for) income taxes

(170
)

(119
)

(337
)

(4,174
)

1,372

(4,689
)

(145
)

(450
)
Net income (loss) including noncontrolling interests

(13,552
)

777

(27,353
)

(117,350
)

(24,570
)

(13,116
)

(12,835
)

(16,141
)
Net (income) loss attributable to noncontrolling interests in operating subsidiaries

422

(4,463
)

43

1,440

149

167

420

(103
)
Net loss attributable to Acacia Research Corporation

$
(13,130
)

$
(3,686
)

$
(27,310
)

$
(115,910
)

$
(24,421
)

$
(12,949
)

$
(12,415
)

$
(16,244
)
Net loss per common share attributable to Acacia Research Corporation:

Basic and diluted income (loss) per share

$
(0.27
)

$
(0.08
)

$
(0.55
)

$
(2.33
)

$
(0.51
)

$
(0.27
)

$
(0.26
)

$
(0.34
)
Weighted-average number of shares outstanding, basic and diluted

49,212,207

49,423,472

49,630,369

49,749,941

48,329,375

48,543,334

48,806,334

48,944,914

X

- Definition
QUARTERLY FINANCIAL DATA (unaudited) [Abstract]
+ References
No definition available.
+ Details

Name: actg_QuarterlyFinancialDataUnauditedAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the quarterly financial data in the annual financial statements. The disclosure includes financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income (loss) before extraordinary items and cumulative effect of a change in accounting principle and earnings per share data.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)-(j)
-URI http://asc.fasb.org/extlink&oid=35737889&loc=d3e1280-108306
+ Details

Name: us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 50 R34.htm IDEA: XBRL DOCUMENT v3.3.1.900

Summary of Significant Accounting Policies (Details)
12 Months Ended

Dec. 31, 2015

Lag time in recognizing revenues from licensee's quarter 3 months

Minimum [Member]

Period after quarter end licensees report activity 30 days

Patents, useful life 1 year

Maximum [Member]

Period after quarter end licensees report activity 45 days

Patents, useful life 10 years

X

- Definition
Lag time in recognizing revenues from licensees' quarter
+ References
No definition available.
+ Details

Name: actg_LagTimeInRecognizingRevenuesFromLicenseesQuarter

Namespace Prefix: actg_

Data Type: us-types:durationStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Period after quarter end licensees report activity
+ References
No definition available.
+ Details

Name: actg_PeriodAfterQuarterEndLicenseesReportActivity

Namespace Prefix: actg_

Data Type: us-types:durationStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 51 R35.htm IDEA: XBRL DOCUMENT v3.3.1.900

Summary of Significant Accounting Policies Concentrations (Details)
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Licensee 1 [Member] | Revenue, Rights Granted [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 24.00% 22.00% 38.00%

Licensee 1 [Member] | Accounts Receivable [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 72.00% 30.00%

Licensee 2 [Member] | Revenue, Rights Granted [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 20.00% 22.00% 16.00%

Licensee 2 [Member] | Accounts Receivable [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 21.00% 17.00%

Licensee 3 [Member] | Revenue, Rights Granted [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 16.00%

Licensee 3 [Member] | Accounts Receivable [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 15.00%

Licensees in foreign jurisdictions [Member] | Revenue, Rights Granted [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 49.00% 43.00% 24.00%

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ConcentrationRiskLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6351-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=35750535&loc=d3e13531-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6404-108592

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=35750535&loc=d3e13537-108611
+ Details

Name: us-gaap_ConcentrationRiskPercentage1

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=actg_Licensee1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueRightsGrantedMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=actg_Licensee2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=actg_Licensee3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=actg_LicenseesInForeignJurisdictionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 52 R36.htm IDEA: XBRL DOCUMENT v3.3.1.900

Summary of Significant Accounting Policies Property and Equipment (Details)
12 Months Ended

Dec. 31, 2015

Furniture and Fixtures [Member] | Minimum [Member]

Property and Equipment [Line Items]

Estimated useful lives, years 3

Furniture and Fixtures [Member] | Maximum [Member]

Property and Equipment [Line Items]

Estimated useful lives, years 5

Computer Hardware and Software [Member] | Minimum [Member]

Property and Equipment [Line Items]

Estimated useful lives, years 3

Computer Hardware and Software [Member] | Maximum [Member]

Property and Equipment [Line Items]

Estimated useful lives, years 5

Leasehold Improvements [Member] | Minimum [Member]

Property and Equipment [Line Items]

Estimated useful lives, years 2

Leasehold Improvements [Member] | Maximum [Member]

Property and Equipment [Line Items]

Estimated useful lives, years 5

X

- Definition
Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 35
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6539997&loc=d3e1205-110223
+ Details

Name: us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=actg_ComputerHardwareAndSoftwareMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 53 R37.htm IDEA: XBRL DOCUMENT v3.3.1.900

Summary of Significant Accounting Policies Earnings per share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended

Dec. 31, 2015

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Accounting Policies [Abstract]

Net income (loss) attributable to Acacia Research Corporation $ (115,910) $ (27,310) $ (3,686) $ (13,130) $ (16,244) $ (12,415) $ (12,949) $ (24,421) $ (160,036) $ (66,029) $ (56,434)

Payments of Dividends (25,434) (25,039) (18,633)

Dividends attributable to common stockholders under the two class method 24,740 24,313 18,122

Net Loss Available to Common Stockholders, Basic and Diluted $ (160,730) $ (66,755) $ (56,945)

Weighted Average Number of Shares Outstanding, Basic and Diluted 49,749,941 49,630,369 49,423,472 49,212,207 48,944,914 48,806,334 48,543,334 48,329,375 49,505,817 48,658,088 48,155,832

Earnings Per Share, Basic and Diluted $ (2.33) $ (0.55) $ (0.08) $ (0.27) $ (0.34) $ (0.26) $ (0.27) $ (0.51) $ (3.25) $ (1.37) $ (1.18)

Anti-dilutive equity-based incentive awards excluded from the computation of diluted income (loss) per share 71,468 27,760 27,760

X

- Definition
Add Back of Dividends attributable to common stockholders under the two class method
+ References
No definition available.
+ Details

Name: actg_Dividendsattributabletocommonstockholdersunderthetwoclassmethod

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Antidilution
-URI http://asc.fasb.org/extlink&oid=6505113

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Diluted Earnings Per Share
-URI http://asc.fasb.org/extlink&oid=6510752

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Contingent Stock Agreement
-URI http://asc.fasb.org/extlink&oid=6508534

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=6518256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.18)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.22)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=6519514

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 19
-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 20
-Article 9
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1377-109256
+ Details

Name: us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfDividends

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
+ References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 54 R38.htm IDEA: XBRL DOCUMENT v3.3.1.900

Summary of Significant Accounting Policies Impact of revision (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended

Dec. 31, 2015

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Accounting Policies [Abstract]

Net income (loss) attributable to Acacia Research Corporation $ (115,910) $ (27,310) $ (3,686) $ (13,130) $ (16,244) $ (12,415) $ (12,949) $ (24,421) $ (160,036) $ (66,029) $ (56,434)

Net Loss Available to Common Stockholders, Basic and Diluted $ (160,730) $ (66,755) $ (56,945)

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=6518256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.18)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.22)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=6519514

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 19
-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 20
-Article 9
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1377-109256
+ Details

Name: us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 55 R39.htm IDEA: XBRL DOCUMENT v3.3.1.900

Short-term Investments (Details) - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Schedule of Available-for-sale Securities [Line Items]

Available-for-sale securities, amortized cost $ 58,819

Available-for-sale securities, gross unrealized gains 2

Available-for-sale securities, gross unrealized losses (263)

Available-for-sale securities, fair value 58,558

Available-for-sale Securities, Gross Realized Gains $ 1,174

Available-for-sale Securities, Gross Realized Losses $ 617 2,188 981

Proceeds from Sale and Maturity of Marketable Securities $ 82,115 $ 182,115 $ 239,370

Maximum [Member]

Schedule of Available-for-sale Securities [Line Items]

Investment Maturity Date Dec. 31, 2015

X

- Definition
The maturity date of the investment.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 12
-Section 12
-Sentence Column A
+ Details

Name: invest_InvestmentMaturityDate1

Namespace Prefix: invest_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 25
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=28360136&loc=d3e22054-111558

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 5
-Subparagraph (aa)
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27232-111563

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26610-111562
+ Details

Name: us-gaap_AvailableForSaleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.2)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AvailableForSaleSecuritiesAmortizedCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This item represents the gross profit realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27357-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesGrossRealizedGains

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This item represents the gross loss realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27357-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of unrealized gain before deducting unrealized loss on investments in debt and equity securities classified as available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of unrealized loss before deducting unrealized gain on investments in available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26853-111562

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133
+ Details

Name: us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 56 R40.htm IDEA: XBRL DOCUMENT v3.3.1.900

Short-term Investments Marketable Securities (Details)
$ in Thousands
12 Months Ended

Dec. 31, 2014

USD ($)

Schedule of Available-for-sale Securities [Line Items]

Available-for-sale Securities, Amortized Cost Basis $ 58,819

Available-for-sale Securities, Gross Unrealized Gain 2

Available-for-sale Securities, Gross Unrealized Loss 263

Available-for-sale Securities $ 58,558

X

- Definition
Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 25
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=28360136&loc=d3e22054-111558

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 5
-Subparagraph (aa)
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27232-111563

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26610-111562
+ Details

Name: us-gaap_AvailableForSaleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.2)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AvailableForSaleSecuritiesAmortizedCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of unrealized gain before deducting unrealized loss on investments in debt and equity securities classified as available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of unrealized loss before deducting unrealized gain on investments in available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 57 R41.htm IDEA: XBRL DOCUMENT v3.3.1.900

Furniture and Equipment (Details) - USD ($)
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Property, Plant and Equipment [Abstract]

Depreciation expense $ 222,000 $ 304,000 $ 236,000

Property, Plant and Equipment, Disposals 30,000 330,000

Gain (Loss) on Disposition of Property Plant Equipment $ 14,000 $ 71,000

X

- Definition
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585
+ Details

Name: us-gaap_Depreciation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585
+ Details

Name: us-gaap_GainLossOnSaleOfPropertyPlantEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of divestiture of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.
+ References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentDisposals

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 58 R42.htm IDEA: XBRL DOCUMENT v3.3.1.900

Furniture and Equipment Summary of Property and Equipment (Details) - USD ($)
$ in Thousands

Dec. 31, 2015

Dec. 31, 2014

Property and Equipment [Line Items]

Furniture and fixtures $ 739 $ 761

Computer hardware and software 649 650

Leasehold improvements 145 144

Property and equipment, gross 1,533 1,555

Less: accumulated depreciation and amortization (1,261) (1,055)

Furniture and equipment, net $ 272 $ 500

X

- Definition
Computer Hardware and Software
+ References
No definition available.
+ Details

Name: actg_ComputerHardwareAndSoftware

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.14)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 14
-Article 5
+ Details

Name: us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_FurnitureAndFixturesGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 4
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6812-107765
+ Details

Name: us-gaap_LeaseholdImprovementsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 13
-Subparagraph a
-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 8
-Article 7
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 59 R43.htm IDEA: XBRL DOCUMENT v3.3.1.900

Accounts Payable and Accrued Expenses (Details) - USD ($)
$ in Thousands

Dec. 31, 2015

Dec. 31, 2014

Accounts Payable and Accrued Liabilities, Current [Abstract]

Payroll and other employee benefits $ 576 $ 1,481

Accrued vacation 701 806

Accrued legal expenses - patent 10,135 8,410

Accrual for court ordered attorneys fees 0 1,548

Foreign taxes payable 3,960 0

Accrued consulting and other professional fees 1,592 1,530

Other accrued liabilities 383 1,085

Accounts payable and accrued expenses $ 17,347 $ 14,860

X

- Definition
Accrual for court ordered attorneys fees
+ References
No definition available.
+ Details

Name: actg_Accrualforcourtorderedattorneysfees

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Accrued Legal Expenses - Patent
+ References
No definition available.
+ Details

Name: actg_AccruedLegalExpensesPatent

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amounts due to foreign jurisdictions for income taxes.
+ References
No definition available.
+ Details

Name: actg_Foreigntaxespayable

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: instant

X

- Definition
Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 20
-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 19
-Article 5
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Liabilities
-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 20
-Article 5
+ Details

Name: us-gaap_AccruedProfessionalFeesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.15(a))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15(5))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 710
-SubTopic 10
-Section 25
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6409733&loc=d3e19396-108361

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 15
-Subparagraph 5
-Article 9

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 15
-Subparagraph a
-Article 7
+ Details

Name: us-gaap_AccruedVacationCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 20
-Article 5
+ Details

Name: us-gaap_EmployeeRelatedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e7018-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Liabilities
-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 20
-Article 5
+ Details

Name: us-gaap_OtherAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 60 R44.htm IDEA: XBRL DOCUMENT v3.3.1.900

Patents (Details) - USD ($)
3 Months Ended 12 Months Ended

Dec. 31, 2015

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Patents [Line Items]

Patents, net $ 162,642,000 $ 286,636,000 $ 162,642,000 $ 286,636,000

Patents, weighted average useful life 5 years

Payments to acquire intangible assets $ 19,504,000 42,746,000 $ 25,061,000

Accrued patent acquisition related payments 1,000,000 16,700,000 1,000,000 16,700,000

Accelerated amortization expense 1,247,000 592,000

Accelerated amortization expense (termination) 380,000 2,702,000 1,747,000

Impairment of Patent-Related Intangible Assets 74,731,000 $ 0 $ 0 $ 0 931,000 $ 0 $ 0 $ 2,566,000 $ 74,731,000 3,497,000 $ 4,619,000

Minimum [Member]

Patents [Line Items]

Patents, useful life 1 year

Acquired Finite Lived Intangible Asset, Useful Life 2 years

Maximum [Member]

Patents [Line Items]

Patents, useful life 10 years

Acquired Finite Lived Intangible Asset, Useful Life 10 years

Patents [Member]

Patents [Line Items]

Gross carrying amount - patents 444,137,000 453,201,000 $ 444,137,000 453,201,000

Accumulated amortization - patents 281,495,000 166,565,000 281,495,000 166,565,000

Patents, net $ 162,642,000 $ 286,636,000 $ 162,642,000 $ 286,636,000

Patents [Member] | Minimum [Member]

Patents [Line Items]

Patents, useful life 1 year

Patents [Member] | Maximum [Member]

Patents [Line Items]

Patents, useful life 8 years

X

- Definition
Accelerated amortization expense
+ References
No definition available.
+ Details

Name: actg_AcceleratedAmortizationExpense

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Accelerated amortization expense (termination/sale)
+ References
No definition available.
+ Details

Name: actg_Acceleratedamortizationexpenseterminationsale

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Accrued Patent Acquisition Related Payments
+ References
No definition available.
+ Details

Name: actg_AccruedPatentAcquisitionRelatedPayments

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Acquired Finite Lived Intangible Asset, Useful Life
+ References
No definition available.
+ Details

Name: actg_AcquiredFiniteLivedIntangibleAssetUsefulLife

Namespace Prefix: actg_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Patents, Accumulated Amortization
+ References
No definition available.
+ Details

Name: actg_PatentsAccumulatedAmortization

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Patents, Gross
+ References
No definition available.
+ Details

Name: actg_PatentsGross

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying value for patents, net of accumulated amortization.
+ References
No definition available.
+ Details

Name: actg_PatentsNetOfAccumulatedAmortization

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275
+ Details

Name: us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16373-109275
+ Details

Name: us-gaap_ImpairmentOfIntangibleAssetsFinitelived

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133
+ Details

Name: us-gaap_PaymentsToAcquireIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 61 R45.htm IDEA: XBRL DOCUMENT v3.3.1.900

Patents Cost and Accumulated Amortization (Details) - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Patents [Line Items]

Patent cost, disposals $ 500 $ 3,000 $ 3,500

Accumulated amortization, disposals 120 298 1,753

Proceeds from Sale of Intangible Assets $ 750 $ 3,500 $ 1,000

X

- Definition
Accumulated amortization, disposals
+ References
No definition available.
+ Details

Name: actg_AccumulatedAmortizationDisposals

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Patent cost, disposals
+ References
No definition available.
+ Details

Name: actg_PatentCostDisposals

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash inflow from disposal of asset without physical form usually arising from contractual or other legal rights, excluding goodwill.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133
+ Details

Name: us-gaap_ProceedsFromSaleOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 62 R46.htm IDEA: XBRL DOCUMENT v3.3.1.900

Patents Future Amortization Expense (Details)

Dec. 31, 2015

USD ($)

Patents [Abstract]

2015 $ 43,218,000

2016 40,577,000

2017 35,777,000

2018 19,410,000

2019 6,787,000

After Year Five $ 16,873,000

X

- Definition
Patents [Abstract]
+ References
No definition available.
+ Details

Name: actg_PatentsAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 63 R47.htm IDEA: XBRL DOCUMENT v3.3.1.900

Goodwill and Patent Impairment Charges (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended

Dec. 31, 2015

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Feb. 29, 2016

Jan. 02, 2015

Subsequent Event [Line Items]

Goodwill $ 0 $ 30,149 $ 0 $ 30,149

Share Price $ 4.29 $ 4.29 $ 3.16 $ 16.72

Estimated Fair Value of the Reporting Unit $ 252,000 $ 252,000

Estimated Carrying Value of Reporting Unit, Market Capitalization Plus Cost Synergies Approach 344,300 344,300

Assets 347,901 536,348 347,901 536,348

Impairment of Goodwill $ 30,149 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 30,149 $ 0 $ 0

X

- Definition
Estimated Carrying Value of Reporting Unit, Market Capitalization Plus Cost Synergies Approach
+ References
No definition available.
+ Details

Name: actg_EstimatedCarryingValueofReportingUnitMarketCapitalizationPlusCostSynergiesApproach

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Estimated Fair Value of the Reporting Unit, Cost Synergies Approach
+ References
No definition available.
+ Details

Name: actg_EstimatedFairValueoftheReportingUnit

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.18)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 12
-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 18
-Article 5
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266
+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillImpairmentLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Price of a single share of a number of saleable stocks of a company.
+ References
No definition available.
+ Details

Name: us-gaap_SharePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.
+ References
No definition available.
+ Details

Name: us-gaap_SubsequentEventLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 64 R48.htm IDEA: XBRL DOCUMENT v3.3.1.900

Stockholders' Equity (Details) - USD ($)
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Nov. 15, 2013

Stockholders Equity [Line Items]

Stock repurchase program, authorized amount $ 70,000,000

Dividends declared, per share $ 0.50

Common stock dividends declared, quarterly $ 0.125

Payments of Dividends $ 25,434,000 $ 25,039,000 $ 18,633,000

X

- Definition
Common stock dividends declared, quarterly
+ References
No definition available.
+ Details

Name: actg_Commonstockdividendsdeclaredquarterly

Namespace Prefix: actg_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
[Line Items] for Stockholders' Equity [Table]
+ References
No definition available.
+ Details

Name: actg_StockholdersEquityLineItems

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate dividends declared during the period for each share of common stock outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_CommonStockDividendsPerShareDeclared

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfDividends

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of stock repurchase plan authorized.
+ References
No definition available.
+ Details

Name: us-gaap_StockRepurchaseProgramAuthorizedAmount1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 65 R49.htm IDEA: XBRL DOCUMENT v3.3.1.900

Stockholders' Equity Repurchases of Common Stock (Details) - USD ($)

Dec. 11, 2013

Dec. 31, 2014

Stockholders' Equity Note [Abstract]

Treasury stock, shares acquired 600,000

Treasury stock acquired, average price paid per share $ 13.18

Stock repurchase program, remaining authorized repurchase amount $ 0

X

- Definition
Amount remaining of a stock repurchase plan authorized.
+ References
No definition available.
+ Details

Name: us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityNoteAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Total cost of shares repurchased divided by the total number of shares repurchased.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655
+ Details

Name: us-gaap_TreasuryStockAcquiredAverageCostPerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares that have been repurchased during the period and are being held in treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30
-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_TreasuryStockSharesAcquired

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 66 R50.htm IDEA: XBRL DOCUMENT v3.3.1.900

Income Taxes (Details) - USD ($)
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Income Taxes [Line Items]

Operating loss carryforwards, federal $ 160,840,000

Operating loss carryforwards, state 55,215,000

Deferred tax assets, valuation allowance 75,179,000 $ 35,927,000

Federal NOL annual utilization limit 14,100,000

Net operating losses, unrecognized excess tax benefits, federal 1,928,000

Net operating losses, unrecognized excess tax benefits, state 37,771,000

Capital loss carryovers 3,423,000

Deferred Tax Asset, Operating and Capital Loss Carryforwards and Credits 71,494,000 59,427,000

Foreign withholding taxes $ 4,605,000

Excess tax benefits from stock-based compensation 0 0 (1,398,000)

Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 1,917,000 2,713,000 $ 1,398,000

Foreign tax credits, additional paid in capital benefit 34,298,000

Foreign tax credits utilized for financial statement purposes $ 20,313,000

Tax Benefit From Reversal of the Net Deferred Tax Liability $ 1,735,000

Effective Income Tax Rate Reconciliation, Percent 3.00% 6.00% (27.00%)

Effective tax rate excluding valuation allowance (28.00%) (33.00%) 31.00%

Unrecognized tax benefits $ 2,127,000

unrecognized tax benefits primarily associated with state taxes 85,000

Domestic Tax Authority [Member]

Income Taxes [Line Items]

Net operating losses included in deferred tax assets 0

State and Local Jurisdiction [Member]

Income Taxes [Line Items]

Net operating losses included in deferred tax assets 441,000

Capital Loss Carryforward Related to Business Acquisition [Member] | Internal Revenue Service (IRS) [Member]

Income Taxes [Line Items]

Operating Loss Carryforwards $ 29,318,000

X

- Definition
Capital loss carryovers
+ References
No definition available.
+ Details

Name: actg_Capitallosscarryovers

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss and capital loss carryforwards and credits
+ References
No definition available.
+ Details

Name: actg_DeferredTaxAssetOperatingAndCapitalLossCarryforwardsAndCredits

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Effective tax rate excluding valuation allowance
+ References
No definition available.
+ Details

Name: actg_Effectivetaxrateexcludingvaluationallowance

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Federal NOL Annual Utilization Limit
+ References
No definition available.
+ Details

Name: actg_FederalNolAnnualUtilizationLimit

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Foreign tax credits that have not been recorded as a deferred tax asset as the benefit will be credited to additional paid in capital when realized as a reduction of tax payable on the tax return.
+ References
No definition available.
+ Details

Name: actg_ForeignTaxCreditsAdditionalPaidInCapitalBenefit

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: instant

X

- Definition
Foreign tax credits utilized for financial statement purposes
+ References
No definition available.
+ Details

Name: actg_Foreigntaxcreditsutilizedforfinancialstatementpurposes

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
[Line Items] for Income Taxes [Table]
+ References
No definition available.
+ Details

Name: actg_IncomeTaxesLineItems

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Net operating losses, unrecognized excess tax benefits, federal
+ References
No definition available.
+ Details

Name: actg_NetOperatingLossesUnrecognizedExcessTaxBenefitsFederal

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Net operating losses, unrecognized tax benefits, state
+ References
No definition available.
+ Details

Name: actg_NetOperatingLossesUnrecognizedTaxBenefitsState

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Operating loss carryforwards, federal
+ References
No definition available.
+ Details

Name: actg_OperatingLossCarryforwardsFederal

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Operating loss carryforwards, state
+ References
No definition available.
+ Details

Name: actg_OperatingLossCarryforwardsState

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Tax Benefit From Reversal of the Net Deferred Tax Liability
+ References
No definition available.
+ Details

Name: actg_TaxBenefitFromReversaloftheNetDeferredTaxLiability

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Unrecognized tax benefits primarily associated with state taxes
+ References
No definition available.
+ Details

Name: actg_UnrecognizedTaxBenefitsPrimarilyAssociatedWithStateTaxes

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: instant

X

- Definition
Valuation Allowance on Foreign Tax Credits
+ References
No definition available.
+ Details

Name: actg_ValuationAllowanceonForeignTaxCredits

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase in additional paid in capital (APIC) resulting from a tax benefit associated with share-based compensation plan other than an employee stock ownership plan (ESOP). Includes, but is not limited to, excess tax benefit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 740
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6419406&loc=d3e23524-113945

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644
+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=29652012&loc=d3e28680-109314

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319
+ Details

Name: us-gaap_DeferredTaxAssetsOperatingLossCarryforwards

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Subparagraph 2
-Article 4
+ Details

Name: us-gaap_EffectiveIncomeTaxRateContinuingOperations

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow from realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11374-113907
+ Details

Name: us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319
+ Details

Name: us-gaap_OperatingLossCarryforwards

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of unrecognized tax benefits pertaining to uncertain tax positions taken in tax returns.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=SL6600010-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Unrecognized Tax Benefit
-URI http://asc.fasb.org/extlink&oid=6527854
+ Details

Name: us-gaap_UnrecognizedTaxBenefits

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TaxCreditCarryforwardAxis=actg_CapitalLossCarryforwardRelatedToBusinessAcquisitionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 67 R51.htm IDEA: XBRL DOCUMENT v3.3.1.900

Income Taxes Provision for Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended

Dec. 31, 2015

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Current:

Federal $ 0 $ 0 $ 0

State taxes 379 289 113

Foreign taxes 4,421 5,359 4,405

Total current 4,800 5,648 4,518

Deferred:

Federal 0 (1,867) (26,151)

State taxes 0 131 (325)

Total deferred 0 (1,736) (26,476)

(Provision) benefit for income taxes $ 4,174 $ 337 $ 119 $ 170 $ 450 $ 145 $ 4,689 $ (1,372) $ 4,800 $ 3,912 $ (21,958)

X

- Definition
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6509736

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 6
-Section I
-Paragraph Question 1-7

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4
+ Details

Name: us-gaap_CurrentFederalTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4
+ Details

Name: us-gaap_CurrentForeignTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6509736

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 6
-Section I
-Subsection 7
+ Details

Name: us-gaap_CurrentIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6509736

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 6
-Section I
-Subsection 7
+ Details

Name: us-gaap_CurrentStateAndLocalTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6510177

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 6
-Section I
-Subsection 7
+ Details

Name: us-gaap_DeferredFederalIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6510177

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 6
-Section I
-Subsection 7
+ Details

Name: us-gaap_DeferredIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6510177

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 6
-Section I
-Subsection 7

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4
+ Details

Name: us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Income Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6515339

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 68 R52.htm IDEA: XBRL DOCUMENT v3.3.1.900

Income Taxes Deferred Taxes (Details) - USD ($)
$ in Thousands

Dec. 31, 2015

Dec. 31, 2014

Deferred tax assets:

Deferred Tax Asset, Operating and Capital Loss Carryforwards and Credits $ 71,494 $ 59,427

Stock compensation 1,385 1,800

Deferred tax assets intangibles and fixed assets 1,359 0

Basis of investments in affiliates 499 1,437

Accrued liabilities and other 442 409

Unrealized loss on short-term investments 0 92

State taxes 81 26

Total deferred tax assets 75,260 63,191

Deferred tax liabilities:

Fixed assets and intangibles 0 (27,157)

Other (81) (107)

Deferred Tax Liabilities, Gross (81) (27,264)

Net deferred tax liabilities 0 0

Less: valuation allowance (75,179) (35,927)

Net deferred taxes $ 81 $ 27,264

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss and capital loss carryforwards and credits
+ References
No definition available.
+ Details

Name: actg_DeferredTaxAssetOperatingAndCapitalLossCarryforwardsAndCredits

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences from tangible and intangible assets.
+ References
No definition available.
+ Details

Name: actg_DeferredTaxLiabilitiesFixedAssetsAndIntangibles

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax liability attributable to taxable temporary differences, net of deferred tax asset attributable to deductible temporary differences and carryforwards.
+ References
No definition available.
+ Details

Name: actg_DeferredTaxLiabilitiesNetOfDeferredTaxAssets

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Deferred tax assets intangibles and fixed assets
+ References
No definition available.
+ Details

Name: actg_Deferredtaxassetsintangiblesandfixedassets

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Liability
-URI http://asc.fasb.org/extlink&oid=6510232

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 15
-Subparagraph b(2)
-Article 7
+ Details

Name: us-gaap_DeferredIncomeTaxLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Asset
-URI http://asc.fasb.org/extlink&oid=6510090
+ Details

Name: us-gaap_DeferredTaxAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_DeferredTaxAssetsGrossAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the entity's investment in its wholly-owned subsidiaries.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=29652012&loc=d3e28680-109314

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319
+ Details

Name: us-gaap_DeferredTaxAssetsInvestmentInSubsidiaries

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b),(c)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses in other comprehensive income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=18498875&loc=d3e39076-109324

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=29652012&loc=d3e28680-109314

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxAssetsOtherComprehensiveLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from state taxes.
+ References
No definition available.
+ Details

Name: us-gaap_DeferredTaxAssetsStateTaxes

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=29652012&loc=d3e28680-109314

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=29652012&loc=d3e28680-109314

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences not separately disclosed.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=29652012&loc=d3e28680-109314

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxLiabilitiesOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 69 R53.htm IDEA: XBRL DOCUMENT v3.3.1.900

Income Taxes Income Tax Rate (Details)
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Income Tax Disclosure [Abstract]

Effective income tax rate reconciliation goodwill 7.00% 0.00% 0.00%

Effective Income Tax Rate, Continuing Operations, Tax Rate Reconciliation [Abstract]

Statutory federal tax rate (35.00%) (35.00%) (35.00%)

State income and foreign taxes, net of federal tax effect 3.00% 9.00% 5.00%

Foreign tax credit (3.00%) (8.00%) (6.00%)

Noncontrolling interests in operating subsidiaries (1.00%) 0.00% 1.00%

Non deductible permanent items 0.00% 1.00% 2.00%

Expired net operating loss carryforwards 1.00% 0.00% 2.00%

Valuation allowance 31.00% 39.00% 4.00%

Total 3.00% 6.00% (27.00%)

X

- Definition
Effective income tax rate reconcilation, expired net operating losses
+ References
No definition available.
+ Details

Name: actg_EffectiveIncomeTaxRateReconcilationExpiredNetOperatingLosses

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Effective income tax rate reconciliation goodwill
+ References
No definition available.
+ Details

Name: actg_Effectiveincometaxratereconciliationgoodwill

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Subparagraph 2
-Article 4
+ Details

Name: us-gaap_EffectiveIncomeTaxRateContinuingOperations

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 70 R54.htm IDEA: XBRL DOCUMENT v3.3.1.900

Stock-Based Incentive Plans (Details) - USD ($)
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2009

Dec. 31, 2008

Share-based Compensation Arrangement by Share-based Payment Award

Ownership percent of voting stock 10.00%

Aggregate intrinsic value of options exercised $ 751,000 $ 518,000 $ 2,024,000

Number of shares of common stock reserved for issuance 2,903,000

Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Weighted average grant date fair value of restricted stock granted $ 12.83 $ 14.41 $ 24.31

Aggregate fair value of restricted stock vested $ 11,494,000 $ 21,490,000 $ 22,317,000

Total unrecognized compensation expense for nonvested awards $ 9,264,000

Weighted average period over which unrecognized compensation expense will be recognized 1 year 7 months

Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Weighted average grant date fair value of restricted stock granted $ 16.72 $ 0.00 $ 14.33

Aggregate fair value of restricted stock vested $ 480,000 $ 460,000 $ 469,000

Total unrecognized compensation expense for nonvested awards $ 482,000

Weighted average period over which unrecognized compensation expense will be recognized 1 year 8 months

2007 Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Increase in number of shares available, percentage of outstanding shares on last trading day of prior December 2.00%

Number of shares available for grant 0 560,000

Discretionary Option Grant Program [Member] | Nonstatutory Options [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Percentage of fair market value on grant date, minimum exercise price 85.00%

Stock Issuance Program [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Percentage of fair market value on grant date, minimum exercise price 100.00%

2013 Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Number of shares available for grant 4,750,000

Number of shares of common stock reserved for issuance 2,778,000

Less than 10% [Member] | Discretionary Option Grant Program [Member] | Incentive Stock Options [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Percentage of fair market value on grant date, minimum exercise price 100.00%

10% or More [Member] | Discretionary Option Grant Program [Member] | Incentive Stock Options [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Percentage of fair market value on grant date, minimum exercise price 110.00%

X

- Definition
Ownership Percent of Voting Stock
+ References
No definition available.
+ Details

Name: actg_OwnershipPercentOfVotingStock

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Increase By Percentage
+ References
No definition available.
+ Details

Name: actg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIncreaseByPercentage

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate number of common shares reserved for future issuance.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockCapitalSharesReservedForFutureIssuance

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Unrecognized cost of unvested share-based compensation awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Purchase price of common stock expressed as a percentage of its fair value.
+ References
No definition available.
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=actg_A2007PlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=actg_DiscretionaryOptionGrantProgramMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_NonstatutoryOptionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=actg_StockIssuanceProgramMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=actg_A2013PlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: actg_OwnershipOfVotingInterestsAxis=actg_LessThan10Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_IncentiveStockOptionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: actg_OwnershipOfVotingInterestsAxis=actg_A10OrMoreMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 71 R55.htm IDEA: XBRL DOCUMENT v3.3.1.900

Stock-Based Incentive Plans Stock Options (Details)
12 Months Ended

Dec. 31, 2015

USD ($)

$ / shares

shares

Share-based Compensation [Abstract]

Outstanding at December 31, 2012 | shares 150,000

Exercised | shares (135,000)

Outstanding at December 31, 2013 | shares 15,000

Vested | shares 15,000

Exercisable at December 31, 2013 | shares 15,000

Outstanding at December 31, 2012, weighted average exercise price | $ / shares $ 7.59

Exercised, weighted average exercise price | $ / shares 6.95

Outstanding at December 31, 2013, weighted average exercise price | $ / shares 13.38

Vested, weighted average exercise price | $ / shares 13.38

Exercisable, weighted average exercise price | $ / shares $ 13.38

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 1 year

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term 1 year

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 1 year

Outstanding at December 31, 2013, aggregate, intrinsic value | $ $ 0

Vested, aggregate intrinsic value | $ 0

Exercisable, aggregate intrinsic value | $ $ 0

X

- References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount by which the current fair value of the underlying stock exceeds the exercise price of fully vested and expected to vest options outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
As of the balance sheet date, the number of shares into which fully vested and expected to vest stock options outstanding can be converted under the option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
As of the balance sheet date, the weighted-average exercise price for outstanding stock options that are fully vested or expected to vest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which option holders acquired shares when converting their stock options into shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28,29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30
-Article 5

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 72 R56.htm IDEA: XBRL DOCUMENT v3.3.1.900

Stock-Based Incentive Plans Nonvested Restriced Stock (Details) - Restricted Stock [Member] - $ / shares
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Share-based Compensation Arrangement by Share-based Payment Award

Nonvested at December 31, 2012 1,018,000

Granted 894,000

Vested (615,000)

Canceled (468,000)

Nonvested at December 31, 2013 829,000 1,018,000

Nonvested, weighted average grant date fair value at December 31, 2011 $ 18.71

Granted, weighted average grant date fair value 12.83 $ 14.41 $ 24.31

Vested, weighted average grant date fair value 18.69

Canceled, weighted average grant date fair value 15.13

Nonvested, weighted average grant date fair value at December 31, 2012 $ 14.41 $ 18.71

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(3)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 73 R57.htm IDEA: XBRL DOCUMENT v3.3.1.900

Stock-Based Incentive Plans Nonvested Restricted Stock Units (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Share-based Compensation Arrangement by Share-based Payment Award

Nonvested at December 31, 2012 33,000

Granted 28,000

Vested (26,000)

Nonvested at December 31, 2013 35,000 33,000

Vested outstanding 75,000

Nonvested, weighted average grant date fair value at December 31, 2011 $ 17.10

Granted, weighted average grant date fair value 16.72 $ 0.00 $ 14.33

Vested, weighted average grant date fair value 18.48

Nonvested, weighted average grant date fair value at December 31, 2012 15.78 $ 17.10

Vested outstanding, weighted average grant date fair value $ 23.32

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested Outstanding
+ References
No definition available.
+ Details

Name: actg_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedOutstanding

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Weighted Average Grant Date Fair Value
+ References
No definition available.
+ Details

Name: actg_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValue

Namespace Prefix: actg_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 74 R58.htm IDEA: XBRL DOCUMENT v3.3.1.900

Commitments and Contingencies (Details) - USD ($)
3 Months Ended 12 Months Ended

Dec. 31, 2015

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2011

Commitments and Contingencies Disclosure [Abstract]

Rent expense $ 1,926,000 $ 1,523,000 $ 1,312,000

Other $ 250,000 $ 3,465,000 $ 0 $ 426,000 $ 0 $ 1,548,000 $ 0 $ 0 4,141,000 1,548,000 $ 3,506,000

Partners' capital, authorized 250,000,000 250,000,000

Cash and other assets, IP Fund 7,740,000 2,823,000 7,740,000 2,823,000

Patents, net of accumulated amortization, IP Fund 147,000 967,000 147,000 967,000

Investments, IP Fund 5,829,000 8,281,000 5,829,000 8,281,000

Total assets, IP Fund 13,716,000 12,071,000 13,716,000 12,071,000

Accrued expenses and contributions, IP Fund 7,436,000 1,876,000 7,436,000 1,876,000

Total liabilities, IP Fund 7,436,000 1,876,000 7,436,000 1,876,000

Net assets, IP Fund $ 6,280,000 $ 10,195,000 6,280,000 10,195,000

Revenues, IP Fund 18,000 1,560,000

IP Fund, Operating expenses 1,617,000 1,724,000

IP Fund, Gain from Operations (1,599,000) (164,000)

IP Fund, Net Loss in Equity Method Investment 6,922,000 (1,807,000)

IP Fund, Net Loss $ 5,323,000 $ (1,971,000)

Line of Credit Facility, Commitment Fee Percentage 1.15%

X

- Definition
Accrued expenses and contributions, IP Fund
+ References
No definition available.
+ Details

Name: actg_AccruedExpensesAndContributionsIpFund

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Cash and other assets, IP Fund
+ References
No definition available.
+ Details

Name: actg_CashAndOtherAssetsIpFund

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
IP Fund, Gain from Operations
+ References
No definition available.
+ Details

Name: actg_IPFundGainfromOperations

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
IP Fund, Net Loss
+ References
No definition available.
+ Details

Name: actg_IPFundNetLoss

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
IP Fund, Net Loss in Equity Method Investment
+ References
No definition available.
+ Details

Name: actg_IPFundNetLossinEquityMethodInvestment

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
IP Fund, Operating expenses
+ References
No definition available.
+ Details

Name: actg_IPFundOperatingexpenses

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Investments, IP Fund
+ References
No definition available.
+ Details

Name: actg_InvestmentsIpFund

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fund net assets
+ References
No definition available.
+ Details

Name: actg_NetAssetsFundRelated

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: instant

X

- Definition
Authorized amount of capital to be raised by the fund.
+ References
No definition available.
+ Details

Name: actg_PartnersCapitalAuthorized

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: instant

X

- Definition
Patents, net of accumulated amortization, IP Fund
+ References
No definition available.
+ Details

Name: actg_PatentsNetOfAccumulatedAmortizationIpFund

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Revenues, IP Fund
+ References
No definition available.
+ Details

Name: actg_RevenuesIPFund

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total assets, IP Fund
+ References
No definition available.
+ Details

Name: actg_TotalAssetsIpFund

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Total liabilities, IP Fund
+ References
No definition available.
+ Details

Name: actg_TotalLiabilitiesIpFund

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
No definition available.
+ Details

Name: us-gaap_LeaseAndRentalExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.
+ References
No definition available.
+ Details

Name: us-gaap_LineOfCreditFacilityCommitmentFeePercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 3
-Article 5
+ Details

Name: us-gaap_OtherCostAndExpenseOperating

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 75 R59.htm IDEA: XBRL DOCUMENT v3.3.1.900

Commitments and Contingencies Operating Leases (Details)
$ in Thousands

Dec. 31, 2015

USD ($)

Year:

2014 $ 1,459

2015 1,557

2016 1,612

2017 1,669

2018 166

Total minimum lease payments $ 6,463

X

- Definition
Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 76 R60.htm IDEA: XBRL DOCUMENT v3.3.1.900

Supplemental Cash Flow Information (Details) - USD ($)
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Supplemental Cash Flow Information [Abstract]

Estimated federal income taxes paid $ 0 $ 0 $ 3,000,000

Income Taxes Receivable 3,251,000

Cash paid for state income taxes 211,000 172,000 516,000

Foreign withholding taxes $ 4,421,000 $ 5,159,000 $ 4,605,000

X

- Definition
Cash paid for state income taxes during the period.
+ References
No definition available.
+ Details

Name: actg_CashPaidForStateIncomeTaxes

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
Estimated federal income taxes paid
+ References
No definition available.
+ Details

Name: actg_Estimatedfederalincometaxespaid

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Foreign withholding taxes
+ References
No definition available.
+ Details

Name: actg_ForeignWithholdingTaxes

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.8)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 8
-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 5
-Subparagraph c
-Article 7
+ Details

Name: us-gaap_IncomeTaxReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 77 R61.htm IDEA: XBRL DOCUMENT v3.3.1.900

Quarterly Financial Data (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended

Dec. 31, 2015

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

QUARTERLY FINANCIAL DATA (unaudited) [Abstract]

Revenues $ 37,497 $ 12,994 $ 40,336 $ 34,210 $ 31,030 $ 37,192 $ 50,076 $ 12,578

Inventor royalties 7,756 116 1,265 9,325 4,358 4,667 10,694 951 $ 18,462 $ 20,670 $ 29,724

Contingent legal fees 3,901 1,972 5,512 4,784 7,296 7,663 7,077 1,527 16,169 23,563 24,784

Litigation and licensing expenses - patents 11,341 10,345 9,012 8,675 8,208 9,592 10,820 8,994 39,373 37,614 39,335

Amortization of patents 13,113 13,688 13,228 13,038 12,796 13,511 15,532 11,906 53,067 53,745 49,039

Marketing, general and administrative expenses (including non-cash stock compensation expense) (8,572) (9,442) (9,587) (10,575) (12,044) (11,636) (13,181) (11,693) (38,176) (48,554) (59,229)

Research, consulting and other expenses - business development 860 802 732 997 637 1,208 1,003 992 3,391 3,840 3,251

Impairment of Patent-Related Intangible Assets 74,731 0 0 0 931 0 0 2,566 74,731 3,497 4,619

Impairment of Goodwill 30,149 0 0 0 0 0 0 0 30,149 0 0

Other 250 3,465 0 426 0 1,548 0 0 4,141 1,548 3,506

Total operating costs and expenses 150,673 39,830 39,336 47,820 46,270 49,825 58,307 38,629 277,659 193,031 213,487

Operating loss (113,176) (26,836) 1,000 (13,610) (15,240) (12,633) (8,231) (26,051) (152,622) (62,155) (82,931)

Total other income (expense) 0 (180) (104) 228 (451) (57) (196) 109 (56) (595) 2,131

Income (loss) from operations before (provision for) benefit from income taxes (113,176) (27,016) 896 (13,382) (15,691) (12,690) (8,427) (25,942) (152,678) (62,750) (80,800)

(Provision) benefit for income taxes (4,174) (337) (119) (170) (450) (145) (4,689) 1,372 (4,800) (3,912) 21,958

Net loss including noncontrolling interests in operating subsidiaries (117,350) (27,353) 777 (13,552) (16,141) (12,835) (13,116) (24,570) (157,478) (66,662) (58,842)

Net (income) loss attributable to noncontrolling interests in operating subsidiaries (1,440) (43) 4,463 (422) 103 (420) (167) (149) 2,558 (633) (2,408)

Net loss attributable to Acacia Research Corporation $ (115,910) $ (27,310) $ (3,686) $ (13,130) $ (16,244) $ (12,415) $ (12,949) $ (24,421) $ (160,036) $ (66,029) $ (56,434)

Earnings Per Share, Basic and Diluted $ (2.33) $ (0.55) $ (0.08) $ (0.27) $ (0.34) $ (0.26) $ (0.27) $ (0.51) $ (3.25) $ (1.37) $ (1.18)

Weighted Average Number of Shares Outstanding, Basic and Diluted 49,749,941 49,630,369 49,423,472 49,212,207 48,944,914 48,806,334 48,543,334 48,329,375 49,505,817 48,658,088 48,155,832

X

- Definition
Contingent legal fees paid or payable to external counsel.
+ References
No definition available.
+ Details

Name: actg_ContingentLegalFees

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Expenses incurred directly related to litigation and licensing of patents.
+ References
No definition available.
+ Details

Name: actg_LitigationAndLicensingExpensesPatents

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
QUARTERLY FINANCIAL DATA (unaudited) [Abstract]
+ References
No definition available.
+ Details

Name: actg_QuarterlyFinancialDataUnauditedAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Expenses incurred directly related to business development research, consulting and other expenses.
+ References
No definition available.
+ Details

Name: actg_ResearchConsultingAndOtherExpensesBusinessDevelopment

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275
+ Details

Name: us-gaap_AmortizationOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688
+ Details

Name: us-gaap_GeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillImpairmentLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16373-109275
+ Details

Name: us-gaap_ImpairmentOfIntangibleAssetsFinitelived

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 20
-Section 25
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35710027&loc=d3e41242-110953

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 10
-Article 5
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Income Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6515339

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=6518256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.18)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.22)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=6519514

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 19
-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 20
-Article 9
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of Net Income (Loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684
+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingCostsAndExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 3
-Article 5
+ Details

Name: us-gaap_OtherCostAndExpenseOperating

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.9)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 9
-Article 5
+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a),(c)
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 1
-Article 5
+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688
+ Details

Name: us-gaap_RoyaltyExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
+ References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 78 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; EXCEL 79 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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html 110 330 1 false 32 0 false 4 false false R1.htm 0001000 - Document - Document and Entity Information Document Sheet http://www.acaciaresearch.com/role/DocumentAndEntityInformationDocument Document and Entity Information Document Cover 1 false false R2.htm 1001000 - Statement - Consolidated Balance Sheets Sheet http://www.acaciaresearch.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 1001001 - Statement - Consolidated Balance Sheets Parentheticals Sheet http://www.acaciaresearch.com/role/ConsolidatedBalanceSheetsParentheticals Consolidated Balance Sheets Parentheticals Statements 3 false false R4.htm 1002000 - Statement - Consolidated Statements of Operations Sheet http://www.acaciaresearch.com/role/ConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 1002001 - Statement - Consolidated Statements of Operations Parentheticals Sheet http://www.acaciaresearch.com/role/ConsolidatedStatementsOfOperationsParentheticals Consolidated Statements of Operations Parentheticals Statements 5 false false R6.htm 1003000 - Statement - Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.acaciaresearch.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss Consolidated Statements of Comprehensive Income (Loss) Statements 6 false false R7.htm 1004000 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.acaciaresearch.com/role/ConsolidatedStatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 7 false false R8.htm 1005000 - Statement - Consolidated Statements of Cash Flows Sheet http://www.acaciaresearch.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 8 false false R9.htm 2101100 - Disclosure - Description of Business Sheet http://www.acaciaresearch.com/role/DescriptionOfBusiness Description of Business Notes 9 false false R10.htm 2102100 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 2104100 - Disclosure - Short-term Investments Sheet http://www.acaciaresearch.com/role/ShortTermInvestments Short-term Investments Notes 11 false false R12.htm 2105100 - Disclosure - Furniture and Equipment Sheet http://www.acaciaresearch.com/role/FurnitureAndEquipment Furniture and Equipment Notes 12 false false R13.htm 2106100 - Disclosure - Accounts Payable and Accrued Expenses Sheet http://www.acaciaresearch.com/role/AccountsPayableAndAccruedExpenses Accounts Payable and Accrued Expenses Notes 13 false false R14.htm 2108100 - Disclosure - Patents Sheet http://www.acaciaresearch.com/role/Patents Patents Notes 14 false false R15.htm 2112100 - Disclosure - Goodwill and Patent Impairment Charges (Notes) Notes http://www.acaciaresearch.com/role/GoodwillAndPatentImpairmentChargesNotes Goodwill and Patent Impairment Charges (Notes) Notes 15 false false R16.htm 2113100 - Disclosure - Stockholders' Equity Sheet http://www.acaciaresearch.com/role/StockholdersEquity Stockholders' Equity Notes 16 false false R17.htm 2114100 - Disclosure - Income Taxes Sheet http://www.acaciaresearch.com/role/IncomeTaxes Income Taxes Notes 17 false false R18.htm 2115100 - Disclosure - Stock-Based Incentive Plans Sheet http://www.acaciaresearch.com/role/StockBasedIncentivePlans Stock-Based Incentive Plans Notes 18 false false R19.htm 2116100 - Disclosure - Commitments and Contingencies Sheet http://www.acaciaresearch.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 19 false false R20.htm 2117100 - Disclosure - Retirement Savings Plan and Executive Severance Policy Sheet http://www.acaciaresearch.com/role/RetirementSavingsPlanAndExecutiveSeverancePolicy Retirement Savings Plan and Executive Severance Policy Notes 20 false false R21.htm 2118100 - Disclosure - Supplemental Cash Flow Information Sheet http://www.acaciaresearch.com/role/SupplementalCashFlowInformation Supplemental Cash Flow Information Notes 21 false false R22.htm 2119100 - Disclosure - Quarterly Financial Data Sheet http://www.acaciaresearch.com/role/QuarterlyFinancialData Quarterly Financial Data Notes 22 false false R23.htm 2202201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies 23 false false R24.htm 2302302 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies 24 false false R25.htm 2304301 - Disclosure - Short-term Investments (Tables) Sheet http://www.acaciaresearch.com/role/ShortTermInvestmentsTables Short-term Investments (Tables) Tables http://www.acaciaresearch.com/role/ShortTermInvestments 25 false false R26.htm 2305301 - Disclosure - Furniture and Equipment (Tables) Sheet http://www.acaciaresearch.com/role/FurnitureAndEquipmentTables Furniture and Equipment (Tables) Tables http://www.acaciaresearch.com/role/FurnitureAndEquipment 26 false false R27.htm 2306301 - Disclosure - Accounts Payable and Accrued Expenses (Tables) Sheet http://www.acaciaresearch.com/role/AccountsPayableAndAccruedExpensesTables Accounts Payable and Accrued Expenses (Tables) Tables http://www.acaciaresearch.com/role/AccountsPayableAndAccruedExpenses 27 false false R28.htm 2308301 - Disclosure - Patents (Tables) Sheet http://www.acaciaresearch.com/role/PatentsTables Patents (Tables) Tables http://www.acaciaresearch.com/role/Patents 28 false false R29.htm 2313301 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.acaciaresearch.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.acaciaresearch.com/role/StockholdersEquity 29 false false R30.htm 2314301 - Disclosure - Income Taxes (Tables) Sheet http://www.acaciaresearch.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.acaciaresearch.com/role/IncomeTaxes 30 false false R31.htm 2315301 - Disclosure - Stock-Based Incentive Plans (Tables) Sheet http://www.acaciaresearch.com/role/StockBasedIncentivePlansTables Stock-Based Incentive Plans (Tables) Tables http://www.acaciaresearch.com/role/StockBasedIncentivePlans 31 false false R32.htm 2316301 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.acaciaresearch.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.acaciaresearch.com/role/CommitmentsAndContingencies 32 false false R33.htm 2319301 - Disclosure - Quarterly Financial Data (Tables) Sheet http://www.acaciaresearch.com/role/QuarterlyFinancialDataTables Quarterly Financial Data (Tables) Tables http://www.acaciaresearch.com/role/QuarterlyFinancialData 33 false false R34.htm 2402403 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables 34 false false R35.htm 2402404 - Disclosure - Summary of Significant Accounting Policies Concentrations (Details) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails Summary of Significant Accounting Policies Concentrations (Details) Details 35 false false R36.htm 2402405 - Disclosure - Summary of Significant Accounting Policies Property and Equipment (Details) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails Summary of Significant Accounting Policies Property and Equipment (Details) Details 36 false false R37.htm 2402406 - Disclosure - Summary of Significant Accounting Policies Earnings per share (Details) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails Summary of Significant Accounting Policies Earnings per share (Details) Details 37 false false R38.htm 2402407 - Disclosure - Summary of Significant Accounting Policies Impact of revision (Details) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesImpactOfRevisionDetails Summary of Significant Accounting Policies Impact of revision (Details) Details 38 false false R39.htm 2404402 - Disclosure - Short-term Investments (Details) Sheet http://www.acaciaresearch.com/role/ShortTermInvestmentsDetails Short-term Investments (Details) Details http://www.acaciaresearch.com/role/ShortTermInvestmentsTables 39 false false R40.htm 2404403 - Disclosure - Short-term Investments Marketable Securities (Details) Sheet http://www.acaciaresearch.com/role/ShortTermInvestmentsMarketableSecuritiesDetails Short-term Investments Marketable Securities (Details) Details 40 false false R41.htm 2405402 - Disclosure - Furniture and Equipment (Details) Sheet http://www.acaciaresearch.com/role/FurnitureAndEquipmentDetails Furniture and Equipment (Details) Details http://www.acaciaresearch.com/role/FurnitureAndEquipmentTables 41 false false R42.htm 2405403 - Disclosure - Furniture and Equipment Summary of Property and Equipment (Details) Sheet http://www.acaciaresearch.com/role/FurnitureAndEquipmentSummaryOfPropertyAndEquipmentDetails Furniture and Equipment Summary of Property and Equipment (Details) Details 42 false false R43.htm 2406402 - Disclosure - Accounts Payable and Accrued Expenses (Details) Sheet http://www.acaciaresearch.com/role/AccountsPayableAndAccruedExpensesDetails Accounts Payable and Accrued Expenses (Details) Details http://www.acaciaresearch.com/role/AccountsPayableAndAccruedExpensesTables 43 false false R44.htm 2408402 - Disclosure - Patents (Details) Sheet http://www.acaciaresearch.com/role/PatentsDetails Patents (Details) Details http://www.acaciaresearch.com/role/PatentsTables 44 false false R45.htm 2408403 - Disclosure - Patents Cost and Accumulated Amortization (Details) Sheet http://www.acaciaresearch.com/role/PatentsCostAndAccumulatedAmortizationDetails Patents Cost and Accumulated Amortization (Details) Details 45 false false R46.htm 2408404 - Disclosure - Patents Future Amortization Expense (Details) Sheet http://www.acaciaresearch.com/role/PatentsFutureAmortizationExpenseDetails Patents Future Amortization Expense (Details) Details 46 false false R47.htm 2412402 - Disclosure - Goodwill and Patent Impairment Charges (Details) Sheet http://www.acaciaresearch.com/role/GoodwillAndPatentImpairmentChargesDetails Goodwill and Patent Impairment Charges (Details) Details http://www.acaciaresearch.com/role/GoodwillAndPatentImpairmentChargesNotes 47 false false R48.htm 2413402 - Disclosure - Stockholders' Equity (Details) Sheet http://www.acaciaresearch.com/role/StockholdersEquityDetails Stockholders' Equity (Details) Details http://www.acaciaresearch.com/role/StockholdersEquityTables 48 false false R49.htm 2413403 - Disclosure - Stockholders' Equity Repurchases of Common Stock (Details) Sheet http://www.acaciaresearch.com/role/StockholdersEquityRepurchasesOfCommonStockDetails Stockholders' Equity Repurchases of Common Stock (Details) Details 49 false false R50.htm 2414402 - Disclosure - Income Taxes (Details) Sheet http://www.acaciaresearch.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.acaciaresearch.com/role/IncomeTaxesTables 50 false false R51.htm 2414403 - Disclosure - Income Taxes Provision for Taxes (Details) Sheet http://www.acaciaresearch.com/role/IncomeTaxesProvisionForTaxesDetails Income Taxes Provision for Taxes (Details) Details 51 false false R52.htm 2414404 - Disclosure - Income Taxes Deferred Taxes (Details) Sheet http://www.acaciaresearch.com/role/IncomeTaxesDeferredTaxesDetails Income Taxes Deferred Taxes (Details) Details 52 false false R53.htm 2414405 - Disclosure - Income Taxes Income Tax Rate (Details) Sheet http://www.acaciaresearch.com/role/IncomeTaxesIncomeTaxRateDetails Income Taxes Income Tax Rate (Details) Details 53 false false R54.htm 2415402 - Disclosure - Stock-Based Incentive Plans (Details) Sheet http://www.acaciaresearch.com/role/StockBasedIncentivePlansDetails Stock-Based Incentive Plans (Details) Details http://www.acaciaresearch.com/role/StockBasedIncentivePlansTables 54 false false R55.htm 2415403 - Disclosure - Stock-Based Incentive Plans Stock Options (Details) Sheet http://www.acaciaresearch.com/role/StockBasedIncentivePlansStockOptionsDetails Stock-Based Incentive Plans Stock Options (Details) Details 55 false false R56.htm 2415404 - Disclosure - Stock-Based Incentive Plans Nonvested Restriced Stock (Details) Sheet http://www.acaciaresearch.com/role/StockBasedIncentivePlansNonvestedRestricedStockDetails Stock-Based Incentive Plans Nonvested Restriced Stock (Details) Details 56 false false R57.htm 2415405 - Disclosure - Stock-Based Incentive Plans Nonvested Restricted Stock Units (Details) Sheet http://www.acaciaresearch.com/role/StockBasedIncentivePlansNonvestedRestrictedStockUnitsDetails Stock-Based Incentive Plans Nonvested Restricted Stock Units (Details) Details 57 false false R58.htm 2416402 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.acaciaresearch.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://www.acaciaresearch.com/role/CommitmentsAndContingenciesTables 58 false false R59.htm 2416403 - Disclosure - Commitments and Contingencies Operating Leases (Details) Sheet http://www.acaciaresearch.com/role/CommitmentsAndContingenciesOperatingLeasesDetails Commitments and Contingencies Operating Leases (Details) Details 59 false false R60.htm 2418401 - Disclosure - Supplemental Cash Flow Information (Details) Sheet http://www.acaciaresearch.com/role/SupplementalCashFlowInformationDetails Supplemental Cash Flow Information (Details) Details http://www.acaciaresearch.com/role/SupplementalCashFlowInformation 60 false false R61.htm 2419402 - Disclosure - Quarterly Financial Data (Details) Sheet http://www.acaciaresearch.com/role/QuarterlyFinancialDataDetails Quarterly Financial Data (Details) Details http://www.acaciaresearch.com/role/QuarterlyFinancialDataTables 61 false false All Reports Book All Reports actg-20151231.xml actg-20151231.xsd actg-20151231_cal.xml actg-20151231_def.xml actg-20151231_lab.xml actg-20151231_pre.xml true true ZIP 84 0000934549-16-000100-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000934549-16-000100-xbrl.zip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
)V1TB$ '"+QW:]7Z[+8LWD.5VTB?5F-_U[G9=@(9E]\78W/YJM\^"\. M@.G^#Z>'^%VQ"G.MF@?O\X>@\LNWLWRNYC?NU\*HR)F\7L^GD M2TI:WG\*VOPA;/ROY@_%KG3KT-^[X(621SE-#X&&2O1^4597<=X'692;0LBO M.]PH.6F#HH3KH\<'R,#3 NB%*[J M-C'#/(5,U!!0Q\90T2213 _?%>D5LK'>"SDM39(C; 2'U@K"E=3"<.UJGAD# M4?7OAKO3T9= #Z9$G@;/*!/HF-?"<@$@K5X")\8)(VL6".3T"E(B.TOA2"9= M' Q7*='QID0.(<@K28GT3"'"J42*>\=]M9V!F@V W+A*,D3A?S0E\C3V1YL2 M";U!FC&*+2.26,()I(U"D[@@Q" ID=%2/(/](=(K#EH$NZA"]0[&. MD#$).'52>,X-A%0!CAK6A<-1#Q\FF[_#6-IIH+NHUFQ22:N:N?GF#86_!+"/ MUCTX::!,&:@\D=5#K]1XBQR#N@8":1#U(G:RU>/2.M0#@F-2I=?[<[RCQLF, MQY32X.Q8R!CWW%AM&QA4W/,6R;)(1Z9($0!>5(^BE"83W@<6,3=4 DL1,4R1 MFD$OXXJ=)\L?O;2&G(A69W58%I,_?%P\!%BJT&RE#'CW5OQ:IBKI.U^ ML^I]-/_+G5\#IR2&%EO!I**28&T:^U-PTA96_!;.KZ&$U:/;0"/N/&%*,-$$ MB2SW Q5KZO'\NK-,H\^O3X-LK.?7F[HV'P*)RS>WMOBU>IC'_6,=UK-'X<3C MI]L=1\@H #SX=XY;:YT(\J'@JY5FX\)OHSG[[JP,+P+\*< ;Y "GE?#6BG*= MQ\@ $LQ)A2$BR'$,H7?-^8F2A(_V5+UW^9ZN/V=!^"^G26,[S;\>!1I<<7YY M_Z$L\N6Z?$1KZX'RX4X9TM((35BP%K34$$!E8,V@%"/+$4@@M^=OEO:%U%!9 M/9VS\* D!&KC!"52:HVL9$W0D6@85=UAN&*%B2R16'A&F;,5O'LA@9=,,1UT M%7)-F@,F@3P;K;T0(84CR5MQ,%RE1,>V;P\KR!%%N/O._,'8"8$!\]5;45AJ M(D"3NB8Y&BAE.DD4,C9&D0:ZRY^+),O\D8Z%"0B0AH0H@#!DM,E,QS*N_O1( M,G_ZUZ$>$!R3*O6:^4,4Q1PX2!GQUCGIM6S09BRN/.Y(,G^2*U($@%>8^0, M8O37:%?-3O>7G3Z3#P M[,$S!HWUB$!J(4)002/9KD2 \@**-B,T]0EA*X?+0RQV/T$\\QN9=5XJAQ@( MJX:D@#I"=@\F**<-'O/[O"B7GZ;W;V[_ MNEA-YQ]?A7'#VK0Z=+S8H5>F' , *Z4XL0%X(# D#:\8#Q3,CPSD#2;H12I MCYIG)^O!P4.>3OTR9$UP3XA1R"(!!$-:VYKT8&V.[^)MK_+H)N.SH+HJ:8\E M'#A>(9\OW-?%$!Q0#5H3 M99XVS"!TQ(2UAP-OM82,!89J1J36X\VKBA/' 9F>!<852W)84!>] 1 C&3M=3LJB MPB@OO[RYKW[X2]@G5F_+Q<9+)C MO3ZDV!L6D0LFQ)T6S,?-,B4%F^%S&@-4\3% <9,*JET%<_6RI\M(",%I?*%(WGI] C0?3?RML M+^".S;V[8CT=7#_?%*KVO?18V%RHM=,'<@%9RAI3U#5O, M1D7ZTN7.7E2PSY.O>\ SQC;^>3%?KO+5.LAAYUT=OM)TO$/&+& F$$NJ;,W@ M@#G-:O_:6PG&$;L?E?![!31&^DT^UD;I.LG_2)>,.J&IE91XQ0'61&-3'RQZ M"E!4_"]=MNIH-* _2(??*'X) EN^>__+J1O&TWZ9$AP #)'@%%BID :BWIP] M)R*JW&JZ+-8Q:$X*7(>R@W]M3WG[]3ET;]?EY%/XY=O ;/"+0^^[Q7S#\MO@ M5V\RQ(Y;PTD^FC&HG F2XE)(3DR%=QV]\AKC*[-X$N8;CD4$4;'?6-Q^7E<" MV45QEF&=KRXX%_K+CO3\X\%W&A-^LGIA3A,JB=>$8($5X9 VBX(U48'-RQEJ M_>OLR 1P5A[<[JMUDLIFXK0FP>WKE"%FE/'.^](/)7I,B/;HYM3ID'T.?GG\R@QEX'UU]2IRP% *'F[,Y#Z*-\H73% MG*]?K<\4P)BU>Q=+<)_#;C1=5M9(V)>FBYL/BU4^>S4/CN-\.9W\-9^MC][) M&N#S&>),"&.DY50+0ZC%0C6@A\TQ1NO3U:2^0JU/)XPQSX!MC:I7\^6J7&]" M,V]6GXJR2H;?X;&9\@T8?RNF'S^MBAM5/2#[L=C\954XWN?3,MDTZ9O&S(3= M&&-/( C>,( <,(>'1M$93RD*\Q]A7/IPA*[Z@GWUV*YJFZ"/UI]+CN[CA&4 M"65Q6/^THD(B+3RGL+[%X9E2404XTM4D_Q:G4H_B&6#>N+O[V>)+4;PORH?I MI-@/R\^+3L-SP]/COJV)*/R]6_Z]8O2LFBX_S%L\ZV3TL=KN'%&$>54);?H/:/10+7K.#;^1VVH Q65FFFU MRPK8)07\N]#20?4!4! AL"/>BB!@2,+^RA1&V&#C46NEQD2@756A)4R"BTHI M DB2*GF%64=J" V" Z4%IRZTU%E1DA5:.@WG?*3OO\3=X4$(42>-0+PJ10P5 M$0[5O&OBONW"2YT%?_0.SVD0CB'$= 57(D1PR@@"'D#G"0@.&H.P 57(\=9] MC]2-(>Y&Q&'Z;X7M!=QQW^&Y*CV]=&IVY!T>@0'65@0\%:O>]ZG>7:G98B*N M!--UW>'I+-A.=WA.PW,,RUATJ+YQ/[<9%A13U2/.9X2+2?,E*)7/6$>'H,/(+<@0Q3RS0C'BNNI)6<8-FL1D[@J)S) M,>=^CV\ZG"60JYX-3T]R1W#6GPE!N> -E,"8))Z[9Z;W 4;;.F'/:QS<; MSA+(5<\&ORAOB^FE)\0+*C+) 9 ":1@,7\48<1(T"Q)0.JI.W)BSZLNJ9]BW MF/$,B1<2446Y9IX(J&$PHW?BDPA%A37'G/$\OKF65F)7/>&>VKCCG' GTI@I MPZ@!1DE=U4TV@AG":_$AP:(\IS'G18]OPJ65V%5/N)T!O2Z+Y3AGVRD$9HA1 M(5PP1S# 3A#I'-'-\7_PEK^U).SQ3;6$XAI%FN"3XD'_3A8\J)D<4A^$*:JG MB;W0!&A/MZ(%@$C8-A/_G2Q89-YQ@SSEA%#L!1.<*UM#*-"W\BIC9T5)EBQX M&L[?5K(@=M(2+*1CR!*&N:2\09\!%Y<#?RW)@IT%?S19\#0(QV L7D'N58". M.8^A0HQ(0+UAD->@4H/%E20+=M:-(9*PXC#]M\+V NZXDP6O2D\OG2S84QU7 MB^0F98XKS[&@4$-D:C:M-U&UBZXK>;"SH$^JXWH:KF-8WKZI)$* 9;#:J?&> M<(\)HH:S&GZLT#>71!CMOXQ4(E<](4:81,BL14@:C+&#%GN/-&[4@[BHZ3#F M),+Q38>S!'+5LV%\280*^[ 688,EM,8!)S&&-?C&\JBSYS$G$8YO-IPED*.S MH>^"X!U9>;->+5?Y_&8Z_[A'PXP^LQDH@R12'Q/O&ID4N2L/'7)'T M5 T?N4"N>KW_=O(!6?#4O.(: TIU<.& 5:(6FH,@ZM'7,><#CF^?2":LJYYA MWV(^H%%$2LNU5@12+@4@5#4+I"??7#[@^.9:6HE=]83[%O,!H763Q3;T=:&C(VN2;IO_QI,0MJOMR*=MBO1:5! M'EH(7XQ^+&&QK4NF->7.(8"\DD@S983=U02V7$C05I4YFNA#68+'FF< ",4% MMM8 +!%0(-"\(Y9AAP=*QMJ;\-@1AK1M[[55@QJP]M6:O6Z,6\6FU; M,O2.]LMXM;Q*S[%4 A$GD1.^!EHJ'55G/%'&7C\R?FX5]HC. *[1,RI;DY/V MML\$E2IP5*4G0B T9!ZJ9G89KT>;#M>3M)[7S>X1I&]&!\:6838FT0\N\D>PD(Y*QF1Q$V4 G7CM[/F1(Y7&L\"HPAHET5<>^* M^^:UY<7',K_[^N2CNENLYZMC[S%T'"%# D"GJW+M '"K@EOEFDDB:*OU.HP> M]&X:ID5IV,EOIP_3F^ '+=\6Y<87M\5D%OYU+!NC2_?,*P$]TQ!KIS#'D!&H M:Z89Y%&E9WK/*TJF&@D@BHG:;KHIR]F6/I+MWSK2 M*F@9%898R1A$M#&3.?4VZBV5WC-FTGB'*0 :8/;O FW+-[>-:AZ9['M:9PI+ MAXB65<39>Q*,)-.@!3B..B#HO:Q4LKE]/B+IHXU/6/ZZ106:'Z], \4<7SK7 M:;^YOKO+RR]O;M]//\ZGM]-)/E^IR:3:BZ?SCV\7L^ED.@8*S&(3ABWS#@'@ MQ.; (T+>39>_'8MHMG?*L!=*^6#Q! >*(V(5D&XS&2S4$OJV,.% 3+;=D][? M(?.:,XHH59++X"88PA3;,:>L! -='SAZZ;D/T;RP9WH 8ZQQT!?,Z2\=[BD? MZ95I(R$DVMM@\#-*@5%4U[@HIL=X:_E<";60HYY<36[&$MQQL+[45FB[0P?7/:,+:HZ+B4 MX'P7^/4TL+,L"G@PS+FO6:8$8)I2HZIW K6T))CQ-6&<]P1)E'<5$ M 0J":2F!A2C8#T%A5&UR*@_%. )$B844A\4Y0EJ^FOM%603_\W^OR^GR9CK9 M>)G=1'>T<\8,5,)29S *.X&GDG/T%0D55?8I65'Q1 +M$Z%! OXO-G5=S">? M[O+RM]/=G"==,P DQU9SKZ4*:P^V'M&&603=,(OPR'R=53G8V\M!Q4V'8D.'.F4<0DFYX=9[ K$P85O+8#_3J=$>+HC]QO:@: MU!- VC [C1C^:Z8%-.':O=LE?^A+IFD1C(ML(15,H0#1*K&F:JM;;SDX899814:44 4Z-I6#Y&3=AF7 A.C/0Z43/*6>6#4,RI5<(V08@9R*U%C,/*X MJP;I*OJ>;_"F1BCJW#'_^"'L+J_F[XK)(KB&_PSNX"Z@M?0!A(:R';$'CR!/ M'"=#0H#@#F-E((;!]<98FD:?.92CFLY]"3\Q2@.LW;Y"O7@]?:BJ4:S"*C<- MUK]:+HO5+\OB=CU[/;T]YNAVZ9Y)*A30&\VGTD"CL8$UTP#&J4:Z8J[].<() MP!E!4,GEY3S\\=$UJO2W%SH1]NKN/DS*-[=A DXKXWHTA(WGJL/;'""N7!Y0%[]" L.\XHI' .P"083ZJ9&//@<<^Q7CP MY;=>81IKB/(@DYVN473HG7%M@J<"-! >(X89(:[!B>*AU"GR$;B^=.#Y+<3> M<1OBZNE!+ (%K2DE'7IG0G!:!:AGF^/8J\2>>Y)]81034JHJ]JQ71?E?>7GS>[ZAX?WB=E7]>#R-O;5C MYK@.1!M#P^8+K&(> ][,#J6B$LZ2!8U2"#@)3@/,]-=%OBRJ>@+!Z2X7#]N7 M_5JG^I%>&5?5@S+<>J6@-=8I97W-(L,N*O,H69 HY5SO#Z2A3F [IT6X (1T MQ"#AO3$,:PC0(TBB+O,EOJ*0W'^(16>4Q^L.4LI16)(H8*CB15!0LR"L8Z.U M^B.D<.2O=[F'/P(8B9%P'LU'X M'TV8.(W]T29,:&^=IQHY"2V3@#H(;!T&-"4=8CR M;/?WVQ.*?&;RY2<_6_S^:GZ[*.\VEQ\N^.GV@]L__5C]S:_!4?K/__C_4$L# M!!0 ( #A^;TCR9\4<^<4 +!]"@ 5 86-T9RTR,#$U,3(S,5]L86(N M>&UL[+UK<]PXMB7Z?7X%;L^'4Q4A=_']Z#CG3( @<(YFW+:O[>J>&Q43&70F M)'$J1:I)IFWUK[\ 7YE**5, "##IFHF.=LFRE'OMM8&%#6 #^-?_]OU^"[[2 MJL[+XM_^9/_9^A.@Q;K'?>F,[;US[S]_KS9\ \["H6]L"1H8?__[LY[^Y[4_; M<1S_TO[K^*-U_M(/LH^U?_F??WW[J?7S35[435:LZ9_^_;\ T-%1E5OZD=X M_M]?/UZ?1!?_PG_BEX+>9E_HEL%H/^VNHCQ,\_4C/FKJ'A8F.B_1Y_K&;L>B$;;1EEDVTUMXQG'WD2\Y;_ MU%OV5?^#_-//R&]KO!?5@P^FWQM:;.BF%T6?B3# O/^:UH7>ZJ=3%!A0@=\&7/_K M7W_9._.$PG+]4IMHT=QD]9<64N\W@V9[O]!M4P_?><._\\:R^Q'VO[Y.T#&K MY5HGJQU)6YY)E%7?"I\T%EBM05EM:,4RG.&7LFK]2C3ZG_AE7;)A^Z%Y\R0P M/-/1[TBIO<5UW#!77N+E62?BN1208-6,@\BK_4J;49E>UIP8Y,YTM0$G M*&_ @!1DQ0:,,,%O+=#3W!X>+?NNG![JL&=8 M"E^6ORO \;'T@R&4U$ M'(O)W]ST:E0^,8*-R)\ :V>43R?GRQ ]K1Z5YEJH M)JGC=M/R/LN+512%OH4#B(D;1M!FUJQDL.RA)-8B=1+V+BIU'49=8B?#\D2Q M,T2P ;%[C>)YY6[/FXK<*;"^<+E3\4A4[I39$I4[LJN*O-E5E%DE^7?^5?U7 M>O^%5BN+I!8S%V/'MXAE1Z[+,LO>8!BEB8S*33!C6-Q&9&W7&["!WSITDK(V MA4TQ-9N)2#D14^70B&Z=9NB,7&F@=1DJI<.14GN3$].D;-W%+J;W9RVO21M:]NZ1&S&7B,/>1$A" 4N(EM.0=S<4]&B<0_U;#N MM$"4MBXDB!&3%#.%OE+_5[)>]&>_]>\R.]W][T-2#S/)T'B0\^W(I(2' :##>AYJ4S?E_MD MP[V_!Z,XH9 D24P!S/$CIP'"U!A1@2-_2^7B';TW""-ALTP M%-E8:E% @[F+% 6!WSA T"+451(DP;"8OLQ,KISHO%+W+4+OO.5 (VDJU4#R MC"]#N'0Z)%H+I,K59(G#=9/?\\-OO];T9K=]FW^E]2I!"%HLS[*P[SJ$. C% MP^D;%/N6JT7ME"P;%KX1$]BUH,"6H[H"CS2K:DV2I\;X1/4S3K9&(;P"^S!T M<$&+=R&:^!*5*O(X*20+5\IIOHF*I@8&A4\.-LP.M_G^YE-3KG_G>U-,7CB4 MYG$\M8CC,+1P:",8Q'[D(]:T[!#B$*6>A5,4B9Y@TV+,7.\=\?&C@H<(_P5T M&"]V1%>(N3.=52_SR^BDFGTZ/KQF@#'I3MD?CTO3E&5/86A[KH,#DH0P&HRX M'I&J:9;\:,-IR;[#J9W E>1)4J7T4Z0J1YRX!4D[G&XCTH MI?J/B61*:HEQ'N6D19I"LPKS$CLB@C.)U87ISS1?3LF1!H9$U>G(5'\"C/B> MC2,7XIB9LP*,$A(,MFP_EE(E-0LSJY%BB8HB>V(R9)ZX:?)SH0J6%VDYHSO3 M:%R&WDSTH=39L.3TA5FY+XMV,C:H6X90W.A68$Q,3\R2):R_T,/M_9%F^[PR6@B"P991#Y?,-:\< :9)Z*/$FIA^F M*9-3$%FVC&C("Y2<49$I!"Y#1R9Y4.IK3G): C>;G)\JS;8?LGQS7:#L(6^R M;6_3(2CQ[#C%*'2#E"#/L_S!9N+*S76F63*L+WMP@*-[DQ>@QZ>H-1-Y%5.= M^2B5TY\I;)JY$/8<46=420_!R] G3;X[+=]/?M_E+HB3)]5TUJV!PI: MI. )5-!A!3^]+>OZ9U5YTQ<"0:F["/N2LJ>7>%-78XOQ>$X5M<=B(0JIWZ_G M]V@;84[X5"5MLKR@&YQ515[<#@>UXQ!Z/K'I.O\T91^50I%).Y&=B3T[0!$!@074BW7B;FC$A-9'(9BC35B>/#FSHX M$=6:=\S%LFB8N^R';J\+UFMIW?0F/2>T Y1:*$AMXED8.\Q\;]+VH-1RU21# MAG7G*38P@%.]1V8:IV(2-!N=EPI#;0]Q1*D MM^/!CC@BD>5A*TQLPE*OQ(G]H9K QJEBW9'XQ\]7HOA6]928"FEBZF.8+SG- MD:3*;$G16X$37A/86X:J3''@5,60*A>B"L+F;7RYGJ:T^^]U\;R^^B-3-%)6 MW[)JLW))$EM,RTCL0 L[(8[C8$3A1%*S+=VV#6O/ !?\- #^&>3%B9,)'#?H M@4OJD_:0B(G7):,AIVP& F%$_209/2.-IF*S#-TTYETY3PN7S=F.;3)!8G1&%_NKAZ"%: M@>QE%F RNG#L@[!$)-F6/Q,LFQC.$QG19')QX9!-0)_K\148G0"]%^#0#="4 MX,1D>>[,50?[9[/=6<.[#*6?V^EG6?4%.%;6?9&X6#>]+26L.\0K4+4A0[E$J5]\JT"LFV;-Q M*B?$AS6Y5Z!#=@7>"S!INC[W&4MBI;KJY"Y#!O6X.(($^LQ&ZD/AI/-CP",M[OM+J2RF\,2+UV3*=YQ"&^ H^;=@$G7-;($HL+D-T%+$?;W),8$#X%JGLL;V)__U-FG_--[38 M,$MVZ@61[3HD97_XH>-%Z6"))(&S*N@M+Y#X+'%EE((9H8X1=QWC&2+A3C(@ MXQ>?C-@D[X52X5!,2HSQIG;'DQ179NYP>D[(&0V90M\RE&22!\>W+DUF0VK= M[;JN=W23[BH^Y6LG)G_+MCOZCGYK_Z5>619_]SQ,/,>+DP1A%*9.F%@.A"2, MO)3(;9_JL&A\1Y6?LNE0@@XFZ'!>@1;I%6!8NQ^0U"!-C$LLE\U*ML)JV&2> MS:UUO4;=:TM9VJA?AL9I]NFEA2C-C"D=P.QFBG#]CUU>T5H$[9H<)3)!TAC;-W"SIV0'$X]RA@ZF0F$UD62(KFX]@E91,G5MS MR=A9QE[+Q/30O0Q5T^G02SF83JZ4$K VY1M$%96\7KBY*S>;[D^ MA+:% G^4UR"T'.5,3-7@S"G9FB'C2SKZ4C-EIA5RM#E(GI:L]5/. >,5X"A! M!_."B=L)XD0SN*F\+T/T]+IT+J?3P]=KPM>^!CXL]#%B1\WEU115OF[H9MUN M7K9]?Y7:[46M21#8+@P]_ORN-:HN0D+WB&DV:5C\'H8U[*8$>ZA@CQ6L#VHA MQ#10-^GG5?""?,OIX(] ]:9<[_AGM7O'2Z3\"<"YJ3\:A#@-?&CQ;:6%H,<3L90<74TZ51ENCEBV>+IMO__'] V^R-?Y.JW7.DOY5%,>IC>,TBGR/ MH!"F,!R>#+!A$GMR12L& !BO;.EFP66'"] !V+ JJF7+9U($)NW_S$6]Y,H# M1_7F2[OFP*_1H$6==;705<7?*&Z/[7UY!(<_UWW,%!G]J?@:F MECJWWEW'8V/)CFR [=H+(PH$7Q^-] M@2Z4.V:HW_HL:[XO*/)7#EG?'KPB]=/WX\VSKGUOOON1'O.HN^X]?]=G9]D(.M#[!?@8*V2]0W975#\V:G.5E6#)B. M;-E\K/3I\U!U<"JEYF55;9B(0)@ND!^_R+5R@CPM2J7(.M@45N^7 MC5E^$+DALH@-B>>1U/:\X>". Q,GE%R?4#-B? WBR1R8?N=?\X7![LK#INQ6 M!,>,F#_C>[!JV/UCQJ?%L@*LR+F@QIHG6\^JP\QR**UXTWAO/V?>$%O0F;PCS[F4 )"^R8LUD%*Z;_&O>Y+1>.0FR46@'?N1& MF-\,FXZ%8@Z,223UY)A1)(:3S0X\:++OX$L'OP:\H70"]D*&*?EDF=DHB6G> M<@(D)XU];!APT"/O0G,ZJQSQ@[T#,[^7-H7K,WH[3PR7(>3RI^Z ^$_ WX@_-EY M\.+I-3;Y>'MN7K!,EO*3X>S;]>Y+G6_RK#HG'W,%3$SC+QLK.5U__;CY(FX; MDJ;TC'R;"\\R)-N@?^?.NAM@4O@\?%6N*=W4?)@82BP^EW_-B[+*F\=VX.@O M-5HE.$W<(,41\A$*(N*FWE!7X:3$EGHS1J-9PV*,>"AX<-KE@39QDU3?QW8U M5_*(O<:PB"GOA2(B)[D#R"X./WW85WW]?$ILYSZO+TSC&9DU$(MEZ*L)QXX/ M_9OB3E1125G1_+9 NZJBQ?KQ,_LKS@*QC @@.T@,/M4ZHKL,+ M@)R*:B7?B(K*$'E&1XW$8QE*:L:UF>P.#R??%=?&5#>RMLJ^",$2! M@T/?@G;$+"6Q%XT+%G8H]5[.5%N&-7,/[["3 M9G#T#*B>1D=L5T<4YBY:1P M&J=&M.\5LL[(G2Z:EZ%PVKPIS31&.1T;$M!A6C+<$\_3U#2O]U/,4_/__^R3 M5A]&_!B#&P5A#&WL)4XRPK-P$"M<5C<;-J%^//F&NR>0%59+'^4T=+[(BHGM MLJ*I\TFS*S#XTLW_GP7ZU%-HO4?SZKBN.)P1_-E#O8R187ZWRPMWL8N\ A*& MCAM$D9]$ ?$"*TQ<.%S ZOAV[/7WPN-B(U@@-@\L&5EZZH&P/KWV LC_T:]& MB,9G&5HRM]-F7HV0XUS+JQ&A'WN)[2?8#JW(LA.6)B>#R8C$L:PZ3#(V0Y]7 M?C'BAWGG0)3D971,4QQ8) M_#0-H.NXB>/%)'JM.ECI,PWNUG5(P&\#%L''"M6HD;K9PAQ%:O=72% E>D?% M$Q=?T(1)3"SBO@E%Z*6&EB#?QS^W SC]WB1;?DD%=GT?$A(A$KNVZS-3H3\8 M(F[J2UQ$I/+QAI>J>U#RW5V6)7$]-$B0HBJVB "'!%I,"NHH2Y>\1AJD;:)2 MBM,GI9A/'7Y%-Q7968YZJCKP@H9.XD)"2?GMC35+R;(U:SZ[]AA7=L_G2O]L M&Q+[ESK;TOJAKP-A?R^;.UJUO]8?^VK*APXS_T'V YN\?BC97XY]"& 2A&$4 M>Q:$$?("UT;!X$/J64(W12P3^2SZWUZTV1VI.W 9'/I\>!"O\PRTKK6_-#JG M0RL71+[XJ+4@T*8'1('&JBH5 ;KK2'1&S0 MDF7JU,!EC/$%#%[F?"OG:+.2YQ;S(F_HV_PKW5RS-ESX"@17@%.HS@[3F*S9PV%*#M3%&55M:745REUZ7C4X7Z M^1)*U/^C+#??\BUKDINN6U_?/V1YQ4=L=)=5MW1?!H)#VX->X"7830,7NK[C M=/64*,5>Z K5'6@T9ZY+#B#;U>M^G7R/$_1 U2JX=/(MD0)>B'>UY$\?_V)9 MGS@YI_(] _0N(-,SX55IME%*G@G9?:GI/W;,'F:99=.NT*]0&B0X=&.2D 3[ MR H]CS!3"41.&'J1)75#NXH!P]G;'A-H0?6[.E\2DO48R M24,W\:)TDK"(VIA;6S@P-E S:!/U19A$-8DQP=]$E1&A;A:EZ;F1$!M9-I>I M-])>O"(Y:JQ,4)VTO,_R8A7:@16@&'F6F\0L\?79!+*W1WS/EGO:2]G*992G M S==>T2I5%8? RQJT9_7")Q+@3H<EB54C6C]=U2(D9125ZFQ?TNJ'W M]0H3+PJ0YR8V@6PV1TB:N'VZA5(7RKU]I6ID]MD5AP9:;--D2()')14R0^'4 MJ98(>W-HT,B.N 3)$[I(!5)PX[P J?(BJC_#LM+*24/;#CV2>*D-7==Q210. MBT968B$9O1'^4,/Z,N"0DQ)Q2L2DPP@;:HOT\ZK"8/6,"DASLXQ>+P^[G-@F M%)YK^U#E:[KR4\?'Q'+"-/!1PC0D\?:+P3"2NMY2XF--9PX<"6BA*#RJ)LB, M8&9@AA3)7$" #W/OI;5VSXWU\A0MHY^K '_I+305WX5VI''=Y/?\) 7)\JI] MT[>\:>YH5[.:%[>_%GFSBJ/0B?S(]WP70\=!'G;@8#=BM B7BVJQ9E@91HR M@^P>R.8/K#*<8 0*.%*)C6@]-)_7D\LP+"\"N/VQ;\8;NK>8,;V]O0W%9AE-@V(<@)K-1V;0^ZD3>@ MC.W$D1]IYL,VV[@TN+3OT<>]N7,,//4,<->D._HRPBXS\BTSXJKCY/^!P589 MB9<9]*GC]JS!EQS2M3'^:@(P?VR7E"Y
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end

Document and Entity Information Document - USD ($)	12 Months Ended
Document and Entity Information Document - USD ($)	Dec. 31, 2015	Mar. 11, 2016	Jun. 30, 2015
Entity Information [Line Items]
Entity Registrant Name	ACACIA RESEARCH CORP
Entity Central Index Key	0000934549
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-K
Document Period End Date	Dec. 31, 2015
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Common Stock, Shares Outstanding		50,458,905
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 437,867,000

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 135,223	$ 134,466
Restricted cash	10,725	0
Short-term investments	0	58,558
Accounts receivable	33,500	20,168
Deferred income tax	210	1,161
Prepaid expenses and other current assets	4,219	4,355
Total current assets	183,877	218,708
Furniture and equipment, net of accumulated depreciation and amortization	272	500
Patents, net of accumulated amortization	162,642	286,636
Goodwill	0	30,149
Other assets	1,110	355
Total assets	347,901	536,348
Current liabilities:
Accounts payable and accrued expenses	17,347	14,860
Accrued patent investment costs	1,000	16,700
Royalties and contingent legal fees payable	14,878	14,351
Total current liabilities	33,225	45,911
Deferred income taxes	210	1,161
Other liabilities	311	228
Total liabilities	$ 33,746	$ 47,300
Commitments and contingencies (Note 11)
Stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding	$ 0	$ 0
Common stock, par value $0.001 per share; 100,000,000 shares authorized; 50,651,239 shares issued and outstanding as of December 31, 2015 and 50,065,382 shares issued and outstanding as of December 31, 2014	51	50
Treasury stock, at cost, 1,729,408 shares as of December 31, 2015 and December 31, 2014	(34,640)	(34,640)
Additional paid-in capital	633,146	646,595
Accumulated comprehensive loss	(215)	(353)
Accumulated deficit	(288,131)	(128,095)
Total Acacia Research Corporation stockholders’ equity	310,211	483,557
Noncontrolling interests in operating subsidiaries	3,944	5,491
Total stockholders’ equity	314,155	489,048
Total liabilities and stockholders' equity	$ 347,901	$ 536,348

Consolidated Balance Sheets Parentheticals - $ / shares	Dec. 31, 2015	Dec. 31, 2014
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, par value per share	$ 0.001	$ 0.001
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value per share	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	50,651,239	50,065,382
Common stock, shares outstanding	50,651,239	50,065,382
Treasury stock, shares	1,729,408	1,729,408

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Statement [Abstract]
Revenues	$ 125,037	$ 130,876	$ 130,556
Cost of revenues:
Inventor royalties	18,462	20,670	29,724
Contingent legal fees	16,169	23,563	24,784
Litigation and licensing expenses - patents	39,373	37,614	39,335
Amortization of patents	53,067	53,745	49,039
Marketing, general and administrative expenses (including non-cash stock compensation expense of $11,048 in 2015, $18,115 in 2014 and $27,894 in 2013)	38,176	48,554	59,229
Research, consulting and other expenses - business development	3,391	3,840	3,251
Impairment of Patent-Related Intangible Assets	74,731	3,497	4,619
Impairment of Goodwill	30,149	0	0
Other	4,141	1,548	3,506
Total operating costs and expenses	277,659	193,031	213,487
Operating loss	(152,622)	(62,155)	(82,931)
Total other income (expense)	(56)	(595)	2,131
Loss from operations before (provision for) benefit from income taxes	(152,678)	(62,750)	(80,800)
(Provision for) benefit from income taxes	(4,800)	(3,912)	21,958
Net loss including noncontrolling interests in operating subsidiaries	(157,478)	(66,662)	(58,842)
Net (income) loss attributable to noncontrolling interests in operating subsidiaries	(2,558)	633	2,408
Net loss attributable to Acacia Research Corporation	(160,036)	(66,029)	(56,434)
Net Loss Available to Common Stockholders, Basic and Diluted	$ (160,730)	$ (66,755)	$ (56,945)
Earnings Per Share, Basic and Diluted	$ (3.25)	$ (1.37)	$ (1.18)
Weighted Average Number of Shares Outstanding, Basic and Diluted	49,505,817	48,658,088	48,155,832
Common Stock, Dividends, Per Share, Cash Paid	$ 0.500	$ 0.500	$ 0.375

Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Treasury Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Deficit [Member]	Noncontrolling Interests [Member]
Balance at Dec. 31, 2012	$ 618,478	$ 49	$ (26,731)	$ 644,982	$ (1,166)	$ (5,632)	$ 6,976
Common stock, shares outstanding at Dec. 31, 2012		49,160,844
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss) attributable to Acacia Research Corporation	(56,434)					(56,434)
Payments of Dividends	(18,633)			(18,633)
Stock Issued During Period, Value, New Issues	(18,633)
Treasury stock, shares acquired		(600,000)
Stock Repurchased During Period, Shares		(666)
Treasury stock, cost of shares acquired	(7,910)		(7,909)
payments to repurchase restricted common stock	(16)			(16)
Stock options exercised, shares		115,346
Stock options exercised, value	486			486
Stock issued during period, shares, share-based compensation, net of forfeitures		709,533
Compensation expense related to stock options and restricted stock awards	27,894	$ 1		27,893
Excess tax benefits from stock-based compensation	(1,398)			(1,398)
Net (income) loss attributable to noncontrolling interests in operating subsidiaries	(2,408)						(2,408)
Contributions from noncontrolling interests in operating subsidiary, net	1,920						1,920
Unrealized Gain (Loss) on Investments	219				219
Balance at Dec. 31, 2013	562,198	$ 49	(34,640)	653,314	(947)	(62,066)	6,488
Common stock, shares outstanding at Dec. 31, 2013		49,385,057
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss) attributable to Acacia Research Corporation	(66,029)					(66,029)
Payments of Dividends	(25,039)			(25,039)
Stock Issued During Period, Value, New Issues	(25,039)
Stock options exercised, shares		44,506
Stock options exercised, value	206			206
Stock issued during period, shares, share-based compensation, net of forfeitures		635,819
Compensation expense related to stock options and restricted stock awards	18,115	$ 1		18,114
Excess tax benefits from stock-based compensation	0
Net (income) loss attributable to noncontrolling interests in operating subsidiaries	(633)						(633)
Foreign Currency Transaction Gain (Loss), Unrealized	(99)				(99)
Unrealized Gain (Loss) on Investments	693				693
Distributions to noncontrolling interests in operating subsidiary	364						364
Balance at Dec. 31, 2014	$ 489,048	$ 50	(34,640)	646,595	(353)	(128,095)	5,491
Common stock, shares outstanding at Dec. 31, 2014	50,065,382	50,065,382
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss) attributable to Acacia Research Corporation	$ (160,036)					(160,036)
Payments of Dividends	$ (25,434)			(25,434)
Stock options exercised, shares	135,000	135,000
Stock options exercised, value	$ 938			938
Stock issued during period, shares, share-based compensation, net of forfeitures		450,857
Compensation expense related to stock options and restricted stock awards	11,048	$ 1		11,047
Excess tax benefits from stock-based compensation	0
Net (income) loss attributable to noncontrolling interests in operating subsidiaries	2,558						2,558
Foreign Currency Transaction Gain (Loss), Unrealized	(123)				(123)
Unrealized Gain (Loss) on Investments	261				261
Distributions to noncontrolling interests in operating subsidiary	4,105						4,105
Balance at Dec. 31, 2015	$ 314,155	$ 51	$ (34,640)	$ 633,146	$ (215)	$ (288,131)	$ 3,944
Common stock, shares outstanding at Dec. 31, 2015	50,651,239	50,651,239

Description of Business	12 Months Ended
Description of Business	Dec. 31, 2015
DESCRIPTION OF BUSINESS [Abstract]
Description of Business	DESCRIPTION OF BUSINESS Description of Business. As used herein, “Acacia” and the “Company” refer to Acacia Research Corporation and/or its wholly and majority-owned and controlled operating subsidiaries, and/or where applicable, its management. All patent investment, prosecution, licensing and enforcement activities are conducted solely by certain of Acacia’s wholly and majority-owned and controlled operating subsidiaries. Acacia’s operating subsidiaries invest in, license and enforce patented technologies. Acacia’s operating subsidiaries partner with inventors and patent owners, applying their legal and technology expertise to patent assets to unlock the financial value in their patented inventions. Acacia is an intermediary in the patent marketplace, bridging the gap between invention and application, facilitating efficiency and delivering monetary rewards to patent owners. Acacia’s operating subsidiaries generate revenues and related cash flows from the granting of intellectual property rights for the use of patented technologies that its operating subsidiaries control or own. Acacia’s operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation. Acacia’s operating subsidiaries are principals in the licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright. Acacia’s operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain foreign counterparts, covering technologies used in a wide variety of industries. Acacia was incorporated on January 25, 1993 under the laws of the State of California. In December 1999, Acacia changed its state of incorporation from California to Delaware.

Retirement Savings Plan and Executive Severance Policy	12 Months Ended
Retirement Savings Plan and Executive Severance Policy	Dec. 31, 2015
RETIREMENT SAVINGS PLAN AND EXECUTIVE SEVERANCE POLICY [Abstract]
Retirement Savings Plan and Executive Severance Policy	RETIREMENT SAVINGS PLAN AND EXECUTIVE SEVERANCE POLICY Retirement Savings Plan. Acacia has an employee savings and retirement plan under section 401(k) of the Code (the “Plan”). The Plan is a defined contribution plan in which eligible employees may elect to have a percentage of their compensation contributed to the Plan, subject to certain guidelines issued by the Internal Revenue Service. Acacia may contribute to the Plan at the discretion of the board of directors. There were no contributions made by Acacia during the periods presented. Executive Severance Policy. Under Acacia’s Amended Executive Severance Policy, full-time employees with the title of Senior Vice President and higher (“SVP and higher”) are entitled to receive certain benefits upon termination of employment. If employment of an SVP and higher employee is terminated for other than cause or other than on account of death or disability, Acacia will (i) promptly pay to the SVP and higher employee a lump sum amount equal to the aggregate of (a) accrued obligations (i.e., annual base salary through the date of termination to the extent not theretofore paid and any compensation previously deferred (together with any accrued interest or earnings thereon) and any accrued vacation pay, and reimbursable expenses, in each case to the extent not theretofore paid) and (b) three (3) months of base salary for each full year that the SVP and higher employee was employed by the Company (the “Severance Period”), up to a maximum of twelve (12) months (eighteen (18) months for executive officers of Acacia Research Corporation) of base salary, and (ii) provide to the SVP and higher employee, Acacia paid COBRA coverage for the medical and dental benefits selected in the year in which the termination occurs, for the duration of the Severance Period.

Supplemental Cash Flow Information	12 Months Ended
Supplemental Cash Flow Information	Dec. 31, 2014
Supplemental Cash Flow Information [Abstract]
Supplemental Cash Flow Information	SUPPLEMENTAL CASH FLOW INFORMATION Federal taxes paid totaled $0, $0 and $3,000,000 for the years ended December 31, 2015, 2014 and 2013, respectively. At December 31, 2013, prepaid expenses and other current assets included federal and state income taxes receivable totaling $3,251,000. Cash paid for state income taxes totaled $211,000, $172,000 and $516,000 for the years ended December 31, 2015, 2014 and 2013, respectively. Foreign taxes withheld totaled $4,421,000, $5,159,000 and $4,605,000 for the years ended December 31, 2015, 2014 and 2013. Refer to Note 6 to these notes to consolidated financial statements for information regarding noncash investing activity related to the investment in patent portfolios for the periods presented.

Summary of Significant Accounting Policies (Details)	12 Months Ended
Summary of Significant Accounting Policies (Details)	Dec. 31, 2015
Lag time in recognizing revenues from licensee's quarter	3 months
Minimum [Member]
Period after quarter end licensees report activity	30 days
Patents, useful life	1 year
Maximum [Member]
Period after quarter end licensees report activity	45 days
Patents, useful life	10 years

Summary of Significant Accounting Policies Property and Equipment (Details)	12 Months Ended
	Dec. 31, 2015
Furniture and Fixtures [Member] \| Minimum [Member]
Property and Equipment [Line Items]
Estimated useful lives, years	3
Furniture and Fixtures [Member] \| Maximum [Member]
Property and Equipment [Line Items]
Estimated useful lives, years	5
Computer Hardware and Software [Member] \| Minimum [Member]
Property and Equipment [Line Items]
Estimated useful lives, years	3
Computer Hardware and Software [Member] \| Maximum [Member]
Property and Equipment [Line Items]
Estimated useful lives, years	5
Leasehold Improvements [Member] \| Minimum [Member]
Property and Equipment [Line Items]
Estimated useful lives, years	2
Leasehold Improvements [Member] \| Maximum [Member]
Property and Equipment [Line Items]
Estimated useful lives, years	5

Summary of Significant Accounting Policies Earnings per share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Accounting Policies [Abstract]
Net income (loss) attributable to Acacia Research Corporation	$ (115,910)	$ (27,310)	$ (3,686)	$ (13,130)	$ (16,244)	$ (12,415)	$ (12,949)	$ (24,421)	$ (160,036)	$ (66,029)	$ (56,434)
Payments of Dividends									(25,434)	(25,039)	(18,633)
Dividends attributable to common stockholders under the two class method									24,740	24,313	18,122
Net Loss Available to Common Stockholders, Basic and Diluted									$ (160,730)	$ (66,755)	$ (56,945)
Weighted Average Number of Shares Outstanding, Basic and Diluted	49,749,941	49,630,369	49,423,472	49,212,207	48,944,914	48,806,334	48,543,334	48,329,375	49,505,817	48,658,088	48,155,832
Earnings Per Share, Basic and Diluted	$ (2.33)	$ (0.55)	$ (0.08)	$ (0.27)	$ (0.34)	$ (0.26)	$ (0.27)	$ (0.51)	$ (3.25)	$ (1.37)	$ (1.18)
Anti-dilutive equity-based incentive awards excluded from the computation of diluted income (loss) per share									71,468	27,760	27,760

Short-term Investments (Details) - USD ($) $ in Thousands	12 Months Ended
Short-term Investments (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, amortized cost		$ 58,819
Available-for-sale securities, gross unrealized gains		2
Available-for-sale securities, gross unrealized losses		(263)
Available-for-sale securities, fair value		58,558
Available-for-sale Securities, Gross Realized Gains			$ 1,174
Available-for-sale Securities, Gross Realized Losses	$ 617	2,188	981
Proceeds from Sale and Maturity of Marketable Securities	$ 82,115	$ 182,115	$ 239,370
Maximum [Member]
Schedule of Available-for-sale Securities [Line Items]
Investment Maturity Date	Dec. 31, 2015

Short-term Investments Marketable Securities (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2014 USD ($)
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale Securities, Amortized Cost Basis	$ 58,819
Available-for-sale Securities, Gross Unrealized Gain	2
Available-for-sale Securities, Gross Unrealized Loss	263
Available-for-sale Securities	$ 58,558

Furniture and Equipment (Details) - USD ($)	12 Months Ended
Furniture and Equipment (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 222,000	$ 304,000	$ 236,000
Property, Plant and Equipment, Disposals	30,000	330,000
Gain (Loss) on Disposition of Property Plant Equipment	$ 14,000	$ 71,000

Furniture and Equipment Summary of Property and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Property and Equipment [Line Items]
Furniture and fixtures	$ 739	$ 761
Computer hardware and software	649	650
Leasehold improvements	145	144
Property and equipment, gross	1,533	1,555
Less: accumulated depreciation and amortization	(1,261)	(1,055)
Furniture and equipment, net	$ 272	$ 500

Accounts Payable and Accrued Expenses (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Accounts Payable and Accrued Liabilities, Current [Abstract]
Payroll and other employee benefits	$ 576	$ 1,481
Accrued vacation	701	806
Accrued legal expenses - patent	10,135	8,410
Accrual for court ordered attorneys fees	0	1,548
Foreign taxes payable	3,960	0
Accrued consulting and other professional fees	1,592	1,530
Other accrued liabilities	383	1,085
Accounts payable and accrued expenses	$ 17,347	$ 14,860

Patents (Details) - USD ($)	3 Months Ended								12 Months Ended
Patents (Details) - USD ($)	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Patents [Line Items]
Patents, net	$ 162,642,000				$ 286,636,000				$ 162,642,000	$ 286,636,000
Patents, weighted average useful life									5 years
Payments to acquire intangible assets									$ 19,504,000	42,746,000	$ 25,061,000
Accrued patent acquisition related payments	1,000,000				16,700,000				1,000,000	16,700,000
Accelerated amortization expense										1,247,000	592,000
Accelerated amortization expense (termination)									380,000	2,702,000	1,747,000
Impairment of Patent-Related Intangible Assets	74,731,000	$ 0	$ 0	$ 0	931,000	$ 0	$ 0	$ 2,566,000	$ 74,731,000	3,497,000	$ 4,619,000
Minimum [Member]
Patents [Line Items]
Patents, useful life									1 year
Acquired Finite Lived Intangible Asset, Useful Life									2 years
Maximum [Member]
Patents [Line Items]
Patents, useful life									10 years
Acquired Finite Lived Intangible Asset, Useful Life									10 years
Patents [Member]
Patents [Line Items]
Gross carrying amount - patents	444,137,000				453,201,000				$ 444,137,000	453,201,000
Accumulated amortization - patents	281,495,000				166,565,000				281,495,000	166,565,000
Patents, net	$ 162,642,000				$ 286,636,000				$ 162,642,000	$ 286,636,000
Patents [Member] \| Minimum [Member]
Patents [Line Items]
Patents, useful life									1 year
Patents [Member] \| Maximum [Member]
Patents [Line Items]
Patents, useful life									8 years

Patents Future Amortization Expense (Details)	Dec. 31, 2015 USD ($)
Patents [Abstract]
2015	$ 43,218,000
2016	40,577,000
2017	35,777,000
2018	19,410,000
2019	6,787,000
After Year Five	$ 16,873,000

Stockholders' Equity (Details) - USD ($)	12 Months Ended
Stockholders' Equity (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Nov. 15, 2013
Stockholders Equity [Line Items]
Stock repurchase program, authorized amount				$ 70,000,000
Dividends declared, per share	$ 0.50
Common stock dividends declared, quarterly	$ 0.125
Payments of Dividends	$ 25,434,000	$ 25,039,000	$ 18,633,000

Stockholders' Equity Repurchases of Common Stock (Details) - USD ($)	Dec. 11, 2013	Dec. 31, 2014
Stockholders' Equity Note [Abstract]
Treasury stock, shares acquired	600,000
Treasury stock acquired, average price paid per share	$ 13.18
Stock repurchase program, remaining authorized repurchase amount		$ 0

Income Taxes (Details) - USD ($)	12 Months Ended
Income Taxes (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Taxes [Line Items]
Operating loss carryforwards, federal	$ 160,840,000
Operating loss carryforwards, state	55,215,000
Deferred tax assets, valuation allowance	75,179,000	$ 35,927,000
Federal NOL annual utilization limit	14,100,000
Net operating losses, unrecognized excess tax benefits, federal	1,928,000
Net operating losses, unrecognized excess tax benefits, state	37,771,000
Capital loss carryovers	3,423,000
Deferred Tax Asset, Operating and Capital Loss Carryforwards and Credits	71,494,000	59,427,000
Foreign withholding taxes			$ 4,605,000
Excess tax benefits from stock-based compensation	0	0	(1,398,000)
Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation	1,917,000	2,713,000	$ 1,398,000
Foreign tax credits, additional paid in capital benefit	34,298,000
Foreign tax credits utilized for financial statement purposes	$ 20,313,000
Tax Benefit From Reversal of the Net Deferred Tax Liability		$ 1,735,000
Effective Income Tax Rate Reconciliation, Percent	3.00%	6.00%	(27.00%)
Effective tax rate excluding valuation allowance	(28.00%)	(33.00%)	31.00%
Unrecognized tax benefits	$ 2,127,000
unrecognized tax benefits primarily associated with state taxes	85,000
Domestic Tax Authority [Member]
Income Taxes [Line Items]
Net operating losses included in deferred tax assets	0
State and Local Jurisdiction [Member]
Income Taxes [Line Items]
Net operating losses included in deferred tax assets	441,000
Capital Loss Carryforward Related to Business Acquisition [Member] \| Internal Revenue Service (IRS) [Member]
Income Taxes [Line Items]
Operating Loss Carryforwards	$ 29,318,000

Income Taxes Deferred Taxes (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Deferred tax assets:
Deferred Tax Asset, Operating and Capital Loss Carryforwards and Credits	$ 71,494	$ 59,427
Stock compensation	1,385	1,800
Deferred tax assets intangibles and fixed assets	1,359	0
Basis of investments in affiliates	499	1,437
Accrued liabilities and other	442	409
Unrealized loss on short-term investments	0	92
State taxes	81	26
Total deferred tax assets	75,260	63,191
Deferred tax liabilities:
Fixed assets and intangibles	0	(27,157)
Other	(81)	(107)
Deferred Tax Liabilities, Gross	(81)	(27,264)
Net deferred tax liabilities	0	0
Less: valuation allowance	(75,179)	(35,927)
Net deferred taxes	$ 81	$ 27,264

Income Taxes Income Tax Rate (Details)	12 Months Ended
Income Taxes Income Tax Rate (Details)	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Effective income tax rate reconciliation goodwill	7.00%	0.00%	0.00%
Effective Income Tax Rate, Continuing Operations, Tax Rate Reconciliation [Abstract]
Statutory federal tax rate	(35.00%)	(35.00%)	(35.00%)
State income and foreign taxes, net of federal tax effect	3.00%	9.00%	5.00%
Foreign tax credit	(3.00%)	(8.00%)	(6.00%)
Noncontrolling interests in operating subsidiaries	(1.00%)	0.00%	1.00%
Non deductible permanent items	0.00%	1.00%	2.00%
Expired net operating loss carryforwards	1.00%	0.00%	2.00%
Valuation allowance	31.00%	39.00%	4.00%
Total	3.00%	6.00%	(27.00%)

Stock-Based Incentive Plans (Details) - USD ($)	12 Months Ended
Stock-Based Incentive Plans (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2009	Dec. 31, 2008
Share-based Compensation Arrangement by Share-based Payment Award
Ownership percent of voting stock	10.00%
Aggregate intrinsic value of options exercised	$ 751,000	$ 518,000	$ 2,024,000
Number of shares of common stock reserved for issuance	2,903,000
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Weighted average grant date fair value of restricted stock granted	$ 12.83	$ 14.41	$ 24.31
Aggregate fair value of restricted stock vested	$ 11,494,000	$ 21,490,000	$ 22,317,000
Total unrecognized compensation expense for nonvested awards	$ 9,264,000
Weighted average period over which unrecognized compensation expense will be recognized	1 year 7 months
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Weighted average grant date fair value of restricted stock granted	$ 16.72	$ 0.00	$ 14.33
Aggregate fair value of restricted stock vested	$ 480,000	$ 460,000	$ 469,000
Total unrecognized compensation expense for nonvested awards	$ 482,000
Weighted average period over which unrecognized compensation expense will be recognized	1 year 8 months
2007 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Increase in number of shares available, percentage of outstanding shares on last trading day of prior December				2.00%
Number of shares available for grant	0				560,000
Discretionary Option Grant Program [Member] \| Nonstatutory Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Percentage of fair market value on grant date, minimum exercise price	85.00%
Stock Issuance Program [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Percentage of fair market value on grant date, minimum exercise price	100.00%
2013 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares available for grant	4,750,000
Number of shares of common stock reserved for issuance	2,778,000
Less than 10% [Member] \| Discretionary Option Grant Program [Member] \| Incentive Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Percentage of fair market value on grant date, minimum exercise price	100.00%
10% or More [Member] \| Discretionary Option Grant Program [Member] \| Incentive Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Percentage of fair market value on grant date, minimum exercise price	110.00%

Stock-Based Incentive Plans Stock Options (Details)	12 Months Ended
Stock-Based Incentive Plans Stock Options (Details)	Dec. 31, 2015 USD ($) $ / shares shares
Share-based Compensation [Abstract]
Outstanding at December 31, 2012 \| shares	150,000
Exercised \| shares	(135,000)
Outstanding at December 31, 2013 \| shares	15,000
Vested \| shares	15,000
Exercisable at December 31, 2013 \| shares	15,000
Outstanding at December 31, 2012, weighted average exercise price \| $ / shares	$ 7.59
Exercised, weighted average exercise price \| $ / shares	6.95
Outstanding at December 31, 2013, weighted average exercise price \| $ / shares	13.38
Vested, weighted average exercise price \| $ / shares	13.38
Exercisable, weighted average exercise price \| $ / shares	$ 13.38
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	1 year
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term	1 year
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	1 year
Outstanding at December 31, 2013, aggregate, intrinsic value \| $	$ 0
Vested, aggregate intrinsic value \| $	0
Exercisable, aggregate intrinsic value \| $	$ 0

Commitments and Contingencies (Details) - USD ($)	3 Months Ended								12 Months Ended
Commitments and Contingencies (Details) - USD ($)	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2011
Commitments and Contingencies Disclosure [Abstract]
Rent expense									$ 1,926,000	$ 1,523,000		$ 1,312,000
Other	$ 250,000	$ 3,465,000	$ 0	$ 426,000	$ 0	$ 1,548,000	$ 0	$ 0	4,141,000	1,548,000	$ 3,506,000
Partners' capital, authorized	250,000,000								250,000,000
Cash and other assets, IP Fund	7,740,000				2,823,000				7,740,000	2,823,000
Patents, net of accumulated amortization, IP Fund	147,000				967,000				147,000	967,000
Investments, IP Fund	5,829,000				8,281,000				5,829,000	8,281,000
Total assets, IP Fund	13,716,000				12,071,000				13,716,000	12,071,000
Accrued expenses and contributions, IP Fund	7,436,000				1,876,000				7,436,000	1,876,000
Total liabilities, IP Fund	7,436,000				1,876,000				7,436,000	1,876,000
Net assets, IP Fund	$ 6,280,000				$ 10,195,000				6,280,000	10,195,000
Revenues, IP Fund									18,000	1,560,000
IP Fund, Operating expenses									1,617,000	1,724,000
IP Fund, Gain from Operations									(1,599,000)	(164,000)
IP Fund, Net Loss in Equity Method Investment									6,922,000	(1,807,000)
IP Fund, Net Loss									$ 5,323,000	$ (1,971,000)
Line of Credit Facility, Commitment Fee Percentage									1.15%

Commitments and Contingencies Operating Leases (Details) $ in Thousands	Dec. 31, 2015 USD ($)
Year:
2014	$ 1,459
2015	1,557
2016	1,612
2017	1,669
2018	166
Total minimum lease payments	$ 6,463

Supplemental Cash Flow Information (Details) - USD ($)	12 Months Ended
Supplemental Cash Flow Information (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Supplemental Cash Flow Information [Abstract]
Estimated federal income taxes paid	$ 0	$ 0	$ 3,000,000
Income Taxes Receivable		3,251,000
Cash paid for state income taxes	211,000	172,000	516,000
Foreign withholding taxes	$ 4,421,000	$ 5,159,000	$ 4,605,000